10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED MARCH 31, 2017
	OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM ______________TO_______________

Commission File Number: 001-00652

UNIVERSAL CORPORATION

(Exact name of registrant as specified in its charter)

Virginia (State or other jurisdiction of incorporation or organization)	54-0414210 (I.R.S. Employer Identification Number)
9201 Forest Hill Avenue, Richmond, Virginia (Address of principal executive offices)	23235 (Zip Code)

Registrant's telephone number, including area code: 804-359-9311

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Common Stock, no par value Name of each exchange on which registered New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes þ No o

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 (d) of the Act.

Yes o No þ

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes þ  No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or a emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer þ Accelerated filer o Non-accelerated filer o

Smaller reporting company o Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ

The aggregate market value of the registrant's voting and non-voting common equity held by non-affiliates, based upon the closing sales price on the New York Stock Exchange of the registrant's common stock on September 30, 2016, the last day of the registrant's most recently completed second fiscal quarter, was approximately $1.3 billion.

As of May 19, 2017, the total number of shares of common stock outstanding was 25,274,506.

DOCUMENTS INCORPORATED BY REFERENCE

Certain information contained in the 2017 Proxy Statement for the Annual Meeting of Shareholders of the registrant is incorporated by reference into Part III hereof.

UNIVERSAL CORPORATION

FORM 10-K

TABLE OF CONTENTS

Item No.		Page
	PART I
1.	Business	3
1A.	Risk Factors	9
1B.	Unresolved Staff Comments	13
2.	Properties	14
3.	Legal Proceedings	15
4.	Mine Safety Disclosures	15
	PART II
5.	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	16
6.	Selected Financial Data	17
7.	Management's Discussion and Analysis of Financial Condition and Results of Operations	19
7A.	Quantitative and Qualitative Disclosures About Market Risk	34
8.	Financial Statements and Supplementary Data	35
9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	83
9A.	Controls and Procedures	83
9B.	Other Information	83
	PART III
10.	Directors, Executive Officers, and Corporate Governance	84
11.	Executive Compensation	85
12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	85
13.	Certain Relationships and Related Transactions, and Director Independence	85
14.	Principal Accounting Fees and Services	85
	PART IV
15.	Exhibits, Financial Statement Schedules	86
16.	Form 10-K Summary	86
	Signatures	88

2

General

This Annual Report on Form 10-K, which we refer to herein as our Annual Report, contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Among other things, these statements relate to Universal Corporation’s financial condition, results of operations and future business plans, operations, opportunities, and prospects. In addition, Universal Corporation and its representatives may make written or oral forward-looking statements from time to time, including statements contained in other filings with the Securities and Exchange Commission (the “SEC”) and in reports to shareholders. These forward-looking statements are generally identified by the use of words such as we “expect,” “believe,” “anticipate,” “could,” “should,” “may,” “plan,” “will,” “predict,” “estimate,” and similar expressions or words of similar import. These forward-looking statements are based upon management’s current knowledge and assumptions about future events and involve risks and uncertainties that could cause actual results, performance, or achievements to be materially different from any anticipated results, prospects, performance, or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: anticipated levels of demand for and supply of our products and services; costs incurred in providing these products and services; timing of shipments to customers; changes in market structure; government regulation; product taxation; industry consolidation and evolution; changes in exchange rates and interest rates; impacts of regulation and litigation on our customers; and general economic, political, market, and weather conditions. For a description of factors that may cause actual results to differ materially from such forward-looking statements, see Item 1A, “Risk Factors.” We caution investors not to place undue reliance on any forward-looking statements as these statements speak only as of the date when made, and we undertake no obligation to update any forward-looking statements made in this report. In addition, the discussion of the impact of current trends on our business in “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Other Information Regarding Trends and Management’s Actions” in Item 7 should be read carefully in connection with evaluating our business and the forward-looking statements contained in this Annual Report.

This Annual Report uses the terms “Universal,” “the Company,” “we,” “us,” and “our” to refer to Universal Corporation and its subsidiaries when it is not necessary to distinguish among Universal Corporation and its various operating subsidiaries or when any distinction is clear from the context in which it is used.

See the “Results of Operations” section in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 for a discussion of segment operating income, a non-GAAP financial measure that we refer to in this Annual Report on Form 10-K and consider useful in understanding our business results and trends.

PART I

Item 1.   Business

A. The Company

Overview 

We are the leading global leaf tobacco supplier. We operate in over 30 countries on five continents and procure, finance, process, pack, store and ship leaf tobacco and other agri-products. Tobacco has been our principal focus since our founding in 1918. The largest portion of our business involves procuring and processing flue-cured and burley leaf tobacco for manufacturers of consumer tobacco products. We do not manufacture any consumer products. Rather, we support consumer product manufacturers by selling them processed raw products and performing related services for them. Our reportable segments for our flue-cured and burley tobacco operations are North America and Other Regions. We also have a third reportable segment, Other Tobacco Operations, which comprises our dark tobacco business, our oriental tobacco joint venture, and certain tobacco- and non-tobacco-related services. We generated approximately $2.1 billion in consolidated revenues and earned $188.5 million in total segment operating income in fiscal year 2017. Universal Corporation is a holding company that operates through numerous directly and indirectly owned subsidiaries. Universal Corporation’s primary subsidiary is Universal Leaf Tobacco Company, Incorporated. See Exhibit 21, “Subsidiaries of the Registrant,” for additional subsidiary information.

3

Key Operating Principles

We believe that by following several key operating principles we can continue to produce good financial returns from our business and enhance shareholder value. These key operating principles are:

• Strategic market position. We work closely with both our customers and suppliers to ensure that we deliver a product that meets our customers' needs while cultivating a strong, sustainable supplier base. We balance purchases of leaf tobacco against indicated customer demand and maintain global procurement and production operations to maximize supply chain efficiencies.

• Strong local management. Having strong local management in all of our key supply origins allows us to identify and react to constantly shifting market conditions. Empowered and experienced local management, coupled with global coordination, affords us the flexibility and knowledge necessary to adapt quickly in order to continually deliver high quality, competitively-priced products and services.

• Compliant products. Customers expect a sustainable supply of compliant, traceable, competitively-priced product, and we believe that we lead in delivering these products. Among other initiatives, we invest in training farmers in good agricultural practices that encompass crop quality, environmental stewardship and agricultural labor standards.

• Diversified sources. We operate in over 30 countries on five continents and maintain a presence in all major flue-cured, burley, oriental, and dark air-cured tobacco origin markets. This global presence allows us to meet our customers' diverse leaf requirements while minimizing the effects of adverse crop conditions and other localized supply disruptions.

• Financial strength. Financial strength is critical and enables us to fund our global operations efficiently and to facilitate investment when suitable opportunities arise. Management of liquidity, interest expense and capital costs provides us with a competitive advantage and affords us flexibility when responding to customer requirements and market changes.

Additional Information

Our website address is www.universalcorp.com. We post regulatory filings on this website as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. These filings include annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements, Section 16 reports on Forms 3, 4, and 5, and any amendments to those reports filed with or furnished to the SEC. Access to these filings on our website is available free of charge. Copies are also available, without charge, from Universal Corporation Investor Relations, 9201 Forest Hill Avenue, Richmond, VA 23235. Reports filed with the SEC may be viewed at www.sec.gov or obtained at the SEC Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. Information regarding the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330. We also post our press releases on our website. Information on our website is not deemed to be incorporated by reference into this Annual Report.

In addition, our Corporate Governance Guidelines, Code of Conduct, and charters for the Audit Committee, the Executive Committee, the Executive Compensation, Nominating and Corporate Governance Committee, the Pension Investment Committee, and the Finance Committee are available free of charge to shareholders and the public through the “Corporate Governance” section of our website. Printed copies of the foregoing are available to any shareholder upon written request to our Treasurer at the address set forth on the cover of this Annual Report or may be requested through our website, www.universalcorp.com.

4

B. Description of Business

General

Our primary business is procuring, financing, processing, packing, storing, and shipping leaf tobacco for sale to manufacturers of consumer tobacco products. Procuring leaf tobacco involves contracting with, providing agronomy support to, and financing farmers in many origins. We do not manufacture cigarettes or other consumer tobacco products. Rather, we support consumer product manufacturers by selling them processed leaf tobacco and performing related services for them. Through various operating subsidiaries and unconsolidated affiliates located in tobacco-growing origins around the world, we contract, purchase, process, and sell flue-cured and burley tobaccos, as well as dark air-cured and oriental tobaccos. Flue-cured, burley, and oriental tobaccos are used principally in the manufacture of cigarettes, and dark air-cured tobaccos are used mainly in the manufacture of cigars, smokeless, and pipe tobacco products. We also provide value-added services to our customers, including blending, chemical and physical testing of tobacco, service cutting for select manufacturers, manufacturing reconstituted leaf tobacco, and managing just-in-time inventory.

Several important operating factors characterize our company and our primary business, leaf tobacco:

• Experience dealing with large numbers of farmers,

• Expertise in delivering a sustainable supply of compliant, traceable, competitively-priced leaf tobacco,

• Capability to meet unique customer requirements for style, volume and quality,

• Longstanding customer relationships,

• Presence in all major leaf tobacco sourcing areas, and

• Financial strength and flexibility.

In addition to our leaf tobacco business, we are involved in other smaller-scale agribusiness opportunities. We participate in a joint venture that supplies liquid nicotine, manufactured in the United States, to the vapor products industry. We also have businesses that test and analyze tobacco products, produce high-quality dehydrated and juiced fruit and vegetable products, and recycle waste materials from tobacco production. When looking at new opportunities, we seek prospects where we believe we can earn an adequate return, leverage our assets and expertise, and enhance our farmer base.

With respect to our leaf tobacco business, we generate our revenues from product sales of processed, packed tobacco that we source, from processing fees for tobacco owned by third parties, and from fees for other services. Sales to our six largest customers, with whom we have longstanding relationships, have accounted for more than two-thirds of our consolidated revenues for each of the past three fiscal years.  Our sales consist primarily of flue-cured and burley tobaccos. For the fiscal year ended March 31, 2017, our flue-cured and burley operations accounted for 89% of our revenues and 95% of our segment operating income.

We conduct our business in varying degrees in a number of countries, including Bangladesh, Brazil, the Dominican Republic, Germany, Guatemala, Hungary, India, Indonesia, Italy, Malawi, Mexico, Mozambique, the Netherlands, Nicaragua, Paraguay, the People’s Republic of China, the Philippines, Poland, Russia, Singapore, South Africa, Spain, Switzerland, Tanzania, the United Arab Emirates, the United States, and Zimbabwe. In addition, our oriental tobacco joint venture, Socotab, L.L.C. has operations in Bulgaria, Greece, Macedonia, and Turkey.

Because unprocessed, or “green,” leaf tobacco is a perishable product, timely processing is an essential service to our customers. Our processing of leaf tobacco includes grading in the factories, blending, removal of non-tobacco material, separation of leaf from the stems, drying, packing to precise moisture targets for proper aging, as well as temporary storage. Accomplishing these tasks generally requires investments in factories and machinery in areas where the tobacco is grown. Processed tobacco that has been properly packed can be stored by customers for a number of years prior to use, but most processed tobacco is used within two to three years.  

We are a major purchaser and processor in the chief exporting regions for flue-cured and burley tobacco throughout the world. Africa, Brazil, and the United States produce approximately two-thirds of the flue-cured and burley tobacco grown outside of China. We estimate that we have historically handled, through leaf sales or processing, between 30% and 40% of the annual production of such tobaccos in both Africa and the United States and between 15% and 25% in Brazil. These percentages can change from year to year based on the size, price, and quality of the crops. We participate in the procurement, processing, storage, and sale of oriental tobacco through ownership of a 49% equity interest in Socotab, L.L.C., a leading supplier of oriental tobaccos. In addition, we maintain a presence, and in certain cases, a leading presence, in all other major tobacco growing regions in the world. We believe that our leading position in the leaf tobacco industry is based on our operating presence in all of the major sourcing areas, our ability to meet customer style, volume, and quality requirements, our expertise in dealing with large numbers of farmers, our long-standing relationships with customers, our development of processing equipment and technologies, and our financial position. The efficiencies that we offer our customers, due to our established network of operational expertise and infrastructure on the ground and our ability to market most styles and grades of leaf to a diverse customer base, are also key to our success.

We also have a leading position in worldwide dark tobacco markets. Our dark tobacco operations are located in most of the major producing countries and in other smaller markets. We operate in major dark tobacco producing countries, including the

5

United States, the Dominican Republic, Indonesia, Paraguay, the Philippines, Nicaragua, and Brazil. Dark tobaccos are typically used in the manufacture of cigars, pipe tobacco, and smokeless tobacco products, and as components of certain “roll-your-own” cigarette products.

Sales are made by our sales force and, to a much smaller degree, through the use of commissioned agents. Most customers are long-established tobacco product manufacturers. Customer contract arrangements vary around the world and include negotiated pricing as well as cost plus arrangements. Discussions of a customer’s longer-term needs may begin as early as one to two years in advance of a particular crop purchase. These discussions are key to our future crop production planning. Prior to planting each year, we use early customer indications for type, style, processing, and volume requirements for the upcoming season’s crop to help us determine our farmer contracting and grower input needs in our origins. We work with our farmers and customers continually throughout the crop season. As crops progress through the growing season, customers will inspect the crop, and a customer’s early indications may be refined based upon emerging crop qualities and quantities and market pricing expectations. Ultimately, purchase agreements specifying quantity, quality, grade and price are executed, leading to inventory allocations of harvested green or processed leaf that we have acquired.

In the majority of the countries where we operate, we contract directly with tobacco farmers or tobacco farmer cooperatives. In most countries outside the United States, we advance seed or seedlings, fertilizer, and other agricultural inputs to farmers. These advances are repaid by farmers with the tobacco they produce. We are dedicated to promoting a sustainable farmer base and provide our farmers with agronomy support. Our Good Agricultural Practices programs educate farmers in such matters as the reduction of non-tobacco related materials, product traceability, environmental sustainability, agricultural labor standards, and social responsibility. In Malawi and Zimbabwe, we also purchase some tobacco under auction systems.

Our foreign operations are subject to international business risks, including unsettled political conditions, expropriation, import and export restrictions, exchange controls, and currency fluctuations. During the tobacco season in many of the countries listed above, we advance funds, guarantee local loans, or do both, each in substantial amounts, for the eventual purchase of tobacco. The majority of these seasonal advances and loan guarantees mature in one year or less upon the farmers’ delivery of contracted tobaccos. Most advances to farmers are denominated in local currency, which is a source of foreign currency exchange rate risk. Most tobacco sales are denominated in U.S. dollars, which reduces our foreign currency exchange risk after the tobacco has been purchased. See Item 1A, “Risk Factors” for more information about our foreign currency exchange and other risks.

For a discussion of recent developments and trends in our business, along with factors that may affect our business, see Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Item 1A, “Risk Factors.”

Seasonality

Our operations are seasonal in nature. Tobacco in Brazil is usually purchased from January through July, while buying in Malawi, Mozambique, and other African countries typically begins around April and continues through November. Farmers begin to sell U.S. flue-cured tobacco in late July, and the marketing season lasts for approximately four months.

We normally operate each of our processing plants for seven to nine months of the year. During this period for each region, inventories of green tobacco, inventories of processed tobacco, and trade accounts receivable normally reach peak levels in succession. We normally finance this expansion of current assets with cash, short-term borrowings from banks, and customer advances, and these funding sources normally reach their peak usage in each region during its respective purchasing or processing period. Our balance sheet at our fiscal year end reflects seasonal expansions in working capital in South America and Central America. Our financial performance is also impacted by the seasonality of our business. Due to global tobacco growing cycles, as well as customer shipment preferences, we typically ship a larger portion of our volumes in the second half of our fiscal year. Changes in customer shipment schedules or changes in crop timing in a season can shift recognition of revenue in a given fiscal year or between fiscal years.

Customers

A material part of our business is dependent upon a few customers. Our six largest customers are Altria Group Inc., British American Tobacco plc, China Tobacco International, Inc., Imperial Brands plc, Japan Tobacco, Inc., and Philip Morris International, Inc.   In the aggregate, these customers have accounted for more than two-thirds of our consolidated revenues for each of the past three fiscal years.  For the fiscal year ended March 31, 2017, each of British American Tobacco plc, Imperial Brands plc, and Philip Morris International, Inc., including their respective affiliates, accounted for 10% or more of our revenues. The loss of, or substantial reduction in business from, any of these customers could have a material adverse effect on our results. We have longstanding relationships with all of these customers.  

We had commitments from customers for approximately $450 million of the tobacco in our inventories at March 31, 2017. Based upon historical experience, we expect that at least 90% of such orders will be delivered during fiscal year 2018. Most of our product requires shipment via trucks and oceangoing vessels to reach customer destinations. Delays in the delivery of orders can result from such factors as truck and container availability, port access and capacity, vessel scheduling, and changing customer requirements for shipment.

6

As more fully described in Note 1 to the consolidated financial statements in Item 8 of this Annual Report, we recognize revenue from the sale of tobacco when title and risk of loss is transferred to our customer. Individual shipments may be large, and since the customer typically specifies shipping dates, our financial results may vary significantly between reporting periods due to timing of sales. In some markets, including the United States, Italy, Tanzania, Poland, and Brazil, we process tobacco that is owned by our customers, and we recognize the revenue for that service when the processing is completed.

Competition

Competition among leaf tobacco suppliers is based on the ability to meet customer specifications in the growing, buying, processing, and financing of tobacco, and on the prices charged for products and services. Competition varies depending on the market or country involved. The number of competitors varies from country to country, but there is competition in most areas to buy and sell the available tobacco. Our principal competitor is Alliance One International, Inc. (“Alliance One”). Alliance One operates in many of the countries where we operate. We consider ourselves and Alliance One to be the only global leaf suppliers based on our worldwide scope of operations. Most of our major customers are partially vertically integrated, and thus also compete with us for the purchase of leaf tobacco in several of the major markets.

In most major markets, smaller competitors are very active. These competitors typically have lower overhead requirements and provide less support to customers and farmers. Due to their lower cost structures, they can often offer a price on products that is lower than our price. However, we believe that we provide quality controls and farm programs that add value for our customers in an increasingly regulated world and make our products highly desirable. Our Good Agricultural Practices support an approach to farming that is focused on sustainability, employing sound field production and labor management practices that meet our customers’ needs, promote farmer profitability, and reflect environmental sensitivity. We provide comprehensive training, technical support in the field, and crop analytics through ongoing research and development. We believe that our major customers increasingly require these services and that our programs increase the quality and value of the products and services we offer. We also believe that our customers value the security of supply that we are able to provide due to our strong relationships with our farmer base and our global footprint.

Reportable Segments

We evaluate the performance of our leaf tobacco business by geographic region, although the dark air-cured and oriental tobacco businesses are each evaluated on the basis of their worldwide operations. Performance of the oriental tobacco operations is evaluated based on our equity in the pretax earnings of our affiliate. Under this structure, we have the following primary operating segments: North America, South America, Africa, Europe, Asia, Dark Air-Cured, Oriental, and Special Services. North America, South America, Africa, Europe, and Asia are primarily involved in flue-cured and burley leaf tobacco operations for supply to cigarette manufacturers. Our Dark Air-Cured group supplies dark air-cured tobacco principally to manufacturers of cigars, pipe tobacco, and smokeless tobacco products, and our Oriental business supplies oriental tobacco to cigarette manufacturers. Our Special Services group provides laboratory services, including physical and chemical product testing, electronic nicotine delivery system and e-liquid testing, and smoke testing for customers. Our liquid nicotine joint venture and our fruit and vegetable ingredients business are also included in the Special Services group.

The five regional operating segments serving our cigarette manufacturer customers share similar characteristics in the nature of their products and services, production processes, class of customer, product distribution methods, and regulatory environment. Based on the applicable accounting guidance, four of the regions – South America, Africa, Europe, and Asia – are aggregated into a single reporting segment, Other Regions, because they also have similar economic characteristics. North America is reported as an individual operating segment, because its economic characteristics differ from the other regions, generally because its operations require lower working capital investments for crop financing and inventory. The Dark Air-Cured, Oriental, and Special Services segments, which have differing characteristics in some of the categories mentioned above, are reported together as Other Tobacco Operations, because each is below the measurement threshold for separate reporting.

Financial Information about Segments

Our North America and Other Regions reportable segments, which represent our flue-cured and burley tobacco operations, accounted for 20% and 69% of our revenues and 19% and 76% of our segment operating income, respectively, in fiscal year 2017. Our Other Tobacco Operations reportable segment accounted for 11% of our revenues and 5% of our segment operating income in fiscal year 2017. Sales and other operating revenues and operating income attributable to our reportable segments for each of the last three fiscal years, along with segment assets for each reportable segment at March 31, 2017, 2016, and 2015, are set forth in Note 14 to the consolidated financial statements, which are included in Item 8 of this Annual Report. Information with respect to the geographic distribution of our revenues and long-lived assets is also set forth in Note 14 to the consolidated financial statements.

C. Employees

We employed over 24,000 employees throughout the world during the fiscal year ended March 31, 2017. We estimated this figure because the majority of our personnel are seasonal employees.

7

D. Research and Development

We did not expend material amounts for research and development during the fiscal years ended March 31, 2017, 2016, or 2015.

E. Patents, etc.

We hold no material patents, licenses, franchises, or concessions.

F. Government Regulation, Environmental Matters, and Other Matters

Our business is subject to general governmental regulation in the United States and in foreign jurisdictions where we conduct business. Such regulation includes, but is not limited to, matters relating to environmental protection. To date, governmental provisions regulating the discharge of material into the environment have not had a material effect upon our capital expenditures, earnings, or competitive position. See Item 1A, “Risk Factors” for a discussion of government regulations and other factors that may affect our business.

8

Item 1A. Risk Factors

Operating Factors

In areas where we purchase leaf tobacco directly from farmers, we bear the risk that the tobacco we receive will not meet quality and quantity requirements.

When we contract directly with tobacco farmers or tobacco farmer cooperatives, which is the method we use to purchase tobacco in most countries, we bear the risk that the tobacco delivered may not meet customer quality and quantity requirements. If the tobacco does not meet such market requirements, we may not be able to fill all of our customers’ orders, and such failure would have an adverse effect on profitability and results of operations. In a contract market our obligation is to purchase the entire tobacco plant, which encompasses many leaf styles, therefore, we also have a risk that not all of that production will be readily marketable at prices that support acceptable margins. In addition, in many foreign countries where we purchase tobacco directly from farmers, we provide them with financing. Unless we receive marketable tobacco that meets the quality and quantity specifications of our customers, we bear the risk that we will not be able to fully recover our crop advances or recover them in a reasonable period of time.

The leaf tobacco industry is competitive, and we are heavily reliant on a few large customers.

We are one of two major independent global competitors in the leaf tobacco industry, both of whom are reliant upon a few large customers. The loss of one of those large customers or a significant decrease in their demand for our products or services could significantly decrease our sales of products or services, which would have a material adverse effect on our results of operations. The competition among leaf tobacco suppliers and dealers is based on the ability to meet customer requirements in the buying, processing, and financing of tobacco, and on the price charged for products and services. We believe that we consistently meet our customers’ requirements and charge competitive prices. Since we rely upon a few significant customers, the consolidation or failure of any of these large customers, or a significant increase in their vertical integration, could contribute to a significant decrease in our sales of products and services.

We compete for both the purchase and sale of leaf with smaller leaf tobacco suppliers in some of the markets where we conduct business. Some of these smaller leaf tobacco suppliers operate in more than one country. Since they typically provide little or no support to farmers, these leaf tobacco suppliers typically have lower overhead requirements than we do. Due to their lower cost structures, they often can offer prices on products and services that are lower than our prices. Our customers also directly source leaf tobacco from farmers to meet some of their raw material needs. Direct sourcing provides our customers with some qualities and quantities of leaf tobacco that they prefer not to use in their existing blends and that may be offered for sale. This competition for both the sale and purchase of leaf could reduce the volume of the leaf we handle and could negatively impact our financial results.

Our financial results can be significantly affected by changes in the balance of supply and demand for leaf tobacco.

As a leaf tobacco supplier, our financial results can be significantly affected by changes in the overall balance of worldwide supply and demand for leaf tobacco. The demand for leaf tobacco, which is based upon customers’ expectations of their future requirements, can change from time to time depending upon factors affecting the demand for their products. Our customers’ expectations and their demand for leaf tobacco are influenced by a number of factors, including:

• trends in the global consumption of cigarettes,

• trends in consumption of cigars and other tobacco products,

• trends in consumption of alternative tobacco products, such as electronic nicotine delivery systems and non-combustible products,

• levels of competition among our customers, and

• regulatory and governmental factors.

The world supply of leaf tobacco at any given time is a function of current tobacco production, inventories held by manufacturers, and the stocks of leaf tobacco held by leaf tobacco suppliers. Production of tobacco in a given year may be significantly affected by such factors as:

• demographic shifts that change the number of farmers or the amount of land available to grow tobacco,

• decisions by farmers to grow crops other than leaf tobacco,

• volume of annual tobacco plantings and yields realized by farmers,

• availability of crop inputs,

• weather and natural disasters, including any adverse weather conditions that may result from climate change, and

• crop infestation and disease.

Any significant change in these factors could cause a material imbalance in the supply of and demand for tobacco, which would affect our results of operations.

9

Our financial results will vary according to tobacco growing conditions, customer requirements, and other factors. These factors may also limit the ability to accurately forecast our future performance and increase the risk of an investment in our common stock or other securities.

Our financial results, particularly our year-over-year quarterly comparisons, may be significantly affected by variations in tobacco growing seasons and fluctuations in crop sizes. The timing of the cultivation and delivery of tobacco is dependent upon a number of factors, including weather and other natural events, and our processing schedules and results of operations can be significantly altered by these factors. In addition, the potential impact of climate change is uncertain and may vary by geographic region. The possible effects, as described in various public accounts, could include changes in rainfall patterns, water shortages, changing storm patterns and intensities, and changing temperature levels that could adversely impact our costs and business operations and the supply and demand for leaf tobacco. Our operations also rely on dependable and efficient transportation services. A disruption in transportation services, as a result of climate change or otherwise, may also significantly impact our results of operations.

Further, the timing and unpredictability of customer orders and shipments may require us to keep tobacco in inventory and may also result in variations in quarterly and annual financial results. We base sales recognition on the passage of ownership. Since individual shipments may represent significant amounts of revenue, our quarterly and annual financial results may vary significantly depending on the timing of needs and shipping instructions of our customers and the availability of transportation services. These fluctuations result in varying volumes and sales in given periods, which also reduce the comparability of financial results.

Major shifts in customer requirements for tobacco supply may significantly affect our operating results.

If our customers significantly alter their requirements for tobacco volumes from certain regions, we may have to change our production facilities and alter our fixed asset base in certain origins. Permanent or long-term reduction in demand for tobacco from origins where we have operations may trigger restructuring and impairment charges. We may also need to make significant capital investments in other regions to develop the needed infrastructure to meet customer supply requirements.

Weather and other conditions can affect the marketability of our products.

Tobacco crops are subject to vagaries of weather and the environment that can, in some cases, change the quality or size of the crops. If a weather event is particularly severe, such as a major drought or hurricane, the affected crop could be destroyed or damaged to an extent that it would be less desirable to manufacturers, which would result in a reduction in revenues. If such an event is also widespread, it could affect our ability to acquire the quantity of tobacco required by our customers. In addition, other factors can affect the marketability of tobacco, including, among other things, the presence of excess residues of crop protection agents or non-tobacco related materials. A significant event impacting the condition or quality of a large amount of any of the crops that we buy could make it difficult for us to sell these products or to fill customers’ orders.

Our food ingredient business is subject to industry-specific risks which could adversely affect our operating results.

Our food ingredients business is subject to risks posed by food spoilage or food contamination; shifting consumer preferences; federal, state, and local food processing regulations; product tampering; and product liability claims. If one or more of these risks were to materialize, our revenues and operating results could be adversely affected, and our Company’s reputation might be damaged.

We may be adversely impacted if our information technology systems fail to perform adequately, including with respect to cybersecurity issues.

The efficient operation of our business depends on our information technology systems. We rely on our information technology systems to effectively manage our business data, communications, supply chain, order entry and fulfillment, and other business processes. The failure of our information technology systems (including those provided to us by third parties) to perform as we anticipate could disrupt our business and affect our results of operations.

In addition, our information technology systems may be vulnerable to damage or interruption from circumstances beyond our control, including fire, natural disasters, systems failures, security breaches or intrusions (including theft of confidential data), and viruses. If we are unable to prevent physical and electronic break-ins, cyber-attacks and other information security breaches, we may suffer financial and reputational damage, be subject to litigation, or incur remediation costs or penalties because of the unauthorized disclosure of confidential information belonging to us or to our partners, customers, suppliers or employees.

10

Regulatory and Governmental Factors

Government efforts to regulate the production and consumption of tobacco products could have a significant impact on the businesses of our customers, which would, in turn, affect our results of operations.

About 5% of cigarettes manufactured worldwide are consumed in the United States. Nationally, the U.S. federal government and certain state and local governments have taken or proposed actions that may have the effect of reducing U.S. consumption of tobacco products and indirectly reducing demand for our products and services. These activities have included:

• restrictions on the use of tobacco products in public places and places of employment,

• legislation authorizing the U.S. Food and Drug Administration (the “FDA”) to regulate the manufacturing and marketing of all tobacco products,

• increases in the federal, state, and local excise taxes on cigarettes and other tobacco products, and

• the policy of the U.S. government to link certain federal grants to the enforcement of state laws restricting the sale of tobacco products.

Numerous other legislative and regulatory anti-smoking measures have been proposed at the federal, state, and local levels.

Globally, a number of foreign governments and non-government organizations also have taken or proposed steps to restrict or prohibit tobacco product advertising and promotion, to increase taxes on tobacco products, to indirectly limit the use of certain types of tobacco, and to discourage tobacco product consumption. A number of such measures, including plain packaging, are included in the Framework Convention on Tobacco Control (“FCTC”), which was negotiated and promoted globally under the auspices of the World Health Organization (“WHO”). We cannot predict the extent or speed at which the efforts of governments or non-governmental agencies to reduce tobacco consumption might affect the business of our primary customers. However, a significant decrease in worldwide tobacco consumption brought about by existing or future governmental laws and regulations would reduce demand for tobacco products and services and could have a material adverse effect on our results of operations.

Government actions can have a significant effect on the sourcing of tobacco. If some of the current efforts are successful, we could have difficulty obtaining sufficient tobacco to meet our customers’ requirements, which could have an adverse effect on our performance and results of operations.

The WHO, through the FCTC, created a formal study group in 2007 to identify and assess crop diversification initiatives and alternatives to growing leaf tobacco in countries whose economies depend upon tobacco production. If certain countries were to partner with the FCTC study group and seek to eliminate or significantly reduce leaf tobacco production, we could encounter difficulty in sourcing leaf tobacco to fill customer requirements, which could have an adverse effect on our results of operations.

Certain recommendations by the WHO, through the FCTC, may cause shifts in customer usage of certain styles of tobacco. As seen in countries like Canada and Brazil and in the European Union, efforts have been taken to eliminate ingredients from the manufacturing process for tobacco products. Recently, the FCTC and the FDA have discussed formulating a nicotine strategy (limitations on the level of nicotine allowed in tobacco and tobacco smoke). Such decisions could cause a change in requirements for certain styles of tobacco in particular countries. Shifts in customer demand from one type of tobacco to another could create sourcing challenges as requirements move from one origin to another.

Trade proposals have included provisions that could effectively allow governments to regulate tobacco products differently than other products. These “carve outs” could negatively impact the industry and reduce requirements for leaf tobacco.

In addition, continued government and public emphasis on environmental issues, including climate change, conservation, and natural resource management, could result in new or more stringent forms of regulatory oversight of industry activities, which may lead to increased levels of expenditures for environmental controls, land use restrictions affecting us or our suppliers, and other conditions that could have a material adverse effect on our business, financial condition, and results of operations. For example, certain aspects of our business generate carbon emissions. Regulatory restrictions on greenhouse gas emissions have been proposed. These may include limitations on such emissions, taxes or emission allowance fees on such emissions, various restrictions on industrial operations, and other measures that could affect land-use decisions, the cost of agricultural production, and the cost and means of processing and transporting our products. These actions could adversely affect our business, financial condition, and results of operations.

Because we conduct a significant portion of our operations internationally, political and economic uncertainties in certain countries could have an adverse effect on our performance and results of operations.

Our international operations are subject to uncertainties and risks relating to the political stability of certain foreign governments, principally in developing countries and emerging markets, and also to the effects of changes in the trade policies and economic regulations of foreign governments. These uncertainties and risks, which include undeveloped or antiquated commercial law, the expropriation, indigenization, or nationalization of assets, and the authority to revoke or refuse to renew business licenses and work permits, may adversely impact our ability to effectively manage our operations in those countries. We have substantial capital investments in South America and Africa, and the performance of our operations in those regions can materially affect our

11

earnings. If the political situation in any of the countries where we conduct business were to deteriorate significantly, our ability to recover assets located there could be impaired. To the extent that we do not replace any lost volumes of tobacco with tobacco from other sources, or we incur increased costs related to such replacement, our financial condition or results of operations, or both, would suffer.

In addition, there have been recent public announcements by members of the U.S. Congress and President Trump and his administration regarding their plans to make substantial changes in the taxation of U.S. companies and their foreign operations, including the possible implementation of a border tax, tariff or increase in customs duties on products manufactured outside of, and imported into, the United States, as well as the renegotiation of U.S. trade agreements, including the North American Free Trade Agreement. In the event such taxes, tariffs, increased customs duties or other measures are implemented, they could have a materially adverse effect on our business, financial condition and results of operations. Due to broad uncertainty regarding the timing, content and extent of any regulatory changes in the United States or abroad, we cannot predict the impact, if any, that these changes could have to our business, financial condition and results of operations.

Changes in tax laws in the countries where we do business may adversely affect our results of operations.

Through our subsidiaries, we are subject to the tax laws of many jurisdictions. Changes in tax laws or the interpretation of tax laws can affect our earnings, as can the resolution of various pending and contested tax issues. In most jurisdictions, we regularly have audits and examinations by the designated tax authorities, and additional tax assessments are common. We believe that we comply with applicable tax laws in the jurisdictions where we operate, and we vigorously contest all significant tax assessments where we believe we are in compliance with the tax laws.

Financial Factors

Failure of our customers or suppliers to repay extensions of credit could materially impact our results of operations.

We extend credit to both suppliers and customers. A significant bad debt provision related to amounts due could adversely affect our results of operations. In addition, crop advances to farmers are generally secured by the farmers’ agreement to deliver green tobacco. In the event of crop failure, delivery failure, or permanent reductions in crop sizes, full recovery of advances may never be realized, or otherwise could be delayed until future crops are delivered. See Notes 1 and 13 to the consolidated financial statements in Item 8 for more information on these extensions of credit.

Fluctuations in foreign currency exchange rates may affect our results of operations.

We account for most of our tobacco operations using the U.S. dollar as the functional currency. The international tobacco trade generally is conducted in U.S. dollars, and we finance most of our tobacco operations in U.S. dollars. Although this generally limits foreign exchange risk to the economic risk that is related to leaf purchase and production costs, overhead, and income taxes in the source country, significant currency movements could materially impact our results of operations. Changes in exchange rates can make a particular crop more or less expensive in U.S. dollar terms. If a particular crop is viewed as expensive in U.S. dollar terms, it may be less attractive in the world market. This could negatively affect the profitability of that crop and our results of operations. In tobacco markets that are primarily domestic, such as Eastern Europe and the Philippines, the local currency is the functional currency. In addition, the local currency is the functional currency in other markets, such as Western Europe, where export sales have been denominated primarily in local currencies. In these markets, reported earnings are affected by the translation of the local currency into the U.S. dollar. See Item 7A, “Qualitative and Quantitative Disclosure About Market Risk” for additional discussion related to foreign currency exchange risk.

Our purchases of tobacco are generally made in local currency, and we also provide farmer advances that are denominated in the local currency. We account for currency remeasurement gains or losses on those advances as period costs, and they are usually accompanied by offsetting increases or decreases in the purchase cost of tobacco, which is priced in the local currency. The effect of differences in the cost of tobacco is generally not realized in our earnings until the tobacco is sold, which often occurs in a quarter or fiscal year subsequent to the recognition of the related remeasurement gains or losses. The difference in timing could affect our profitability in a given quarter or fiscal year.

We have used currency hedging strategies to reduce our foreign currency exchange rate risks in some markets. In addition, where we source tobacco in countries with illiquid or nonexistent forward foreign exchange markets, we often manage our foreign exchange risk by matching funding for inventory purchases with the currency of sale and by minimizing our net investment in these countries. To the extent that we have net monetary assets or liabilities in local currency, and those balances are not hedged, we may have currency remeasurement gains or losses that will affect our results of operations.

12

Changes in interest rates may affect our results of operations.

We generally use both fixed and floating interest rate debt to finance our operations. Changes in market interest rates expose us to changes in cash flows for floating rate instruments and to changes in fair value for fixed-rate instruments. We normally maintain a proportion of our debt in both variable and fixed interest rates to manage this exposure, and from time to time we may enter hedge agreements to swap the interest rates. In addition, our customers may pay market rates of interest for inventory purchased on order, which could mitigate a portion of the floating interest rate exposure on short-term borrowings. To the extent we are unable to match these interest rates, a decrease in interest rates could increase our net financing costs. We also periodically have large cash balances and may receive deposits from customers, both of which we use to fund seasonal purchases of tobacco, reducing our financing needs. Decreases in short-term interest rates could reduce the income we derive from those investments. Changes in interest rates also affect expense related to our defined benefit pension plan, as described below.

Low investment performance by our defined benefit pension plan assets and changes in pension plan valuation assumptions may increase our pension expense and may require us to fund a larger portion of our pension obligations, thus diverting funds from other potential uses.

We sponsor domestic defined benefit pension plans that cover certain eligible employees. Our results of operations may be positively or negatively affected by the amount of expense we record for these plans. U.S. generally accepted accounting principles (“GAAP”) require that we calculate expense for the plans using actuarial valuations. These valuations reflect assumptions about financial market and other economic conditions that may change based on changes in key economic indicators. The most significant year-end assumptions we used to estimate pension expense for fiscal year 2017 were the discount rate, the expected long-term rate of return on plan assets, and the mortality rates. In addition, we are required to make an annual measurement of plan assets and liabilities, which may result in a significant change to shareholders’ equity through a reduction or increase to the “Pension and other postretirement benefit plans” component of Accumulated Other Comprehensive Loss. At the end of fiscal year 2017, the projected benefit obligation of our qualified U.S. pension plan was $223 million and plan assets were $207 million. For a discussion regarding how our financial statements can be affected by pension plan valuation assumptions, see “Critical Accounting Estimates – Pension and Other Postretirement Benefit Plans” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 and in Note 10 to the consolidated financial statements in Item 8. Although GAAP expense and pension funding contributions are not directly related, key economic factors that affect GAAP expense can also affect the amount of cash we are required to contribute to our pension plans under requirements of the Employee Retirement Income Security Act (“ERISA”). Failure to achieve expected returns on plan assets could also result in an increase to the amount of cash we would be required to contribute to our pension plans. In order to maintain or improve the funded status of our plans, we may also choose to contribute more cash to our plans than required by ERISA regulations.

Item 1B. Unresolved Staff Comments

None 

13

Item 2.      Properties

We own the following significant properties (greater than 500,000 square feet):

Location	Principal Use	Building Area
		(Square Feet)
Flue-Cured and Burley Leaf Tobacco Operations:
North America:
United States
Nash County, North Carolina	Factory and storages	1,323,000
Other Regions:
Brazil
Santa Cruz	Factory and storages	2,386,000
Malawi
Lilongwe	Factory and storages	942,000
Mozambique
Tete	Factory and storages	770,000
Philippines
Agoo, La Union	Factory and storages	770,000
Tanzania
Morogoro	Factory and storages	895,000
Zimbabwe
Harare (1)	Factory and storages	1,445,000
Other Tobacco Operations:
United States
Lancaster, Pennsylvania	Factory and storages	793,000

⁽¹⁾  Owned by an unconsolidated subsidiary.

We lease headquarters office space of about 50,000 square feet at 9201 Forest Hill Avenue in Richmond, Virginia, which we believe is adequate for our current needs.

Our business involves, among other things, storing and processing green tobacco and storing processed tobacco. We operate processing facilities in major tobacco growing areas. In addition, we require tobacco storage facilities that are in close proximity to the processing facilities. We own most of the tobacco storage facilities, but we lease additional space as needs arise, and expenses related to such leases are not material. We believe that the properties currently utilized in our tobacco operations are maintained in good operating condition and are suitable and adequate for our purposes at our current volumes.

In addition to our significant properties listed above, we own other processing facilities in the following countries: Germany, Guatemala, Italy, the Netherlands, Poland, and the United States. In addition, we have an ownership interest in a processing plant in Mexico and have access to processing facilities in other areas, such as India, the People’s Republic of China, and South Africa. Socotab L.L.C., an oriental tobacco joint venture in which we own a noncontrolling interest, owns tobacco processing plants in Turkey, Macedonia, and Bulgaria.

Except for the Lancaster, Pennsylvania facility, the facilities described above are engaged primarily in processing tobaccos used by manufacturers in the production of cigarettes. The Lancaster facility, as well as facilities in Brazil, the Dominican Republic, Indonesia, and Paraguay, process tobaccos used in making cigar, pipe, and smokeless products, as well as components of certain “roll-your-own” products.

14

Item 3.   Legal Proceedings

Some of our subsidiaries are involved in litigation or legal matters incidental to their business activities.  While the outcome of these matters cannot be predicted with certainty, we are vigorously defending the matters and do not currently expect that any of them will have a material adverse effect on our business or financial position.  However, should one or more of these matters be resolved in a manner adverse to our current expectation, the effect on our results of operations for a particular fiscal reporting period could be material.

Item 4.   Mine Safety Disclosures

Not applicable.

15

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Common Equity

Our common stock is traded on the New York Stock Exchange (“NYSE”) under the symbol “UVV.” The following table sets forth the high and low sales prices per share of the common stock on the NYSE Composite Tape, based upon published financial sources, and the dividends declared on each share of common stock for the quarter indicated.

	First Quarter		Second Quarter		Third Quarter		Fourth Quarter
Fiscal Year Ended March 31, 2017
Cash dividends declared	$	0.53	$	0.53	$	0.54	$	0.54
Market price range:
High	57.75		61.69		64.20		83.35
Low	52.26		55.29		52.40		63.30
Fiscal Year Ended March 31, 2016
Cash dividends declared	$	0.52	$	0.52	$	0.53	$	0.53
Market price range:
High	57.76		58.41		57.72		57.27
Low	46.80		46.98		49.70		51.49

Our current dividend policy anticipates the payment of quarterly dividends in the future. However, the declaration and payment of dividends to holders of common stock is at the discretion of the Board of Directors and will be dependent upon our future earnings, financial condition, and capital requirements. Under certain of our credit facilities, we must meet financial covenants relating to minimum tangible net worth and maximum levels of debt. If we were not in compliance with them, these financial covenants could restrict our ability to pay dividends. We were in compliance with all such covenants at March 31, 2017. At May 19, 2017, there were 1,126 holders of record of our common stock. See Notes 5 and 11 to the consolidated financial statements in Item 8 for more information on debt covenants and equity securities.

Purchases of Equity Securities

As indicated in the following table, we did not repurchase shares of our common stock or our Series B 6.75% Convertible Perpetual Preferred Stock during the three-month period ended March 31, 2017.

	Common Stock				Series B 6.75% Convertible Perpetual Preferred Stock (4)
Period(1)	Total Number of Shares Repurchased	Average Price Paid Per Share(2)		Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs (3)	Total Number of Shares Repurchased	Average Price Paid Per Share(2)		Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs (3)	Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(3)
January 1-31, 2017	—	$	—	—	—	$	—	—	$	100,000,000
February 1-28, 2017	—	—		—	—	—		—	100,000,000
March 1-31, 2017	—	—		—	—	—		—	100,000,000
Total	—	$	—	—	—	$	—	—	$	100,000,000

⁽¹⁾  Repurchases are based on the date the shares were traded. This presentation differs from the consolidated statement of cash flows, where the cost of share repurchases is based on the date the transactions were settled.

⁽²⁾  Amounts listed for average price paid per share include broker commissions paid in the transactions.

⁽³⁾  A stock repurchase plan, which was authorized by our Board of Directors, became effective and was publicly announced on November 5, 2015. This stock repurchase plan authorizes the purchase of up to $100 million in common and/or preferred stock in open market or privately negotiated transactions, subject to market conditions and other factors, and will expire on the earlier of November 15, 2017, or when we have exhausted the funds authorized for the program. The conversion of the remaining shares of our Series B 6.75% Convertible Perpetual Preferred Stock did not affect our stock repurchase plan.

⁽⁴⁾  On January 9, 2017, the Company announced a mandatory conversion of all 107,418 remaining outstanding shares of the preferred stock after meeting the requirements to initiate the mandatory conversion under the original terms of the preferred shares. The Company chose to satisfy the full conversion obligation for the mandatory conversion in cash, paying approximately $178.4 million for those preferred shares on January 31, 2017 to complete the conversion.

16

Item 6.   Selected Financial Data

	Fiscal Year Ended March 31,
	2017			2016			2015			2014			2013
	(in thousands, except share and per share data, ratios, and number of shareholders)
Summary of Operations
Sales and other operating revenues	$	2,071,218		$	2,120,373		$	2,271,801		$	2,542,115		$	2,461,699
Operating income	$	178,351		$	181,647		$	167,874		$	246,151		$	223,009
Segment operating income (1)	$	188,484		$	186,068		$	167,225		$	175,175		$	232,757
Net income	$	112,506		$	118,148		$	120,461		$	155,155		$	140,919
Net income attributable to Universal Corporation (2)	$	106,304		$	109,016		$	114,608		$	149,009		$	132,750
Earnings available to Universal Corporation common shareholders	$	20,890		$	94,268		$	99,748		$	134,159		$	117,900
Return on beginning common shareholders’ equity	1.7		%	8.2		%	8.6		%	12.8		%	12.1		%
Earnings per share attributable to Universal Corporation common shareholders:
Basic	$	0.89		$	4.16		$	4.33		$	5.77		$	5.05
Diluted	$	0.88		$	3.92		$	4.06		$	5.25		$	4.66
Financial Position at Year End
Current ratio	5.83			6.65			5.96			3.66			2.77
Total assets	$	2,123,405		$	2,231,177		$	2,186,476		$	2,264,401		$	2,285,987
Long-term debt	$	368,733		$	368,380		$	368,027		$	239,508		$	180,060
Working capital	$	1,293,403		$	1,392,276		$	1,329,770		$	1,200,023		$	1,094,764
Total Universal Corporation shareholders’ equity	$	1,286,489		$	1,414,222		$	1,378,230		$	1,378,230		$	1,258,571
General
Ratio of earnings to fixed charges	10.25			10.22			8.46			10.73			8.87
Ratio of earnings to combined fixed charges and preference dividends	5.30			4.59			4.05			5.49			4.69
Number of common shareholders	1,131			1,182			1,225			1,295			1,354
Weighted average common shares outstanding:
Basic	23,433,860			22,683,290			23,035,920			23,238,978			23,354,793
Diluted	23,770,088			27,825,491			28,221,264			28,392,033			28,478,058
Dividends per share of convertible perpetual preferred stock (annual)	$	50.63		$	67.50		$	67.50		$	67.50		$	67.50
Dividends per share of common stock (annual)	$	2.14		$	2.10		$	2.06		$	2.02		$	1.98
Book value per common share	$	50.90		$	52.94		$	50.95		$	50.19		$	44.79

⁽¹⁾ The Company evaluates the performance of its segments based on operating income after allocated overhead expenses (excluding significant charges or credits), plus equity in the pretax earnings of unconsolidated affiliates. See Note 14 to the consolidated financial statements in Item 8 of this Annual Report.

⁽²⁾ We hold less than a 100% financial interest in certain consolidated subsidiaries, and a portion of net income is attributable to the noncontrolling interests in those subsidiaries.

17

The calculations of the ratio of earnings to fixed charges and the ratio of earnings to combined fixed charges and preference dividends are shown in Exhibit 12. Fixed charges primarily represent interest expense we incurred during the designated fiscal year, and preference dividends represent the pretax equivalent of dividends on preferred stock.

Significant items included in the operating results in the above table are as follows:

• Fiscal Year 2017 – $4.4 million restructuring and impairment costs, primarily related to our decision to close our tobacco processing facility in Hungary. We are now processing tobaccos sourced from Hungary in our facilities in Italy. The restructuring and impairment costs reduced net income by $2.8 million, or $0.10 per diluted share. In addition, all 218,490 outstanding shares of our Series B 6.75% Convertible Perpetual Preferred Stock were converted during the third and fourth quarters. Of the total shares converted, 107,418 shares were converted for cash, resulting in a reduction of retained earnings of approximately $74.4 million for the excess of the conversion cost over the carrying value of the shares. The reduction in retained earnings resulted in a corresponding one-time reduction of earnings available to common shareholders for purposes of determining the amounts reported for basic and diluted earnings per share for the year. The reduction in earnings available to common shareholders decreased diluted earnings per share by $2.99.

• Fiscal Year 2016 – a $3.4 million pretax gain arising from the acquisition of a joint venture partner's 50% ownership interest in a tobacco processing entity in Guatemala. The transaction increased our ownership interest in the entity to 100%, requiring us to consolidate the financial statements of the entity and to remeasure our original 50% ownership interest to fair value, resulting in the gain. In addition, we recorded restructuring and impairment costs of $2.4 million related to a decision to significantly scale back our operations in Zambia. The net effect of the gain and the restructuring and impairment costs increased pretax income by $1 million and net income by $0.7 million, or $0.02 per diluted share.

• Fiscal Year 2015 – a $12.7 million benefit to pretax earnings from the reversal of a valuation allowance on the remaining unused balance of the excise tax credits realized from the favorable outcome of litigation by our subsidiary in Brazil in fiscal year 2014. In addition, we recorded a consolidated income tax benefit of $8.0 million arising from the ability of our subsidiary, Deltafina S.p.A. ("Deltafina"), to pay a significant portion of the European Commission fine and related interest charges settled during the first quarter following the unsuccessful appeal of the case related to tobacco buying practices in Italy. The effect of those items was partially offset by restructuring costs of $4.9 million, primarily related to downsizing certain functions at our operations in Brazil and the decision to suspend our operations in Argentina. On a combined basis, the net effect of these items increased pretax income by $7.8 million and net income by $13.1 million, or $0.46 per diluted share.

• Fiscal Year 2014 – an $81.6 million pretax gain resulting from the favorable outcome of litigation by our operating subsidiary in Brazil related to previous years’ excise tax credits. In addition to the gain, we recorded restructuring costs of $6.7 million, primarily related to the closure of a tobacco processing facility in Brazil and the consolidation of these operations into our main processing facility there. The net effect of the gain and the restructuring costs increased pretax income by $74.9 million and net income by $48.7 million, or $1.72 per diluted share.

• Fiscal Year 2013 – $4.1 million in restructuring costs, primarily related to workforce reductions in Africa. The effect of those charges was a reduction in net income of $1.8 million, or $0.06 per diluted share.

18

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of financial condition and results of operations is provided to enhance the understanding of, and should be read in conjunction with, Part I, Item 1, “Business” and Item 8, “Financial Statements and Supplementary Data.” For information on risks and uncertainties related to our business that may make past performance not indicative of future results, or cause actual results to differ materially from any forward-looking statements, see “General,” and Part I, Item 1A, “Risk Factors.”

OVERVIEW

We are the leading global leaf tobacco supplier. We derive most of our revenues from sales of processed tobacco to manufacturers of tobacco products throughout the world and from fees and commissions for specific services. We hold a strategic position in the world leaf markets where we work closely with both our customers and farmers to ensure that we deliver a compliant product that meets our customers' needs while promoting a strong supplier base. We adapt to meet changes in customer requirements as well as broader changes in the leaf markets, while continuing to provide the stability of supply and high level of service that distinguishes us in the marketplace. We believe that we have successfully met the needs of both our customers and suppliers while adapting to changes in leaf markets. Over the last three fiscal years, we have generated over $660 million in net cash flow from operations, invested over $145 million in our businesses, settled the mandatory conversion of our Series B 6.75% Convertible Perpetual Preferred Stock ("Series B Preferred Stock") for about $178 million in cash, and returned over $210 million to our shareholders through a combination of dividends and share repurchases.

We have also faced challenging market conditions over the last three fiscal years. In fiscal year 2015, declines in some of our customers’ sales volumes in the U.S. and Western European markets, partially due to weak economic conditions, reduced demand for leaf tobacco. At the same time, crops sold in fiscal year 2015 were larger than those sold in fiscal year 2014. Given fiscal year 2015’s oversupplied market conditions, we were pleased with the results we achieved. We ended the year with strong fourth quarter results, which helped to bring our segment operating earnings for the fiscal year in line with our expectations. We also realized higher margins and maintained our solid financial position. We believe that our performance that year demonstrated our ability to execute well on our objective of delivering a compliant product in an efficient manner to our customers, under challenging circumstances.

We achieved improved results in fiscal year 2016, after managing through a second year of oversupplied market conditions. As anticipated, we ended the year with strong fourth quarter volumes, primarily driven by later timing of customer shipping orders in Brazil and Asia, and the positive change in leaf supply arrangements in our North America segment. We also achieved modest growth in overall volumes for the full fiscal year and improved our margins, and our selling, general, and administrative costs were lower. Our inventories continued to be well-managed, and uncommitted stocks declined from fiscal year 2015’s level, in line with our target.

We delivered solid results again in fiscal year 2017 despite supply headwinds, most notably from the weather-reduced crop sizes in Brazil and ongoing challenging market conditions in Tanzania. Although we had anticipated ending the year with slightly lower volumes, earlier shipment timing as well as attractive green prices in some origins resulting in some additional purchases by our customers boosted shipments later in our fiscal year, allowing us to improve our market share and achieve lamina sales volumes that were slightly above those of the prior fiscal year.

Our segment operating income for the 2017 fiscal year was also improved, primarily attributable to a reduction in selling, general, and administrative costs and earlier receipt of distributions from unconsolidated subsidiaries. We believe that our success reflects our continuing efforts to bring efficiencies to the leaf tobacco supply chain. Through the hard work of our dedicated employees around the world, we have been able to expand services that we provide our customers and, despite continuing slow decline in demand for consumer tobacco products, maintain our volumes handled.

We also maintained our strong balance sheet in fiscal year 2017, and our lower working capital requirements from smaller crops and prudent buying programs helped us to retain the necessary cash reserves to support our working capital needs in fiscal year 2018. In addition, in fiscal year 2017, we continued our focus on providing returns to our shareholders through completion of the conversion of our preferred stock, increasing the common dividend rate, and returning more than $60 million in dividends.

As we move into fiscal year 2018, we are forecasting that global flue-cured tobacco production outside of China will increase by about 9%, largely from the recovery of the Brazilian crop due to better weather conditions there, and that burley tobacco production will decrease by approximately 8%, primarily due to reductions in Africa. Although it is too early to determine whether the additional purchases by customers in fiscal year 2017 may impact their requirements in fiscal year 2018, we continue to strive to be our customers’ supplier of choice, providing them compliant products and quality services at a competitive price.

19

RESULTS OF OPERATIONS

Amounts described as net income and earnings per diluted share in the following discussion are attributable to Universal Corporation and exclude earnings related to non-controlling interests in subsidiaries. The total for segment operating income referred to in the discussion below is a non-GAAP financial measure. This measure is not a financial measure calculated in accordance with GAAP and should not be considered as a substitute for net income, operating income, cash flows from operating activities or any other operating performance measure calculated in accordance with GAAP, and it may not be comparable to similarly titled measures reported by other companies. We have provided a reconciliation of the total for segment operating income to consolidated operating income in Note 14. "Operating Segments" to the consolidated financial statements in Item 8. We evaluate our segment performance excluding certain significant charges or credits. We believe this measure, which excludes these items that we believe are not indicative of our core operating results, provides investors with important information that is useful in understanding our business results and trends.

Fiscal Year Ended March 31, 2017, Compared to the Fiscal Year Ended March 31, 2016

Net income for the fiscal year ended March 31, 2017, was $106.3 million, or $0.88 per diluted share, compared with fiscal year 2016’s net income of $109.0 million, or $3.92 per diluted share. The fiscal year 2017 results included a one-time reduction of earnings available to common shareholders of $74.4 million, or $2.99 per diluted share, for purposes of determining the amounts reported for basic and diluted earnings per share, from the conversion for cash of the remaining outstanding shares of our Series B 6.75% Convertible Perpetual Preferred Stock under the mandatory conversion in January 2017. That one-time reduction and certain other non-recurring items are detailed in Other Items below. Excluding those items, diluted earnings per share for the fiscal year of $3.97 increased $0.07 compared to the same period last year. Operating income of $178.4 million for the fiscal year ended March 31, 2017, was down $3.3 million compared to the fiscal year ended March 31, 2016.Segment operating income, which excludes non-recurring items, was $188.5 million for fiscal year 2017, an increase of $2.4 million from the prior year, primarily attributable to improved results for the North America segment, partly offset by a decline for the Other Tobacco Operations segment. Revenues of $2.1 billion for fiscal year 2017 were relatively flat compared with the previous year, as the slightly higher volumes and a benefit from earlier receipt of distributions from unconsolidated subsidiaries were offset by lower green leaf costs and lower processing revenues.

Flue-cured and Burley Leaf Tobacco Operations

Other Regions

Operating income for the Other Regions segment for the fiscal year ended March 31, 2017, of $143.3 million, was nearly flat, down only $0.3 million compared to $143.6 million in the previous fiscal year. Total volumes for the segment declined, but overall margins improved, benefitting from lower selling, general, and administrative expenses and timing of receipt of distributions from unconsolidated subsidiaries. Africa volumes were slightly lower, reflecting challenging market conditions in Tanzania which offset volume improvements in other origins. South America’s results were down, continuing the trend noted throughout the fiscal year from lower volumes and higher factory unit costs as a result of the reduced buying program and lower third-party processing volumes there this year. Selling, general, and administrative expenses for the segment were down significantly for the fiscal year on several items, including the favorable comparison to costs incurred in fiscal year 2016 to settle challenges regarding property rights and valuation of forestry land in South America, the reversal of value-added tax reserves, lower net foreign currency and exchange remeasurement losses, and a reduction in provisions for supplier advances compared to the previous fiscal year. Revenues for the segment were down about $116.0 million to $1.4 billion, on the lower sales volumes at lower average green leaf prices and lower processing revenues, offset in part by increased distributions from unconsolidated subsidiaries.

North America

Operating income for the North America segment was $35.2 million for the fiscal year ended March 31, 2017, up $4.0 million compared with the previous year. Earnings improvements were driven mainly by higher sales volumes, partially due to earlier timing of current crop shipments in fiscal 2017. However, margins for the year were lower from a less favorable product mix, as well as reduced factory yields on weather affected U.S. crops. Fiscal year 2017 revenues for the segment increased by $54.6 million to $416.4 million compared to the previous fiscal year, on those higher sales volumes, at lower green leaf prices, and a less favorable product mix.

Other Tobacco Operations

For the fiscal year ended March 31, 2017, the Other Tobacco Operations segment operating income decreased by $1.3 million to $10.0 million compared with the same period last year. Earnings improved modestly for the dark tobacco operations as higher domestic volumes were largely offset by a less favorable sales mix and higher inventory write-downs this year. Results from the oriental joint venture also improved for the period mainly on favorable comparisons due to tax accruals in the prior year. Those improvements were outweighed by higher losses in the special services group, primarily for the new food ingredients business. Higher selling, general, and administrative costs for the segment also contributed to the declines. Revenues for the segment were up by $12.2 million to $231.8 million for the year ended March 31, 2017, mostly due to increased volumes from the timing of shipments of oriental tobaccos into the United States compared to the previous year.

20

Other Items

Cost of goods sold decreased by about 2% to $1.7 billion for the fiscal year ended March 31, 2017. The decline was consistent with a comparable percentage decline in revenues, mostly as a result of lower green leaf prices. Selling, general, and administrative costs decreased by $14.7 million, or 6%, for the fiscal year ended March 31, 2017, compared with the prior fiscal year. The decline in fiscal year 2017 was mainly due to the favorable comparison to costs incurred in fiscal year 2016 to settle challenges regarding property rights and valuation of forestry land in South America, the reversal of value-added tax reserves, and lower net foreign currency and exchange remeasurement losses compared to the previous fiscal year.

The consolidated effective income tax rates were approximately 34% and 32% for the fiscal years ended March 31, 2017 and 2016, respectively.  Income taxes in both fiscal years were lower than the 35% federal statutory rate on a combination of lower net effective tax rates on income from certain foreign subsidiaries, and effects of changes in local currency exchange rates on deferred income tax balances, mainly in Brazil.

In December 2016, 111,072 shares of the Series B 6.75% Convertible Perpetual Preferred Stock were converted into approximately 2.5 million shares of our common stock. In January 2017, we announced a mandatory conversion of all 107,418 remaining outstanding shares of the preferred stock after meeting the requirements to initiate the mandatory conversion under the original terms of the preferred shares.  We chose to satisfy the conversion obligation for the mandatory conversion in cash.  Although the conversions of the preferred stock into common stock or for cash did not impact net income, the shares converted for cash under the mandatory conversion in January 2017 resulted in a one-time reduction of retained earnings of approximately $74.4 million during the quarter ended March 31, 2017, representing the excess of the conversion cost over the carrying value of those shares.  The reduction in retained earnings resulted in a corresponding one-time reduction of earnings available to common shareholders for the fiscal year ending March 31, 2017 for purposes of determining the amounts reported for basic and diluted earnings per share. The effect of the mandatory conversion on diluted earnings per share for the fiscal year ended March 31, 2017, was ($2.99).

Results for the year ended March 31, 2017, also included restructuring and impairment costs of $4.4 million ($0.10 per diluted share). Results for the year ended March 31, 2016, included restructuring and impairment costs of $2.4 million ($0.06 per diluted share) and a gain of $3.4 million ($0.08 per diluted share) on remeasuring our interest in a tobacco processing joint venture to fair value upon acquiring our partner’s 50% ownership in the third fiscal quarter.

Fiscal Year Ended March 31, 2016, Compared to the Fiscal Year Ended March 31, 2015

Net income for the fiscal year ended March 31, 2016, was $109.0 million, or $3.92 per diluted share, compared with net income for the fiscal year ended March 31, 2015, of $114.6 million, or $4.06 per diluted share. Those results included certain non-recurring items, detailed in Other Items below, which increased diluted earnings per share by $0.02 and $0.46 for the years ended March 31, 2016 and 2015, respectively. Excluding those items in both years, net income for fiscal year 2016 increased $6.8 million ($0.30 per diluted share) compared to the same period in fiscal year 2015. Segment operating income, which excludes those items, was $186.1 million for fiscal year 2016, an increase of $18.8 million, or 11%, from fiscal year 2015. That improvement was primarily attributable to a reduction in selling, general, and administrative costs, as well as improved gross margins on fiscal year 2016’s modestly higher sales volumes. Revenues of $2.1 billion for fiscal year 2016 declined 7% compared with fiscal year 2015, driven mainly by lower green leaf costs and lower processing revenues, partly mitigated by the increase in volumes.

Flue-cured and Burley Leaf Tobacco Operations

Other Regions

Operating income for the Other Regions segment for the fiscal year ended March 31, 2016, was $143.6 million, up 14% compared to $125.8 million for the fiscal year ended March 31, 2015. Better margins, fewer inventory write-downs, and lower selling, general, and administrative expenses drove the earnings improvement. These positive factors outweighed lower margins in Europe and the currency translation effects of a stronger U.S. dollar which negatively impacted results from that region. Strong volumes in most regions were offset by declines in Africa on smaller crop sizes in some origins compared to fiscal year 2015. Selling, general, and administrative expenses for the segment were down significantly for the fiscal year ended March 31, 2016, largely on reductions in local currency-denominated expenses from devaluation of foreign currencies, mainly in South America and Africa, and lower incentive compensation costs. Revenues for the segment were down about 12% to $1.5 billion, driven mostly by lower average green leaf prices and the modestly reduced volumes.

21

North America

Operating income for the North America segment for the fiscal year ended March 31, 2016, of $31.1 million was flat compared with the fiscal year ended March 31, 2015. Earnings improvements from sales volume increases, due in part to old crop sales in the first fiscal quarter of fiscal year 2016, and the previously announced change in business with Philip Morris International, Inc. in the United States from a toll processing model to sales of processed tobacco, were offset by lower margins and lower earnings from Guatemala and Mexico. In addition, processing volumes declined significantly compared with fiscal year 2015 as a result of that change in business, and a portion of crop volumes sold under this new arrangement carried over as shipments in fiscal year 2017. Fiscal year 2016 revenues for the segment increased by 19% to $361.8 million compared to fiscal year 2015, on higher sales volumes at lower green leaf prices, a less favorable product mix, and lower processing revenues.

Other Tobacco Operations

For the fiscal year ended March 31, 2016, the Other Tobacco Operations segment operating income increased by $1.0 million to $11.3 million compared with the fiscal year ended March 31, 2015. Earnings were up significantly for the dark tobacco operations on higher volumes, better margins, and lower selling, general, and administrative costs. That improvement was partly offset by lower results from the oriental joint venture as benefits from improved margins and lower overhead costs were outweighed by higher currency remeasurement losses and tax accruals. The special services group incurred losses for fiscal year 2016, mainly from startup and production testing costs for the new food ingredients business. Revenues for the segment were down by $7.4 million to $219.6 million for the fiscal year ended March 31, 2016, as the higher volumes for the dark tobacco operations were more than offset by reduced volumes at lower prices from the timing of shipments of oriental tobaccos into the United States compared to the fiscal year ended March 31, 2015.

Other Items

Cost of goods sold decreased by about 8% to $1.7 billion for the fiscal year ended March 31, 2016, primarily due to lower green leaf prices and the effects of local-currency devaluations on factory costs compared with the fiscal year ended March 31, 2015. Selling, general, and administrative costs decreased by $23.5 million for the fiscal year ended March 31, 2016, compared with the fiscal year ended March 31, 2015. The decline for fiscal year 2016 was mainly driven by reductions in local currency-denominated expenses from devaluation of foreign currencies in South America and Africa, and lower incentive compensation costs, reduced in part by higher net currency and exchange losses in Asia, as well as costs to settle challenges regarding property rights and valuation in South America.

Interest expense of $15.7 million for the fiscal year ended March 31, 2016, declined by about 8% compared to the fiscal year ended March 31, 2015. The reduction was mostly due to lower average short-term borrowings for seasonal working capital, offset in part by higher effective interest rates on long-term bank loans from fixed interest rate swaps entered on those loans in the fourth quarter of fiscal 2015. The consolidated effective tax rate for the fiscal year ended March 31, 2016, was approximately 32% compared to about 24% for the fiscal year ended March 31, 2015. Income taxes for fiscal year 2015 were reduced by a non-recurring benefit of $8.0 million arising from the partial payment of the European Commission fine by our Italian subsidiary in June 2014. In both fiscal year 2016 and 2015, the decrease from the 35% U.S. statutory rate was also influenced by lower net effective tax rates on income from certain foreign subsidiaries, as well as the effects of changes in local currency exchange rates on deferred income tax balances.

Results for the year ended March 31, 2016, included restructuring and impairment costs of $2.4 million ($0.06 per diluted share) and a gain of $3.4 million ($0.08 per diluted share) on remeasuring our interest in a tobacco processing joint venture to fair value upon acquiring our partner’s 50% ownership in the third fiscal quarter. Results for the year ended March 31, 2015, included an income tax benefit of $8.0 million ($0.28 per diluted share) arising from a subsidiary’s payment of a portion of a fine, restructuring costs of $4.9 million ($0.11 per diluted share), and a gain of $12.7 million ($0.29 per diluted share), from updated projections related to the favorable outcome in fiscal year 2014 of litigation in Brazil regarding previous years’ excise tax credits.

Accounting Pronouncements

See "Accounting Pronouncements" in Note 1 to the consolidated financial statements in Item 8 of this Annual Report for a discussion of recent accounting pronouncements issued by the Financial Accounting Standards Board ("FASB") that will become effective and be adopted by the Company in future reporting periods.

22

LIQUIDITY AND CAPITAL RESOURCES

Overview

Our working capital requirements in fiscal year 2017 were lower than those in fiscal year 2016 due in part to reduced purchase volumes in Brazil. Our buying program in Brazil was reduced in fiscal year 2017 due to the smaller size of the Brazilian crop, largely from El Nino weather patterns, and unsustainable green leaf prices. Similar to last year, our shipments were heavily weighted to the second half of the fiscal year. In fiscal year 2017, we generated $250.3 million in cash flows from our operating activities, and our liquidity was sufficient to meet our needs, including the $178.4 million cash settlement of the mandatory conversion of the remainder of our Series B 6.75% Convertible Perpetual Preferred Stock ("Series B Preferred Stock") in the fourth fiscal quarter. We also continued our conservative financial policies, maintained our discipline on using our free cash flow, and returned funds to shareholders.

Our liquidity and capital resource requirements are predominately short-term in nature and primarily relate to working capital required for tobacco crop purchases. Working capital needs are seasonal within each geographic region. The geographic dispersion and the timing of working capital needs permit us to predict our general level of cash requirements, although crop sizes, prices paid to farmers, shipment and delivery timing, and currency fluctuations affect requirements each year. Peak working capital requirements are generally reached during the first and second fiscal quarters. Each geographic area follows a cycle of buying, processing, and shipping tobacco, and in many regions we also provide agricultural materials to farmers during the growing season. The timing of the elements of each cycle is influenced by such factors as local weather conditions and individual customer shipping requirements, which may change the level or the duration of crop financing. Despite a predominance of short-term needs, we maintain a portion of our total debt as long-term to reduce liquidity risk. We also periodically have large cash balances that we utilize to meet our working capital requirements.

We believe that our financial resources are adequate to support our capital needs for at least the next twelve months. Our seasonal borrowing requirements primarily relate to purchasing crops in South America and Africa and can increase from March to September by more than $300 million. The funding required can vary significantly depending upon such factors as crop sizes, the price of leaf, the relative strength of the U.S. dollar, and the timing of shipments and customer payments. We deal with this uncertainty by maintaining substantial credit lines and cash balances. In addition to our operating requirements for working capital, we expect to spend around $35 to $45 million during fiscal year 2018 for capital expenditures to maintain our facilities and invest in opportunities to grow and improve our businesses. We also expect to provide about $8 million in funding to our pension plans. We have no long-term debt maturing before fiscal year 2020. After balancing our capital structure, any excess cash flow from operations after dividends and capital expenditures will be available to fund expansion, purchase our stock, or otherwise enhance shareholder value.

Cash Flow

Our operations generated about $250.3 million in operating cash flows in fiscal year 2017. That amount was about $63.8 million higher than the $186.5 million we generated in fiscal year 2016, largely due to lower working capital requirements in fiscal year 2017 on the reduced purchase volumes in Brazil, as well as earlier shipment timing in North America and increased trade payables and accrued expenses in Brazil and Africa. During the fiscal year ended March 31, 2017, we spent $35.6 million on capital projects, settled the mandatory conversion of our Series B Preferred Stock for $178.4 million in cash, and returned $60.9 million to shareholders in the form of dividends. At March 31, 2017, cash balances totaled $284.0 million.

Working Capital

Working capital at March 31, 2017, was about $1.3 billion, down $98.9 million from last year's level of about $1.4 billion, largely due to reduced purchase volumes in Brazil, earlier shipment timing in North America, and increased trade payables and accrued expenses in Brazil and Africa in fiscal year 2017 compared to fiscal year 2016. Tobacco inventories of $565.9 million at March 31, 2017, were down $71.2 million compared to inventory levels at the end of the prior fiscal year, largely on the lower purchase volumes and earlier shipments. We usually finance inventory with a mix of cash, notes payable, and customer deposits, depending on our borrowing capabilities, interest rates, and exchange rates, as well as those of our customers. We generally do not purchase material quantities of tobacco on a speculative basis. However, when we contract directly with farmers, we are often obligated to buy all stalk positions, which may contain less marketable leaf styles. Our uncommitted tobacco inventories decreased by approximately $4.6 million to $116.2 million, or about 21% of tobacco inventory, at March 31, 2017. Uncommitted inventories at March 31, 2016, were $120.8 million, which represented 19% of tobacco inventory. The level of these uncommitted inventories is influenced by timing of farmer deliveries of new crops, as well as the receipt of customer orders.

23

Share Activity

During December 2016, holders of 111,072 shares of our Series B Preferred Stock voluntarily exercised their conversion rights. These shares were converted into 2,487,118 shares of our common stock. In January 2017, we exercised our option to mandatorily convert all remaining outstanding shares of our Series B Preferred Stock and elected to settle our conversion obligation in cash. Holders of the Series B Preferred Stock received the product of the conversion rate, 22.4306, and the average volume weighted average price of Universal’s common stock during the cash settlement averaging period for each share of Series B Preferred Stock converted. The cash settlement occurred on January 31, 2017, and totaled approximately $178.4 million on the 107,418 shares of Series B Preferred Stock converted. We used cash on hand for the settlement. All rights of the holders with respect to the Series B Preferred Stock terminated upon conversion. The Series B Preferred Stock dividends, totaling approximately $15 million per annum, are no longer paid.

Our Board of Directors approved our current share repurchase program in November 2015. The program expires in November 2017, authorizes the purchase of up to $100 million of our common and preferred stock. Under the current authorization, we may purchase shares from time to time on the open market or in privately negotiated transactions at prices not exceeding prevailing market rates. In determining our level of common share repurchase activity, our intent is to use only cash available after meeting our anticipated capital investment, dividend, and working capital requirements. Repurchases of shares under the repurchase program may vary based on management discretion, as well as changes in cash flow generation and availability. During fiscal year 2017, we did not purchase any shares of our common or preferred stock under this program. At March 31, 2017, our available authorization under our current share repurchase program was $100 million, and approximately 25.3 million common shares were outstanding.

Capital Spending

Our capital expenditures are generally limited to those that add value, replace or maintain equipment, increase efficiency, or position us for future growth. In deciding where to invest capital resources, we look for opportunities where we believe we can earn an adequate return, leverage our assets and expertise, and enhance our farmer base. During fiscal years 2017 and 2016, we invested $35.6 million and $47.2 million, respectively, in our property, plant, and equipment. Depreciation expense was approximately $35.9 million and $36.8 million, respectively, in fiscal years 2017 and 2016. Generally, our capital spending on maintenance projects is at a level below depreciation expense in order to maintain strong cash flow. In addition, from time to time, we undertake projects that require capital expenditures when we identify opportunities to improve efficiencies, add value for our customers, and position ourselves for future growth. We currently plan to spend approximately $35 to $45 million in fiscal year 2018 on capital projects for maintenance of our facilities and other investments to grow and improve our businesses.

Outstanding Debt and Other Financing Arrangements

We consider the sum of notes payable and overdrafts, long-term debt (including any current portion), and customer advances and deposits, less cash, cash equivalents, and short-term investments on our balance sheet to be our net debt. We also consider our net debt plus shareholders' equity to be our net capitalization. Net debt increased by $23.3 million to $154.9 million during the fiscal year ended March 31, 2017. The increase primarily reflects lower cash balances due mainly to the cash settlement of our Series B Preferred Stock mandatory conversion in the fourth fiscal quarter. Net debt as a percentage of net capitalization was approximately 11% at March 31, 2017, up from 9% at March 31, 2016, and it remains lower than our target limit for peak borrowings of 30% to 40% of net capitalization.

As of March 31, 2017, we had $430 million available under a committed revolving credit facility that will mature in December 2019, and we, together with our consolidated affiliates, had approximately $307 million in uncommitted lines of credit, of which approximately $248 million were unused and available to support seasonal working capital needs. The financial covenants under our committed revolving credit facility require us to maintain certain levels of tangible net worth and observe restrictions on debt levels. As of March 31, 2017, we were in compliance with all covenants of our debt agreements. We also have an active, undenominated universal shelf registration filed with the SEC in November 2014 that provides for future issuance of additional debt or equity securities. We have no long-term debt maturing in fiscal year 2018.

Derivatives

From time to time, we use interest rate swap agreements to manage our exposure to changes in interest rates. Currently, we have interest rate swap agreements that convert the variable benchmark LIBOR rate on our two outstanding term loans to fixed rates. With the swap agreements in place, the effective interest rates on our $150 million five-year term loan and $220 million seven-year term loan were 2.94% and 3.48%, respectively, as of March 31, 2017. These agreements were entered into to eliminate the variability of cash flows in the interest payments on our variable rate five- and seven-year term loans and are accounted for as cash flow hedges. Under the swap agreements, we receive variable rate interest and pay fixed rate interest. At March 31, 2017, the fair value of our open interest rate hedge swaps was a net asset of approximately $2 million.

We also enter forward contracts from time to time to hedge certain foreign currency exposures, primarily related to forecast purchases of tobacco and related processing costs in Brazil, as well as our net monetary asset exposure in local currency there. We generally account for our hedges of forecast tobacco purchases as cash flow hedges. At March 31, 2017, the fair value of those open contracts was an immaterial net asset. We also had other forward contracts outstanding that were not designated as hedges, and the

24

fair value of those contracts was a net asset of approximately $0.8 million at March 31, 2017. For additional information, see Note 8 to the consolidated financial statements in Item 8.

Pension Funding

Funds supporting our ERISA-regulated U.S. defined benefit pension plan increased by $10 million during fiscal year 2016 to $207 million, as contributions and asset returns exceeded benefit payments. The accumulated benefit obligation (“ABO”) and the projected benefit obligation (“PBO”) were both approximately $223 million as of March 31, 2017. The ABO and PBO are calculated on the basis of certain assumptions that are outlined in Note 10 to the consolidated financial statements in Item 8. We expect to make contributions of about $8 million to our pension plans, including $6 million to our ERISA-regulated plan, during the next year. It is our policy to regularly monitor the performance of the funds and to review the adequacy of our funding and plan contributions.

Contractual Obligations

Our contractual obligations as of March 31, 2017, were as follows:

(in thousands of dollars)	Total		2018		2019-2020		2021-2022		After 2022
Notes payable and long-term debt (1)	$	479,404	$	73,007	$	173,012	$	233,385	$	—
Operating lease obligations	50,774		11,512		15,706		9,859		13,697
Inventory purchase obligations:
Tobacco	690,111		622,408		67,703		—		—
Agricultural materials	43,103		43,103		—		—		—
Other purchase obligations	5,314		5,314		—		—		—
Total	$	1,268,706	$	755,344	$	256,421	$	243,244	$	13,697

⁽¹⁾  Includes interest payments. Interest payments on $429.1 million of variable rate debt were estimated based on rates as of March 31, 2017. The Company has entered into interest rate swaps that effectively convert the interest payments on the $370.0 million outstanding balance of its two bank term loans from variable to fixed. The fixed rate has been used to determine the contractual interest payments for all periods.

In addition to principal and interest payments on notes payable and long-term debt, our contractual obligations include operating lease payments, inventory purchase commitments, and capital expenditure commitments. Operating lease obligations represent minimum payments due under leases for various production, storage, distribution, and other facilities, as well as vehicles and equipment. Tobacco inventory purchase obligations primarily represent contracts to purchase tobacco from farmers. The amounts shown above are estimates since actual quantities purchased will depend on crop yield, and prices will depend on the quality of the tobacco delivered. About 43% of our crop year contracts to purchase tobacco are with farmers in Brazil. We have partially funded our tobacco purchases in Brazil and in other regions with advances to farmers and other suppliers, which totaled approximately $104 million, net of allowances, at March 31, 2017. In addition, we have guaranteed bank loans to farmers in Brazil that relate to a portion of our tobacco purchase obligations there. At March 31, 2017, we were contingently liable under those guarantees for outstanding balances of approximately $17 million (including accrued interest), and we had recorded a liability of approximately $1 million for the fair value of those guarantees. As tobacco is purchased and the related bank loans are repaid, our contingent liability is reduced.

25

CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS

In preparing the financial statements in accordance with GAAP, we are required to make estimates and assumptions that have an impact on the assets, liabilities, revenue, and expense amounts reported. These estimates can also affect our supplemental information disclosures, including information about contingencies, risks, and financial condition. We believe, given current facts and circumstances, that our estimates and assumptions are reasonable, adhere to GAAP, and are consistently applied. However, changes in the assumptions used could result in a material adjustment to the financial statements. Our critical accounting estimates and assumptions are in the following areas:

Inventories

Inventories of tobacco are valued at the lower of cost or market with cost determined under the specific cost method. Raw materials are clearly identified at the time of purchase. We track the costs associated with raw materials in the final product lots, and maintain this identification through the time of sale. We also capitalize direct and indirect costs related to processing raw materials. This method of cost accounting is referred to as the specific cost or specific identification method. We write down inventory for changes in market value based upon assumptions related to future demand and market conditions if the indicated market value is below cost. Future demand assumptions can be impacted by changes in customer sales, changes in customers’ inventory positions and policies, competitors’ pricing policies and inventory positions, and varying crop sizes and qualities. Market conditions that differ significantly from those assumed by management could result in additional write-downs. We experience inventory write-downs routinely. Inventory write-downs in fiscal years 2017, 2016, and 2015 were $10.9 million, $11.9 million, and $18.6 million, respectively. The Company incurred a higher level of inventory write-downs in fiscal year 2015 primarily due to the effects of oversupply conditions in the global leaf tobacco markets.

Advances to Suppliers and Guarantees of Bank Loans to Suppliers

In many sourcing origins, we provide tobacco growers with agronomy services and seasonal crop advances of, or for, seed, fertilizer, and other supplies. These advances are short term in nature and are customarily repaid upon delivery of tobacco to us. In several origins, we have also made long-term advances to tobacco farmers to finance curing barns and other farm infrastructure. In Brazil, we also guarantee bank loans made to farmers for seasonal crop financing. In some years, due to low crop yields and other factors, individual farmers may not deliver sufficient volumes of tobacco to repay maturing advances. In those cases, we may extend repayment of the advances into the following crop year or satisfy the guarantee by acquiring the loan from the bank. In either situation, we will incur losses whenever we are unable to recover the full amount of the loans and advances. At each reporting period, we must make estimates and assumptions in determining the valuation allowance for advances to farmers and the liability to accrue for our obligations under bank loan guarantees. At March 31, 2017, the gross balance of advances to suppliers totaled approximately $134 million, and the related valuation allowance totaled approximately $27 million. The fair value of the loan guarantees for farmers in Brazil was a liability of approximately $1 million at March 31, 2017.

Recoverable Value-Added Tax Credits

In many foreign countries, we pay significant amounts of value-added tax (“VAT”) on purchases of unprocessed and processed tobacco, crop inputs, packing materials, and various other goods and services. In some countries, VAT is a national tax, and in other countries it is assessed at the state level. Items subject to VAT vary from jurisdiction to jurisdiction, as do the rates at which the tax is assessed. When we sell tobacco to customers in the country of origin, we generally collect VAT on those sales. We are normally permitted to offset our VAT payments against those collections and remit only the incremental VAT collections to the tax authorities. When tobacco is sold for export, VAT is normally not assessed. In countries where our tobacco sales are predominately for export markets, we often do not generate enough VAT collections on downstream sales to fully offset our VAT payments. In those situations, we can accumulate unused VAT credits. Some jurisdictions have procedures that allow companies to apply for refunds of unused VAT credits from the tax authorities, but the refund process often takes an extended period of time and it is not uncommon for refund applications to be challenged or rejected in part on technical grounds. Other jurisdictions may permit companies to sell or transfer unused VAT credits to third parties in private transactions, although approval for such transactions must normally be obtained from the tax authorities, limits on the amounts that can be transferred may be imposed, and the proceeds realized may be heavily discounted from the face value of the credits. Due to these factors, in some countries we can accumulate significant balances of VAT credits over time. We review these balances on a regular basis, and we record valuation allowances on the credits to reflect amounts that we do not expect to recover, as well as discounts anticipated on credits we expect to sell or transfer. In determining the appropriate valuation allowance to record in a given jurisdiction, we must make various estimates and assumptions about factors affecting the ultimate recovery of the VAT credits. At March 31, 2017, the gross balance of recoverable tax credits (primarily VAT) totaled approximately $45 million, and the related valuation allowance totaled approximately $13 million.

26

Goodwill

We review the carrying value of goodwill for potential impairment on an annual basis and at any time that events or business conditions indicate that it may be impaired. As permitted under Accounting Standards Codification Topic 350 (“ASC 350”), at March 31, 2017 and 2016, we elected to base our initial assessment of potential impairment on qualitative factors. Those factors did not indicate any impairment of our recorded goodwill. In fiscal years prior to basing our initial assessment on qualitative factors, we followed the quantitative approach in ASC 350 in assessing the fair value of our goodwill, which involved the use of discounted cash flow models (Level 3 of the fair value hierarchy under GAAP). Under our current qualitative assessment, we would also use those discounted cash flow models to measure any expected impairment indicated by the assessment. The calculations in these models are not based on observable market data from independent sources and therefore require significant management judgment with respect to operating earnings growth rates and the selection of an appropriate discount rate. Significant adverse changes in our operations or our estimates of future cash flows for a reporting unit with recorded goodwill, such as those caused by unforeseen events or changes in market conditions, could result in an impairment charge. Over 90% of our goodwill balance relates to our reporting unit in Brazil.

Fair Value Measurements

We hold various financial assets and financial liabilities that are required to be measured and reported at fair value in our financial statements, including money market funds, trading securities associated with deferred compensation plans, interest rate swaps, forward foreign currency exchange contracts, and guarantees of bank loans to tobacco growers. We follow the relevant accounting guidance in determining the fair values of these financial assets and liabilities. Money market funds are valued based on net asset value (“NAV”), which is used as a practical expedient to measure the fair value of those funds (not classified within the fair value hierarchy). Quoted market prices (Level 1 of the fair value hierarchy) are used in most cases to determine the fair values of trading securities. Interest rate swaps and forward foreign currency exchange contracts are valued based on dealer quotes using discounted cash flow models matched to the contractual terms of each instrument (Level 2 of the fair value hierarchy). The fair value of the guarantees of bank loans to tobacco growers, which was approximately $1 million at March 31, 2017, is derived using an internally-developed discounted cash flow model. The model requires various inputs, including historical loss percentages for comparable loans and a risk-adjusted interest rate. Because significant management judgment is required in determining and applying these inputs to the valuation model, our process for determining the fair value of these guarantees is classified as Level 3 of the fair value hierarchy. At March 31, 2017, a 1% increase in the expected loss percentage for all guaranteed farmer loans would not have had a material effect on the fair value of the guarantee obligation. In addition, a 1% change in the risk-adjusted interest rate would not have had a material effect on the fair value of the guarantee obligation. We incorporate credit risk in determining the fair values of our financial assets and financial liabilities, but that risk did not materially affect the fair values of any of those assets or liabilities at March 31, 2017.

Income Taxes

Our consolidated effective income tax rate is based on our expected taxable income, tax laws and statutory tax rates, and tax planning opportunities in the various jurisdictions in which we operate. Significant judgment is required in determining the effective tax rate and evaluating our tax position. We are subject to the tax laws of many jurisdictions, and could be subject to a tax audit in each of these jurisdictions, which could result in adjustments to tax expense in future periods. In the event that there is a significant, unusual, or one-time item recognized in our results, the tax attributed to that discrete item would be recorded at the same time as the item.

We have no undistributed earnings of consolidated foreign subsidiaries that are classified as permanently or indefinitely reinvested. We assume that all undistributed earnings of our foreign subsidiaries will be repatriated back to their parent entities in the United States where the funds are best placed to meet our cash flow requirements. In addition, we strive to mitigate economic, political, and currency risk by following a disciplined annual approach to the distribution of excess capital back to the U.S. Based on these assumptions, in our income tax expense for each reporting period we fully provide for all additional U.S. income taxes that are expected to be due on these distributions.

Our accounting for uncertain tax positions requires that we review all significant tax positions taken, or expected to be taken, in income tax returns for all jurisdictions in which we operate. In this review, we must assume that all tax positions will ultimately be audited, and either accepted or rejected based on the applicable tax regulations by the tax authorities for those jurisdictions. We must recognize in our financial statements only the tax benefits associated with tax positions that are “more likely than not” to be accepted upon audit, at the greatest amount that is considered “more likely than not” to be accepted. These determinations require significant management judgment, and changes in any given quarterly or annual reporting period could affect our consolidated income tax rate.

Tax regulations require items to be included in taxable income in the tax return at different times, and in some cases in different amounts, than the items are reflected in the financial statements. As a result, our effective tax rate reflected in the financial statements is different than that reported in our tax returns. Some of these differences are permanent, such as expenses that are not tax deductible, while others are related to timing issues, such as differences in depreciation methods. Timing differences create deferred tax assets and liabilities. Deferred tax liabilities generally represent tax expense recognized in our financial statements for

27

which payment has been deferred or income taxes related to expenses that have not yet been recognized in the financial statements, but have been deducted in our tax return. Deferred tax assets generally represent items that can be used as a tax deduction or credit in future tax returns for which we have already recorded the tax benefit in our financial statements. We record valuation allowances for deferred tax assets when the amount of estimated future taxable income is not likely to support the use of the deduction or credit. Determining the amount of such valuation allowances requires significant management judgment, including estimates of future taxable income in multiple tax jurisdictions where we operate. Based on our periodic earnings forecasts, we project the upcoming year’s taxable income to help us evaluate our ability to realize deferred tax assets.

The functional currency in most of our significant foreign operations is the U.S. dollar, as export tobacco sales are generally made in dollars. Purchasing and processing costs are usually incurred in local currency. When the U.S. dollar is weakening relative to the local currency, purchasing and processing costs increase in dollar terms, resulting in higher cost inventory. The sale of that inventory in dollars generates less taxable income in local currency, which results in lower income taxes owed when translated into U.S. dollars. This causes the effective income tax rate on dollar income to be lower than the statutory rate in the local country. The reverse can occur when the local currency is weakening relative to the U.S. dollar, thereby causing the effective income tax rate on dollar earnings to be above the statutory rate. This impact on our effective income tax rate in a country can be significant during a normal crop cycle. A prolonged period of strengthening or weakening over more than one crop may increase the impact if we sell material quantities of old crop inventories. Lower-taxed foreign source income increases our ability to use foreign tax credits. Higher-taxed foreign source income has the reverse effect. When these changes occur in our larger operations, such as our operations in Brazil, they can have a material impact on our overall tax position.

For additional disclosures on income taxes, see Notes 1 and 4 to the consolidated financial statements in Item 8.

Pension and Other Postretirement Benefit Plans

The measurement of our pension and other postretirement benefit obligations and costs at the end of each fiscal year requires that we make various assumptions that are used by our actuaries in estimating the present value of projected future benefit payments to all plan participants. Those assumptions take into consideration the likelihood of potential future events such as salary increases and demographic experience. The assumptions we use may have an effect on the amount and timing of future contributions to our plans. The plan trustee conducts an independent valuation of the fair value of pension plan assets. The significant assumptions used in the calculation of our pension and other postretirement benefit obligations are:

• Discount rate – The discount rate is based on investment yields on a hypothetical portfolio of actual long-term corporate bonds rated AA that align with the cash flows for our benefit obligations.

• Salary scale – The salary scale assumption is based on our long-term actual experience for salary increases, the near-term outlook, and expected inflation.

• Expected long-term return on plan assets – The expected long-term return on plan assets reflects asset allocations and investment strategy adopted by the Pension Investment Committee of the Board of Directors.

• Retirement and mortality rates – Retirement rates are based on actual plan experience along with our near-term outlook. Early retirement assumptions are based on our actual experience. Mortality rates are based on standard industry group annuity mortality tables which are updated to reflect projected improvements in life expectancy.

• Healthcare cost trend rates – For postretirement medical plan obligations and costs, we make assumptions on future inflationary increases in medical costs. These assumptions are based on our actual experience, along with third-party forecasts of long-term medical cost trends.

From one fiscal year to the next, the rates we use for each of the above assumptions may change based on market developments and other factors. The discount rate reflects prevailing market interest rates at the end of the fiscal year when the benefit obligations are actuarially measured and will increase or decrease based on market patterns. The expected long-term return on plan assets may change based on changes in investment strategy for plan assets or changes in indicated longer-term yields on specific classes of plan assets. Based on the high percentage of retired and inactive participants in our ERISA-regulated domestic defined benefit pension plan (approximately 75% of total participants), as well as the high funded status of the plan, the Pension Investment Committee adopted changes to the underlying plan assets to move toward a liability-driven investment strategy. We reduced our expected long-term return on assets assumption for the actuarial valuations in both fiscal years 2015 and 2016, primarily to reflect those changes. We also adopted revised mortality tables in fiscal year 2015 based on updated actuarial studies reflecting improvements in life expectancy. In addition to the changes in actuarial assumptions from year to year, actual plan experience affecting our net benefit obligations, such as actual returns on plan assets and actual mortality experience, will differ from the assumptions used to measure the obligations. The effects of these changes and differences increase or decrease the obligation we record for our pension and other postretirement benefit plans, and they also create gains and losses that are accumulated and amortized over future periods, thus affecting the expense we recognize for these plans over those periods. Changes in the discount rate from year to year generally have the largest impact on our projected benefit obligation and annual expense, and the effects may be significant, particularly over successive years where the discount rate moves in the same direction.

28

As of March 31, 2017, the effect of the indicated increase or decrease in the selected pension and other postretirement benefit valuation assumptions is shown below. The effect assumes no change in benefit levels.

(in thousands of dollars)	Effect on 2017 Projected Benefit Obligation Increase (Decrease)			Effect on 2018 Annual Expense Increase (Decrease)
Changes in Assumptions for Pension Benefits
Discount Rate:
1% increase	$	(26,653	)	$	(2,597	)
1% decrease	32,337			2,872
Expected Long-Term Return on Plan Assets:
1% increase	—			(2,264		)
1% decrease	—			2,264
Changes in Assumptions for Other Postretirement Benefits
Discount Rate:
1% increase	(3,055		)	(347		)
1% decrease	3,603			165
Healthcare Cost Trend Rate:
1% increase	769			38
1% decrease	(688		)	(37		)

A 1% increase or decrease in the salary scale assumption would not have a material effect on the projected benefit obligation or on annual expense for the Company's pension benefits. See Note 10 to the consolidated financial statements in Item 8 for additional information on pension and other postretirement benefit plans.

Other Estimates and Assumptions

Other management estimates and assumptions are routinely required in preparing our financial statements, including the determination of valuation allowances on accounts receivable and the fair value of long-lived assets. Changes in market and economic conditions, local tax laws, and other related factors are considered each reporting period, and adjustments to the accounts are made based on management’s best judgment.

29

OTHER INFORMATION REGARDING TRENDS

AND MANAGEMENT’S ACTIONS

Our financial performance depends on our ability to obtain an appropriate price for our products and services, to secure the tobacco volumes and quality desired by our customers, and to maintain efficient, competitive operations. We continually monitor issues and opportunities that may impact the supply of and demand for leaf tobacco, the volumes of leaf tobacco that we handle, and the services we provide.

Supply

Global flue-cured and burley tobacco production decreased in our fiscal year 2017, largely due to smaller crops in Brazil following adverse weather conditions there. This was the second fiscal year of declines in crop sizes following oversupplied tobacco markets in fiscal year 2015. Crop sizes for flue-cured tobaccos available for export are expected to increase modestly in fiscal year 2018, primarily on the recovery of the Brazilian tobacco crops due to better weather conditions, while burley crops sizes are expected to decrease. Though we believe that flue-cured tobacco is in a slight oversupply position and burley tobacco production levels are largely in balance with anticipated demand, imbalances in certain leaf styles or types may remain through fiscal year 2018.

Production

Worldwide flue-cured tobacco production outside of China decreased by about 13% in fiscal year 2017 to 1.8 billion kilos, including an approximately 19% reduction in Brazil following El Nino weather patterns there. Worldwide burley crops decreased by about 9% in fiscal year 2017. We estimate that at March 31, 2017, industry uncommitted flue-cured and burley inventories, excluding China, totaled about 83 million kilos, a decrease of about 28% from March 31, 2016 levels.

In the near term, flue-cured tobacco production is expected to increase driven by the recovery of the Brazilian crop, partially offset by smaller crops in many other flue-cured tobacco growing origins. We expect that flue-cured production (excluding China) will increase by about 9%, to about 1.9 billion kilos, in fiscal year 2018, including about a 35% increase in the size of the Brazilian flue-cured crop. Worldwide burley production is forecast to decrease by about 8%. We also forecast that oriental tobacco and dark air-cured production will decline by 5% and 15%, respectively, in fiscal year 2018. Over the long term, we believe that global tobacco production will continue a slight decline in line with slightly declining total demand. South America, Asia, Africa, and North America will remain key sourcing regions for flue-cured and burley tobaccos.

China

China is a significant cigarette market. However, most of the cigarettes consumed in China and the leaf tobacco used in those cigarettes are produced domestically. Therefore, we normally view the Chinese market independently when evaluating worldwide leaf tobacco supply and demand. Recently, the Chinese domestic cigarette consumption level has decreased. We believe that China’s domestic leaf production now exceeds their domestic needs for the local cigarette market, and we have seen a build-up of domestic leaf inventory there. China is currently demonstrating efforts to re-align their domestic leaf production and inventories to balance their needs, and these efforts could influence global supply/demand in the short term.

Pricing

Factors that affect green tobacco prices include global supply and demand, market conditions, production costs, foreign exchange rates, and competition from other crops. We work with farmers to maintain tobacco production and to secure product at price levels that are attractive to both the farmers and our customers. Our objective is to secure compliant tobacco that is produced in a cost-effective manner under a sustainable business model with the desired quality for our customers. In some areas, tobacco competes with agricultural commodity products for farmer production. If prices for soybeans, wheat, rice, and seed oils rise in certain origins, green tobacco prices may have to rise to maintain tobacco production levels. In the past, leaf shortages in specific markets or on a worldwide basis have also led to green tobacco price increases.

30

Demand

Industry data shows that over the past ten years, total world consumption of cigarettes fell at the compound annual rate of 0.8%. We believe that growth in world consumption of cigarettes peaked several years ago and is declining. As a result, we expect that near term global demand for leaf tobacco will continue to slowly decline in line with declining cigarette consumption.

Our sales consist primarily of flue-cured and burley tobaccos. Those types of tobacco, along with oriental tobaccos, are used in American-blend cigarettes which are primarily smoked in Western Europe and the United States. English-blend cigarettes which use flue-cured tobacco are mainly smoked in the United Kingdom and Asia and other emerging markets. Industry data shows that consumption of American-blend cigarettes has declined at a compound annual rate of 2.6% for the ten years ended in 2016. As cigarette consumption declines in developed markets and increases in the emerging markets, there may be less demand for burley and oriental tobaccos and more demand for flue-cured tobacco. However, demand is affected by many factors, including regulation, product taxation, illicit trade, alternative tobacco products, and Chinese imports. To the extent that domestic leaf production and inventory durations in China do not meet requirements for Chinese cigarette blends, that tobacco could be sourced from other origins where we have major market positions. On a year-to-year basis, we are also susceptible to fluctuations in leaf supply due to crop sizes and leaf demand as manufacturers adjust inventories or respond to changes in cigarette markets. With higher projected crop year 2017 leaf tobacco production, we currently expect supply for flue-cured tobacco to be in a slight oversupply position and burley tobacco to be largely in line with anticipated demand. However, inventories held by our customers may affect their near-term demand for leaf tobacco. We also sell oriental tobacco, which is used in American-blend cigarettes, and dark tobacco, which is used in cigars and other smokeless products. While we expect demand for oriental tobacco and dark tobacco used in cigar filler to be generally in line with supply, we are seeing an undersupply of dark tobacco used for cigar wrappers.

Regulation and Product Taxation

Decreased social acceptance of smoking and increased pressure from anti-smoking groups have had an ongoing adverse effect on the percentage of the population using tobacco products, particularly in the United States and Western Europe. Also, many foreign governments have taken or proposed steps to restrict or prohibit cigarette advertising and promotion, to increase taxes on cigarettes, to prohibit smoking in public areas, and to discourage cigarette consumption. A number of such measures are included in the Framework Convention on Tobacco Control (“FCTC”), which was negotiated under the auspices of the WHO and offers guidelines for discouraging or controlling tobacco use. Countries that are parties to the FCTC may choose the level of implementation of the guidelines that is most suitable with their approach to tobacco control. For example, recently China imposed a ban on smoking in public places, and in the United Kingdom and Australia, laws have been passed mandating plain packaging, the removal of branding on cigarette packages. We cannot predict the extent to which government efforts to reduce tobacco consumption might affect the business of our primary customers. However, a significant decrease in worldwide tobacco consumption, as well as shifts to modified risk tobacco products brought about by existing or future governmental laws and regulations, could reduce demand for leaf tobacco and services and could have a material adverse effect on our results of operations.

In addition, certain recommendations by the WHO, through the FCTC, may cause shifts in customer usage of certain types and styles of tobacco. As seen in Canada, Brazil, and the European Union, efforts have been taken to eliminate flavorings from tobacco products. Such decisions could cause a change in requirements for certain tobaccos in particular countries. Shifts in customer demand from one type of tobacco to another could create sourcing issues as requirements move from one origin to another. Furthermore, instruction at the farm level may be required to produce the changing styles of tobacco needed by tobacco product manufacturers. Given our established and well-developed programs at the farm level worldwide, we are particularly well positioned to meet manufacturer requirements.

In 2009, the U.S. Congress passed the Family Smoking Prevention and Tobacco Control Act (“the Act”). This legislation authorizes the FDA to regulate the manufacturing and marketing of all tobacco products. The FDA has banned flavored cigarettes, restricted youth access to tobacco products, banned advertising claims regarding certain tobacco products, established new smokeless tobacco warnings, and issued new cigarette health warnings. In addition, the FDA established the Center for Tobacco Products (“CTP”). The CTP has focused on establishing the scientific foundation and regulatory framework for regulating tobacco products in the United States. On May 10, 2016, the FDA released “deeming” regulations that extend FDA oversight to all tobacco products including electronic nicotine delivery systems, cigars, hookah tobacco, pipe tobacco, dissolvables, and “novel and future products.” The regulations require that tobacco product manufacturers register tobacco products that existed on February 15, 2007, and to seek FDA authorization to sell any products modified or introduced after such date. All such submissions require manufacturers to list ingredients in their products. Regulations impacting our customer base that change the requirements for leaf tobacco or restrict their ability to sell their products will inherently impact our business. As discussed, we have established programs that begin at the farm level to assist our customers with raw material information to support leaf traceability and customer testing requirements. Additionally, given our global presence, we also have the ability to source different types and styles of tobacco for our customers should their needs change due to regulation.

31

A number of governments, particularly federal and local governments in the United States and the European Union, impose excise or similar taxes on tobacco products. There has been, and will likely continue to be, new legislation proposing new or increased taxes on tobacco products. In some cases, proposed legislation seeks to significantly increase existing taxes on tobacco products, or impose new taxes on products that to date have not been subject to tax. Increases in product taxation may reduce the affordability of cigarettes and influence the level of illicit trade, which will affect the global leaf markets.

Illicit Trade

Illicit trade is another factor which influences demand for leaf tobacco. Industry estimates of the illegal, unregulated black market for cigarettes are approximately 10% to 12% of global stick consumption, representing $40 to $50 billion in lost tax revenue globally. We support industry efforts to eradicate illicit trade.

Alternative Tobacco Products

Many of the major tobacco product manufacturers have been developing next generation and modified risk products. These include electronic nicotine delivery systems, liquid vaporizers, and non-combustible products. Electronic nicotine delivery systems and liquid vaporizers use liquid nicotine, which is predominately derived from leaf tobacco, and non-combustible products use leaf tobacco. At this time it is unclear how these new products will affect demand for leaf tobacco. However, as our customers develop these products, we continue to work with them to make sure we are well-positioned to meet their needs for both their traditional and new products. Currently, regulation of these products as well as consumer acceptance and their influence on smoking trends are unclear, and we continue to monitor industry developments. Electronic nicotine delivery systems, non-combustible products, and other next generation products are now primarily consumed in Western Europe, Japan, and the United States, and it is unclear what effect the consumption of these new products may have on global demand for leaf tobacco in the future.

Current Industry Dynamics

Leaf tobacco is sourced directly by product manufacturers, by global leaf suppliers such as ourselves, and by other smaller, mostly regional or local, leaf suppliers. We estimate that, of the flue-cured and burley tobacco grown outside of China, approximately one-third is purchased directly by major manufacturers, slightly over one-third is handled by the global leaf suppliers, and the remainder is sourced by the smaller regional or local suppliers. Although we operate in a mature industry, where demand for the end products is declining at a slow rate, we continually look for ways to grow our business. In recent years, we believe that we have been able to maintain relatively steady tobacco volumes handled, despite declines in demand for leaf tobacco from product manufacturers, by increasing our market share. We also believe that there are several longer term trends in the industry that could provide additional opportunities for us to maintain or increase our market share and to offer additional services to our customers.

Manufacturers naturally seek to mitigate raw materials cost increases, and they are placing increased emphasis on cost containment as they address declining demand. While this is not a new trend, it continues to offer opportunities to us as we bring supply chain efficiencies to the leaf markets. We believe that global leaf suppliers add efficiencies to the markets through economies of scale, as well as through the vital role played in finding buyers for all styles and qualities of leaf tobacco, which achieves overall cost reductions. To understand our business, it is important to note that tobacco is not a commodity product. Flavor and smoking characteristics of tobacco vary based on the type of tobacco and the region where the tobacco is grown. In addition, characteristics of tobacco leaves vary by their position on the stalk of the plant, which means that many different styles and grades of tobacco may be produced in a single tobacco crop. A particular manufacturer, in seeking tobacco for its proprietary blend, may only want and have use for certain leaves of a plant. The leaf tobacco supplier plays a vital role in the industry by finding buyers for all of the leaf grades and styles of tobacco produced in a farmer’s crop. This role helps to eliminate excess tobacco being produced, which improves leaf utilization.

In addition to leaf utilization, we bring operational efficiencies to the industry, which in turn help reduce costs. These efficiencies include economical utilization of processing capacity in our facilities, an established and scalable global network of agronomists and technicians helping maintain a stable, productive, and sustainable farmer base, and agronomic and production improvements to optimize leaf yields and qualities. In addition, we are able to offer manufacturers a complete range of services from the field to the delivery of the packed product that benefit from our efficiencies. These services include such things as buying station optimization, processing to specific customer specifications or needs, storage of green or packed leaf tobacco, and logistical services. In recent years, we have seen an increase in the level of direct purchasing and other supply chain services that we provide our customers, notably in the United States, Mexico, Brazil, Poland, Guatemala, and the Dominican Republic. We believe these moves acknowledge the efficiencies and services that global leaf suppliers bring to the entire supply chain.

We have also seen some reductions in sourcing from lower-volume tobacco growing regions by both global leaf suppliers and major manufacturers. Flue-cured tobacco is produced in over 70 countries around the world, and burley tobacco is grown in over 45 countries.  However, over 80% of the flue-cured tobacco grown outside of China and over 85% of the worldwide burley tobacco production is sourced from the top ten growing areas for each type of tobacco. We believe that these moves to reduce sourcing areas are another way for the industry to increase efficiency and to reduce costs. We maintain a strong presence in all of the major tobacco sourcing areas and believe that any growth in these areas would favor global leaf suppliers such as ourselves. In

32

the future, we expect that increased regulations requiring stringent monitoring and testing of leaf chemistry and compliant sourcing documentation could place greater emphasis on major sourcing areas.

As we have said for a number of years, the production of compliant leaf for the tobacco industry continues to grow in importance. To be considered compliant, leaf tobacco must be grown utilizing Good Agricultural Practices. We have long invested significant resources in the programs and infrastructure needed to work with growers to produce compliant leaf and continue to enhance our ability to monitor and demonstrate this compliance for customers. Our Good Agricultural Practices support an approach to farming that is focused on sustainability, employing sound field production and labor management practices that meet our customers’ needs, promote farmer profitability and reflect environmental sensitivity. To assist them, Universal provides comprehensive training, technical support in the field, and crop analytics through ongoing research and development. We believe that compliant leaf will continue to be important to our customers and should favor global suppliers who are able to deliver this product.

We also believe that a key factor in our ability to perform successfully in this industry is our ability to provide customers with the quality of leaf and the level of service they desire on a global basis at competitive prices, while maintaining a stability of supply. As the leading global leaf tobacco supplier, we add significant value to the supply chain, providing expertise in dealing with large numbers of farmers, efficiently selling various qualities of leaf produced in each crop to a broad global customer base, and delivering products that meet stringent quality and regulatory specifications. We also help stabilize the tobacco markets and influence crop development at the farm level. Our key objective is to continually adapt our business model to meet our customers' evolving needs while continuing to provide stability of supply and the quality that distinguishes our products and services. In addition, we monitor new product developments in the industry to identify areas where we can provide additional value to our customers.

33

Item 7A.  Quantitative and Qualitative Disclosures about Market Risk

Interest Rates

We generally use both fixed and floating interest rate debt to finance our operations. Changes in market interest rates expose us to changes in cash flows for floating rate instruments and to changes in fair value for fixed-rate instruments. We normally maintain a proportion of our debt in both variable and fixed interest rates to manage this exposure, and from time to time we may enter hedge agreements to swap the interest rates. In addition, our customers may pay market rates of interest for inventory purchased on order, which could mitigate a portion of the floating interest rate exposure. We also periodically have large cash balances and may receive deposits from customers, both of which we use to fund seasonal purchases of tobacco, reducing our financing needs. Excluding our bank term loans, which have been converted to fixed-rate borrowings with interest rate swaps, debt carried at variable interest rates was approximately $59 million at March 31, 2017. Although a hypothetical 1% change in short-term interest rates would result in a change in annual interest expense of approximately $0.6 million, that amount would be at least partially mitigated by changes in charges to customers.

In addition, changes in interest rates affect the calculation of our pension plan liabilities. As rates decrease, the liability for the present value of amounts expected to be paid under the plans increases. Rate changes also affect expense. As of the March 31, 2017 measurement date, a 1% decrease in the discount rate would have increased the projected benefit obligation (“PBO”) for pensions by $32 million and increased annual pension expense by $3 million. Conversely, a 1% increase in the discount rate would have reduced the PBO by $27 million and reduced annual pension expense by $3 million.

Currency

The international leaf tobacco trade generally is conducted in U.S. dollars, thereby limiting foreign exchange risk to that which is related to leaf purchase and production costs, overhead, and income taxes in the source country. We also provide farmer advances that are directly related to leaf purchases and are denominated in the local currency. Any currency gains or losses on those advances are usually offset by increases or decreases in the cost of tobacco, which is priced in the local currency. However, the effect of the offset may not occur until a subsequent quarter or fiscal year. Most of our tobacco operations are accounted for using the U.S. dollar as the functional currency. Because there are no forward foreign exchange markets in many of our major countries of tobacco origin, we often manage our foreign exchange risk by matching funding for inventory purchases with the currency of sale, which is usually the U.S. dollar, and by minimizing our net local currency monetary position in individual countries. We are vulnerable to currency remeasurement gains and losses to the extent that monetary assets and liabilities denominated in local currency do not offset each other. We recognized $9.3 million in net remeasurement losses in fiscal year 2017, compared to $22.5 million in net remeasurement losses in fiscal year 2016, and $28.8 million in net remeasurement gains in fiscal year 2015. We recognized $1.3 million in net foreign currency transaction gains in fiscal year 2017, compared to net transaction gains of $8.0 million in fiscal year 2016, and net transaction losses of $17.7 million in fiscal year 2015. In addition to foreign exchange gains and losses, we are exposed to changes in the cost of tobacco due to changes in the value of the local currency in relation to the U.S. dollar. We have entered forward currency exchange contracts to hedge against the effects of currency movements on purchases of tobacco to reduce the volatility of costs. In addition, we periodically enter into forward contracts to hedge balance sheet exposures. See Note 8 to the consolidated financial statements in Item 8 for additional information about our hedging activities.

In certain tobacco markets that are primarily domestic, we use the local currency as the functional currency. Examples of these markets are Poland and the Philippines. In other markets, such as Western Europe, where export sales are primarily in local currencies, we also use the local currency as the functional currency. In each case, reported earnings are affected by the translation of the local currency into the U.S. dollar.

Derivatives Policies

Hedging interest rate exposure using swaps and hedging foreign currency exchange rate exposure using forward contracts are specifically contemplated to manage risk in keeping with management's policies. We may use derivative instruments, such as swaps, forwards, or futures, which are based directly or indirectly upon interest rates and currencies to manage and reduce the risks inherent in interest rate and currency fluctuations. When we use foreign currency derivatives to mitigate our exposure to exchange rate fluctuations, we may choose not to designate them as hedges for accounting purposes, which may result in the effects of the derivatives being recognized in our earnings in periods different from the items that created the exposure.

We do not utilize derivatives for speculative purposes, and we do not enter into market risk-sensitive instruments for trading purposes. Derivatives are transaction-specific so that a specific debt instrument, forecast purchase, contract, or invoice determines the amount, maturity, and other specifics of the hedge. We routinely review counterparty risk as part of our derivative program.

34

Item 8.   Financial Statements and Supplementary Data     

UNIVERSAL CORPORATION

CONSOLIDATED STATEMENTS OF INCOME

	Fiscal Year Ended March 31,
(in thousands of dollars, except share and per share data)	2017			2016			2015
Sales and other operating revenues	$	2,071,218		$	2,120,373		$	2,271,801
Costs and expenses
Cost of goods sold	1,676,539			1,713,042			1,861,527
Selling, general and administrative expenses	211,969			226,685			250,186
Other income	—			(3,390		)	(12,676		)
Restructuring and impairment costs	4,359			2,389			4,890
Operating income	178,351			181,647			167,874
Equity in pretax earnings of unconsolidated affiliates	5,774			5,422			7,137
Interest income	1,397			1,178			576
Interest expense	16,284			15,669			17,120
Income before income taxes	169,238			172,578			158,467
Income taxes	56,732			54,430			38,006
Net income	112,506			118,148			120,461
Less: net income attributable to noncontrolling interests in subsidiaries	(6,202		)	(9,132		)	(5,853		)
Net income attributable to Universal Corporation	106,304			109,016			114,608
Dividends on Universal Corporation convertible perpetual preferred stock	(11,061		)	(14,748		)	(14,824		)
Cost in excess of carrying value on conversion or repurchase of convertible perpetual preferred stock	(74,353		)	—			(36		)
Earnings available to Universal Corporation common shareholders	$	20,890		$	94,268		$	99,748
Earnings per share attributable to Universal Corporation common shareholders:
Basic	$	0.89		$	4.16		$	4.33
Diluted	$	0.88		$	3.92		$	4.06
Weighted average common shares outstanding:
Basic	23,433,860			22,683,290			23,035,920
Diluted	23,770,088			27,825,491			28,221,264

See accompanying notes.

35

UNIVERSAL CORPORATION     

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

	Fiscal Year Ended March 31,
(in thousands of dollars)	2017			2016			2015
Net income	$	112,506		$	118,148		$	120,461
Other comprehensive income (loss):
Foreign currency translation, net of income taxes	(6,899		)	3,934			(22,625		)
Foreign currency hedge, net of income taxes	(933		)	2,509			(2,603		)
Interest rate hedge, net of income taxes	8,395			(5,015		)	(1,374		)
Pension and other postretirement benefit plans, net of income taxes	1,475			1,004			(14,023		)
Total other comprehensive income (loss), net of income taxes	2,038			2,432			(40,625		)
Total comprehensive income	114,544			120,580			79,836
Less: comprehensive income attributable to noncontrolling interests	(5,449		)	(8,920		)	(5,890		)
Comprehensive income attributable to Universal Corporation	$	109,095		$	111,660		$	73,946

See accompanying notes.

36

UNIVERSAL CORPORATION     

CONSOLIDATED BALANCE SHEETS

	March 31,
(in thousands of dollars)	2017			2016
ASSETS
Current assets
Cash and cash equivalents	$	283,993		$	319,447
Accounts receivable, net	439,288			428,659
Advances to suppliers, net	103,750			101,890
Accounts receivable—unconsolidated affiliates	2,373			2,316
Inventories—at lower of cost or market:
Tobacco	565,943			637,132
Other	68,087			60,888
Prepaid income taxes	16,713			17,814
Other current assets	81,252			70,400
Total current assets	1,561,399			1,638,546
Property, plant and equipment
Land	22,852			22,987
Buildings	266,802			264,838
Machinery and equipment	597,213			591,327
	886,867			879,152
Less accumulated depreciation	(569,527		)	(553,265		)
	317,340			325,887
Other assets
Goodwill and other intangibles	98,888			99,071
Investments in unconsolidated affiliates	78,457			82,441
Deferred income taxes	25,422			23,853
Other noncurrent assets	41,899			61,379
	244,666			266,744
Total assets	$	2,123,405		$	2,231,177

37

UNIVERSAL CORPORATION     

CONSOLIDATED BALANCE SHEETS—(Continued)

	March 31,
(in thousands of dollars)	2017			2016
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Notes payable and overdrafts	$	59,133		$	66,179
Accounts payable and accrued expenses	153,515			120,527
Accounts payable—unconsolidated affiliates	7,231			8,343
Customer advances and deposits	11,007			16,438
Accrued compensation	32,007			27,593
Income taxes payable	5,103			7,190
Current portion of long-term debt	—			—
Total current liabilities	267,996			246,270
Long-term debt	368,733			368,380
Pensions and other postretirement benefits	80,689			92,177
Other long-term liabilities	31,424			41,794
Deferred income taxes	47,985			29,494
Total liabilities	796,827			778,115
Shareholders’ equity
Universal Corporation:
Preferred stock:
Series A Junior Participating Preferred Stock, no par value, 500,000 shares authorized, none issued or outstanding	—			—
Series B 6.75% Convertible Perpetual Preferred Stock, no par value, 220,000 shares authorized, no shares outstanding (218,490 shares issued and outstanding at March 31, 2016)	—			211,562
Common stock, no par value, 100,000,000 shares authorized, 25,274,506 shares issued and outstanding (22,717,735 at March 31, 2016)	321,207			208,946
Retained earnings	1,034,841			1,066,064
Accumulated other comprehensive loss	(69,559		)	(72,350		)
Total Universal Corporation shareholders' equity	1,286,489			1,414,222
Noncontrolling interests in subsidiaries	40,089			38,840
Total shareholders' equity	1,326,578			1,453,062
Total liabilities and shareholders' equity	$	2,123,405		$	2,231,177

See accompanying notes.

38

UNIVERSAL CORPORATION     

CONSOLIDATED STATEMENTS OF CASH FLOWS

	Fiscal Year Ended March 31,
(in thousands of dollars)	2017			2016			2015
Cash Flows From Operating Activities:
Net income	$	112,506		$	118,148		$	120,461
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	35,911			36,754			35,394
Provision for losses (recoveries) on advances and guaranteed loans to suppliers	(857		)	815			3,734
Inventory write-downs	10,866			11,899			18,612
Stock-based compensation expense	6,475			5,206			6,230
Foreign currency remeasurement loss (gain), net	9,269			22,517			28,836
Deferred income taxes	16,626			15,046			(13,662		)
Equity in net income of unconsolidated affiliates, net of dividends	396			156			(1,075		)
Gain on favorable outcome of excise tax case in Brazil	—			—			(12,676		)
Fair value gain upon acquisition of partner's interest in joint venture	—			(3,390		)	—
Restructuring and impairment costs	4,359			2,389			4,890
Other, net	(4,463		)	13,204			(7,342		)
Changes in operating assets and liabilities, net:
Accounts and notes receivable	(14,346		)	(2,806		)	49,414
Inventories and other assets	52,139			(7,370		)	37,751
Income taxes	(1,719		)	1,437			5,680
Accounts payable and other accrued liabilities	28,643			(13,678		)	(63,257		)
Customer advances and deposits	(5,490		)	(13,796		)	14,397
Net cash provided by operating activities	250,315			186,531			227,387
Cash Flows From Investing Activities:
Purchase of property, plant and equipment	(35,630		)	(47,153		)	(58,385		)
Purchase of partner's interest in joint venture, net of cash held by the business	—			(5,964		)	—
Proceeds from sale of property, plant and equipment	2,174			2,982			4,522
Other, net	(398		)	(796		)	(141		)
Net cash used by investing activities	(33,854		)	(50,931		)	(54,004		)
Cash Flows From Financing Activities:
Issuance (repayment) of short-term debt, net	(5,349		)	4,880			2,618
Issuance of long-term debt	—			—			370,000
Repayment of long-term debt	—			—			(356,250		)
Dividends paid to noncontrolling interests	(4,200		)	(4,449		)	(4,183		)
Issuance of common stock	—			—			187
Conversion/repurchase of convertible perpetual preferred stock	(178,365		)	—			(1,497		)
Repurchase of common stock	—			—			(31,227		)
Dividends paid on convertible perpetual preferred stock	(11,061		)	(14,748		)	(14,824		)
Dividends paid on common stock	(49,828		)	(47,389		)	(47,337		)
Debt issuance costs and other	(2,441		)	(2,940		)	(4,511		)
Net cash used by financing activities	(251,244		)	(64,646		)	(87,024		)
Effect of exchange rate changes on cash	(671		)	(290		)	(1,108		)
Net (decrease) increase in cash and cash equivalents	(35,454		)	70,664			85,251
Cash and cash equivalents at beginning of year	319,447			248,783			163,532
Cash and Cash Equivalents at End of Year	$	283,993		$	319,447		$	248,783
Supplemental information—cash paid for:
Interest	$	16,284		$	15,704		$	19,184
Income taxes, net of refunds	$	37,294		$	38,732		$	46,044

Non-cash Financing Transaction - The consolidated financial statements for the fiscal year ended March 31, 2017 include a non-cash reclassification of $107.6 million from preferred stock to common stock to reflect the conversion of 111,072 shares of the Company's outstanding Series B 6.75% Convertible Perpetual Preferred Stock into common stock. See Note 11 for additional information.

See accompanying notes.

39

UNIVERSAL CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

	Universal Corporation Shareholders
(in thousands of dollars)	Series B 6.75% Convertible Perpetual Preferred Stock			Common Stock			Retained  Earnings			Accumulated Other Comprehensive Income (Loss)			Non- controlling Interests			Total Shareholders' Equity
Fiscal Year Ended March 31, 2017
Balance at beginning of year	$	211,562		$	208,946		$	1,066,064		$	(72,350	)	$	38,840		$	1,453,062
Changes in preferred and common stock
Conversion of Series B 6.75% convertible perpetual preferred stock for common stock	(107,550		)	107,550			—			—			—			—
Conversion of Series B 6.75% convertible perpetual preferred stock for cash	(104,012		)	—			—			—			—			(104,012		)
Accrual of stock-based compensation	—			6,475			—			—			—			6,475
Withholding of shares from stock-based compensation for grantee income taxes	—			(2,440		)	—			—			—			(2,440		)
Dividend equivalents on restricted stock units (RSUs)	—			676			—			—			—			676
Changes in retained earnings
Net income	—			—			106,304			—			6,202			112,506
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock ($50.63 per share)	—			—			(11,061		)	—			—			(11,061		)
Common stock ($2.14 per share)	—			—			(51,437		)	—			—			(51,437		)
Conversion of Series B 6.75% convertible perpetual preferred stock for cash	—			—			(74,353		)	—			—			(74,353		)
Dividend equivalents on restricted stock units (RSUs)	—			—			(676		)	—			—			(676		)
Other comprehensive income (loss)
Foreign currency translation, net of income taxes	—			—			—			(6,146		)	(753		)	(6,899		)
Foreign currency hedge, net of income taxes	—			—			—			(933		)	—			(933		)
Interest rate hedge, net of income taxes	—			—			—			8,395			—			8,395
Pension and other postretirement benefit plans, net of income taxes	—			—			—			1,475			—			1,475
Other changes in noncontrolling interests
Dividends paid to noncontrolling shareholders	—			—			—			—			(4,200		)	(4,200		)
Balance at end of year	$	—		$	321,207		$	1,034,841		$	(69,559	)	$	40,089		$	1,326,578

40

UNIVERSAL CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY—(Continued)

	Universal Corporation Shareholders
(in thousands of dollars)	Series B 6.75% Convertible Perpetual Preferred Stock		Common Stock			Retained  Earnings			Accumulated Other Comprehensive Income (Loss)			Non- controlling Interests			Total Shareholders' Equity
Fiscal Year Ended March 31, 2016
Balance at beginning of year	$	211,562	$	206,002		$	1,020,155		$	(74,994	)	$	34,369		$	1,397,094
Changes in preferred and common stock
Accrual of stock-based compensation	—		5,206			—			—			—			5,206
Withholding of shares from stock-based compensation for grantee income taxes	—		(2,940		)	—			—			—			(2,940		)
Dividend equivalents on restricted stock units (RSUs)	—		678			—			—			—			678
Changes in retained earnings
Net income	—		—			109,016			—			9,132			118,148
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock ($67.50 per share)	—		—			(14,748		)	—			—			(14,748		)
Common stock ($2.10 per share)	—		—			(47,681		)	—			—			(47,681		)
Dividend equivalents on restricted stock units (RSUs)	—		—			(678		)	—			—			(678		)
Other comprehensive income (loss)
Foreign currency translation, net of income taxes	—		—			—			4,146			(212		)	3,934
Foreign currency hedge, net of income taxes	—		—			—			2,509			—			2,509
Interest rate hedge, net of income taxes	—		—			—			(5,015		)	—			(5,015		)
Pension and other postretirement benefit plans, net of income taxes	—		—			—			1,004			—			1,004
Other changes in noncontrolling interests
Dividends paid to noncontrolling shareholders	—		—			—			—			(4,449		)	(4,449		)
Balance at end of year	$	211,562	$	208,946		$	1,066,064		$	(72,350	)	$	38,840		$	1,453,062

41

UNIVERSAL CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY—(Continued)

	Universal Corporation Shareholders
(in thousands of dollars)	Series B 6.75% Convertible Perpetual Preferred Stock			Common Stock			Retained  Earnings			Accumulated Other Comprehensive Income (Loss)			Non- controlling Interests			Total Shareholders' Equity
Fiscal Year Ended March 31, 2015
Balance at beginning of year	$	213,023		$	206,446		$	993,093		$	(34,332	)	$	32,662		$	1,410,892
Changes in preferred and common stock
Repurchase of Series B 6.75% convertible perpetual preferred stock	(1,461		)	—			—			—			—			(1,461		)
Issuance of common stock	—			187			—			—			—			187
Repurchase of common stock	—			(6,439		)	—			—			—			(6,439		)
Accrual of stock-based compensation	—			6,230			—			—			—			6,230
Withholding of shares from stock-based compensation for grantee income taxes	—			(1,076		)	—			—			—			(1,076		)
Dividend equivalents on restricted stock units (RSUs)	—			654			—			—			—			654
Changes in retained earnings
Net income	—			—			114,608			—			5,853			120,461
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock ($67.50 per share)	—			—			(14,824		)	—			—			(14,824		)
Common stock ($2.06 per share)	—			—			(47,244		)	—			—			(47,244		)
Repurchase of Series B 6.75% convertible perpetual preferred stock	—			—			(36		)	—			—			(36		)
Repurchase of common stock	—			—			(24,788		)	—			—			(24,788		)
Dividend equivalents on restricted stock units (RSUs)	—			—			(654		)	—			—			(654		)
Other comprehensive income (loss)
Foreign currency translation, net of income taxes	—			—			—			(22,662		)	37			(22,625		)
Foreign currency hedge, net of income taxes	—			—			—			(2,603		)	—			(2,603		)
Interest rate hedge, net of income taxes	—			—			—			(1,374		)	—			(1,374		)
Pension and other postretirement benefit plans, net of income taxes	—			—			—			(14,023		)	—			(14,023		)
Other changes in noncontrolling interests
Dividends paid to noncontrolling shareholders	—			—			—			—			(4,183		)	(4,183		)
Balance at end of year	$	211,562		$	206,002		$	1,020,155		$	(74,994	)	$	34,369		$	1,397,094

42

UNIVERSAL CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY—(Continued)

	Fiscal Year Ended March 31,
	2017		2016	2015
Preferred Shares Outstanding:
Series B 6.75% Convertible Perpetual Preferred Stock:
Balance at beginning of year	218,490		218,490	219,999
Conversion of convertible perpetual preferred stock for common stock	(111,072	)	—	—
Conversion of convertible perpetual preferred stock for cash	(107,418	)	—	—
Repurchase of convertible perpetual preferred stock	—		—	(1,509	)
Balance at end of year	—		218,490	218,490
Common Shares Outstanding:
Balance at beginning of year	22,717,735		22,593,266	23,216,312
Issuance of common stock	69,653		124,469	96,947
Conversion of convertible perpetual preferred stock for common stock	2,487,118		—	—
Repurchase of common stock	—		—	(719,993	)
Balance at end of year	25,274,506		22,717,735	22,593,266

See accompanying notes.

43

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(All dollar amounts are in thousands, except per share amounts or as otherwise noted.)

NOTE 1.   NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

Universal Corporation, which together with its subsidiaries is referred to herein as “Universal” or the “Company,” is the leading global leaf tobacco supplier. The Company conducts business in over 30 countries, primarily in major tobacco-producing regions of the world.

Consolidation

The consolidated financial statements include the accounts of Universal Corporation and all domestic and foreign subsidiaries in which the Company maintains a controlling financial interest. Control is generally determined based on a voting interest of greater than 50%, such that Universal controls all significant corporate activities of the subsidiary. All significant intercompany accounts and transactions are eliminated in consolidation.

The equity method of accounting is used for investments in companies where Universal Corporation has a voting interest of 20% to 50%. These investments are accounted for under the equity method because Universal exercises significant influence over those companies, but not control. The Company received dividends totaling $5.1 million in fiscal year 2017, $3.4 million in fiscal year 2016, and $5.2 million in fiscal year 2015, from companies accounted for under the equity method. Investments where Universal has a voting interest of less than 20% are not significant and are accounted for under the cost method. Under the cost method, the Company recognizes earnings upon its receipt of dividends to the extent they represent a distribution of retained earnings.

The Company's 49% ownership interest in Socotab L.L.C. (“Socotab”), a leading supplier of oriental tobaccos with operations located principally in Eastern Europe and Turkey, is the primary investment accounted for under the equity method. The investment in Socotab is an important part of the Company's overall product and service arrangements with its major customers. As discussed further below, the Company reviews the carrying value of its investments in unconsolidated affiliates on a regular basis and considers whether any factors exist that might indicate an impairment in value that is other than temporary. At March 31, 2017, the Company determined that no such factors existed with respect to the investment in Socotab. The Company, together with Socotab management, regularly evaluates the outlook for the business, and an impairment charge could be recorded in a future period if it is determined that the fair value of the investment is less than the carrying value and the decline in value is not temporary.

In fiscal year 2006, the Company deconsolidated its operations in Zimbabwe under accounting requirements that apply under certain conditions to foreign subsidiaries that are subject to foreign exchange controls and other government restrictions. Since that time, the investment has been accounted for using the cost method, as required under the accounting guidance. The investment in the Zimbabwe operations was zero at March 31, 2017 and 2016. The Company has a net foreign currency translation loss associated with the Zimbabwe operations of approximately $7.2 million, which remains a component of accumulated other comprehensive loss. As a regular part of its reporting, the Company reviews the conditions that resulted in the deconsolidation of the Zimbabwe operations to confirm that such accounting treatment is still appropriate. Dividends from the Zimbabwe operations are recorded in income in the period received.

The Company holds less than a 100% financial interest in certain consolidated subsidiaries. The net income and shareholders’ equity attributable to the noncontrolling interests in these subsidiaries are reported on the face of the consolidated financial statements. During fiscal years 2017, 2016, and 2015, there were no changes in the Company’s ownership percentage in any of these subsidiaries.

44

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Investments in Unconsolidated Affiliates

The Company’s equity method investments and its cost method investments, which include its Zimbabwe operations, are non-marketable securities. Universal reviews such investments for impairment whenever events or changes in circumstances indicate that the carrying amount of an investment may not be recovered. For example, the Company would review such an investment for impairment if the investee were to lose a significant customer, suffer a large reduction in sales margins, experience a major change in its business environment, or undergo any other significant change in its normal business. In assessing the recoverability of equity or cost method investments, the Company follows the applicable accounting guidance in determining the fair value of the investments. In most cases, this involves the use of discounted cash flow models (Level 3 of the fair value hierarchy under the accounting guidance). If the fair value of an equity or cost method investee is determined to be lower than its carrying value, an impairment loss is recognized. The determination of fair value using discounted cash flow models is normally not based on observable market data from independent sources and therefore requires significant management judgment with respect to estimates of future operating earnings and the selection of an appropriate discount rate. The use of different assumptions could increase or decrease estimated future operating cash flows, and the discounted value of those cash flows, and therefore could increase or decrease any impairment charge related to these investments.

In its consolidated statements of income, the Company reports its proportional share of the earnings of unconsolidated affiliates accounted for on the equity method based on the pretax earnings of those affiliates, as permitted under the applicable accounting guidance. All applicable foreign and U.S. income taxes are provided on these earnings and reported as a component of consolidated income tax expense. For unconsolidated affiliates located in foreign jurisdictions, repatriation of the Company’s share of the earnings through dividends is assumed in determining consolidated income tax expense.

The following table provides a reconciliation of (1) equity in the pretax earnings of unconsolidated affiliates, as reported in the consolidated statements of income to (2) equity in the net income of unconsolidated affiliates, net of dividends, as reported in the consolidated statements of cash flows for the fiscal years ended March 31, 2017, 2016, and 2015:

	Fiscal Year Ended March 31,
	2017			2016			2015
Equity in pretax earnings reported in the consolidated statements of income	$	5,774		$	5,422		$	7,137
Less: Equity in income taxes	(1,092		)	(2,156		)	(834		)
Equity in net income	4,682			3,266			6,303
Less: Dividends received on investments(1)	(5,078		)	(3,422		)	(5,228		)
Equity in net income, net of dividends, reported in the consolidated statements of cash flows	$	(396	)	$	(156	)	$	1,075

⁽¹⁾  In accordance with the applicable accounting guidance, dividends received from unconsolidated affiliates accounted for on the equity method that represent a return on capital (i.e., a return of earnings on a cumulative basis) are presented as operating cash flows in the consolidated statements of cash flows.

Earnings Per Share

 The Company calculates basic earnings per share based on earnings available to common shareholders after payment of dividends on the Company’s Series B 6.75% Convertible Perpetual Preferred Stock prior to its conversion in fiscal year 2017 (see Note 11). The calculation uses the weighted average number of common shares outstanding during each period. Diluted earnings per share is computed in a similar manner using the weighted average number of common shares and dilutive potential common shares outstanding. Dilutive potential common shares include unvested restricted stock units and performance share awards that are assumed to be fully vested and paid out in shares of common stock, dilutive stock options and stock appreciation rights that were assumed to be exercised, and shares of convertible perpetual preferred stock that were assumed to be converted when the effect was dilutive. In periods when the effect of the convertible perpetual preferred stock was dilutive and these shares were assumed to be converted into common stock, dividends paid on the preferred stock were excluded from the calculation of diluted earnings per share.

Calculations of earnings per share for the fiscal years ended March 31, 2017, 2016, and 2015, are provided in Note 3.

Cash and Cash Equivalents

 All highly liquid investments with a maturity of three months or less at the time of purchase are classified as cash equivalents.

45

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Advances to Suppliers

In many sourcing origins where the Company operates, it provides agronomy services and seasonal advances of seed, fertilizer, and other supplies to tobacco farmers for crop production, or makes seasonal cash advances to farmers for the procurement of those inputs. These advances are short term, are repaid upon delivery of tobacco to the Company, and are reported in advances to suppliers in the consolidated balance sheets. In several origins, the Company has made long-term advances to tobacco farmers to finance curing barns and other farm infrastructure. In some years, due to low crop yields and other factors, individual farmers may not deliver sufficient volumes of tobacco to fully repay their seasonal advances, and the Company may extend repayment of those advances into future crop years. The long-term portion of advances is included in other noncurrent assets in the consolidated balance sheets. Both the current and the long-term portions of advances to suppliers are reported net of allowances recorded when the Company determines that amounts outstanding are not likely to be collected. Short-term and long-term advances to suppliers totaled approximately $134 million at both March 31, 2017 and 2016. The related valuation allowances totaled $27 million at March 31, 2017, and $29 million at March 31, 2016, and were estimated based on the Company’s historical loss information and crop projections. The allowances were reduced by net recoveries of approximately $0.9 million in fiscal year 2017, but increased by net provisions for estimated uncollectible amounts of approximately $0.8 million in fiscal year 2016 and $3.7 million in fiscal year 2015. These provisions are included in selling, general, and administrative expenses in the consolidated statements of income. Interest on advances is recognized in earnings upon the farmers’ delivery of tobacco in payment of principal and interest. Advances on which interest accrual had been discontinued totaled approximately $11 million at both March 31, 2017 and 2016.

Inventories

Tobacco inventories are valued at the lower of cost or market. Raw materials primarily consist of unprocessed leaf tobacco, which is clearly identified by type and grade at the time of purchase. The Company tracks the costs associated with this tobacco in the final product lots, and maintains this identification through the time of sale. This method of cost accounting is referred to as the specific cost or specific identification method. The predominant cost component of the Company’s inventories is the cost of the unprocessed tobacco. Direct and indirect processing costs related to these raw materials are capitalized and allocated to inventory in a systematic manner. The Company does not capitalize any interest or sales-related costs in inventory. Freight costs are recorded in cost of goods sold. Other inventories consist primarily of seed, fertilizer, packing materials, and other supplies, and are valued principally at the lower of average cost or market.

Recoverable Value-Added Tax Credits

In many foreign countries, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”) on purchases of unprocessed and processed tobacco, crop inputs, packing materials, and various other goods and services. In some countries, VAT is a national tax, and in other countries it is assessed at the state level. Items subject to VAT vary from jurisdiction to jurisdiction, as do the rates at which the tax is assessed. When tobacco is sold to customers in the country of origin, the operating subsidiaries generally collect VAT on those sales. The subsidiaries are normally permitted to offset their VAT payments against the collections and remit only the incremental VAT collections to the tax authorities. When tobacco is sold for export, VAT is normally not assessed. In countries where tobacco sales are predominately for export markets, VAT collections generated on downstream sales are often not sufficient to fully offset the subsidiaries’ VAT payments. In those situations, unused VAT credits can accumulate. Some jurisdictions have procedures that allow companies to apply for refunds of unused VAT credits from the tax authorities, but the refund process often takes an extended period of time, and it is not uncommon for refund applications to be challenged or rejected in part on technical grounds. Other jurisdictions may permit companies to sell or transfer unused VAT credits to third parties in private transactions, although approval for such transactions must normally be obtained from the tax authorities, limits on the amounts that can be transferred may be imposed, and the proceeds realized may be heavily discounted from the face value of the credits. Due to these factors, local operating subsidiaries in some countries can accumulate significant balances of VAT credits over time. The Company reviews these balances on a regular basis and records valuation allowances on the credits to reflect amounts that are not expected to be recovered, as well as discounts anticipated on credits that are expected to be sold or transferred. At March 31, 2017 and 2016, the aggregate balances of recoverable tax credits held by the Company’s subsidiaries totaled approximately $45 million and $52 million, respectively, and the related valuation allowances totaled approximately $13 million and $19 million, respectively. The net balances are reported in other current assets and other noncurrent assets in the consolidated balance sheets.

Property, Plant and Equipment

Depreciation of plant and equipment is based upon historical cost and the estimated useful lives of the assets. Depreciation is calculated primarily using the straight-line method. Buildings include tobacco processing and blending facilities, offices, and warehouses. Machinery and equipment consists of processing and packing machinery and transport, office, and computer equipment. Estimated useful lives range as follows: buildings - 15 to 40 years; processing and packing machinery - 3 to 11 years; transport equipment - 3 to 10 years; and office and computer equipment - 3 to 10 years. Where applicable and material in amount, the Company capitalizes related interest costs during periods that property, plant and equipment are being constructed or made ready for service. No interest was capitalized in fiscal years 2017, 2016, or 2015.

46

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Goodwill and Other Intangibles

Goodwill and other intangibles principally consist of the excess of the purchase price of acquired companies over the fair value of the net assets. Goodwill is carried at the lower of cost or fair value. Accounting Standards Codification Topic 350 (“ASC 350”) permits companies to base their initial assessments of potential goodwill impairment on qualitative factors, and the Company elected to use that approach at March 31, 2017 and 2016. Those factors did not indicate any potential impairment of the Company's recorded goodwill.

Reporting units are distinct operating subsidiaries or groups of subsidiaries that typically compose the Company’s business in a specific country or location. Goodwill is allocated to reporting units based on the country or location to which a specific acquisition relates, or by allocation based on expected future cash flows if the acquisition relates to more than one country or location. The majority of the Company’s goodwill relates to its reporting unit in Brazil. Significant adverse changes in the operations or estimated future cash flows for a reporting unit with recorded goodwill could result in an impairment charge. No charges for goodwill impairment were recorded in fiscal years 2017, 2016, or 2015.

Impairment of Long-Lived Assets

The Company reviews long-lived assets for impairment whenever events, changes in business conditions, or other circumstances provide an indication that such assets may be impaired. Potential impairment is initially assessed by comparing management’s undiscounted estimates of future cash flows from the use or disposition of the assets to their carrying value. If the carrying value exceeds the undiscounted cash flows, an impairment charge is recorded to reduce the carrying value of the asset to its fair value determined in accordance with the accounting guidance. In many cases, this involves the use of discounted cash flow models that are not based on observable market data from independent sources (Level 3 of the fair value hierarchy under the accounting guidance). In fiscal year 2017, the Company incurred impairment charges of $2.3 million on factory and equipment assets as a result of the Company's decision to close its tobacco processing facility in Hungary (see Note 2). No significant charges for the impairment of long-lived assets were recorded during fiscal years 2016 or 2015.

Income Taxes

The Company provides deferred income taxes on temporary differences between the book and tax basis of its assets and liabilities. Those differences arise principally from employee benefit accruals, depreciation, deferred compensation, undistributed earnings of unconsolidated affiliates, undistributed earnings of foreign subsidiaries, goodwill, and valuation allowances on farmer advances and value-added tax credits.

Fair Values of Financial Instruments

The fair value of the Company’s long-term debt, disclosed in Note 6, approximates the carrying amount since the variable interest rates in the underlying credit agreement reflect the market interest rates that were available to the Company at March 31, 2017. In periods when fixed-rate obligations are outstanding, fair values are estimated using market prices where they are available and discounted cash flow models based on current incremental borrowing rates for similar classes of borrowers and borrowing arrangements. The fair values of interest rate swap agreements designated as cash flow hedges and used to fix the variable benchmark rate on outstanding long-term debt are determined separately and recorded in other long-term liabilities. Except for interest rate swaps and forward foreign currency exchange contracts that are discussed below, the fair values of all other assets and liabilities that qualify as financial instruments approximate their carrying amounts.

Derivative Financial Instruments

The Company recognizes all derivatives on the balance sheet at fair value. Interest rate swaps and forward foreign currency exchange contracts are used from time to time to manage interest rate risk and foreign currency risk. The Company enters into such contracts only with counterparties of good standing. The credit exposure related to non-performance by the counterparties and the Company is considered in determining the fair values of the derivatives, and the effect has not been material to the financial statements or operations of the Company. Additional disclosures related to the Company’s derivatives and hedging activities are provided in Note 8.

Translation and Remeasurement of Foreign Currencies

The financial statements of foreign subsidiaries having the local currency as the functional currency are translated into U.S. dollars using exchange rates in effect at period end for assets and liabilities and average exchange rates applicable to each reporting period for results of operations. Adjustments resulting from translation of financial statements are reflected as a separate component of other comprehensive income or loss. The financial statements of foreign subsidiaries having the U.S. dollar as the functional currency, with certain transactions denominated in a local currency, are remeasured into U.S. dollars. The remeasurement of local currency amounts into U.S. dollars creates remeasurement gains and losses that are included in earnings as a component of selling, general, and administrative expense. The Company recognized net remeasurement losses of $9.3 million in fiscal year 2017, $22.5 million in fiscal year 2016, and $28.8 million in fiscal year 2015.

47

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Foreign currency transactions and forward foreign currency exchange contracts that are not designated as hedges generate gains and losses when they are settled or when they are marked to market under the prescribed accounting guidance. These transaction gains and losses are also included in earnings as a component of selling, general, and administrative expenses. The Company recognized net foreign currency transaction losses of $1.3 million in fiscal year 2017, net transaction gains of $8.0 million in fiscal year 2016, and net transaction gains of $17.7 million in fiscal year 2015.

Revenue Recognition

Revenue from the sale of tobacco is recognized when title and risk of loss is transferred to the customer and the earnings process is complete. Substantially all sales revenue is recorded based on the physical transfer of products to customers. A large percentage of the Company’s sales are to major multinational manufacturers of consumer tobacco products. The Company works closely with those customers to understand and plan for their requirements for volumes, styles, and grades of leaf tobacco from its various growing regions, and extensive coordination is maintained on an ongoing basis to determine and satisfy their requirements for physical shipment of processed tobacco. The customers typically specify, in sales contracts and in shipping documents, the precise terms for transfer of title and risk of loss for the tobacco. Customer returns and rejections are not significant, and the Company’s sales history indicates that customer-specific acceptance provisions are consistently met upon transfer of title and risk of loss.

While most of the Company’s revenue consists of tobacco that is purchased from farmers, processed and packed in its factories, and then sold to customers, some revenue is earned from processing tobacco owned by customers. These arrangements usually exist in specific markets where the customers contract directly with farmers for leaf production, and they have accounted for less than 5% of total revenue on an annual basis through the fiscal year ended March 31, 2017. Processing and packing of leaf tobacco is a short-duration process. Under normal operating conditions, raw tobacco that is placed into the production line exits as processed and packed tobacco within one hour, and is then later transported to customer-designated storage facilities. The revenue for these services is recognized when processing is completed, and the Company’s operating history indicates that customer requirements for processed tobacco are consistently met upon completion of processing.

Stock-Based Compensation

Share-based payments, such as grants of restricted stock units, performance share awards, restricted stock, stock appreciation rights, and stock options, are measured at fair value and reported as expense in the financial statements over the requisite service period. Additional disclosures related to stock-based compensation are included in Note 12.

Estimates and Assumptions

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Accounting Pronouncements

Pronouncements Recently Adopted

In April 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 was effective for fiscal years beginning after December 31, 2015. The Company adopted ASU 2015-03 effective for the quarter ending June 30, 2016, which was the first quarter of the fiscal year ending March 31, 2017. The implementation of ASU 2015-03, which required retrospective application, resulted in a $1.6 million reclassification of unamortized debt issuance costs from other noncurrent assets to long-term debt for the comparative prior year ended March 31, 2016.

In April 2015, the FASB issued Accounting Standards Update 2015-05, “Intangibles - Goodwill and Other - Internal-Use Software - Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement” (“ASU 2015-05”). ASU 2015-05 requires customers who enter into a cloud computing arrangement that includes a software license to account for the arrangement as an intangible asset. If the cloud computing arrangement does not include a software license, the arrangement is accounted for as a service contract. The guidance was effective for fiscal years beginning after December 31, 2015, and allows for retrospective or prospective adoption. The Company prospectively adopted ASU 2015-05 effective as of April 1, 2016, the beginning of fiscal year 2017. The Company’s adoption of ASU 2015-05 did not have a material impact on its consolidated financial statements.

48

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

In May 2015, the FASB issued Accounting Standards Update No. 2015-07, "Fair Value Measurement, Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share or its Equivalent" ("ASU 2015-07"). ASU 2015-07 removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient and eliminates certain disclosures for investments that are eligible to be measured at fair value using the net asset value per share practical expedient. The Company adopted ASU 2015-07 effective as of April 1, 2016, the beginning of fiscal year 2017. Disclosures for all periods presented in Note 9 - Fair Value Measurements were adjusted accordingly.

In March 2016, the FASB issued Accounting Standards Update No. 2016-09, "Compensation - Stock Compensation (Topic 718)" ("ASU 2016-09"). ASU 2016-09 provides simplification for the accounting for employee stock-based payment transactions, including the related income tax consequences, the classification of awards as either equity or liabilities, and the classification of transactions in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, with early adoption permitted. The Company elected to early-adopt ASU 2016-09 effective April 1, 2016, which was the beginning of its fiscal year ending March 31, 2017. As required by the guidance, employee tax withholding payments and excess tax benefits resulting from stock-based compensation have been classified as financing activities and operating activities, respectively, in the consolidated statements of cash flows for all periods presented.

Pronouncements to be Adopted in Future Periods

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which supersedes substantially all of the current revenue recognition guidance under U.S. generally accepted accounting principles (“U.S. GAAP”).  ASU 2014-09 was developed under a joint project with the International Accounting Standards Board (“IASB”) to improve and converge the existing revenue recognition accounting guidance in U.S. GAAP and International Accounting Standards.  Under ASU 2014-09, the central underlying principle is to recognize revenues when promised goods or services are transferred to customers at an amount determined by the consideration a company expects to receive for those goods or services.  The guidance outlines a five-step process for determining the amount and timing of revenue to be recognized from those arrangements.  It is more principles-based than the existing guidance under U.S. GAAP, and therefore is expected to require more management judgment and involve more estimates than the current guidance.  ASU 2014-09 is effective for annual periods beginning after December 15, 2017, including all interim periods within the year of adoption.   Companies are allowed to select between two transition methods:  (1) a full retrospective transition method with the application of the new guidance to each prior reporting period presented, or (2) a modified retrospective transition method that recognizes the cumulative effect on prior periods at the date of adoption together with additional footnote disclosures. Since the issuance of ASU 2014-09, the FASB has issued several amendments to provide additional supplemental guidance on certain aspects of the original pronouncement.  Universal expects to adopt ASU 2014-09 and the related supplemental amendments effective April 1, 2018, which is the beginning of its fiscal year ending March 31, 2019.  The Company formed a cross-functional project team to review its current revenue accounting policies and control processes, to complete a comprehensive analysis of the new guidance, and to determine the effect it will have on revenue recognition and financial statement disclosures for all customer contracts. The team has classified its customer contracts into primary revenue streams and is currently in the process of completing individual contract reviews and making final determinations with respect to provisions in the new guidance that may impact the timing of revenue recognition for certain customer arrangements. As these activities remain underway at this time, the Company is not currently able to conclude on the impact that ASU 2014-09 will have on its consolidated financial statements. Although a final determination has not been made, it is likely that the Company will select the modified retrospective transition method as its method of adoption.

In July 2015, the FASB issued Accounting Standards Update No. 2015-11, “Simplifying the Measurement of Inventory” (“ASU 2015-11”). ASU 2015-11 requires that most inventory be measured at the lower of cost or net realizable value. ASU 2015-11 defines net realizable value as the "estimated selling price in the ordinary course of business, less reasonable predictable costs of completion, disposal, and transportation." ASU 2015-11 is effective for fiscal years beginning after December 31, 2016, and will be adopted effective April 1, 2017, which is the beginning of its fiscal year ending March 31, 2018. ASU 2015-11 will be applied prospectively after the date of adoption, as required by the guidance, and will not have a material impact on the Company's consolidated financial statements.

In January 2016, the FASB issued Accounting Standards Update No. 2016-01 “Financial Instruments-Recognition and Measurement of Financial Assets and Financial Liabilities” ("ASU 2016-01"). ASU 2016-01 requires all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under the equity method of accounting or those that result in consolidation of the investee). This guidance is effective for fiscal years beginning after December 15, 2017. The Company is currently evaluating the impact that the adoption of ASU 2016-01 will have on its consolidated financial statements.

49

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). ASU 2016-02 requires a lessee to recognize lease payment obligations as a lease liability and the corresponding right-of-use asset as a leased asset in the balance sheet for the term of the lease. This guidance supersedes Topic 840 “Leases” and is effective for fiscal years beginning after December 15, 2018. The Company will be required to adopt ASU 2016-02 effective April 1, 2019, which is the beginning of its fiscal year ending March 31, 2020, and is currently evaluating the impact that the updated guidance will have on its consolidated financial statements.

In January 2017, the FASB issued Accounting Standards Update No. 2017-04, "Intangibles - Goodwill and Other (Topic 350)" ("ASU 2017-04"). ASU 2017-04 eliminated Step 2 from the goodwill impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of the reporting unit's goodwill with the carrying amount of the goodwill. The guidance is effective for fiscal years beginning after December 15, 2019. The Company will be required to adopt ASU 2017-04 effective April 1, 2020, which is the beginning of its fiscal year ending March 31, 2021, and is currently evaluating the impact that the updated guidance will have on its consolidated financial statements.

In March 2017, the FASB issued Accounting Standards Update No. 2017-07, "Compensation - Retirement Benefits (Topic 715)" ("ASU 2017-07"). ASU 2017-07 requires that an employer report the service cost component of pension or other postretirement benefits expense in the same line item or items as other compensation costs arising from services rendered by the pertinent employees during the period. The other components of net benefit cost are required to be presented in the income statement separately from the service cost component and outside a subtotal of income from operations, if one is presented. If a separate line item or items are used to present the other components of net benefit cost, the line item or items must be appropriately described. If a separate line item or items are not used, the line item or items used in the income statement to present the other components of net benefit cost must be disclosed. The guidance is effective for fiscal years beginning after December 15, 2016. The Company will be required to adopt ASU 2017-07 effective April 1, 2017, which is the beginning of its fiscal year ending March 31, 2018. The line item classification changes required by the new guidance will not impact the Company's pretax earnings or net income; however, operating income and interest expense will increase by offsetting amounts that are not expected to be material to the Company's consolidated financial statements.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year’s presentation.

NOTE 2. RESTRUCTURING AND IMPAIRMENT COSTS

During the three fiscal years ended March 31, 2017, 2016, and 2015, Universal recorded restructuring and impairment costs related to various initiatives to adjust certain operations and reduce costs. For all three fiscal years, the restructuring and impairment costs incurred primarily related to operations that are part of the Other Regions reportable segment of the Company's flue-cured and burley leaf tobacco operations.

Fiscal Year Ended March 31, 2017

In fiscal year 2017, the Company recorded restructuring and impairment costs totaling $4.4 million, primarily related to the Company's decision to close its tobacco processing facility in Hungary. The Company is now processing tobaccos sourced from Hungary in its factories in Italy. The costs incurred for the change in operations in Hungary included statutory employee termination benefits and impairment charges related to certain property and equipment. Restructuring costs were also incurred in connection with downsizing efforts at several other locations around the Company.

Fiscal Year Ended March 31, 2016

In fiscal year 2016, the Company recorded restructuring and impairment costs totaling $2.4 million, related to a decision to significantly scale back its operations in Zambia. Those costs primarily included statutory employee termination benefits, impairment charges related to outstanding balances on loans to farmers whose contracts were terminated as a result of the decision, and impairment charges on certain property and equipment.

Fiscal Year Ended March 31, 2015

In fiscal year 2015, the Company recorded restructuring costs totaling $4.9 million, primarily related to downsizing certain functions at its operations in Brazil and a decision to suspend its operations in Argentina. The costs in Argentina included employee termination benefits, as well as costs to exit the Company's business arrangements with a supplier. Restructuring costs were also incurred in connection with downsizing efforts at several other locations around the Company.

50

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

A summary of the restructuring and impairment costs incurred during the fiscal years ended March 31, 2017, 2016, and 2015, is as follows:

	Fiscal Years Ended March 31,
	2017		2016		2015
Restructuring Costs:
Employee termination benefits	$	2,083	$	1,629	$	4,354
Other restructuring costs	—		96		536
	2,083		1,725		4,890
Impairment Costs:
Property and equipment and farmer loans	2,276		664		—
Total restructuring and impairment costs	$	4,359	$	2,389	$	4,890

A reconciliation of the Company’s liability for employee termination benefits and other restructuring costs for fiscal years 2015 through 2017 is as follows:

	Employee Termination Benefits			Other Costs			Total
Balance at April 1, 2014	$	2,026		$	160		$	2,186
Fiscal Year 2015 Activity:
Costs charged to expense	4,354			536			4,890
Payments	(5,684		)	(498		)	(6,182		)
Balance at March 31, 2015	696			198			894
Fiscal Year 2016 Activity:
Costs charged to expense	1,629			96			1,725
Payments	(2,246		)	(92		)	(2,338		)
Balance at March 31, 2016	79			202			281
Fiscal Year 2017 Activity:
Costs charged to expense	2,083			—			2,083
Payments	(1,861		)	(159		)	(2,020		)
Balance at March 31, 2017	$	301		$	43		$	344

The majority of the restructuring liability at March 31, 2017 will be paid in the early part of fiscal year 2018. Universal continually reviews its business for opportunities to realize efficiencies, reduce costs, and realign its operations in response to business changes. The Company may incur additional restructuring and impairment costs in future periods as business changes occur and additional cost savings initiatives are implemented.

51

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 3.   EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share:

	Fiscal Year Ended March 31,
(in thousands, except share and per share data)	2017			2016			2015
Basic Earnings Per Share
Numerator for basic earnings per share
Net income attributable to Universal Corporation	$	106,304		$	109,016		$	114,608
Less: Dividends on convertible perpetual preferred stock	(11,061		)	(14,748		)	(14,824		)
Less: Cost in excess of carrying value on conversion or repurchase of convertible perpetual preferred stock	(74,353		)	—			(36		)
Earnings available to Universal Corporation common shareholders for calculation of basic earnings per share	20,890			94,268			99,748
Denominator for basic earnings per share
Weighted average shares outstanding	23,433,860			22,683,290			23,035,920
Basic earnings per share	$	0.89		$	4.16		$	4.33
Diluted Earnings Per Share
Numerator for diluted earnings per share
Earnings available to Universal Corporation common shareholders	$	20,890		$	94,268		$	99,748
Add: Dividends on convertible perpetual preferred stock (if conversion assumed)	—			14,748			14,824
Add: Cost in excess of carrying value on conversion or repurchase of convertible perpetual preferred stock (if dilutive)	—			—			36
Earnings available to Universal Corporation common shareholders for calculation of diluted earnings per share	20,890			109,016			114,608
Denominator for diluted earnings per share
Weighted average shares outstanding	23,433,860			22,683,290			23,035,920
Effect of dilutive securities (if conversion or exercise assumed)
Convertible perpetual preferred stock	—			4,853,268			4,843,309
Employee share-based awards	336,228			288,933			342,035
Denominator for diluted earnings per share	23,770,088			27,825,491			28,221,264
Diluted earnings per share	$	0.88		$	3.92		$	4.06

In December 2016, 111,072 shares of the Company’s Series B 6.75% Convertible Perpetual Preferred Stock were converted into approximately 2.5 million shares of the Company's common stock. In January 2017, the Company announced a mandatory conversion of all 107,418 remaining outstanding shares of the preferred stock after meeting the requirements to initiate the mandatory conversion under the original terms of the preferred shares. The Company chose to satisfy the conversion obligation for the mandatory conversion in cash. Although the conversions of the preferred stock into common stock or for cash did not impact the Company’s net income, the shares converted for cash under the mandatory conversion in January 2017 resulted in a one-time reduction of retained earnings of approximately $74.4 million during the fourth quarter ending March 31, 2017, representing the excess of the conversion cost over the carrying value of those shares. The reduction in retained earnings resulted in a corresponding one-time reduction of earnings available to common shareholders for the fiscal year ending March 31, 2017 for purposes of determining the amounts reported for basic and diluted earnings per share. The effects of the conversions on the computation of basic and diluted earnings per share for the fiscal year ended March 31, 2017, are included in the table above. See Note 11 for additional information.

52

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For the fiscal years ended March 31, 2017, 2016, and 2015, the Company had the following potentially dilutive securities (stock appreciation rights) outstanding that were not included in the computation of diluted earnings per share because their effect would have been antidilutive:

	Fiscal Year Ended March 31,
	2017		2016		2015
Potentially dilutive securities	—		133,600		156,200
Weighted-average exercise price	$	—	$	62.66	$	61.83

NOTE 4.   INCOME TAXES

The Company operates in the United States and many foreign countries and is subject to the tax laws of many jurisdictions. Changes in tax laws or the interpretation of tax laws can affect the Company’s earnings, as can the resolution of pending and contested tax issues. The Company's consolidated effective income tax rate is affected by a number of factors, including the mix of domestic and foreign earnings, the effect of exchange rate changes on deferred taxes, and the Company’s ability to utilize foreign tax credits.

Income Tax Expense

Income taxes for the fiscal years ended March 31, 2017, 2016, and 2015 consisted of the following: 

	Fiscal Year Ended March 31,
	2017		2016			2015
Current
United States	$	3,422	$	5,371		$	4,126
State and local	147		1,116			657
Foreign	36,537		32,897			46,885
	40,106		39,384			51,668
Deferred
United States	5,434		5,780			3,352
State and local	561		(445		)	159
Foreign	10,631		9,711			(17,173		)
	16,626		15,046			(13,662		)
Total	$	56,732	$	54,430		$	38,006

Foreign taxes include U.S. tax expense on earnings of foreign subsidiaries. The Company has no undistributed earnings of consolidated foreign subsidiaries that are classified as permanently reinvested.

Consolidated Effective Income Tax Rate

A reconciliation of the statutory U.S. federal rate to the Company’s effective income tax rate is as follows:

	Fiscal Year Ended March 31,
	2017		2016		2015
Statutory tax rate	35.0	%	35.0	%	35.0	%
State income taxes, net of federal benefit	0.3		0.3		0.3
Dividends received from deconsolidated operations	(2.3	)	(1.5	)	(1.3	)
Effect of exchange rate changes on deferred income taxes	0.4		(1.6	)	(4.9	)
Tax benefit arising from payment of a portion of a fine by a subsidiary	—		—		(5.0	)
Other, including changes in liabilities recorded for uncertain tax positions	0.1		(0.7	)	(0.1	)
Effective income tax rate	33.5	%	31.5	%	24.0	%

53

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

During the first quarter of fiscal year 2015, the Company recorded a consolidated income tax benefit of $8 million arising from the ability of its subsidiary, Deltafina S.p.A., to pay a significant portion of a fine and related interest charges in Italy that were settled during that quarter following the unsuccessful appeal of a case involving anti-competitive activities in the Italian tobacco market. Deltafina and Universal Corporation were jointly liable for the fine and interest charges. The Company’s initial accrual of the amounts imposed in September 2011 assumed that the entire obligation would be paid by Universal Corporation due to uncertainty with respect to Deltafina’s financial capacity to bear any significant portion of the cost upon the eventual settlement and to uncertainty as to when the payment would be made. Deltafina ultimately was able to assume responsibility for approximately $30 million of the total $53 million obligation for the fine and interest when those amounts were paid. Although the portion of the fine paid by Deltafina was not deductible for income tax purposes in Italy, it reduced the subsidiary’s cumulative undistributed earnings and the associated consolidated tax liability, resulting in the $8 million benefit in the Company's consolidated income tax provision. This discrete item reduced the effective income tax rate for fiscal year 2015 by 5.0%.

Components of Income Before Income Taxes

The U.S. and foreign components of income before income taxes were as follows:

	Fiscal Year Ended March 31,
	2017		2016		2015
United States	$	31,468	$	37,877	$	27,181
Foreign	137,770		134,701		131,286
Total	$	169,238	$	172,578	$	158,467

Deferred Income Tax Liabilities and Assets

Significant components of deferred tax liabilities and assets were as follows:  

	March 31,
	2017			2016
Liabilities
Foreign withholding taxes	$	44,702		$	39,770
Undistributed earnings	24,629			19,553
Goodwill	30,851			30,851
All other	11,015			10,424
Total deferred tax liabilities	$	111,197		$	100,598
Assets
Employee benefit plans	$	38,804		$	43,362
Reserves and accruals	11,756			12,911
Deferred income	4,672			3,938
Currency translation losses of foreign subsidiaries	13,244			9,939
Local currency exchange losses of foreign subsidiaries	3,669			3,597
Foreign tax credit carryforward	2,799			4,664
All other	14,327			16,546
Total deferred tax assets	89,271			94,957
Valuation allowance	(636		)	—
Net deferred tax assets	$	88,635		$	94,957

At March 31, 2017, the Company had no material net operating loss carryforwards in either its domestic or foreign operations.

54

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Combined Income Tax Expense (Benefit)

The combined income tax expense (benefit) allocable to continuing operations, other comprehensive income, and direct adjustments to shareholders' equity was as follows:

	Fiscal Year Ended March 31,
	2017		2016			2015
Continuing operations	$	56,732	$	54,430		$	38,006
Other comprehensive income	1,503		1,423			(21,900		)
Direct adjustments to shareholders' equity	—		(805		)	(932		)
Total	$	58,235	$	55,048		$	15,174

Uncertain Tax Positions

A reconciliation of the beginning and ending balance of the gross liability for uncertain tax positions for the fiscal years ended March 31, 2017, 2016 and 2015, is as follows:

	Fiscal Year Ended March 31,
	2017			2016			2015
Liability for uncertain tax positions, beginning of year	$	2,407		$	2,894		$	3,809
Additions:
Related to tax positions for the current year	94			98			272
Related to tax positions for prior years	—			—			—
Reductions:
Due to lapses of statutes of limitations	(112		)	(215		)	(478		)
Related to tax positions for prior years	(3		)	—			(143		)
Effect of currency rate movement	40			(370		)	(566		)
Liability for uncertain tax positions, end of year	$	2,426		$	2,407		$	2,894

Of the total liability for uncertain tax positions at March 31, 2017, approximately $1.8 million could have an effect on the consolidated effective tax rate if the tax benefits are recognized. The liability for uncertain tax positions includes $0.1 million related to tax positions for which it is reasonably possible that the amounts could change significantly before March 31, 2018. This amount reflects a possible decrease in the liability for uncertain tax positions that could result from the completion and resolution of tax audits and the expiration of open tax years in various tax jurisdictions.

The Company recognizes accrued interest related to uncertain tax positions as interest expense, and it recognizes penalties as a component of income tax expense. Amounts accrued or reversed for interest and penalties were not material for any of the fiscal years 2015 through 2017, and liabilities recorded for interest and penalties at March 31, 2017 and 2016 also were not material.

Universal and its subsidiaries file a U.S. federal consolidated income tax return, as well as returns in several U.S. states and a number of foreign jurisdictions. As of March 31, 2017, the Company's earliest open tax year for U.S. federal income tax purposes was its fiscal year ended 2014. Open tax years in state and foreign jurisdictions generally range from 3 to 6 years.

55

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 5.   CREDIT FACILITIES

Bank Credit Agreements

In December 2014, the Company entered into a senior unsecured bank credit agreement that replaced its previous short-term and long-term borrowing facilities, consolidating and extending the maturities of those facilities. The agreement established a $430 millionfive-year revolving credit facility, along with a $150 millionfive-year term loan and a $220 millionseven-year term loan. Borrowings under the revolving credit facility bear interest at a variable rate based on either (1) LIBOR plus a margin that is based on the Company's credit measures or (2) the higher of the federal funds rate plus 0.5%, prime rate, or one-month LIBOR plus 1.0%, each plus a margin. In addition to interest, the Company pays a facility fee on the revolving credit facility. No amounts were outstanding under the revolving credit facility at March 31, 2017. The credit agreement provides for an expansion of the facility under certain conditions to allow additional borrowings of up to $100 million. Additional information related to the term loans is provided in Note 6. The credit agreement includes financial covenants that require the Company to maintain a minimum level of tangible net worth and observe limits on debt levels. The Company was in compliance with those covenants at March 31, 2017.

Short-Term Credit Facilities

The Company maintains short-term uncommitted lines of credit in the United States and in a number of foreign countries. Foreign borrowings are generally in the form of overdraft facilities at rates competitive in the countries in which the Company operates. Generally, each foreign line is available only for borrowings related to operations of a specific country. As of March 31, 2017 and 2016, approximately $59 million and $66 million, respectively, were outstanding under these uncommitted lines of credit. The weighted-average interest rates on short-term borrowings outstanding as of March 31, 2017 and 2016, were approximately 3.1% and 2.2%, respectively. At March 31, 2017, the Company and its consolidated affiliates had unused uncommitted lines of credit totaling approximately $248 million.

NOTE 6.   LONG-TERM DEBT

The Company's long-term debt at March 31, 2017 and 2016 consisted of the following:

	March 31,
	2017			2016
Senior bank term loans	$	370,000		$	370,000
Total outstanding	370,000			370,000
Less: current portion	—			—
Less: unamortized debt issuance costs	(1,267		)	(1,620		)
Long-term debt	$	368,733		$	368,380

As discussed in Note 5, the Company entered into a bank credit agreement in December 2014 that established a $150 millionfive-year term loan and a $220 millionseven-year term loan. Both term loans were fully funded at closing, and the Company concurrently repaid approximately $250 million aggregate principal amount on term loans outstanding under two previous bank credit facilities and reduced its revolving credit borrowings by approximately $120 million. The term loans require no amortization and are prepayable without penalty prior to maturity. Under the credit agreement, both term loans bear interest at variable rates plus a margin based on the Company's credit measures. However, following closing on the term loans, the Company entered into receive-floating / pay-fixed interest rate swap agreements that convert the variable benchmark rate on both loans to a fixed rate over their full terms to maturity. With the swap agreements in place, the effective interest rate on the $150 millionfive-year loan and the $220 millionseven-year loan were 2.94% and 3.48%, respectively, at March 31, 2017 and 2016. The effective rates will change only if a change in the Company's credit measures results in adjustments to the applicable credit spreads specified in the underlying loan agreement. The $150 millionfive-year term loan matures in fiscal year 2020, and the $220 millionseven-year term loan matures in fiscal year 2022.

In November 2014, the Company filed an undenominated universal shelf registration statement with the U.S. Securities and Exchange Commission to provide for the future issuance of an undefined amount of additional debt or equity securities as determined by the Company and offered in one or more prospectus supplements prior to issuance.

Disclosures about the fair value of long-term debt are provided in Note 9.

56

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 7. LEASES

The Company’s subsidiaries lease various production, storage, distribution, and other facilities, as well as vehicles and equipment used in their operations. Some of the leases have options to extend the lease term at market rates. These arrangements are classified as operating leases for accounting purposes. Rent expense on operating leases totaled $15.3 million in fiscal year 2017, $14.7 million in fiscal year 2016, and $15.8 million in fiscal year 2015. Future minimum payments under non-cancelable operating leases total $11.5 million in 2018, $8.5 million in 2019, $7.2 million in 2020, $5.8 million in 2021, $4.1 million in 2022, and $13.7 million after 2022.

NOTE 8.   DERIVATIVES AND HEDGING ACTIVITIES

Universal is exposed to various risks in its worldwide operations and uses derivative financial instruments to manage two specific types of risks – interest rate risk and foreign currency exchange rate risk. Interest rate risk has been managed by entering into interest rate swap agreements, and foreign currency exchange rate risk has been managed by entering into forward foreign currency exchange contracts. However, the Company’s policy also permits other types of derivative instruments. In addition, foreign currency exchange rate risk is also managed through strategies that do not involve derivative instruments, such as using local borrowings and other approaches to minimize net monetary positions in non-functional currencies. The disclosures below provide additional information about the Company’s hedging strategies, the derivative instruments used, and the effects of these activities on the consolidated statements of income and comprehensive income and the consolidated balance sheets. In the consolidated statements of cash flows, the cash flows associated with all of these activities are reported in net cash provided by operating activities.

Cash Flow Hedging Strategy for Interest Rate Risk

In January 2015, the Company entered into receive-floating/pay-fixed interest rate swap agreements that were designated and qualified as hedges of the exposure to changes in interest payment cash flows created by fluctuations in variable interest rates on its two outstanding non-amortizing bank term loans (see Notes 5 and 6). Although no significant ineffectiveness is expected with this hedging strategy, the effectiveness of the interest rate swaps is evaluated on a quarterly basis. At March 31, 2017, the total notional amount of the interest rate swaps was $370 million, which corresponded with the aggregate outstanding balance of the term loans.

Cash Flow Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Forecast Purchases of Tobacco and Related Processing Costs

The majority of the tobacco production in most countries outside the United States where Universal operates is sold in export markets at prices denominated in U.S. dollars. However, purchases of tobacco from farmers and most processing costs (such as labor and energy) in those countries are usually denominated in the local currency. Changes in exchange rates between the U.S. dollar and the local currencies where tobacco is grown and processed affect the ultimate U.S. dollar cost of the processed tobacco. From time to time, the Company enters into forward contracts to sell U.S. dollars and buy the local currency at future dates that coincide with the expected timing of a portion of the tobacco purchases and processing costs. This strategy offsets the variability of future U.S. dollar cash flows for tobacco purchases and processing costs for the foreign currency notional amount hedged. This hedging strategy has been used mainly for tobacco purchases and processing costs in Brazil. The aggregate U.S. dollar notional amount of forward contracts entered for these purposes during fiscal years 2017, 2016, and 2015 was as follows:

	Fiscal Year Ended March 31,
(in millions)	2017		2016		2015
Tobacco purchases	$	70.7	$	43.1	$	105.6
Processing costs	24.0		13.2		22.9
Total	$	94.7	$	56.3	$	128.5

The reduced U.S. dollar notional amounts for tobacco purchases and processing costs hedged during fiscal year 2016 reflected the reduced size of the 2016 Brazilian crop and a variation in the timing of fixed-price orders from customers for their purchases from that crop year. All contracts related to tobacco purchases were designated and qualified as hedges of the future cash flows associated with the forecast purchases of tobacco. As a result, except for amounts related to any ineffective portion of the hedging strategy or any early de-designation of the hedge arrangement, changes in fair values of the forward contracts have been recognized in comprehensive income as they occurred, but only recognized in earnings upon sale of the related tobacco to third-party customers. Forward contracts related to processing costs have not been designated as hedges, and gains and losses on those contracts have been recognized in earnings on a mark-to-market basis.

57

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For substantially all hedge gains and losses recorded in accumulated other comprehensive loss at March 31, 2017, the Company expects to complete the sale of the tobacco and recognize the amounts in earnings during fiscal year 2018. At March 31, 2017, all hedged forecast purchases of tobacco not yet completed remained probable of occurring within the originally designated time period and, as a result, no hedges had been discontinued. Purchases of the 2017 Brazilian crop are expected to be completed by July 2017, and all forward contracts to hedge those purchases will mature and be settled by that time.

Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Net Local Currency Monetary Assets and Liabilities of Foreign Subsidiaries

Most of the Company’s foreign subsidiaries transact the majority of their sales in U.S. dollars and finance the majority of their operating requirements with U.S. dollar borrowings, and therefore use the U.S. dollar as their functional currency. These subsidiaries normally have certain monetary assets and liabilities on their balance sheets that are denominated in the local currency. Those assets and liabilities can include cash and cash equivalents, accounts receivable and accounts payable, advances to farmers and suppliers, deferred income tax assets and liabilities, recoverable value-added taxes, and other items. Net monetary assets and liabilities denominated in the local currency are remeasured into U.S. dollars each reporting period, generating gains and losses that the Company records in earnings as a component of selling, general, and administrative expenses. The level of net monetary assets or liabilities denominated in the local currency normally fluctuates throughout the year based on the operating cycle, but it is most common for monetary assets to exceed monetary liabilities, sometimes by a significant amount. When this situation exists and the local currency weakens against the U.S. dollar, remeasurement losses are generated. Conversely, remeasurement gains are generated on a net monetary asset position when the local currency strengthens against the U.S. dollar. To manage a portion of its exposure to currency remeasurement gains and losses, the Company enters into forward contracts to buy or sell the local currency at future dates coinciding with expected changes in the overall net local currency monetary asset or liability position of the subsidiary. Gains and losses on the forward contracts are recorded in earnings as a component of selling, general, and administrative expenses for each reporting period as they occur, and thus directly offset the related remeasurement losses or gains in the consolidated statements of income for the notional amount hedged. The Company does not designate these contracts as hedges for accounting purposes. The contracts are generally arranged to hedge the subsidiary's projected exposure to currency remeasurement risk for specified periods of time, and new contracts are entered as necessary throughout the year to replace previous contracts as they mature.  During the fiscal years ended March 31, 2017, 2016, and 2015, the Company used forward currency contracts to manage its exposure to currency remeasurement risk in Brazil. The total notional amounts of contracts outstanding at March 31, 2017 and 2015 were approximately $33.0 million and $80.4 million, respectively. At March 31, 2016 , the net local monetary asset position in Brazil was not significant, and there were no foreign currency contracts outstanding. To further mitigate currency remeasurement exposure, the Company’s foreign subsidiaries may utilize short-term local currency financing during certain periods. This strategy, while not involving the use of derivative instruments, is intended to minimize the subsidiary’s net monetary position by financing a portion of the local currency monetary assets with local currency monetary liabilities and thus hedging a portion of the overall position.

Several of the Company’s foreign subsidiaries transact the majority of their sales and finance the majority of their operating requirements in their local currency, and therefore use their respective local currencies as the functional currency for reporting purposes. From time to time, these subsidiaries sell tobacco to customers in transactions that are not denominated in the functional currency. In those situations, the subsidiaries routinely enter into forward exchange contracts to offset currency risk for the period of time that a fixed-price order and the related trade account receivable are outstanding with the customer. The contracts are not designated as hedges for accounting purposes.

58

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Effect of Derivative Financial Instruments on the Consolidated Statements of Income

The table below outlines the effects of the Company’s use of derivative financial instruments on the consolidated statements of income for the fiscal years ended March 31, 2017, 2016, and 2015.

	Fiscal Year Ended March 31,
	2017			2016			2015
Cash Flow Hedges - Interest Rate Swap Agreements
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	8,999		$	(12,824	)	$	(4,044	)
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	(3,916	)	$	(5,108	)	$	(1,929	)
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Interest expense
Ineffective Portion of Hedge
Gain (loss) recognized in earnings	$	—		$	—		$	—
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Floating rate interest payments on term loans
Cash Flow Hedges - Forward Foreign Currency Exchange Contracts
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	454		$	1,774		$	1,410
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	945		$	993		$	3,099
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Cost of goods sold
Ineffective Portion and Early De-designation of Hedges
Gain (loss) recognized in earnings	$	246		$	685		$	257
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Forecast purchases of tobacco in Brazil
Derivatives Not Designated as Hedges - Forward Foreign Currency Exchange Contracts
Gain (loss) recognized in earnings	$	(2,591	)	$	5,973		$	13,178
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses

For the interest rate swap agreements, the effective portion of the gain or loss on the derivative is recorded in accumulated other comprehensive loss and any ineffective portion is recorded in selling, general and administrative expenses. For the forward foreign currency exchange contracts designated as cash flow hedges of tobacco purchases in Brazil, an immaterial net hedge gain, representing unrealized gains on contracts related to the 2017 crop, remained in accumulated other comprehensive loss at March 31, 2017. No hedge gain or loss had been reclassified to earnings at March 31, 2017 since shipments of those tobaccos had not yet started. The majority of the balance in accumulated other comprehensive loss will be recognized in earnings as a component of cost of goods sold in fiscal year 2018 as the 2017 Brazilian crop tobacco is sold to customers. Based on the hedging strategy, as the gain or loss is recognized in earnings, it is expected to be offset by a change in the direct cost for the tobacco or by a change in sales prices if the strategy has been mandated by the customer. Generally, margins on the sale of the tobacco will not be significantly affected.

59

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Effect of Derivative Financial Instruments on the Consolidated Balance Sheets

The table below outlines the effects of the Company’s derivative financial instruments on the consolidated balance sheets at March 31, 2017 and 2016:

	Derivatives in a Fair Value Asset Position					Derivatives in a Fair Value Liability Position
	Balance Sheet Location	Fair Value as of March 31,				Balance Sheet Location	Fair Value as of March 31,
		2017		2016			2017		2016
Derivatives Designated as Hedging Instruments
Interest rate swap agreements	Other non-current assets	$	2,149	$	—	Other long-term liabilities	$	—	$	10,766
Forward foreign currency exchange contracts	Other current assets	56		475		Accounts payable and accrued expenses	55		—
Total		$	2,205	$	475		$	55	$	10,766
Derivatives Not Designated as Hedging Instruments
Forward foreign currency exchange contracts	Other current assets	$	917	$	297	Accounts payable and accrued expenses	$	120	$	5
Total		$	917	$	297		$	120	$	5

Substantially all of the Company's forward foreign currency exchange contracts are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. The Company has elected to present these contracts on a gross basis in the consolidated balance sheets.

NOTE 9.   FAIR VALUE MEASUREMENTS

Universal measures certain financial and nonfinancial assets and liabilities at fair value based on applicable accounting guidance. The financial assets and liabilities measured at fair value include money market funds, trading securities associated with deferred compensation plans, interest rate swap agreements, forward foreign currency exchange contracts, and guarantees of bank loans to tobacco growers. The application of the fair value guidance to nonfinancial assets and liabilities primarily includes the determination of fair values for goodwill and long-lived assets when indicators of potential impairment are present.

Under the accounting guidance, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The framework for measuring fair value is based on a fair value hierarchy that distinguishes between observable inputs and unobservable inputs. Observable inputs are based on market data obtained from independent sources. Unobservable inputs require the Company to make its own assumptions about the value placed on an asset or liability by market participants because little or no market data exists. There are three levels within the fair value hierarchy.

Level	Description
1	quoted prices in active markets for identical assets or liabilities that the Company has the ability to access as of the reporting date;
2	quoted prices in active markets for similar assets or liabilities, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability; and
3	unobservable inputs for the asset or liability.

As permitted under the accounting guidance, the Company uses net asset value per share ("NAV") as a practical expedient to measure the fair value of its money market funds. As discussed in Note 1, under updated accounting guidance adopted effective

60

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

April 1, 2016, the fair values for those funds are no longer categorized within the fair value hierarchy and are presented under the heading "NAV" in the tables that follow in this disclosure.

In measuring the fair value of liabilities, the Company considers the risk of non-performance in determining fair value. Universal has not elected to report at fair value any financial instruments or any other assets or liabilities that are not required to be reported at fair value under current accounting guidance.

At March 31, 2017 and 2016, the Company had certain financial assets and financial liabilities that were required to be measured and reported at fair value on a recurring basis. These assets and liabilities are listed in the tables below and are classified based on how their values were determined under the fair value hierarchy or the NAV practical expedient:

	March 31, 2017
			Fair Value Hierarchy
	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	137,145	$	—	$	—	$	—	$	137,145
Trading securities associated with deferred compensation plans	—		17,726		—		—		17,726
Interest rate swap agreements	—		—		2,149		—		2,149
Forward foreign currency exchange contracts	—		—		973		—		973
Total financial assets measured and reported at fair value	$	137,145	$	17,726	$	3,122	$	—	$	157,993
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,177	$	1,177
Forward foreign currency exchange contracts	—		—		175		—		175
Total financial liabilities measured and reported at fair value	$	—	$	—	$	175	$	1,177	$	1,352
	March 31, 2016
			Fair Value Hierarchy
	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	116,618	$	—	$	—	$	—	$	116,618
Trading securities associated with deferred compensation plans	—		17,817		—		—		17,817
Forward foreign currency exchange contracts	—		—		772		—		772
Total financial assets measured and reported at fair value	$	116,618	$	17,817	$	772	$	—	$	135,207
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,628	$	1,628
Interest rate swap agreements	—		—		10,766		—		10,766
Forward foreign currency exchange contracts	—		—		5		—		5
Total financial liabilities measured and reported at fair value	$	—	$	—	$	10,771	$	1,628	$	12,399

61

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Money market funds

The fair value of money market funds, which are reported in cash and cash equivalents in the consolidated balance sheets, is based on NAV, which is the amount at which the funds are redeemable and is used as a practical expedient for fair value. These funds are not classified in the fair value hierarchy, but are disclosed as part of the fair value table above.

Trading securities associated with deferred compensation plans

Trading securities represent mutual fund investments that are matched to employee deferred compensation obligations. These investments are bought and sold as employees defer compensation, receive distributions, or make changes in the funds underlying their accounts. Quoted market prices (Level 1) are used to determine the fair values of the mutual funds.

Interest rate swap agreements

The fair values of interest rate swap agreements are determined based on dealer quotes using a discounted cash flow model matched to the contractual terms of each instrument. Since inputs to the model are observable and significant judgment is not required in determining the fair values, interest rate swaps are classified within Level 2 of the fair value hierarchy.

Forward foreign currency exchange contracts

The fair values of forward foreign currency exchange contracts are also determined based on dealer quotes using a discounted cash flow model matched to the contractual terms of each instrument. Since inputs to the model are observable and significant judgment is not required in determining the fair values, forward foreign currency exchange contracts are classified within Level 2 of the fair value hierarchy.

Guarantees of bank loans to tobacco growers

The Company guarantees bank loans to tobacco growers in Brazil for crop financing. In the event that the farmers default on their payments to the banks, the Company would be required to perform under the guarantees. The Company regularly evaluates the likelihood of farmer defaults based on an expected loss analysis and records the fair value of its guarantees as an obligation in its consolidated financial statements. The fair value of the guarantees is determined using the expected loss data for all loans outstanding at each measurement date. The present value of the cash flows associated with the estimated losses is then calculated at a risk-adjusted interest rate that is aligned with the expected duration of the liability and includes an adjustment for nonperformance risk. This approach is sometimes referred to as the “contingent claims valuation method.” Although historical loss data is an observable input, significant judgment is required in applying this information to the portfolio of guaranteed loans outstanding at each measurement date and in selecting a risk-adjusted interest rate. Significant increases or decreases in the risk-adjusted interest rate may result in a significantly higher or lower fair value measurement. The guarantees of bank loans to tobacco growers are therefore classified within Level 3 of the fair value hierarchy.

A reconciliation of the change in the balance of the financial liability for guarantees of bank loans to tobacco growers (Level 3) for the fiscal years ended March 31, 2017 and 2016 is provided below.

	Fiscal Year Ended March 31,
	2017			2016
Balance at beginning of year	$	1,628		$	1,674
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of prior crop year loans from the portfolio)	(2,550		)	(1,826		)
Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop year loans)	1,854			1,834
Change in discount rate and estimated collection period	59			106
Currency remeasurement	186			(160		)
Balance at end of year	$	1,177		$	1,628

Long-term Debt

The fair value of the Company’s long-term debt was approximately $370 million at each of the balance sheet dates March 31, 2017 and 2016. The Company estimates the fair value of its long-term debt using Level 2 inputs which are based upon quoted market prices for the same or similar obligations or on calculations that are based on the current interest rates available to the Company for debt of similar terms and maturities.

62

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 10.   PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS

Defined Benefit Plans

Description of Plans

 The Company sponsors several defined benefit pension plans covering U.S. salaried employees and certain foreign and other employee groups. These plans provide retirement benefits based primarily on employee compensation and years of service. Plan assets consist primarily of equity and fixed income investments. The Company also sponsors defined benefit plans that provide postretirement health and life insurance benefits for eligible U.S. employees who have attained specific age and service levels, although postretirement life insurance benefits were discontinued for active employees during fiscal year 2015. The health benefits are funded by the Company as the costs of those benefits are incurred. The plan design includes cost-sharing features such as deductibles and coinsurance. The life insurance benefits are funded with deposits to a reserve account held by an insurance company. The Company has the right to amend or discontinue its pension and other postretirement benefit plans at any time.

In the following disclosures, the term “accumulated benefit obligation” (“ABO”) represents the actuarial present value of estimated future benefit payments earned by participants in the Company's defined benefit pension plans as of the balance sheet date without regard to the estimated effect of future compensation increases on those benefits. The term does not apply to other postretirement benefits. “Projected benefit obligation” refers to the projected benefit obligation (“PBO”) for pension benefits and the accumulated postretirement benefit obligation (“APBO”) for other postretirement benefits. These amounts represent the actuarial present value of estimated future benefit payments earned by participants in the benefit plans as of the balance sheet date. For pension benefits, the projected benefit obligation includes the estimated effect of future compensation increases on those benefits.

Actuarial Assumptions

Assumptions used for financial reporting purposes to compute net periodic benefit cost and benefit obligations for the Company's primary defined benefit plans were as follows:

	Pension Benefits						Other Postretirement Benefits
	2017		2016		2015		2017		2016		2015
Discount rates:
Benefit cost for plan year	4.10	%	3.80	%	4.50	%	3.80	%	3.70	%	4.30	%
Benefit obligation at end of plan year	4.10	%	4.10	%	3.80	%	3.90	%	3.80	%	3.70	%
Expected long-term return on plan assets:
Benefit cost for plan year	7.00	%	7.25	%	7.75	%	3.00	%	3.00	%	4.30	%
Salary scale:
Benefit cost for plan year	4.00	%	4.50	%	4.50	%	4.00	%	4.50	%	4.50	%
Benefit obligation at end of plan year	4.00	%	4.00	%	4.50	%	4.00	%	4.00	%	4.50	%
Healthcare cost trend rate	N/A		N/A		N/A		6.70	%	7.00	%	7.20	%

Changes in the discount rates in the above table reflect prevailing market interest rates at the end of each fiscal year when the benefit obligations are actuarially measured. The reduction in the expected long-term return on plan assets assumption from fiscal year 2015 to fiscal year 2016 is primarily due to changes in the underlying plan assets. These changes reflect a move toward a liability-driven investment strategy in the Company's ERISA-regulated U.S. defined benefit pension plan due to the high percentage of retired and inactive participants in the plan and the high funded status of the plan. The healthcare cost trend rate used by the Company is based on a study of medical cost inflation rates that is reviewed annually for continued applicability. The revised trend assumption of 6.70% in 2017 declines gradually to 4.50% in 2037.

63

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Benefit Obligations, Plan Assets, and Funded Status

The following table reflects the changes in benefit obligations and plan assets in 2017 and 2016, as well as the funded status of the plans at March 31, 2017 and 2016:

	Pension Benefits						Other Postretirement Benefits
	March 31,						March 31,
	2017			2016			2017			2016
Actuarial present value of benefit obligation:
Accumulated benefit obligation	$	266,764		$	273,479
Projected benefit obligation	269,250			275,505			$	36,786		$	37,225
Change in projected benefit obligation:
Projected benefit obligation, beginning of year	$	275,505		$	288,908		$	37,225		$	40,863
Service cost	5,382			5,953			247			286
Interest cost	10,441			10,037			1,535			1,539
Effect of discount rate change	489			(10,036		)	(191		)	(402		)
Foreign currency exchange rate changes	(1,111		)	330			286			(215		)
Settlements	(10,955		)	—			—			—
Other	4,108			(486		)	766			(1,104		)
Benefit payments	(14,609		)	(19,201		)	(3,082		)	(3,742		)
Projected benefit obligation, end of year	$	269,250		$	275,505		$	36,786		$	37,225
Change in plan assets:
Plan assets at fair value, beginning of year	$	217,859		$	224,553		$	1,565		$	2,115
Actual return on plan assets	16,450			61			71			69
Employer contributions	10,676			12,504			4,500			3,123
Settlements	(10,322		)	—			—			—
Foreign currency exchange rate changes	97			(58		)	—			—
Benefit payments	(14,609		)	(19,201		)	(3,082		)	(3,742		)
Plan assets at fair value, end of year	$	220,151		$	217,859		$	3,054		$	1,565
Funded status:
Funded status of the plans, end of year	$	(49,099	)	$	(57,646	)	$	(33,732	)	$	(35,660	)

The settlements for pension benefits in fiscal year 2017 were attributable to the termination of a foreign pension plan during the year and the transfer of assets in settlement of the participants' benefit obligations to defined contribution plans. The Company funds its non-regulated U.S. pension plan, one of its foreign pension plans, and its postretirement medical plans on a pay-as-you-go basis as the benefit payments are incurred. Those plans account for approximately 71% of the $49.1 million unfunded pension obligation and approximately 85% of the $33.7 million unfunded postretirement benefit obligation shown on the funded status line in the above table at March 31, 2017.

64

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The funded status of the Company’s plans at the end of fiscal years 2017 and 2016 was reported in the consolidated balance sheets as follows:

	Pension Benefits						Other Postretirement Benefits
	March 31,						March 31,
	2017			2016			2017			2016
Non-current asset (included in other noncurrent assets)	$	1,710		$	2,044		$	—		$	—
Current liability (included in accounts payable and accrued expenses)	(1,106		)	(630		)	(2,746		)	(2,543		)
Non-current liability (reported as pensions and other postretirement benefits)	(49,703		)	(59,060		)	(30,986		)	(33,117		)
Amounts recognized in the consolidated balance sheets	$	(49,099	)	$	(57,646	)	$	(33,732	)	$	(35,660	)

Additional information on the funded status of the Company’s plans as of the respective measurement dates for the fiscal years ended March 31, 2017 and 2016, is as follows:

	Pension Benefits				Other Postretirement Benefits
	March 31,				March 31,
	2017		2016		2017		2016
For plans with a projected benefit obligation in excess of plan assets:
Aggregate projected benefit obligation (PBO)	$	260,826	$	270,058	$	36,786	$	37,225
Aggregate fair value of plan assets	210,017		210,368		3,054		1,565
For plans with an accumulated benefit obligation in excess of plan assets:
Aggregate accumulated benefit obligation (ABO)	258,424		268,087		N/A		N/A
Aggregate fair value of plan assets	210,017		210,368		N/A		N/A

Net Periodic Benefit Cost

The components of the Company’s net periodic benefit cost were as follows:

	Pension Benefits									Other Postretirement Benefits
	Fiscal Year Ended March 31,									Fiscal Year Ended March 31,
	2017			2016			2015			2017			2016			2015
Components of net periodic benefit cost:
Service cost	$	5,382		$	5,953		$	5,099		$	247		$	286		$	347
Interest cost	10,441			10,037			11,215			1,535			1,539			1,699
Expected return on plan assets	(15,154		)	(15,110		)	(15,493		)	(42		)	(58		)	(102		)
Curtailment gain	—			—			—			—			—			(1,465		)
Settlement gain	(912		)	—			—			—			—			—
Net amortization and deferral	4,576			4,394			6,169			(394		)	(431		)	(671		)
Net periodic benefit cost	$	4,333		$	5,274		$	6,990		$	1,346		$	1,336		$	(192	)

The curtailment gain for other postretirement benefits in fiscal year 2015 was attributable to the discontinuation of postretirement life insurance benefits for active U.S. employees. A one-percentage-point increase in the assumed healthcare cost trend rate would increase the March 31, 2017 accumulated postretirement benefit obligation by approximately $800 thousand, while a one-percentage-point decrease would reduce the benefit obligation by approximately $700 thousand. The aggregate service and interest cost components of the net periodic postretirement benefit expense for fiscal year 2018 would not change by a significant amount as a result of a one-percentage-point increase or decrease in the assumed healthcare cost trend rate.

65

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Amounts Included in Accumulated Other Comprehensive Loss

Amounts included in accumulated other comprehensive loss at the beginning of the year are amortized as a component of net periodic benefit cost during the year. The amounts recognized in other comprehensive income or loss for fiscal years 2017 and 2016 and the amounts included in accumulated other comprehensive loss at the end of those fiscal years are shown below. All amounts shown are before allocated income taxes.

	Pension Benefits						Other Postretirement Benefits
	March 31,						March 31,
	2017			2016			2017			2016
Change in net actuarial loss (gain):
Net actuarial loss (gain), beginning of year	$	79,299		$	81,544		$	(7,234	)	$	(6,402	)
Losses (gains) arising during the year	2,313			4,787			554			(1,263		)
Amortization included in net periodic benefit cost during the year	(7,567		)	(7,032		)	394			431
Net actuarial loss (gain), end of year	74,045			79,299			(6,286		)	(7,234		)
Change in prior service cost (benefit):
Prior service cost (benefit), beginning of year	(15,061		)	(17,630		)	(108		)	—
Prior service cost (benefit) arising during the year	—			111			(4		)	(108		)
Amortization included in net periodic benefit cost during the year	2,991			2,458			—			—
Prior service cost (benefit), end of year	(12,070		)	(15,061		)	(112		)	(108		)
Total amounts in accumulated other comprehensive loss at end of year, before income taxes	$	61,975		$	64,238		$	(6,398	)	$	(7,342	)

Amounts in the above table reflect the Company and its consolidated subsidiaries. The accumulated other comprehensive loss reported in the consolidated balance sheets also includes pension and other postretirement benefit amounts related to ownership interests in unconsolidated affiliates.

The Company expects to recognize approximately $5.2 million of the March 31, 2017 net actuarial loss and $2.4 million of the March 31, 2017 prior service benefit in net periodic benefit cost during fiscal year 2018.

Allocation of Pension Plan Assets

The Company has established, and periodically adjusts, target asset allocations for its investments in its U.S. ERISA-regulated defined benefit pension plan, which represents 94% of consolidated plan assets and 83% of consolidated PBO at March 31, 2017, to balance the needs of liquidity, total return, and risk control. The assets are required to be diversified across asset classes and investment styles to achieve that balance. During the year, the asset allocation is reviewed for adherence to the target policy and rebalanced to the targeted weights. The Company reviews the expected long-term returns of the asset allocation each year to help determine whether changes are needed. The return is evaluated on a weighted-average basis in relation to inflation. The assumed long-term rate of return used to calculate annual benefit expense is based on the asset allocation and expected market returns for the respective asset classes.

66

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The weighted–average target pension asset allocation and target ranges at the March 31, 2017 measurement date and the actual asset allocations at the March 31, 2017 and 2016 measurement dates by major asset category were as follows:

							Actual Allocation
	Target Allocation						March 31,
Major Asset Category			Range				2017		2016
Equity securities	26.0	%	16	%	-	36%	31.9	%	22.4	%
Fixed income securities (1)	69.0	%	59	%	-	79%	61.7	%	71.5	%
Alternative investments	5.0	%	0	%	-	10%	6.4	%	6.1	%
Total	100.0	%					100.0	%	100.0	%

⁽¹⁾  Actual amounts include high yield securities and cash balances held for the payment of benefits.

Universal makes regular contributions to its pension and other postretirement benefit plans. As previously noted, for postretirement health benefits, contributions reflect funding of those benefits as they are incurred. The Company expects to make contributions of approximately $7.8 million to its defined benefit pension plans in fiscal year 2018, including $6.0 million to its ERISA-regulated U.S. plan and $1.8 million to its non-ERISA regulated and other plans.

Estimated future benefit payments to be made from the Company’s plans are as follows:

Fiscal Year	Pension Benefits		Other Postretirement Benefits
2018	$	15,031	$	3,142
2019	22,040		3,129
2020	20,162		3,015
2021	16,727		2,930
2022	17,019		2,797
2023 - 2027	88,929		12,554

Fair Values of Pension Plan Assets

Assets held by the Company's defined benefit pension plans primarily consist of equity securities, fixed income securities, and alternative investments. Equity securities are primarily invested in actively-traded mutual funds with underlying common stock investments in U.S. and foreign companies ranging in size from small to large corporations. Fixed income securities are also held primarily through actively-traded mutual funds with the underlying investments in both U.S. and foreign securities. The methodologies for determining the fair values of the plan assets are outlined below. Where the values are based on quoted prices for the securities in an active market, they are classified as Level 1 of the fair value hierarchy. Where secondary pricing sources are used, they are classified as Level 2 of the hierarchy. Pricing models that use significant unobservable inputs are classified as Level 3.

• Equity securities: Investments in equity securities through actively-traded mutual funds are valued based on the net asset values of the units held in the respective funds, which are determined by obtaining quoted prices on nationally recognized securities exchanges. These securities are classified as Level 1.

• Fixed income securities: Fixed income investments that are held through mutual funds are valued based on the net asset values of the units held in the respective funds, which are determined by obtaining quoted prices on nationally recognized securities exchanges. These securities are classified as Level 1. Other fixed income investments are valued at an estimated price that a dealer would pay for a similar security on the valuation date using observable market inputs and are classified as Level 2. These market inputs may include yield curves for similarly rated securities. Small amounts of cash are held in common collective trusts. Fixed income securities also include insurance assets, which are valued based on an actuarial calculation. Those securities are classified as Level 3.

67

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

• Alternative investments: Real estate assets are valued using valuation models that incorporate income and market approaches, including external appraisals, to derive fair values. The hedge fund allocation is a fund of hedge funds and is valued by the manager based on the net asset value of each fund. These models use significant unobservable inputs and are classified as Level 3 within the fair value hierarchy.

Fair values of the assets of the Company’s pension plans as of March 31, 2017 and 2016, classified based on how their values were determined under the fair value hierarchy are as follows:

	March 31, 2017
	Level 1		Level 2		Level 3		Total
Equity securities	$	65,637	$	—	$	—	$	65,637
Fixed income securities(1)	128,215		10,134		3,072		141,421
Alternative investments	—		—		13,094		13,094
Total investments	$	193,852	$	10,134	$	16,166	$	220,152

	March 31, 2016
	Level 1		Level 2		Level 3		Total
Equity securities	$	43,807	$	—	$	—	$	43,807
Fixed income securities(1)	141,218		7,491		13,382		162,091
Alternative investments	—		—		11,961		11,961
Total investments	$	185,025	$	7,491	$	25,343	$	217,859

⁽¹⁾  Includes high yield securities and cash and cash equivalent balances.

Other Benefit Plans

Universal and several subsidiaries offer employer defined contribution savings plans. Amounts charged to expense for these plans were approximately $2.6 million for fiscal year 2017, $2.4 million for fiscal year 2016, and $1.5 million for fiscal year 2015.

NOTE 11.   COMMON AND PREFERRED STOCK

Common Stock

At March 31, 2017, the Company’s shareholders had authorized 100,000,000 shares of its common stock, and 25,274,506 shares were issued and outstanding. Holders of the common stock are entitled to one vote for each share held on all matters requiring a vote. Holders of the common stock are also entitled to receive dividends when, as, and if declared by the Company’s Board of Directors. The Board of Directors customarily declares and pays regular quarterly dividends on the outstanding common shares; however, such dividends are at the Board’s full discretion, and there is no obligation to continue them.

Preferred Stock

Authorized and Outstanding Shares

The Company is also authorized to issue up to 5,000,000 shares of preferred stock, 500,000 shares of which are reserved for Series A Junior Participating Preferred Stock and 220,000 of which were reserved for Series B 6.75% Convertible Perpetual Preferred Stock. No Series A Junior Participating Preferred Stock has been issued. In 2006, 220,000 shares of Series B 6.75% Convertible Perpetual Preferred Stock were issued under this authorization. As discussed below, all of those shares were converted during fiscal year 2017, and none were outstanding at March 31, 2017.

Conversion of Series B 6.75% Convertible Perpetual Preferred Stock

In December 2016, holders of 111,072 shares of the Series B 6.75% Convertible Perpetual Preferred Stock voluntarily exercised their conversion rights under the original issuance terms of the preferred shares. The Company chose to satisfy the full conversion obligation for those preferred shares with shares of its common stock, issuing 2,487,118 common shares at the applicable conversion rate in exchange for the preferred shares tendered. The consolidated balance sheet at March 31, 2017 reflects a non-cash reclassification of $107.6 million from preferred stock to common stock to reflect the conversion of those preferred shares.

68

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

On January 9, 2017, the Company announced a mandatory conversion of all 107,418 remaining outstanding shares of the preferred stock after meeting the requirements to initiate the mandatory conversion under the original terms of the preferred shares. The Company chose to satisfy the conversion obligation for the mandatory conversion in cash, paying approximately $178.4 million for those preferred shares on January 31, 2017 to complete the conversion.

With the completion of the mandatory conversion in January 2017, the Company’s outstanding equity securities consist only of its common stock. Dividend payments on the preferred shares, which previously totaled approximately $15 million annually, have been discontinued. Although the conversions of the preferred stock into common stock or for cash did not impact the Company’s net income, the shares converted for cash under the mandatory conversion in January 2017 resulted in a one-time reduction of retained earnings of approximately $74.4 million during the fourth quarter ended March 31, 2017, representing the excess of the conversion cost over the carrying value of those shares. The reduction in retained earnings resulted in a corresponding one-time reduction of earnings available to common shareholders for the fiscal year ended March 31, 2017 for purposes of determining the amounts reported for basic and diluted earnings per share.

Share Repurchase Programs

Universal’s Board of Directors has authorized programs to repurchase outstanding shares of the Company’s capital stock (common and preferred stock). Under these programs, the Company has made and may continue to make share repurchases from time to time in the open market or in privately negotiated transactions at prices not exceeding prevailing market rates. Programs have been in place continuously throughout fiscal years 2015 through 2017. The current program, which replaced an expiring program, was authorized and became effective on November 5, 2015. It authorizes the purchase of up to $100 million of the Company's outstanding common stock and expires on the earlier of November 15, 2017, or when the funds authorized for the program have been exhausted. At March 31, 2017, the full $100 million authorization remained available for share repurchases under the current program.

Share repurchases under the programs for the fiscal years ended March 31, 2017, 2016, and 2015 were as follows:

	Fiscal Year Ended March 31,
	2017		2016		2015
Common Stock
Number of shares repurchased	—		—		719,993
Cost of shares repurchased (in thousands of dollars)	$	—	$	—	$	31,227
Weighted-average cost per share	$	—	$	—	$	43.37
Series B 6.75% Convertible Perpetual Preferred Stock
Number of shares repurchased	—		—		1,509
Cost of shares repurchased (in thousands of dollars)	$	—	$	—	$	1.497
Weighted-average cost per share	$	—	$	—	$	992.27

NOTE 12.   EXECUTIVE STOCK PLANS AND STOCK-BASED COMPENSATION

Executive Stock Plans

The Company’s shareholders have approved executive stock plans under which officers, directors, and employees of the Company may receive grants and awards of common stock, restricted stock, restricted stock units (“RSUs”), performance share awards (“PSAs”), stock appreciation rights (“SARs”), incentive stock options, and non-qualified stock options. Currently, grants are outstanding under the 1997 Executive Stock Plan, the 2002 Executive Stock Plan, and the 2007 Stock Incentive Plan. Together, these plans are referred to in this disclosure as the “Plans.” Up to 2 million shares of the Company’s common stock may be issued under each of the Plans; however, direct awards of common stock, restricted stock, or RSUs are limited to 500,000 shares under the 2002 Executive Stock Plan and 1,350,000 shares under the 2007 Stock Incentive Plan.

The Company’s practice is to award grants of stock-based compensation to officers at the first regularly-scheduled meeting of the Executive Compensation, Nominating, and Corporate Governance Committee of the Board of Directors (the “Compensation Committee”) in the fiscal year following the public release of the Company’s financial results for the prior year. In recent years, the Compensation Committee has awarded only grants of RSUs and PSAs, and all stock options and SARs granted in previous years were either exercised or had expired by the end of fiscal year 2017. Outside directors automatically receive restricted stock units following each annual meeting of shareholders.

69

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Non-qualified stock options and SARs previously granted under the Plans had an exercise price equal to the market price of a share of common stock on the date of grant. SARs granted under the Plans vested in equal one-third tranches one, two, and three years after the grant date and expired 10 years after the grant date, except that SARs granted after fiscal year 2007 expired on the earlier of 3 years after the grantee’s retirement date or 10 years after the grant date. RSUs awarded under the Plans vest 5 years from the grant date and are then paid out in shares of common stock. Under the terms of the RSU awards, grantees receive dividend equivalents in the form of additional RSUs that vest and are paid out on the same date as the original RSU grant. The PSAs vest 3 years from the grant date, are paid out in shares of common stock at the vesting date, and do not carry rights to dividends or dividend equivalents prior to vesting. Shares ultimately paid out under PSA grants are dependent on the achievement of predetermined performance measures established by the Compensation Committee and can range from zero to 150% of the stated award. RSUs awarded to outside directors vest 3 years after the grant date, and restricted stock vests upon the individual’s retirement from service as a director.

Stock Options and SARs

The following tables summarize the Company’s stock option and SAR activity and related information for fiscal years 2015 through 2017:

	Shares		Weighted-Average Exercise Price
Fiscal Year Ended March 31, 2015:
Outstanding at beginning of year	257,340		$	54.83
Exercised	(63,539	)	38.50
Cancelled/expired	(24,200	)	62.66
Outstanding at end of year	169,601		59.82
Fiscal Year Ended March 31, 2016:
Exercised	(6,200	)	51.32
Cancelled/expired	(11,200	)	62.66
Outstanding at end of year	152,201		59.96
Fiscal Year Ended March 31, 2017:
Exercised	(135,334	)	61.72
Cancelled/expired	(16,867	)	45.82
Outstanding at end of year	—		$	—

As indicated in the table, with the exercise and/or expiration of all remaining SARs during fiscal year 2017, there were no SARs or stock options outstanding at March 31, 2017.

	Fiscal Year Ended March 31,
	2017		2016		2015
Total intrinsic value of stock options and SARs exercised	$	555	$	26	$	1,091
Total fair value of SARs vested	$	—	$	—	$	375

Intrinsic value in the above table is based on the difference between the market price of the underlying shares at the exercise date and the exercise price of the SARs or stock options.

70

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

RSUs, Restricted Stock, and PSAs

The following table summarizes the Company’s RSU, restricted stock, and PSA activity for fiscal years 2015 through 2017:

	RSUs				Restricted Stock				PSAs
	Shares		Weighted-Average Grant Date Fair Value		Shares		Weighted-Average Grant Date Fair Value		Shares		Weighted-Average Grant Date Fair Value
Fiscal Year Ended March 31, 2015:
Unvested at beginning of year	293,180		$	44.33	48,100		$	42.33	149,387		$	41.76
Granted	94,539		51.86		—		—		57,580		46.41
Vested	(123,322	)	42.02		—		—		(50,092	)	31.95
Forfeited	—		—		—		—		(3,400	)	53.56
Unvested at end of year	264,397		48.10		48,100		42.33		153,475		45.58
Fiscal Year Ended March 31, 2016:
Granted	80,932		51.62		—		—		86,212		45.06
Vested	(42,384	)	41.64		—		—		(85,387	)	38.14
Unvested at end of year	302,945		49.95		48,100		42.33		154,300		48.13
Fiscal Year Ended March 31, 2017:
Granted	74,776		55.27		—		—		58,805		49.17
Vested	(51,544	)	44.57		(17,900	)	42.26		(52,230	)	53.56
Forfeited	(539	)	55.63		—		—		(525	)	49.17
Unvested at end of year	325,638		$	52.01	30,200		$	42.37	160,350		$	46.86

Shares granted and vested in the above table include dividend equivalents on RSUs and any shares awarded above the base grant under the performance provisions of PSAs. Shares forfeited or canceled include any reductions from the base PSA grant under those same performance provisions. The fair values of RSUs, restricted stock, and PSAs are based on the market price of the common stock on the grant date.

Stock-Based Compensation Expense

Fair value expense for stock-based compensation is recognized ratably over the period from grant date to the earlier of (1) the vesting date of the award, or (2) the date the grantee is eligible to retire without forfeiting the award. For employees who are already eligible to retire at the date an award is granted, the total fair value of the award is recognized as expense at the date of grant. For the fiscal years ended March 31, 2017, 2016, and 2015, total stock-based compensation expense and the related income tax benefit recognized were as follows:

	Fiscal Year Ended March 31,
	2017		2016		2015
Total stock-based compensation expense	$	6,475	$	5,206	$	6,230
Income tax benefit recorded on stock-based compensation expense	$	2,266	$	1,822	$	2,181

At March 31, 2017, the Company had $6.0 million of unrecognized compensation expense related to stock-based awards, which will be recognized over a weighted-average period of approximately 1.1 years. All stock options were exercised, cancelled, or expired before the end of fiscal year 2015, and cash proceeds from the exercise of stock options were not material for that fiscal year.

71

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 13.   COMMITMENTS, CONTINGENCIES, AND OTHER MATTERS

Commitments

The Company enters into contracts to purchase tobacco from farmers in a number of the countries where it operates. Contracts in most countries cover one annual growing season. Primarily with the farmer contracts in Brazil, Malawi, Mozambique, the Philippines, Guatemala, and Mexico, the Company provides seasonal financing to support the farmers’ production of their crops or guarantees their financing from third-party banks. At March 31, 2017, the Company had contracts to purchase approximately $622 million of tobacco to be delivered during the coming fiscal year and $68 million of tobacco to be delivered in subsequent years. These amounts are estimates since actual quantities purchased will depend on crop yields, and prices will depend on the quality of the tobacco delivered and other market factors. Tobacco purchase obligations have been partially funded by advances to farmers and other suppliers, which totaled approximately $104 million, net of allowances, at March 31, 2017. The Company withholds payments due to farmers on delivery of the tobacco to satisfy repayment of the financing it provided to the farmers. As noted above and discussed in more detail below, the Company also has arrangements to guarantee bank loans to farmers in Brazil, and payments are also withheld on delivery of tobacco to satisfy repayment of those loans. In addition to its contractual obligations to purchase tobacco, the Company had commitments related to agricultural materials, approved capital expenditures, and various other requirements that approximated $48 million at March 31, 2017.

Guarantees and Other Contingent Liabilities

Guarantees of Bank Loans and Other Contingent Liabilities

Guarantees of bank loans to growers for crop financing have long been industry practice in Brazil and support the farmers’ production of tobacco there. The Company's operating subsidiary in Brazil had guarantees outstanding at March 31, 2017, all of which expire within one year. As noted above, the subsidiary withholds payments due to the farmers on delivery of tobacco and forwards those payments to the third-party banks. Failure of farmers to deliver sufficient quantities of tobacco to the subsidiary to cover their obligations to the third-party banks could result in a liability for the subsidiary under the related guarantees; however, in that case, the subsidiary would have recourse against the farmers. The maximum potential amount of future payments that the Company’s subsidiary could be required to make at March 31, 2017, was the face amount, $17 million including unpaid accrued interest ($13 million as of March 31, 2016). The fair value of the guarantees was a liability of approximately $1 million at March 31, 2017 ($2 million at March 31, 2016). In addition to these guarantees, the Company has other contingent liabilities totaling approximately $2 million at March 31, 2017, primarily under outstanding letters of credit.

Value-Added Tax Assessments in Brazil

As discussed in Note 1, the Company's local operating subsidiaries pay significant amounts of value-added tax ("VAT") in connection with their normal operations. In Brazil, VAT is assessed at the state level when green tobacco is transferred between states. The Company's operating subsidiary there pays VAT when tobaccos grown in the states of Santa Catarina and Parana are transferred to its factory in the state of Rio Grande do Sul for processing. The subsidiary has received assessments for additional VAT plus interest and penalties from the tax authorities for the states of Santa Catarina and Parana based on audits of the subsidiary's VAT filings for specified periods. In June 2011, tax authorities for the state of Santa Catarina issued assessments for tax, interest, and penalties for periods from 2006 through 2009 totaling approximately $15 million. In September 2014, tax authorities for the state of Parana issued an assessment for tax, interest, and penalties for periods from 2009 through 2014 totaling approximately $18 million. These amounts are based on the exchange rate for the Brazilian currency at March 31, 2017. Management of the operating subsidiary and outside counsel believe that errors were made by the tax authorities for both states in determining all or significant portions of these assessments and that various defenses support the subsidiary's positions.

With respect to the Santa Catarina assessments, the subsidiary took appropriate steps to contest the full amount of the claims. As of March 31, 2017, a portion of the subsidiary's arguments had been accepted, and the outstanding assessment had been reduced, although interest on the remaining assessment has continued to accumulate. The reduced assessment, together with the related accumulated interest through the end of the current reporting period, totaled approximately $15 million at the March 31, 2017 exchange rate. The subsidiary is continuing to contest the full remaining amount of the assessment. While the range of reasonably possible loss is zero up to the full $15 million remaining assessment, based on the strength of the subsidiary's defenses, no loss within that range is considered probable at this time and no liability has been recorded at March 31, 2017.

With respect to the Parana assessment, management of the subsidiary and outside counsel challenged the full amount of the claim. A significant portion of the Parana assessment was based on positions taken by the tax authorities that management and outside counsel believe deviate significantly from the underlying statutes and relevant case law. In addition, under the law, the subsidiary's tax filings for certain periods covered in the assessment were no longer open to any challenge by the tax authorities. In December 2015, the Parana tax authorities withdrew the initial claim and subsequently issued a new assessment covering the same tax periods. The new assessment totaled approximately $6 million at the March 31, 2017 exchange rate, reflecting a substantial reduction from the original $18 million assessment. Notwithstanding the reduction, management and outside counsel continue to

72

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

believe that the new assessment is not supported by the underlying statutes and relevant case law and have taken the necessary steps to challenge the full amount of the claim. The range of reasonably possible loss is considered to be zero up to the full $6 million assessment. However, based on the strength of the subsidiary's defenses, no loss within that range is considered probable at this time and no liability has been recorded at March 31, 2017.

In both states, the process for reaching a final resolution to the assessments is expected to be lengthy, and management is not currently able to predict when either case will be concluded. Should the subsidiary ultimately be required to pay any tax, interest, or penalties in either case, the portion paid for tax would generate value-added tax credits that the subsidiary may be able to recover.

Other Contingent Liabilities

Various subsidiaries of the Company are involved in other litigation and tax examinations incidental to their business activities.  While the outcome of these matters cannot be predicted with certainty, management is vigorously defending the matters and does not currently expect that any of them will have a material adverse effect on the Company’s business or financial position.  However, should one or more of these matters be resolved in a manner adverse to management’s current expectation, the effect on the Company’s results of operations for a particular fiscal reporting period could be material.

Major Customers

A material part of the Company’s business is dependent upon a few customers. The Company's six largest customers are Altria Group, Inc, British American Tobacco plc, China Tobacco International, Inc., Imperial Brands plc, Japan Tobacco, Inc., and Philip Morris International, Inc. In the aggregate, these customers have accounted for more than 65% of consolidated revenue for each of the past three fiscal years. For the fiscal years ended March 31, 2017, 2016, and 2015, revenue from Philip Morris International, Inc. was approximately $590 million, $640 million, and $580 million, respectively. For the same periods, British American Tobacco plc accounted for revenue of approximately $220 million, $230 million, and $220 million, respectively, and Imperial Brands plc accounted for revenue of approximately $230 million, $210 million, and $280 million, respectively. These customers primarily do business with various affiliates in the Company’s flue-cured and burley leaf tobacco operations. The loss of, or substantial reduction in business from, any of these customers could have a material adverse effect on the Company.

Accounts Receivable

The Company’s operating subsidiaries perform credit evaluations of customers’ financial condition prior to the extension of credit. Generally, accounts receivable are unsecured and are due within 30 days. When collection terms are extended for longer periods, interest and carrying costs are usually recovered. Credit losses are provided for in the financial statements, and historically such amounts have not been material. The allowance for doubtful accounts was approximately $4 million and $9 million at March 31, 2017 and 2016, respectively. At March 31, 2017 and 2016, net accounts receivable by reportable operating segment were as follows:

	March 31,
	2017		2016
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	111,520	$	85,985
Other Regions	294,799		303,932
Subtotal	406,319		389,917
Other Tobacco Operations	32,969		38,742
Consolidated accounts receivable, net	$	439,288	$	428,659

Acquisition of Partner's Interest in Tobacco Processing Joint Venture

For a number of years, the Company held a 50% joint venture ownership interest in Procesadora Unitab, S.A., a tobacco processing entity in Guatemala. In December 2015, the Company acquired the 50% interest held by its joint venture partner for $6 million in cash. In accordance with Accounting Standards Codification Topic 805, "Business Combinations" (“ASC 805”), the transaction was accounted for using the acquisition method of accounting, which required the Company to record all underlying assets and liabilities of the entity at their fair values as of the transaction date and to consolidate the financial statements of the entity.  Based on those fair values, the Company recorded a pretax gain of $3.4 million on the transaction during the third quarter of fiscal year 2016. The gain is reported in Other Income in the consolidated statements of income. The purchase price of the newly-acquired 50% interest approximated fair value, and the gain resulted from remeasuring the Company’s original 50% ownership interest in the entity to fair value. No goodwill or identifiable intangible assets were recorded as part of the transaction, and acquisition-related costs were not significant.

73

UNIVERSAL CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The allocation of the fair values to the net assets acquired was complete at the time the transaction was recorded. Based on the nature of its operations, the net assets of the acquired entity are comprised primarily of property, plant, and equipment, and the fair values recorded for those assets totaled approximately $12 million based primarily on a third-party appraisal. The acquired entity is included in the Company’s North America operating segment.

Reversal of Valuation Allowance on IPI Tax Credits in Brazil

During fiscal year 2014, a longstanding lawsuit filed by the Company’s operating subsidiary in Brazil related to certain excise tax credits (IPI tax credits) was concluded following a decision in the subsidiary’s favor in the Brazilian federal courts and the expiration of the time period for the government to appeal the decision. IPI tax credits were established under Brazilian tax laws to allow recovery of a portion of the excise taxes paid on manufactured products when those products are sold in export markets; however, the Brazilian tax authorities subsequently issued certain regulations that prevented the subsidiary from claiming those credits. The lawsuit filed by the subsidiary challenged the denial of the tax credits based on the law.

The final court decision entitled the subsidiary to approximately $104 million of IPI tax credits (based on the exchange rate at the date of the decision), which were eligible to be used to offset other Brazilian federal tax payments for a period of up to five years from the date the subsidiary’s right to claim the credits was confirmed. The subsidiary recorded a gain on the favorable outcome of the case in fiscal year 2014, which was net of a valuation allowance based on estimates of the tax credits that were not probable of being realized prior to their expiration. In the fourth quarter of fiscal year 2015, based on actual realization of the tax credits to date, as well as updated tax payment projections for future periods, revised estimates indicated that all remaining IPI tax credits would be fully utilized prior to their expiration. On that basis, the subsidiary reversed the full valuation allowance on the credits of $12.7 million (based on the then current exchange rate) during that quarter. That reversal was reported in Other Income in the consolidated statement of income.

NOTE 14.   OPERATING SEGMENTS

Universal’s operations involve selecting, procuring, processing, packing, storing, shipping, and financing leaf tobacco for sale to, or for the account of, manufacturers of consumer tobacco products throughout the world. Through various operating subsidiaries located in tobacco-growing countries around the world and significant ownership interests in unconsolidated affiliates, the Company processes and/or sells flue-cured and burley tobaccos, dark air-cured tobaccos, and oriental tobaccos. Flue-cured, burley, and oriental tobaccos are used principally in the manufacture of cigarettes, and dark air-cured tobaccos are used mainly in the manufacture of cigars, pipe tobacco, and smokeless tobacco products. A substantial portion of the Company’s revenues are derived from sales to a limited number of large, multinational cigarette manufacturers.

The principal approach used by management to evaluate the Company’s performance is by geographic region, although the dark air-cured and oriental tobacco businesses are each evaluated on the basis of their worldwide operations. Oriental tobacco operations consist principally of a 49% interest in an affiliate, and the performance of those operations is evaluated based on the Company’s equity in the pretax earnings of that affiliate. Under this structure, the Company has the following primary operating segments: North America, South America, Africa, Europe, Asia, Dark Air-Cured, Oriental, and Special Services. North America, South America, Africa, Europe, and Asia are primarily involved in flue-cured and/or burley leaf tobacco operations for supply to cigarette manufacturers. The Dark Air-Cured group supplies dark air-cured tobacco principally to manufacturers of cigars, pipe tobacco, and smokeless tobacco products, and the Oriental business supplies oriental tobacco to cigarette manufacturers. From time to time, the segments may trade in tobaccos that differ from their main varieties, but those activities are not significant to their overall results. Special Services includes the Company's laboratory services business, which provides physical and chemical product testing and smoke testing for customers, its food ingredients business, as well as its liquid nicotine joint venture.

The five regional operating segments serving the Company’s cigarette manufacturer customer base share similar characteristics in the nature of their products and services, production processes, class of customer, product distribution methods, and regulatory environment. Based on the applicable accounting guidance, four of the regions – South America, Africa, Europe, and Asia – are aggregated into a single reporting segment, “Other Regions”, because they also have similar economic characteristics. North America is reported as an individual operating segment because its economic characteristics differ from the other regions, generally because its operations require lower working capital investments for crop financing and inventory. The Dark Air-Cured, Oriental and Special Services segments, which have dissimilar characteristics in some of the categories mentioned above, are reported together as “Other Tobacco Operations” because each is below the measurement threshold for separate reporting.

Universal incurs overhead expenses related to senior management, sales, finance, legal, and other functions that are centralized at its corporate headquarters, as well as functions performed at several sales and administrative offices around the world. These overhead expenses are allocated to the various operating segments, generally on the basis of tobacco volumes planned to be purchased and/or processed. Management believes this method of allocation is representative of the value of the related services provided to the operating segments. The Company evaluates the performance of its segments based on operating income after allocated overhead expenses, plus equity in the pretax earnings of unconsolidated affiliates.

74

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Reportable segment data as of, or for, the fiscal years ended March 31, 2017, 2016, and 2015, is as follows:

	Sales and Other Operating Revenues						Operating Income
	Fiscal Year Ended March 31,						Fiscal Year Ended March 31,
	2017		2016		2015		2017			2016			2015
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	416,438	$	361,827	$	305,028	$	35,151		$	31,147		$	31,060
Other Regions(1)	1,422,991		1,538,971		1,739,781		143,349			143,596			125,839
Subtotal	1,839,429		1,900,798		2,044,809		178,500			174,743			156,899
Other Tobacco Operations(2)	231,789		219,575		226,992		9,984			11,325			10,326
Segment total	2,071,218		2,120,373		2,271,801		188,484			186,068			167,225
Deduct: Equity in pretax earnings of unconsolidated affiliates (3)							(5,774		)	(5,422		)	(7,137		)
Restructuring and impairment costs(4)							(4,359		)	(2,389		)	(4,890		)
Add: Other income(5)							—			3,390			12,676
Consolidated total	$	2,071,218	$	2,120,373	$	2,271,801	$	178,351		$	181,647		$	167,874
	Segment Assets						Goodwill
	March 31,						March 31,
	2017		2016		2015		2017			2016			2015
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	357,406	$	364,003	$	281,449	$	—		$	—		$	—
Other Regions(1)	1,465,109		1,548,517		1,607,846		97,159			97,318			97,372
Subtotal	1,822,515		1,912,520		1,889,295		97,159			97,318			97,372
Other Tobacco Operations(2)	300,890		318,657		297,180		1,644			1,713			1,713
Segment and consolidated totals	$	2,123,405	$	2,231,177	$	2,186,475	$	98,803		$	99,031		$	99,085
	Depreciation and Amortization						Capital Expenditures
	Fiscal Year Ended March 31,						Fiscal Year Ended March 31,
	2017		2016		2015		2017			2016			2015
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	4,626	$	4,314	$	4,284	$	4,202		$	2,282		$	5,814
Other Regions(1)	26,106		29,187		28,827		21,619			25,122			39,303
Subtotal	30,732		33,501		33,111		25,821			27,404			45,117
Other Tobacco Operations (2)	5,238		4,143		4,213		9,809			19,749			13,268
Segment and consolidated totals	$	35,970	$	37,644	$	37,324	$	35,630		$	47,153		$	58,385

⁽¹⁾  Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

⁽²⁾  Includes Dark Air-Cured, Oriental, and Special Services, as well as intercompany eliminations. Sales and other operating revenues, goodwill, depreciation and amortization, and capital expenditures include limited amounts or no amounts for Oriental because the business is accounted for on the equity method and its financial results consist principally of equity in the pretax earnings of the unconsolidated affiliate. The investment in the unconsolidated affiliate is included in segment assets and was approximately $78.1 million, $81.8 million, and $74.9 million, at March 31, 2017, 2016, and 2015, respectively.

⁽³⁾  Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income.

⁽⁴⁾  Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income (see Note 2).

⁽⁵⁾  Other income in fiscal year 2016 represents a gain from remeasuring to fair value the Company's original 50% ownership in Procesadora Unitab, S.A., a tobacco processing joint venture in Guatemala, upon acquiring the 50% interest held by the Company's joint venture partner (See Note 13). Other income in fiscal year 2015 represents the reversal of a valuation allowance on IPI excise tax credits in Brazil (See Note 13).

75

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Geographic data as of, or for, the fiscal years ended March 31, 2017, 2016, and 2015, is presented below. Sales and other operating revenues are attributed to individual countries based on the final destination of the shipment. Long-lived assets generally consist of net property, plant, and equipment, goodwill, and other intangibles.

Geographic Data	Sales and Other Operating Revenues
	Fiscal Year Ended March 31,
	2017		2016		2015
Belgium	$	320,735	$	371,580	$	336,396
United States	320,731		275,147		290,950
Germany	123,649		155,180		170,338
China	137,855		135,032		174,872
Netherlands	91,266		121,767		113,297
Russia	84,784		109,559		126,652
All other countries	992,198		952,108		1,059,296
Consolidated total	$	2,071,218	$	2,120,373	$	2,271,801
	Long-Lived Assets
	March 31,
	2017		2016		2015
United States	$	85,145	$	84,072	$	70,929
Brazil	134,074		133,727		135,980
Mozambique	50,311		53,069		55,733
All other countries	146,698		154,090		141,893
Consolidated total	$	416,228	$	424,958	$	404,535

76

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 15. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The following table summarizes the changes in the balances for each component of accumulated other comprehensive income (loss) attributable to the Company for the fiscal years ended March 31, 2017, 2016, and 2015:

	Fiscal Year Ended March 31,
(in thousands of dollars)	2017			2016			2015
Foreign currency translation:
Balance at beginning of year	$	(26,992	)	$	(31,138	)	$	(8,476	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on foreign currency translation (net of tax (expense) benefit of $3,715, $(2,119), and $12,181)	(6,899		)	3,934			(22,625		)
Less: Net loss (gain) on foreign currency translation attributable to noncontrolling interests	753			212			(37		)
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(6,146		)	4,146			(22,662		)
Balance at end of year	$	(33,138	)	$	(26,992	)	$	(31,138	)
Foreign currency hedge:
Balance at beginning of year	$	675		$	(1,834	)	$	769
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $991, $(1,060), and $2,304)	(1,841		)	1,969			(4,280		)
Reclassification of net loss to earnings (net of tax benefit of $(489), $(291), and $(903))(1)	908			540			1,677
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(933		)	2,509			(2,603		)
Balance at end of year	$	(258	)	$	675		$	(1,834	)
Interest rate hedge:
Balance at beginning of year	$	(6,997	)	$	(1,982	)	$	(608	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $(3,150), $4,489, and $1,416)	5,849			(8,335		)	(2,628		)
Reclassification of net loss to earnings (net of tax benefit of $(1,370), $(1,788), and $(675))(2)	2,546			3,320			1,254
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	8,395			(5,015		)	(1,374		)
Balance at end of year	$	1,398		$	(6,997	)	$	(1,982	)
Pension and other postretirement benefit plans:
Balance at beginning of year	$	(39,036	)	$	(40,040	)	$	(26,017	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net losses arising during the year (net of tax benefit of $751, $1,035, and $9,719)(3)	(1,395		)	(1,921		)	(18,049		)
Amortization included in earnings (net of tax benefit of $(1,546), $(1,576), and $(2,163)) (4)	2,870			2,925			4,026
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	1,475			1,004			(14,023		)
Balance at end of year	$	(37,561	)	$	(39,036	)	$	(40,040	)
Total accumulated other comprehensive income (loss) at end of year	$	(69,559	)	$	(72,350	)	$	(74,994	)

77

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

⁽¹⁾Gain (loss) on foreign currency cash flow hedges related to forecast purchases of tobacco is reclassified from accumulated other comprehensive income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 8 for additional information.

⁽²⁾Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when the related interest payments are made on the debt or upon termination of the interest rate swap agreements prior to their scheduled maturity dates. See Note 8 for additional information.

⁽³⁾These items arise from the remeasurement of the assets and liabilities of the Company's defined benefit pension plans. Those remeasurements are made on an annual basis at the end of the fiscal year. See Note 10 for additional information.

⁽⁴⁾This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 10 for additional information.

78

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 16.   UNAUDITED QUARTERLY FINANCIAL DATA

Unaudited quarterly financial data for the fiscal years ended March 31, 2017 and 2016 is provided in the table below. Due to the seasonal nature of the Company's business, management believes it is generally more meaningful to focus on cumulative rather than quarterly results.

	First Quarter			Second Quarter		Third Quarter		Fourth Quarter
Fiscal Year Ended March 31, 2017
Operating Results:
Sales and other operating revenues	$	295,475		$	456,942	$	668,771	$	650,030
Gross profit	52,197			87,844		135,453		119,185
Net income (loss)	(7,504		)	26,498		57,062		36,450
Net income (loss) attributable to Universal Corporation	(5,476		)	25,264		53,647		32,869
Earnings (loss) available to Universal Corporation common shareholders after dividends on convertible perpetual preferred stock	(9,163		)	21,577		49,960		(41,484		)
Earnings (loss) per share attributable to Universal Corporation common shareholders:
Basic	(0.40		)	0.95		2.17		(1.64		)
Diluted	(0.40		)	0.90		1.92		(1.64		)
Cash Dividends Declared:
Per share of convertible perpetual preferred stock	16.88			16.87		16.88		—
Per share of common stock	0.53			0.53		0.54		0.54
Market Price Range of Common Stock:
High	57.75			61.69		64.20		83.35
Low	52.26			55.29		52.40		63.30
Fiscal Year Ended March 31, 2016
Operating Results:
Sales and other operating revenues	$	275,419		$	456,382	$	584,592	$	803,980
Gross profit	48,389			98,094		119,906		140,942
Net income (loss)	(6,125		)	25,064		46,615		52,594
Net income (loss) attributable to Universal Corporation	(5,947		)	22,465		44,534		47,964
Earnings (loss) available to Universal Corporation common shareholders after dividends on convertible perpetual preferred stock	(9,634		)	18,778		40,847		44,277
Earnings (loss) per share attributable to Universal Corporation common shareholders:
Basic	(0.43		)	0.83		1.80		1.95
Diluted	(0.43		)	0.81		1.60		1.72
Cash Dividends Declared:
Per share of convertible perpetual preferred stock	16.88			16.87		16.88		16.87
Per share of common stock	0.52			0.52		0.53		0.53
Market Price Range of Common Stock:
High	57.76			58.41		57.72		57.27
Low	46.80			46.98		49.70		51.49

79

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Note: Earnings per share amounts for each fiscal year may not equal the total of the four quarterly amounts due to differences in weighted-average outstanding shares for the respective periods and to the fact that the Company’s convertible perpetual preferred stock may be antidilutive for some periods.

Significant items included in the quarterly results were as follows:

Fiscal Year Ended March 31, 2017

• Second Quarter – Restructuring and impairment costs totaling $3.7 million, primarily related to the Company's decision to close its tobacco processing facility in Hungary. The Company is now processing tobaccos sourced from Hungary in its factories in Italy. The costs incurred for the change in operations in Hungary included statutory employee termination benefits and impairment charges related to certain property and equipment. Those costs reduced net income attributable to Universal Corporation by $2.4 million and diluted earnings per share by $0.09.

• Fourth Quarter – The conversion of 107,418 shares of the Company's Series B 6.75% Convertible Perpetual Preferred Stock for cash resulted in a one-time reduction of retained earnings of approximately $74.4 million during the quarter ending March 31, 2017, representing the excess of the conversion cost over the carrying value of those preferred shares. The reduction in retained earnings resulted in a corresponding one-time reduction of earnings available to common shareholders for purposes of determining the amounts reported for basic and diluted earnings per share for those periods. The reduction in earnings available to common shareholders decreased diluted earnings per share for the quarter by $2.90.

Fiscal Year Ended March 31, 2016

• First Quarter – Restructuring and impairment costs totaling $2.4 million, related to a decision to significantly scale back the Company's operations in Zambia. The costs included statutory employee termination benefits, impairment charges related to outstanding balances on loans to farmers whose contracts were terminated as a result of the decision, and impairment charges on certain property and equipment. The restructuring and impairment costs reduced net income attributable to Universal Corporation by $1.6 million and diluted earnings per share by $0.06.

• Third Quarter – A $3.4 million pretax gain arising from the acquisition of a joint venture partner's 50% ownership interest in a tobacco processing entity in Guatemala. The transaction increased the Company's ownership interest in the entity to 100%, requiring consolidation of the financial statements of the entity and remeasurement of the Company's original 50% ownership interest to fair value, resulting in the gain. The gain increased net income attributable to Universal Corporation by $2.2 million and diluted earnings per share by $0.08.

80

Report of Ernst & Young LLP, Independent Registered Public Accounting Firm

The Board of Directors and Shareholders of

Universal Corporation

We have audited the accompanying consolidated balance sheets of Universal Corporation as of March 31, 2017 and 2016, and the related consolidated statements of income, comprehensive income, changes in shareholders' equity, and cash flows for each of the three years in the period ended March 31, 2017. Our audits also included the financial statement schedule listed in the Index at Item 15(a). These financial statements and schedule are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Universal Corporation at March 31, 2017 and 2016, and the consolidated results of its operations and its cash flows for each of the three years in the period ended March 31, 2017, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Universal Corporation’s internal control over financial reporting as of March 31, 2017, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated May 26, 2017 expressed an unqualified opinion thereon.

/s/ Ernst & Young LLP

Richmond, Virginia

May 26, 2017

81

Report of Ernst & Young LLP, Independent Registered Public Accounting Firm,

on Internal Control Over Financial Reporting

The Board of Directors and Shareholders of

Universal Corporation

We have audited Universal Corporation’s internal control over financial reporting as of March 31, 2017, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). Universal Corporation’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting in Item 9A. Our responsibility is to express an opinion on the company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, Universal Corporation maintained, in all material respects, effective internal control over financial reporting as of

March 31, 2017, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Universal Corporation as of March 31, 2017 and 2016, and the related consolidated statements of income, comprehensive income, changes in shareholders’ equity, and cash flows for each of the three years in the period ended March 31, 2017 and our report dated May 26, 2017 expressed an unqualified opinion thereon.

/s/ Ernst & Young LLP

Richmond, Virginia

May 26, 2017

82

Item 9.   Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

For the three years ended March 31, 2017, there were no changes in independent auditors, nor were there any disagreements between the Company and its independent auditors on any matter of accounting principles, practices, or financial disclosures.

Item 9A. Controls and Procedures

Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in reports filed by the Company under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. The Company’s Chief Executive Officer and Chief Financial Officer evaluated, with the participation of the Company’s management, the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)), as of the end of the period covered by this Annual Report. Based on this evaluation, the Company’s management, including its Chief Executive Officer and Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were effective.

Management’s Report on Internal Control Over Financial Reporting

The Company’s management is responsible for establishing and maintaining effective internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. The Company’s internal control over financial reporting is designed to provide reasonable assurance to management and the Board of Directors regarding the preparation and fair presentation of the consolidated financial statements. Due to inherent limitations, internal control over financial reporting may not prevent or detect all errors or misstatements in the financial statements, and even control procedures that are determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions.

As required by Exchange Act Rule 13a-15(c), the Company’s Chief Executive Officer and Chief Financial Officer, with the participation of other members of management, assessed the effectiveness of the Company’s internal control over financial reporting as of March 31, 2017. The evaluation was based on the criteria set forth in “Internal Control – Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (“the COSO criteria”). Based on this assessment, the Company’s management concluded that the Company’s internal control over financial reporting was effective as of March 31, 2017.

The Company’s independent registered public accounting firm, Ernst & Young LLP, has audited the Company’s internal control over financial reporting as of March 31, 2017. Their report on this audit appears on page 82 of this Annual Report.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Item 9B. Other Information

None.

83

PART III

Item 10.   Directors, Executive Officers, and Corporate Governance

Except as to the matters set forth below, information required by this Item is incorporated herein by reference to the Company’s 2017 Proxy Statement.

The following are executive officers of the Company as of May 26, 2017:

Name and Age	Position	Business Experience During Past The Five Years
G. C. Freeman, III (53)	Chairman, President, and Chief Executive Officer	Mr. Freeman was elected Chairman of the Board in August 2008, Chief Executive Officer effective April 2008, President in December 2006, and Vice President in November 2005. Mr. Freeman served as General Counsel and Secretary from February 2001 until November 2005 and has been employed with the Company since 1997.
A. L. Hentschke (47)	Senior Vice President and Chief Operating Officer	Mr. Hentschke was elected Senior Vice President and Chief Operating Officer in April 2015. From January 2013 to April 2015, he served as Executive Vice President of Universal Leaf. Tobacco Company, Incorporated ("Universal Leaf"). From November 2009 to January 2013, Mr. Hentschke served as President and Chief Executive Officer of Universal Leaf Tabacos, Limitada, the Company's operating subsidiary in Brazil. He has been employed with the Company and its affiliates since 1991.
D. C. Moore (61)	Senior Vice President and Chief Financial Officer	Mr. Moore was elected Senior Vice President and Chief Financial Officer effective September 2008. Mr. Moore served as Vice President and Chief Administrative Officer from April 2006 until September 2008, as Senior Vice President of Universal Leaf from September 2005 until April 2006, and as Managing Director of Universal Leaf International SA from April 2002 until September 2005. He has been employed with the Company since 1978.
T. G. Broome (63)	Executive Vice President and Sales Director, Universal Leaf Tobacco Company, Inc.	Mr. Broome was elected Executive Vice President and Sales Director, Universal Leaf, in October 2012. From April 2011 through October 2012, Mr. Broome served as Executive Vice President. From September 1998 through March 2011, Mr. Broome served as Senior Vice President-Sales. He has been employed with the Company since 1994.
P. D. Wigner (48)	Vice President, General Counsel and Secretary	Mr. Wigner was elected Vice President in August 2007, and General Counsel and Secretary in November 2005 and also served as Chief Compliance Officer from November 2007 until September 2012. Mr. Wigner served as Senior Counsel of Universal Leaf from November 2004 until November 2005. He has been employed with the Company since 2003.
J. A. Huffman (55)	Senior Vice President, Information and Planning, Universal Leaf Tobacco Company, Inc.	Mr. Huffman was elected Senior Vice President, Information and Planning, Universal Leaf, in August 2007. From September 2003 to August 2007, Mr. Huffman served as Senior Vice President. From September 2002 to September 2003, Mr. Huffman served as Vice President and Controller. He has been employed with the Company since 1996.
C. C. Formacek (57)	Vice President and Treasurer	Ms. Formacek was elected Vice President and Treasurer effective April 2012. Ms. Formacek served as Treasurer of Universal Leaf from April 2011 through March 2012. She joined the Company in September 2009 and served as Assistant Treasurer of Universal Leaf from that time through March 2011.
R. M. Peebles (59)	Vice President and Controller	Mr. Peebles was elected Vice President and Controller in April 2011. Mr. Peebles joined the Company in September 2003 and served as Controller from that time through March 2011.

There are no family relationships between any of the above officers.

84

The Company has a Code of Conduct that includes the NYSE requirements for a “Code of Business Conduct and Ethics” and the SEC requirements for a “Code of Ethics for Senior Financial Officers.” The Code of Conduct is applicable to all officers, employees, and outside directors of the Company, including the principal executive officer, principal financial officer, and principal accounting officer. A copy of the Code of Conduct is available through the “Corporate Governance-Overview” section of the Company’s website at www.universalcorp.com. If the Company amends a provision of the Code of Conduct, or grants a waiver from any such provision to a director or executive officer, the Company will disclose such amendments and the details of such waivers on the Company’s website www.universalcorp.com to the extent required by the SEC or the NYSE.

The information required by Items 407(c)(3), (d)(4) and (d)(5) of Regulation S-K is contained under the captions “Corporate Governance and Committees—Committees of the Board—Compensation Committee,” “Corporate Governance and Committees—Committees of the Board—Audit Committee” of the Company’s 2017 Proxy Statement and such information is incorporated by reference herein.

Item 11.   Executive Compensation

Refer to the captions “Executive Compensation” and “Directors’ Compensation” in the Company’s 2017 Proxy Statement, which information is incorporated herein by reference.

Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Refer to the caption “Stock Ownership” in the Company’s 2017 Proxy Statement, which information is incorporated herein by reference.

Item 13.   Certain Relationships and Related Transactions, and Director Independence

Refer to the caption “Certain Transactions” in the Company’s 2017 Proxy Statement, which information is incorporated herein by reference. The information required by Item 407(a) of Regulation S-K is contained under the caption “Corporate Governance and Committees—Director Independence” of the Company’s 2017 Proxy Statement and such information is incorporated by reference herein.

Item 14.   Principal Accounting Fees and Services

Refer to the captions “Audit Information – Fees of Independent Auditors” and “Audit Information – Pre-Approval Policies and Procedures” in the Company’s 2017 Proxy Statement, which information is incorporated herein by reference.

85

PART IV

Item 15.   Exhibits, Financial Statement Schedules

(a) The following are filed as part of this Annual Report:

1. Financial Statements.

Consolidated Statements of Income for the Fiscal Years Ended March 31, 2017, 2016, and 2015

Consolidated Statements of Comprehensive Income for the Fiscal Years Ended March 31, 2017, 2016, and 2015

Consolidated Balance Sheets at March 31, 2017 and 2016

Consolidated Statements of Cash Flows for the Fiscal Years Ended March 31, 2017, 2016, and 2015

Consolidated Statements of Changes in Shareholders’ Equity for the Fiscal Years Ended March 31, 2017, 2016, and 2015

Notes to Consolidated Financial Statements for the Fiscal Years Ended March 31, 2017, 2016, and 2015

Report of Ernst & Young LLP, Independent Registered Public Accounting Firm

Report of Ernst & Young LLP, Independent Registered Public Accounting Firm, on Internal Control Over Financial Reporting

2. Financial Statement Schedules.

Schedule II – Valuation and Qualifying Accounts

3. Exhibits. The exhibits are listed in the Exhibit Index immediately following the signature pages to this Annual Report.

(b) Exhibits

The response to this portion of Item 15 is submitted as a separate section to this Annual Report.

(c)    Financial Statement Schedules

Schedule II – Valuation and Qualifying Accounts appears on the following page of this Annual Report. All other schedules are not required under the related instructions or are not applicable and therefore have been omitted.

Item 16.   Form 10-K Summary

None.

86

Schedule II - Valuation and Qualifying Accounts

Universal Corporation

Fiscal Years Ended March 31, 2017, 2016, and 2015

Description	Balance at Beginning of Year		Net Additions (Reversals) Charged to Expense			Additions Charged to Other Accounts		Deductions(1)			Balance at End of Year
(in thousands of dollars)
Fiscal Year Ended March 31, 2015:
Allowance for doubtful accounts (deducted from accounts receivable)	$	6,536	$	1,341		$	—	$	(2,395	)	$	5,482
Allowance for supplier accounts (deducted from advances to suppliers and other noncurrent assets)	46,078		3,734			—		(15,139		)	34,673
Allowance for recoverable taxes (deducted from other current assets and other noncurrent assets)	29,504		1,855			—		(8,141		)	23,218
Fiscal Year Ended March 31, 2016:
Allowance for doubtful accounts (deducted from accounts receivable)	$	5,482	$	6,970		$	—	$	(3,353	)	$	9,099
Allowance for supplier accounts (deducted from advances to suppliers and other noncurrent assets)	34,673		815			—		(6,623		)	28,865
Allowance for recoverable taxes (deducted from other current assets and other noncurrent assets)	23,218		1,755			—		(6,221		)	18,752
Fiscal Year Ended March 31, 2017:
Allowance for doubtful accounts (deducted from accounts receivable)	$	9,099	$	(5,071	)	$	—	$	(81	)	$	3,947
Allowance for supplier accounts (deducted from advances to suppliers and other noncurrent assets)	28,865		(857		)	—		(934		)	27,074
Allowance for recoverable taxes (deducted from other current assets and other noncurrent assets)	18,752		(3,392		)	—		(2,808		)	12,552

⁽¹⁾ Includes direct write-offs of assets and currency remeasurement.

87

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		UNIVERSAL CORPORATION
May 26, 2017
	By:	/s/ GEORGE C. FREEMAN, III
		George C. Freeman, III Chairman, President, and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Signature	Title	Date
/s/ GEORGE C. FREEMAN, III	Chairman, President, Chief Executive Officer, and Director	May 26, 2017
George C. Freeman, III	(Principal Executive Officer)
/s/ DAVID C. MOORE	Senior Vice President and Chief Financial Officer	May 26, 2017
David C. Moore	(Principal Financial Officer)
/s/ ROBERT M. PEEBLES	Vice President and Controller	May 26, 2017
Robert M. Peebles	(Principal Accounting Officer)
/s/ JOHN B. ADAMS, JR.	Director	May 26, 2017
John B. Adams, Jr.
/s/ DIANA F. CANTOR	Director	May 26, 2017
Diana F. Cantor
/s/ LENNART R. FREEMAN	Director	May 26, 2017
Lennart R. Freeman
/s/ THOMAS H. JOHNSON	Director	May 26, 2017
Thomas H. Johnson
/s/ MICHAEL T. LAWTON	Director	May 26, 2017
Michael T. Lawton
/s/ EDDIE N. MOORE, JR.	Director	May 26, 2017
Eddie N. Moore, Jr.
/s/ ROBERT C. SLEDD	Director	May 26, 2017
Robert C. Sledd

88

EXHIBIT INDEX

3.1	Amended and Restated Articles of Incorporation, effective August 9, 2011 (incorporated herein by reference to the Registrant’s Current Report on Form 8-K Registration Statement filed August 9, 2011, File No. 001-00652).
3.2	Amended and Restated Bylaws (as of August 3, 2010) (incorporated herein by reference to the Registrant’s Current Report on Form 8-K dated August 3, 2010, File No. 001-00652).
4.1	Indenture between the Registrant and Chemical Bank, as trustee (incorporated herein by reference to the Registrant’s Current Report on Form 8-K dated February 25, 1991, File No. 001-00652).
4.2	Specimen Common Stock Certificate (incorporated herein by reference to the Registrant’s Amendment No. 1 to Registrant’s Form 8-A Registration Statement, dated May 7, 1999, File No. 001-00652).
10.1	Form of Universal Leaf Tobacco Company, Incorporated Executive Life Insurance Agreement (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1994, File No. 001-00652).
10.2	Universal Leaf Tobacco Company, Incorporated Deferred Income Plan (incorporated herein by reference to the Registrant’s Report on Form 8-K, dated February 8, 1991, File No. 001-00652).
10.3	Universal Leaf Tobacco Company, Incorporated Benefit Replacement Plan (incorporated herein by reference to the Registrant’s Report on Form 8-K, dated February 8, 1991, File No. 001-00652).
10.4	Universal Leaf Tobacco Company, Incorporated 1994 Benefit Replacement Plan (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1994, File No. 001-00652).
10.5	Universal Leaf Tobacco Company, Incorporated 1996 Benefit Restoration Plan (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1996, File No. 001-00652).
10.6	Universal Leaf Tobacco Company, Incorporated 1994 Deferred Income Plan, amended and restated as of July 1, 1998 (incorporated herein by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 1998, File No. 001-00652).
10.7	Universal Corporation Outside Directors’ Deferred Income Plan, restated as of October 1, 1998 (incorporated herein by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 1998, File No. 001-00652).
10.8	Revised Form of Universal Corporation Non-Employee Director Restricted Stock Agreement (incorporated herein by reference to the Registrant’s Current Report on Form 8-K dated June 9, 2010, File No. 001-00652).
10.9	Form Change of Control Agreement (incorporated herein by reference to the Registrant’s Current Report on Form 8-K filed November 10, 2008, File No. 001-00652).
10.10	Universal Corporation Director’s Charitable Award Program (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1998, File No. 001-00652).
10.11	Universal Corporation 1997 Executive Stock Plan, as amended on August 7, 2003 (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, File No. 001-00652).
10.12	Universal Corporation 2002 Executive Stock Plan, as amended on August 7, 2003 (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, File No. 001-00652).
10.13	Form of Restricted Stock Units Award Agreement (incorporated herein by reference to the Registrant’s Current Report on Form 8-K filed November 10, 2008, File No. 001-00652).
10.14	Universal Corporation 2007 Amended and Restated Stock Incentive Plan effective August 7, 2012 (incorporated herein by reference to Exhibit A to the Registrant’s definitive proxy statement filed June 28, 2012, File No. 001-00652).

89

10.15	Universal Corporation Executive Officer Annual Incentive Plan, as amended (incorporated herein by reference to the Registrant's definitive proxy statement filed June 25, 2014, File No. 001-00652).
10.16	Form of Universal Corporation 2010 Restricted Stock Units Agreement with Schedule of Awards to named executive officers (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2010, File No. 001-00652).
10.17	Universal Leaf Tobacco Company, Incorporated Deferred Income Plan III, amended and restated as of December 31, 2008 (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2010, File No. 001-00652).
10.18	Universal Corporation Outside Directors' Deferred Income Plan III, amended and restated as of December 31, 2008, and amended as of February 1, 2010 (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2010, File No. 001-00652).
10.19	Form of Universal Corporation 2011 Restricted Stock Units Agreement (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2011, File No. 001-00652).
10.20	Form of Universal Corporation Performance Share Award Agreement (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2011, File No. 001-00652).
10.21	Credit Agreement dated December 30, 2014 among the Company, JPMorgan Chase Bank, N.A., as Administrative Agent, SunTrust Bank and AgFirst Farm Credit Bank, as Co-Syndication Agents and Keybank National Association and Capital One, National Association, as Co-Documentation Agents (incorporated herein by reference to the Registrant’s Current Report on Form 8-K dated December 30, 2014 (December 23, 2014), File No. 001-00652).
12	Ratio of Earnings to Fixed Charges and Ratio of Earnings to Combined Fixed Charges and Preference Dividends.*
21	Subsidiaries of the Registrant.*
23	Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.*
31.1	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1	Statement of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350.*
32.2	Statement of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350.*
101	Interactive Data File (Annual Report on Form 10-K for the fiscal year ended March 31, 2017, furnished in XBRL (eXtensible Business Reporting Language)).*
	Attached as Exhibit 101 to this report are the following documents formatted in XBRL: (i) the Consolidated Statements of Income for each of the three years ended March 31, 2017, 2016 and 2015, (ii) the Consolidated Statements of Comprehensive Income for each of the three years ended March 31, 2017, 2016 and 2015, (iii) the Consolidated Balance Sheets at March 31, 2017 and 2016, (iv) the Consolidated Statement of Cash Flows for each of the three years ended March 31, 2017, 2016 and 2015, (v) the Consolidated Statement of Shareholders’ Equity for each of the three years ended March 31, 2017, 2016 and 2015, (vi) the Notes to Consolidated Financial Statements, (vii) Schedule II - Valuation and Qualifying Accounts.

_________

*    Filed herewith.

90

EX-12

Exhibit 12

UNIVERSAL CORPORATION

RATIO OF EARNINGS TO FIXED CHARGES

AND

RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERENCE DIVIDENDS

	Fiscal Year Ended March 31,
	2017		2016		2015		2014		2013
	(in thousands, except for ratios)
Earnings
Pretax income before equity in pretax earnings (loss) of unconsolidated affiliates	$	163,464	$	167,156	$	151,330	$	226,793	$	201,650
Fixed charges (net of interest capitalized)	18,222		18,499		20,993		23,974		25,646
Distribution of earnings from unconsolidated affiliates	5,078		3,422		5,228		6,508		123
Total Earnings	$	186,764	$	189,077	$	177,551	$	257,275	$	227,419
Fixed Charges and Preference Dividends
Interest expense	$	16,284	$	15,669	$	17,120	$	20,307	$	22,013
Interest capitalized	—		—		—		—		—
Amortization of premiums, discounts, and debt issuance cost(1)	—		851		1,600		1,302		1,343
Interest component of rent expense	1,938		1,979		2,273		2,365		2,290
Total Fixed Charges	18,222		18,499		20,993		23,974		25,646
Dividends on convertible perpetual preferred stock (pretax)	17,017		22,689		22,806		22,846		22,846
Total Fixed Charges and Preference Dividends	$	35,239	$	41,188	$	43,799	$	46,820	$	48,492
Ratio of Earnings to Fixed Charges	10.25		10.22		8.46		10.73		8.87
Ratio of Earnings to Combined Fixed Charges and Preference Dividends	5.30		4.59		4.05		5.49		4.69

⁽¹⁾The Company began reporting the amortization of premiums, discounts, and debt issuance costs in interest expense effective April 1, 2016 (the beginning of fiscal year 2017). No reclassification has been made for prior reporting periods since the amounts are not material.

EX-21

EXHIBIT 21

SUBSIDIARIES OF THE REGISTRANT

Subsidiary Name	Organized under law of
Aviation and Regional Services, Ltd.	Malawi
B.V. Beleggings-en Beheermaatschappij "De Amstel"	Netherlands
CA Bautz GmbH	Germany
Carolina Innovative Food Ingredients, Inc.	Virginia
Carolina Recycled Ag Materials, LLC	Virginia
Casa Export, Limited	Virginia
CATSCO, Inc.	British Virgin Isles
CJSC Universal Tabak	Russia
Continental Tobacco S.A.	Switzerland
B.V. Deli-HTL Tabak Maatschappij	Netherlands
Deltafina, S.r.l.	Italy
Deutsch-hollandische Tabakgesellschaft mbH	Germany
Ermor Tabarama-Tabacos do Brasil Ltda.	Brazil
Gebrueder Kulenkampff GmbH	Germany
Global Laboratory Services, Inc.	Virginia
Harkema Services, Inc.	Virginia
Indoco International B.V.	Netherlands
Inetab-Kaubeck, SRL	Dominican Republic
Itofina, S.A.	Switzerland
J.P. Taylor Company, L.L.C.	Virginia
L’Agricola, S.r.l.	Italy
Lancaster Leaf Tobacco Company of Pennsylvania, Inc.	Virginia
Limbe Leaf Tobacco Company Limited	Malawi
Mozambique Leaf Tobacco, Limitada	Mozambique
Procesadora Unitab, S.A.	Guatemala
PT Pandu Sata Utama	Indonesia
PT Tempu Rejo	Indonesia
Tabacalera San Fernando S.R.L.	Paraguay
Tabacos Del Pacifico Norte, S.A. De C.V.	Mexico
TAES, S.L.	Spain
Tanzania Leaf Tobacco Co., Ltd.	Tanzania

1

EXHIBIT 21

SUBSIDIARIES OF THE REGISTRANT

Tanzania Tobacco Processors Ltd.	Tanzania
ULT Support Services India Private Ltd.	India
Ultoco, S.A.	Switzerland
Ultoco Limited	British Virgin Islands
Ultoco Services, S.A.	Switzerland
Universal Finance B.V.	Netherlands
Universal Innovations Corporation, Inc.	Virginia
Universal Leaf Africa (Pty) Ltd.	South Africa
Universal Leaf (Asia) Pte Ltd.	Singapore
Universal Leaf Far East Ltd.	British Virgin Islands
Universal Leaf Germany GmbH	Germany
Universal Leaf Nicaragua, S.A.	Nicaragua
Universal Leaf North America U. S., Inc.	North Carolina
Universal Leaf Philippines, Inc.	Philippines
Universal Leaf South Africa (Pty) Limited	South Africa
Universal Leaf Tabacos Ltda.	Brazil
Universal Leaf Tabacos S.R.L.	Argentina
Universal Leaf Tobacco Company, Inc.	Virginia
Universal Leaf Tobacco Hungary Private Limited Company	Hungary
Universal Leaf Tobacco International, Inc.	Virginia
Universal Leaf Tobacco Poland Sp. z o.o.	Poland
Virginia Tobacco Company, Inc.	Virginia
Zambia Leaf Tobacco Co., Ltd.	Zambia
Zimleaf Holdings (Private) Limited	Zimbabwe
Zimbabwe Leaf Tobacco Company (Private) Limited	Zimbabwe

2

EX-23

Exhibit 23

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

(1) Registration Statements (Form S-3 No. 333-200433) of Universal Corporation, and

(2)    Registration Statements (Form S-8s Nos. 33-56719, 333-39297, 333-101825, 333-145205) of Universal Corporation;

of our reports dated May 26, 2017, with respect to the consolidated financial statements and schedule of Universal Corporation and the effectiveness of internal control over financial reporting of Universal Corporation included in this Annual Report (Form 10-K) of Universal Corporation for the year ended March 31, 2017.

/s/ ERNST & YOUNG LLP

Richmond, Virginia

May 26, 2017

EX-31.1

Exhibit 31.1

CERTIFICATION

I, George C. Freeman, III certify that:

1. I have reviewed this annual report on Form 10-K of Universal Corporation for the period ended March 31, 2017;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 26, 2017    

/s/ GEORGE C. FREEMAN, III

George C. Freeman, III

Chairman, President, and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, David C. Moore certify that:

1. I have reviewed this annual report on Form 10-K of Universal Corporation for the period ended March 31, 2017;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 26, 2017

/s/ DAVID C. MOORE

David C. Moore

Senior Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report of Universal Corporation (the “Company”) on Form 10-K for the period ended March 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”) and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, George C. Freeman, III certify, to the best of my knowledge and belief, that

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 26, 2017

/s/ GEORGE C. FREEMAN, III

George C. Freeman, III

Chairman, President, and Chief Executive Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report of Universal Corporation (the “Company”) on Form 10-K for the period ended March 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”) and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, David C. Moore certify, to the best of my knowledge and belief, that

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 26, 2017    

/s/ DAVID C. MOORE

David C. Moore

Senior Vice President and Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document And Entity Information - USD ($) $ in Millions	12 Months Ended
	Mar. 31, 2017	May 19, 2017	Sep. 30, 2016
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	FY
Entity Registrant Name	UNIVERSAL CORP /VA/
Entity Central Index Key	0000102037
Current Fiscal Year End Date	--03-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		25,274,506
Entity Well-known Seasoned Issuer	Yes
Entity Public Float			$ 1,326
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No

XML

Consolidated Statements Of Income - USD ($) $ in Thousands		12 Months Ended
		Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Income Statement [Abstract]
Sales and other operating revenues		$ 2,071,218	$ 2,120,373	$ 2,271,801
Costs and expenses
Cost of goods sold		1,676,539	1,713,042	1,861,527
Selling, general and administrative expenses		211,969	226,685	250,186
Other income	[1]	0	(3,390)	(12,676)
Restructuring and impairment costs		4,359	2,389	4,890
Operating income		178,351	181,647	167,874
Equity in pretax earnings of unconsolidated affiliates	[2]	5,774	5,422	7,137
Interest income		1,397	1,178	576
Interest expense		16,284	15,669	17,120
Income before income taxes		169,238	172,578	158,467
Income taxes		56,732	54,430	38,006
Net income		112,506	118,148	120,461
Less: net income attributable to noncontrolling interests in subsidiaries		(6,202)	(9,132)	(5,853)
Net income attributable to Universal Corporation		106,304	109,016	114,608
Dividends on Universal Corporation convertible perpetual preferred stock		(11,061)	(14,748)	(14,824)
Cost in excess of carrying value on repurchase or conversion of convertible perpetual preferred stock		(74,353)	0	(36)
Earnings available to Universal Corporation common shareholders		$ 20,890	$ 94,268	$ 99,748
Earnings per share attributable to Universal Corporation common shareholders:
Basic		$ 0.89	$ 4.16	$ 4.33
Diluted		$ 0.88	$ 3.92	$ 4.06
Weighted average common shares outstanding:
Basic		23,433,860	22,683,290	23,035,920
Diluted		23,770,088	27,825,491	28,221,264

[1] Other income in fiscal year 2016 represents a gain from remeasuring to fair value the Company's original 50% ownership in Procesadora Unitab, S.A., a tobacco processing joint venture in Guatemala, upon acquiring the 50% interest held by the Company's joint venture partner (See Note 13). Other income in fiscal year 2015 represents the reversal of a valuation allowance on IPI excise tax credits in Brazil (See Note 13).

[2] Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income.

XML

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Net income	$ 112,506	$ 118,148	$ 120,461
Other comprehensive income (loss):
Foreign currency translation, net of income taxes	(6,899)	3,934	(22,625)
Pension and other postretirement benefit plans, net of income taxes	1,475	1,004	(14,023)
Total other comprehensive income (loss), net of income taxes	2,038	2,432	(40,625)
Total comprehensive income	114,544	120,580	79,836
Less: comprehensive income attributable to noncontrolling interests	(5,449)	(8,920)	(5,890)
Comprehensive income attributable to Universal Corporation	109,095	111,660	73,946
Foreign currency hedge, net of income taxes [Member]
Other comprehensive income (loss):
Hedges, net of income taxes	(933)	2,509	(2,603)
Interest rate hedge, net of income taxes [Member]
Other comprehensive income (loss):
Hedges, net of income taxes	$ 8,395	$ (5,015)	$ (1,374)

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2017	Mar. 31, 2016
ASSETS
Cash and cash equivalents	$ 283,993	$ 319,447
Accounts receivable, net	439,288	428,659
Advances to suppliers, net	103,750	101,890
Accounts receivable - unconsolidated affiliates	2,373	2,316
Inventories - at lower of cost or market:
Tobacco	565,943	637,132
Other	68,087	60,888
Prepaid income taxes	16,713	17,814
Other current assets	81,252	70,400
Total current assets	1,561,399	1,638,546
Property, plant and equipment
Land	22,852	22,987
Buildings	266,802	264,838
Machinery and equipment	597,213	591,327
Total property, plant and equipment	886,867	879,152
Less accumulated depreciation	(569,527)	(553,265)
Property, plant and equipment, net	317,340	325,887
Other assets
Goodwill and other intangibles	98,888	99,071
Investments in unconsolidated affiliates	78,457	82,441
Deferred income taxes	25,422	23,853
Other noncurrent assets	41,899	61,379
Total other assets	244,666	266,744
Total assets	2,123,405	2,231,177
Liabilities, Current [Abstract]
Notes payable and overdrafts	59,133	66,179
Accounts payable and accrued expenses	153,515	120,527
Accounts payable - unconsolidated affiliates	7,231	8,343
Customer advances and deposits	11,007	16,438
Accrued compensation	32,007	27,593
Income taxes payable	5,103	7,190
Current portion of long-term debt	0	0
Total current liabilities	267,996	246,270
Long-term debt	368,733	368,380
Pensions and other postretirement benefits	80,689	92,177
Other long-term liabilities	31,424	41,794
Deferred income taxes	47,985	29,494
Total liabilities	796,827	778,115
Shareholders' equity
Common stock, no par value, 100,000,000 shares authorized, 25,274,506 shares issued and outstanding (22,717,735 at March 31, 2016)	321,207	208,946
Retained earnings	1,034,841	1,066,064
Accumulated other comprehensive loss	(69,559)	(72,350)
Total Universal Corporation shareholders' equity	1,286,489	1,414,222
Noncontrolling interests in subsidiaries	40,089	38,840
Total shareholders' equity	1,326,578	1,453,062
Total liabilities and shareholders' equity	2,123,405	2,231,177
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
Shareholders' equity
Preferred Stock	$ 0	$ 211,562

XML

Consolidated Balance Sheets (Parenthetical) - shares	Mar. 31, 2017	Mar. 31, 2016
Preferred stock, shares authorized	5,000,000
Common stock, shares authorized	100,000,000
Common stock, shares outstanding	25,274,506
Common Stock [Member]
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	25,274,506	22,717,735
Common stock, shares outstanding	25,274,506	22,717,735
Series A Junior Participating Preferred Stock [Member]
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
Preferred stock, shares authorized	220,000	220,000
Preferred stock, shares issued	0	218,490
Preferred stock, shares outstanding	0	218,490

XML

Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 112,506	$ 118,148	$ 120,461
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	35,911	36,754	35,394
Provisions for losses (recoveries) on advances and guaranteed loans to suppliers	(857)	815	3,734
Inventory write-downs	10,866	11,899	18,612
Stock-based compensation expense	6,475	5,206	6,230
Foreign currency remeasurement loss (gain), net	9,269	22,517	28,836
Deferred income taxes	16,626	15,046	(13,662)
Equity in net income of unconsolidated affiliates, net of dividends	396	156	(1,075)
Gain on favorable outcome of excise tax case in Brazil	0	0	(12,676)
Fair value gain upon acquisition of partner's interest in joint venture	0	(3,390)	0
Restructuring and impairment costs	4,359	2,389	4,890
Other, net	(4,463)	13,204	(7,342)
Changes in operating assets and liabilities, net:
Accounts and notes receivable	(14,346)	(2,806)	49,414
Inventories and other assets	52,139	(7,370)	37,751
Income taxes	(1,719)	1,437	5,680
Accounts payable and accrued liabilities	28,643	(13,678)	(63,257)
Customer advances and deposits	(5,490)	(13,796)	14,397
Net cash provided by operating activities	250,315	186,531	227,387
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment	(35,630)	(47,153)	(58,385)
Purchase of partner's interest in joint venture, net of cash held by the business	0	(5,964)	0
Proceeds from sale of property, plant and equipment	2,174	2,982	4,522
Other, net	(398)	(796)	(141)
Net cash used by investing activities	(33,854)	(50,931)	(54,004)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance (repayment) of short-term debt, net	(5,349)	4,880	2,618
Issuance of long-term debt	0	0	370,000
Repayment of long-term debt	0	0	(356,250)
Dividends paid to noncontrolling interests	(4,200)	(4,449)	(4,183)
Issuance of common stock	0	0	187
Conversion/repurchase of convertible perpetual preferred stock	(178,365)	0	(1,497)
Repurchase of common stock	0	0	(31,227)
Dividends paid on convertible perpetual preferred stock	(11,061)	(14,748)	(14,824)
Dividends paid on common stock	(49,828)	(47,389)	(47,337)
Debt issuance costs and other	(2,441)	(2,940)	(4,511)
Net cash used by financing activities	(251,244)	(64,646)	(87,024)
Effect of exchange rate changes on cash	(671)	(290)	(1,108)
Net increase (decrease) in cash and cash equivalents	(35,454)	70,664	85,251
Cash and cash equivalents at beginning of year	319,447	248,783	163,532
Cash and cash equivalents at end of year	283,993	319,447	248,783
Supplemental information - cash paid for:
Interest	16,284	15,704	19,184
Income taxes, net of refunds	$ 37,294	$ 38,732	$ 46,044

XML

Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Series B 6.75% Convertible Perpetual Preferred Stock [Member]	Series B 6.75% Convertible Perpetual Preferred Stock [Member] Cash conversion of stock [Member]	Series B 6.75% Convertible Perpetual Preferred Stock [Member] Cash repurchase of stock [Member]	Common Stock - Class A [Member]	Forward Foreign Currency Exchange Contracts [Member]	Interest Rate Swap Agreements [Member]	Preferred Stock [Member]	Preferred Stock [Member] Series B 6.75% Convertible Perpetual Preferred Stock [Member]	Common Stock [Member]	Common Stock [Member] Common Stock - Class A [Member]	Retained Earnings [Member]	Retained Earnings [Member] Series B 6.75% Convertible Perpetual Preferred Stock [Member]	Retained Earnings [Member] Common Stock - Class A [Member]	AOCI Attributable to Parent [Member]	AOCI Attributable to Parent [Member] Forward Foreign Currency Exchange Contracts [Member]	AOCI Attributable to Parent [Member] Interest Rate Swap Agreements [Member]	Noncontrolling Interest [Member]
Balance at beginning of year at Mar. 31, 2014	$ 1,410,892							$ 213,023		$ 206,446		$ 993,093			$ (34,332)			$ 32,662
Balance at beginning of year, shares at Mar. 31, 2014		219,999
Balance at beginning of year, shares at Mar. 31, 2014					23,216,312
Changes in preferred and common stock
Issuance of common stock	187									187
Repurchase of stock		$ (1,461)			$ (6,439)				$ (1,461)		$ (6,439)
Conversion of Stock, Shares Converted		0
Issuance of stock, shares					96,947
Conversion of Stock, Shares Issued					0
Repurchase of stock, shares			0	(1,509)	(719,993)
Accrual of stock-based compensation	6,230									6,230
Withholding of shares from stock-based compensation for grantee income taxes	(1,076)									(1,076)
Dividend equivalents on RSUs	654									654
Changes in retained earnings
Net income	120,461											114,608						5,853
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock ($67.50 per share)	(14,824)											(14,824)
Common stock	(47,244)											(47,244)
Repurchase of stock, retained earnings	36	$ 36			$ (24,788)								$ 36	$ (24,788)
Dividend equivalents on RSUs	(654)											(654)
Other comprehensive income (loss)
Foreign currency translation, net of income taxes	(22,625)														(22,662)			37
Hedges, net of income taxes						$ (2,603)	$ (1,374)									$ (2,603)	$ (1,374)
Pension and other postretirement benefit plans, net of income taxes	(14,023)														(14,023)
Other changes in noncontrolling interests
Dividends paid to noncontrolling shareholders	(4,183)																	(4,183)
Balance at end of year at Mar. 31, 2015	1,397,094							211,562		206,002		1,020,155			(74,994)			34,369
Balance at end of year, shares at Mar. 31, 2015		218,490
Balance at end of year, shares at Mar. 31, 2015					22,593,266
Changes in preferred and common stock
Conversion of Stock, Shares Converted		0
Issuance of stock, shares					124,469
Conversion of Stock, Shares Issued					0
Repurchase of stock, shares			0	0	0
Accrual of stock-based compensation	5,206									5,206
Withholding of shares from stock-based compensation for grantee income taxes	(2,940)									(2,940)
Dividend equivalents on RSUs	678									678
Changes in retained earnings
Net income	118,148											109,016						9,132
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock ($67.50 per share)	(14,748)											(14,748)
Common stock	(47,681)											(47,681)
Repurchase of stock, retained earnings	0
Dividend equivalents on RSUs	(678)											(678)
Other comprehensive income (loss)
Foreign currency translation, net of income taxes	3,934														4,146			(212)
Hedges, net of income taxes						2,509	(5,015)									2,509	(5,015)
Pension and other postretirement benefit plans, net of income taxes	1,004														1,004
Other changes in noncontrolling interests
Dividends paid to noncontrolling shareholders	(4,449)																	(4,449)
Balance at end of year at Mar. 31, 2016	1,453,062							211,562		208,946		1,066,064			(72,350)			38,840
Balance at end of year, shares at Mar. 31, 2016		218,490
Balance at end of year, shares at Mar. 31, 2016					22,717,735
Changes in preferred and common stock
Conversion of Stock, Amount Converted									(107,550)		$ 107,550
Conversion of Stock, Shares Converted		(111,072)
Payments for Repurchase of Redeemable Convertible Preferred Stock	(104,012)								$ (104,012)
Issuance of stock, shares					69,653
Conversion of Stock, Shares Issued					2,487,118
Repurchase of stock, shares			(107,418)	0	0
Accrual of stock-based compensation	6,475									6,475
Withholding of shares from stock-based compensation for grantee income taxes	(2,440)									(2,440)
Dividend equivalents on RSUs	676									676
Changes in retained earnings
Net income	112,506											106,304						6,202
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock ($67.50 per share)	(11,061)											(11,061)
Common stock	(51,437)											(51,437)
Repurchase of stock, retained earnings	74,353	$ (74,353)											$ (74,353)
Dividend equivalents on RSUs	(676)											(676)
Other comprehensive income (loss)
Foreign currency translation, net of income taxes	(6,899)														(6,146)			(753)
Hedges, net of income taxes						$ (933)	$ 8,395									$ (933)	$ 8,395
Pension and other postretirement benefit plans, net of income taxes	1,475														1,475
Other changes in noncontrolling interests
Dividends paid to noncontrolling shareholders	(4,200)																	(4,200)
Balance at end of year at Mar. 31, 2017	$ 1,326,578							$ 0		$ 321,207		$ 1,034,841			$ (69,559)			$ 40,089
Balance at end of year, shares at Mar. 31, 2017		0
Balance at end of year, shares at Mar. 31, 2017	25,274,506				25,274,506

XML

Consolidated Statements of Changes in Shareholders' Equity (Parenthetical) - $ / shares	3 Months Ended								12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Statement of Stockholders' Equity [Abstract]
Series B 6.75% convertible perpetual preferred stock, cash dividends declared per share	$ 0.00	$ 16.88	$ 16.87	$ 16.88	$ 16.87	$ 16.88	$ 16.87	$ 16.88	$ 50.63	$ 67.50	$ 67.50
Common stock, cash dividends declared per share	$ 0.54	$ 0.54	$ 0.53	$ 0.53	$ 0.53	$ 0.53	$ 0.52	$ 0.52	$ 2.14	$ 2.10	$ 2.06

XML

Nature Of Operations And Significant Accounting Policies

12 Months Ended

Mar. 31, 2017

Accounting Policies [Abstract]

Nature Of Operations And Significant Accounting Policies

NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

Universal Corporation, which together with its subsidiaries is referred to herein as “Universal” or the “Company,” is the leading global leaf tobacco supplier. The Company conducts business in over 30 countries, primarily in major tobacco-producing regions of the world.

Consolidation

The consolidated financial statements include the accounts of Universal Corporation and all domestic and foreign subsidiaries in which the Company maintains a controlling financial interest. Control is generally determined based on a voting interest of greater than 50%, such that Universal controls all significant corporate activities of the subsidiary. All significant intercompany accounts and transactions are eliminated in consolidation.

The equity method of accounting is used for investments in companies where Universal Corporation has a voting interest of 20% to 50%. These investments are accounted for under the equity method because Universal exercises significant influence over those companies, but not control. The Company received dividends totaling $5.1 million in fiscal year 2017, $3.4 million in fiscal year 2016, and $5.2 million in fiscal year 2015, from companies accounted for under the equity method. Investments where Universal has a voting interest of less than 20% are not significant and are accounted for under the cost method. Under the cost method, the Company recognizes earnings upon its receipt of dividends to the extent they represent a distribution of retained earnings.

The Company's 49% ownership interest in Socotab L.L.C. (“Socotab”), a leading supplier of oriental tobaccos with operations located principally in Eastern Europe and Turkey, is the primary investment accounted for under the equity method. The investment in Socotab is an important part of the Company's overall product and service arrangements with its major customers. As discussed further below, the Company reviews the carrying value of its investments in unconsolidated affiliates on a regular basis and considers whether any factors exist that might indicate an impairment in value that is other than temporary. At March 31, 2017, the Company determined that no such factors existed with respect to the investment in Socotab. The Company, together with Socotab management, regularly evaluates the outlook for the business, and an impairment charge could be recorded in a future period if it is determined that the fair value of the investment is less than the carrying value and the decline in value is not temporary.

In fiscal year 2006, the Company deconsolidated its operations in Zimbabwe under accounting requirements that apply under certain conditions to foreign subsidiaries that are subject to foreign exchange controls and other government restrictions. Since that time, the investment has been accounted for using the cost method, as required under the accounting guidance. The investment in the Zimbabwe operations was zero at March 31, 2017 and 2016. The Company has a net foreign currency translation loss associated with the Zimbabwe operations of approximately $7.2 million, which remains a component of accumulated other comprehensive loss. As a regular part of its reporting, the Company reviews the conditions that resulted in the deconsolidation of the Zimbabwe operations to confirm that such accounting treatment is still appropriate. Dividends from the Zimbabwe operations are recorded in income in the period received.

The Company holds less than a 100% financial interest in certain consolidated subsidiaries. The net income and shareholders’ equity attributable to the noncontrolling interests in these subsidiaries are reported on the face of the consolidated financial statements. During fiscal years 2017, 2016, and 2015, there were no changes in the Company’s ownership percentage in any of these subsidiaries.

Investments in Unconsolidated Affiliates

The Company’s equity method investments and its cost method investments, which include its Zimbabwe operations, are non-marketable securities. Universal reviews such investments for impairment whenever events or changes in circumstances indicate that the carrying amount of an investment may not be recovered. For example, the Company would review such an investment for impairment if the investee were to lose a significant customer, suffer a large reduction in sales margins, experience a major change in its business environment, or undergo any other significant change in its normal business. In assessing the recoverability of equity or cost method investments, the Company follows the applicable accounting guidance in determining the fair value of the investments. In most cases, this involves the use of discounted cash flow models (Level 3 of the fair value hierarchy under the accounting guidance). If the fair value of an equity or cost method investee is determined to be lower than its carrying value, an impairment loss is recognized. The determination of fair value using discounted cash flow models is normally not based on observable market data from independent sources and therefore requires significant management judgment with respect to estimates of future operating earnings and the selection of an appropriate discount rate. The use of different assumptions could increase or decrease estimated future operating cash flows, and the discounted value of those cash flows, and therefore could increase or decrease any impairment charge related to these investments.

In its consolidated statements of income, the Company reports its proportional share of the earnings of unconsolidated affiliates accounted for on the equity method based on the pretax earnings of those affiliates, as permitted under the applicable accounting guidance. All applicable foreign and U.S. income taxes are provided on these earnings and reported as a component of consolidated income tax expense. For unconsolidated affiliates located in foreign jurisdictions, repatriation of the Company’s share of the earnings through dividends is assumed in determining consolidated income tax expense.

The following table provides a reconciliation of (1) equity in the pretax earnings of unconsolidated affiliates, as reported in the consolidated statements of income to (2) equity in the net income of unconsolidated affiliates, net of dividends, as reported in the consolidated statements of cash flows for the fiscal years ended March 31, 2017, 2016, and 2015:

	Fiscal Year Ended March 31,
	2017			2016			2015
Equity in pretax earnings reported in the consolidated statements of income	$	5,774		$	5,422		$	7,137
Less: Equity in income taxes	(1,092		)	(2,156		)	(834		)
Equity in net income	4,682			3,266			6,303
Less: Dividends received on investments(1)	(5,078		)	(3,422		)	(5,228		)
Equity in net income, net of dividends, reported in the consolidated statements of cash flows	$	(396	)	$	(156	)	$	1,075

⁽¹⁾  In accordance with the applicable accounting guidance, dividends received from unconsolidated affiliates accounted for on the equity method that represent a return on capital (i.e., a return of earnings on a cumulative basis) are presented as operating cash flows in the consolidated statements of cash flows.

Earnings Per Share

 The Company calculates basic earnings per share based on earnings available to common shareholders after payment of dividends on the Company’s Series B 6.75% Convertible Perpetual Preferred Stock prior to its conversion in fiscal year 2017 (see Note 11). The calculation uses the weighted average number of common shares outstanding during each period. Diluted earnings per share is computed in a similar manner using the weighted average number of common shares and dilutive potential common shares outstanding. Dilutive potential common shares include unvested restricted stock units and performance share awards that are assumed to be fully vested and paid out in shares of common stock, dilutive stock options and stock appreciation rights that were assumed to be exercised, and shares of convertible perpetual preferred stock that were assumed to be converted when the effect was dilutive. In periods when the effect of the convertible perpetual preferred stock was dilutive and these shares were assumed to be converted into common stock, dividends paid on the preferred stock were excluded from the calculation of diluted earnings per share.

Calculations of earnings per share for the fiscal years ended March 31, 2017, 2016, and 2015, are provided in Note 3.

Cash and Cash Equivalents

 All highly liquid investments with a maturity of three months or less at the time of purchase are classified as cash equivalents.

Advances to Suppliers

In many sourcing origins where the Company operates, it provides agronomy services and seasonal advances of seed, fertilizer, and other supplies to tobacco farmers for crop production, or makes seasonal cash advances to farmers for the procurement of those inputs. These advances are short term, are repaid upon delivery of tobacco to the Company, and are reported in advances to suppliers in the consolidated balance sheets. In several origins, the Company has made long-term advances to tobacco farmers to finance curing barns and other farm infrastructure. In some years, due to low crop yields and other factors, individual farmers may not deliver sufficient volumes of tobacco to fully repay their seasonal advances, and the Company may extend repayment of those advances into future crop years. The long-term portion of advances is included in other noncurrent assets in the consolidated balance sheets. Both the current and the long-term portions of advances to suppliers are reported net of allowances recorded when the Company determines that amounts outstanding are not likely to be collected. Short-term and long-term advances to suppliers totaled approximately $134 million at both March 31, 2017 and 2016. The related valuation allowances totaled $27 million at March 31, 2017, and $29 million at March 31, 2016, and were estimated based on the Company’s historical loss information and crop projections. The allowances were reduced by net recoveries of approximately $0.9 million in fiscal year 2017, but increased by net provisions for estimated uncollectible amounts of approximately $0.8 million in fiscal year 2016 and $3.7 million in fiscal year 2015. These provisions are included in selling, general, and administrative expenses in the consolidated statements of income. Interest on advances is recognized in earnings upon the farmers’ delivery of tobacco in payment of principal and interest. Advances on which interest accrual had been discontinued totaled approximately $11 million at both March 31, 2017 and 2016.

Inventories

Tobacco inventories are valued at the lower of cost or market. Raw materials primarily consist of unprocessed leaf tobacco, which is clearly identified by type and grade at the time of purchase. The Company tracks the costs associated with this tobacco in the final product lots, and maintains this identification through the time of sale. This method of cost accounting is referred to as the specific cost or specific identification method. The predominant cost component of the Company’s inventories is the cost of the unprocessed tobacco. Direct and indirect processing costs related to these raw materials are capitalized and allocated to inventory in a systematic manner. The Company does not capitalize any interest or sales-related costs in inventory. Freight costs are recorded in cost of goods sold. Other inventories consist primarily of seed, fertilizer, packing materials, and other supplies, and are valued principally at the lower of average cost or market.

Recoverable Value-Added Tax Credits

In many foreign countries, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”) on purchases of unprocessed and processed tobacco, crop inputs, packing materials, and various other goods and services. In some countries, VAT is a national tax, and in other countries it is assessed at the state level. Items subject to VAT vary from jurisdiction to jurisdiction, as do the rates at which the tax is assessed. When tobacco is sold to customers in the country of origin, the operating subsidiaries generally collect VAT on those sales. The subsidiaries are normally permitted to offset their VAT payments against the collections and remit only the incremental VAT collections to the tax authorities. When tobacco is sold for export, VAT is normally not assessed. In countries where tobacco sales are predominately for export markets, VAT collections generated on downstream sales are often not sufficient to fully offset the subsidiaries’ VAT payments. In those situations, unused VAT credits can accumulate. Some jurisdictions have procedures that allow companies to apply for refunds of unused VAT credits from the tax authorities, but the refund process often takes an extended period of time, and it is not uncommon for refund applications to be challenged or rejected in part on technical grounds. Other jurisdictions may permit companies to sell or transfer unused VAT credits to third parties in private transactions, although approval for such transactions must normally be obtained from the tax authorities, limits on the amounts that can be transferred may be imposed, and the proceeds realized may be heavily discounted from the face value of the credits. Due to these factors, local operating subsidiaries in some countries can accumulate significant balances of VAT credits over time. The Company reviews these balances on a regular basis and records valuation allowances on the credits to reflect amounts that are not expected to be recovered, as well as discounts anticipated on credits that are expected to be sold or transferred. At March 31, 2017 and 2016, the aggregate balances of recoverable tax credits held by the Company’s subsidiaries totaled approximately $45 million and $52 million, respectively, and the related valuation allowances totaled approximately $13 million and $19 million, respectively. The net balances are reported in other current assets and other noncurrent assets in the consolidated balance sheets.

Property, Plant and Equipment

Depreciation of plant and equipment is based upon historical cost and the estimated useful lives of the assets. Depreciation is calculated primarily using the straight-line method. Buildings include tobacco processing and blending facilities, offices, and warehouses. Machinery and equipment consists of processing and packing machinery and transport, office, and computer equipment. Estimated useful lives range as follows: buildings - 15 to 40 years; processing and packing machinery - 3 to 11 years; transport equipment - 3 to 10 years; and office and computer equipment - 3 to 10 years. Where applicable and material in amount, the Company capitalizes related interest costs during periods that property, plant and equipment are being constructed or made ready for service. No interest was capitalized in fiscal years 2017, 2016, or 2015.

Goodwill and Other Intangibles

Goodwill and other intangibles principally consist of the excess of the purchase price of acquired companies over the fair value of the net assets. Goodwill is carried at the lower of cost or fair value. Accounting Standards Codification Topic 350 (“ASC 350”) permits companies to base their initial assessments of potential goodwill impairment on qualitative factors, and the Company elected to use that approach at March 31, 2017 and 2016. Those factors did not indicate any potential impairment of the Company's recorded goodwill.

Reporting units are distinct operating subsidiaries or groups of subsidiaries that typically compose the Company’s business in a specific country or location. Goodwill is allocated to reporting units based on the country or location to which a specific acquisition relates, or by allocation based on expected future cash flows if the acquisition relates to more than one country or location. The majority of the Company’s goodwill relates to its reporting unit in Brazil. Significant adverse changes in the operations or estimated future cash flows for a reporting unit with recorded goodwill could result in an impairment charge. No charges for goodwill impairment were recorded in fiscal years 2017, 2016, or 2015.

Impairment of Long-Lived Assets

The Company reviews long-lived assets for impairment whenever events, changes in business conditions, or other circumstances provide an indication that such assets may be impaired. Potential impairment is initially assessed by comparing management’s undiscounted estimates of future cash flows from the use or disposition of the assets to their carrying value. If the carrying value exceeds the undiscounted cash flows, an impairment charge is recorded to reduce the carrying value of the asset to its fair value determined in accordance with the accounting guidance. In many cases, this involves the use of discounted cash flow models that are not based on observable market data from independent sources (Level 3 of the fair value hierarchy under the accounting guidance). In fiscal year 2017, the Company incurred impairment charges of $2.3 million on factory and equipment assets as a result of the Company's decision to close its tobacco processing facility in Hungary (see Note 2). No significant charges for the impairment of long-lived assets were recorded during fiscal years 2016 or 2015.

Income Taxes

The Company provides deferred income taxes on temporary differences between the book and tax basis of its assets and liabilities. Those differences arise principally from employee benefit accruals, depreciation, deferred compensation, undistributed earnings of unconsolidated affiliates, undistributed earnings of foreign subsidiaries, goodwill, and valuation allowances on farmer advances and value-added tax credits.

Fair Values of Financial Instruments

The fair value of the Company’s long-term debt, disclosed in Note 6, approximates the carrying amount since the variable interest rates in the underlying credit agreement reflect the market interest rates that were available to the Company at March 31, 2017. In periods when fixed-rate obligations are outstanding, fair values are estimated using market prices where they are available and discounted cash flow models based on current incremental borrowing rates for similar classes of borrowers and borrowing arrangements. The fair values of interest rate swap agreements designated as cash flow hedges and used to fix the variable benchmark rate on outstanding long-term debt are determined separately and recorded in other long-term liabilities. Except for interest rate swaps and forward foreign currency exchange contracts that are discussed below, the fair values of all other assets and liabilities that qualify as financial instruments approximate their carrying amounts.

Derivative Financial Instruments

The Company recognizes all derivatives on the balance sheet at fair value. Interest rate swaps and forward foreign currency exchange contracts are used from time to time to manage interest rate risk and foreign currency risk. The Company enters into such contracts only with counterparties of good standing. The credit exposure related to non-performance by the counterparties and the Company is considered in determining the fair values of the derivatives, and the effect has not been material to the financial statements or operations of the Company. Additional disclosures related to the Company’s derivatives and hedging activities are provided in Note 8.

Translation and Remeasurement of Foreign Currencies

The financial statements of foreign subsidiaries having the local currency as the functional currency are translated into U.S. dollars using exchange rates in effect at period end for assets and liabilities and average exchange rates applicable to each reporting period for results of operations. Adjustments resulting from translation of financial statements are reflected as a separate component of other comprehensive income or loss. The financial statements of foreign subsidiaries having the U.S. dollar as the functional currency, with certain transactions denominated in a local currency, are remeasured into U.S. dollars. The remeasurement of local currency amounts into U.S. dollars creates remeasurement gains and losses that are included in earnings as a component of selling, general, and administrative expense. The Company recognized net remeasurement losses of $9.3 million in fiscal year 2017, $22.5 million in fiscal year 2016, and $28.8 million in fiscal year 2015.

Foreign currency transactions and forward foreign currency exchange contracts that are not designated as hedges generate gains and losses when they are settled or when they are marked to market under the prescribed accounting guidance. These transaction gains and losses are also included in earnings as a component of selling, general, and administrative expenses. The Company recognized net foreign currency transaction losses of $1.3 million in fiscal year 2017, net transaction gains of $8.0 million in fiscal year 2016, and net transaction gains of $17.7 million in fiscal year 2015.

Revenue Recognition

Revenue from the sale of tobacco is recognized when title and risk of loss is transferred to the customer and the earnings process is complete. Substantially all sales revenue is recorded based on the physical transfer of products to customers. A large percentage of the Company’s sales are to major multinational manufacturers of consumer tobacco products. The Company works closely with those customers to understand and plan for their requirements for volumes, styles, and grades of leaf tobacco from its various growing regions, and extensive coordination is maintained on an ongoing basis to determine and satisfy their requirements for physical shipment of processed tobacco. The customers typically specify, in sales contracts and in shipping documents, the precise terms for transfer of title and risk of loss for the tobacco. Customer returns and rejections are not significant, and the Company’s sales history indicates that customer-specific acceptance provisions are consistently met upon transfer of title and risk of loss.

While most of the Company’s revenue consists of tobacco that is purchased from farmers, processed and packed in its factories, and then sold to customers, some revenue is earned from processing tobacco owned by customers. These arrangements usually exist in specific markets where the customers contract directly with farmers for leaf production, and they have accounted for less than 5% of total revenue on an annual basis through the fiscal year ended March 31, 2017. Processing and packing of leaf tobacco is a short-duration process. Under normal operating conditions, raw tobacco that is placed into the production line exits as processed and packed tobacco within one hour, and is then later transported to customer-designated storage facilities. The revenue for these services is recognized when processing is completed, and the Company’s operating history indicates that customer requirements for processed tobacco are consistently met upon completion of processing.

Stock-Based Compensation

Share-based payments, such as grants of restricted stock units, performance share awards, restricted stock, stock appreciation rights, and stock options, are measured at fair value and reported as expense in the financial statements over the requisite service period. Additional disclosures related to stock-based compensation are included in Note 12.

Estimates and Assumptions

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Accounting Pronouncements

Pronouncements Recently Adopted

In April 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 was effective for fiscal years beginning after December 31, 2015. The Company adopted ASU 2015-03 effective for the quarter ending June 30, 2016, which was the first quarter of the fiscal year ending March 31, 2017. The implementation of ASU 2015-03, which required retrospective application, resulted in a $1.6 million reclassification of unamortized debt issuance costs from other noncurrent assets to long-term debt for the comparative prior year ended March 31, 2016.

In April 2015, the FASB issued Accounting Standards Update 2015-05, “Intangibles - Goodwill and Other - Internal-Use Software - Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement” (“ASU 2015-05”). ASU 2015-05 requires customers who enter into a cloud computing arrangement that includes a software license to account for the arrangement as an intangible asset. If the cloud computing arrangement does not include a software license, the arrangement is accounted for as a service contract. The guidance was effective for fiscal years beginning after December 31, 2015, and allows for retrospective or prospective adoption. The Company prospectively adopted ASU 2015-05 effective as of April 1, 2016, the beginning of fiscal year 2017. The Company’s adoption of ASU 2015-05 did not have a material impact on its consolidated financial statements.

In May 2015, the FASB issued Accounting Standards Update No. 2015-07, "Fair Value Measurement, Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share or its Equivalent" ("ASU 2015-07"). ASU 2015-07 removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient and eliminates certain disclosures for investments that are eligible to be measured at fair value using the net asset value per share practical expedient. The Company adopted ASU 2015-07 effective as of April 1, 2016, the beginning of fiscal year 2017. Disclosures for all periods presented in Note 9 - Fair Value Measurements were adjusted accordingly.

In March 2016, the FASB issued Accounting Standards Update No. 2016-09, "Compensation - Stock Compensation (Topic 718)" ("ASU 2016-09"). ASU 2016-09 provides simplification for the accounting for employee stock-based payment transactions, including the related income tax consequences, the classification of awards as either equity or liabilities, and the classification of transactions in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, with early adoption permitted. The Company elected to early-adopt ASU 2016-09 effective April 1, 2016, which was the beginning of its fiscal year ending March 31, 2017. As required by the guidance, employee tax withholding payments and excess tax benefits resulting from stock-based compensation have been classified as financing activities and operating activities, respectively, in the consolidated statements of cash flows for all periods presented.

Pronouncements to be Adopted in Future Periods

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which supersedes substantially all of the current revenue recognition guidance under U.S. generally accepted accounting principles (“U.S. GAAP”).  ASU 2014-09 was developed under a joint project with the International Accounting Standards Board (“IASB”) to improve and converge the existing revenue recognition accounting guidance in U.S. GAAP and International Accounting Standards.  Under ASU 2014-09, the central underlying principle is to recognize revenues when promised goods or services are transferred to customers at an amount determined by the consideration a company expects to receive for those goods or services.  The guidance outlines a five-step process for determining the amount and timing of revenue to be recognized from those arrangements.  It is more principles-based than the existing guidance under U.S. GAAP, and therefore is expected to require more management judgment and involve more estimates than the current guidance.  ASU 2014-09 is effective for annual periods beginning after December 15, 2017, including all interim periods within the year of adoption.   Companies are allowed to select between two transition methods:  (1) a full retrospective transition method with the application of the new guidance to each prior reporting period presented, or (2) a modified retrospective transition method that recognizes the cumulative effect on prior periods at the date of adoption together with additional footnote disclosures. Since the issuance of ASU 2014-09, the FASB has issued several amendments to provide additional supplemental guidance on certain aspects of the original pronouncement.  Universal expects to adopt ASU 2014-09 and the related supplemental amendments effective April 1, 2018, which is the beginning of its fiscal year ending March 31, 2019.  The Company formed a cross-functional project team to review its current revenue accounting policies and control processes, to complete a comprehensive analysis of the new guidance, and to determine the effect it will have on revenue recognition and financial statement disclosures for all customer contracts. The team has classified its customer contracts into primary revenue streams and is currently in the process of completing individual contract reviews and making final determinations with respect to provisions in the new guidance that may impact the timing of revenue recognition for certain customer arrangements. As these activities remain underway at this time, the Company is not currently able to conclude on the impact that ASU 2014-09 will have on its consolidated financial statements. Although a final determination has not been made, it is likely that the Company will select the modified retrospective transition method as its method of adoption.

In July 2015, the FASB issued Accounting Standards Update No. 2015-11, “Simplifying the Measurement of Inventory” (“ASU 2015-11”). ASU 2015-11 requires that most inventory be measured at the lower of cost or net realizable value. ASU 2015-11 defines net realizable value as the "estimated selling price in the ordinary course of business, less reasonable predictable costs of completion, disposal, and transportation." ASU 2015-11 is effective for fiscal years beginning after December 31, 2016, and will be adopted effective April 1, 2017, which is the beginning of its fiscal year ending March 31, 2018. ASU 2015-11 will be applied prospectively after the date of adoption, as required by the guidance, and will not have a material impact on the Company's consolidated financial statements.

In January 2016, the FASB issued Accounting Standards Update No. 2016-01 “Financial Instruments-Recognition and Measurement of Financial Assets and Financial Liabilities” ("ASU 2016-01"). ASU 2016-01 requires all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under the equity method of accounting or those that result in consolidation of the investee). This guidance is effective for fiscal years beginning after December 15, 2017. The Company is currently evaluating the impact that the adoption of ASU 2016-01 will have on its consolidated financial statements.

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). ASU 2016-02 requires a lessee to recognize lease payment obligations as a lease liability and the corresponding right-of-use asset as a leased asset in the balance sheet for the term of the lease. This guidance supersedes Topic 840 “Leases” and is effective for fiscal years beginning after December 15, 2018. The Company will be required to adopt ASU 2016-02 effective April 1, 2019, which is the beginning of its fiscal year ending March 31, 2020, and is currently evaluating the impact that the updated guidance will have on its consolidated financial statements.

In January 2017, the FASB issued Accounting Standards Update No. 2017-04, "Intangibles - Goodwill and Other (Topic 350)" ("ASU 2017-04"). ASU 2017-04 eliminated Step 2 from the goodwill impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of the reporting unit's goodwill with the carrying amount of the goodwill. The guidance is effective for fiscal years beginning after December 15, 2019. The Company will be required to adopt ASU 2017-04 effective April 1, 2020, which is the beginning of its fiscal year ending March 31, 2021, and is currently evaluating the impact that the updated guidance will have on its consolidated financial statements.

In March 2017, the FASB issued Accounting Standards Update No. 2017-07, "Compensation - Retirement Benefits (Topic 715)" ("ASU 2017-07"). ASU 2017-07 requires that an employer report the service cost component of pension or other postretirement benefits expense in the same line item or items as other compensation costs arising from services rendered by the pertinent employees during the period. The other components of net benefit cost are required to be presented in the income statement separately from the service cost component and outside a subtotal of income from operations, if one is presented. If a separate line item or items are used to present the other components of net benefit cost, the line item or items must be appropriately described. If a separate line item or items are not used, the line item or items used in the income statement to present the other components of net benefit cost must be disclosed. The guidance is effective for fiscal years beginning after December 15, 2016. The Company will be required to adopt ASU 2017-07 effective April 1, 2017, which is the beginning of its fiscal year ending March 31, 2018. The line item classification changes required by the new guidance will not impact the Company's pretax earnings or net income; however, operating income and interest expense will increase by offsetting amounts that are not expected to be material to the Company's consolidated financial statements.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year’s presentation.

XML

Restructuring Costs

12 Months Ended

Mar. 31, 2017

Restructuring Costs [Abstract]

Restructuring Costs

RESTRUCTURING AND IMPAIRMENT COSTS

During the three fiscal years ended March 31, 2017, 2016, and 2015, Universal recorded restructuring and impairment costs related to various initiatives to adjust certain operations and reduce costs. For all three fiscal years, the restructuring and impairment costs incurred primarily related to operations that are part of the Other Regions reportable segment of the Company's flue-cured and burley leaf tobacco operations.

Fiscal Year Ended March 31, 2017

In fiscal year 2017, the Company recorded restructuring and impairment costs totaling $4.4 million, primarily related to the Company's decision to close its tobacco processing facility in Hungary. The Company is now processing tobaccos sourced from Hungary in its factories in Italy. The costs incurred for the change in operations in Hungary included statutory employee termination benefits and impairment charges related to certain property and equipment. Restructuring costs were also incurred in connection with downsizing efforts at several other locations around the Company.

Fiscal Year Ended March 31, 2016

In fiscal year 2016, the Company recorded restructuring and impairment costs totaling $2.4 million, related to a decision to significantly scale back its operations in Zambia. Those costs primarily included statutory employee termination benefits, impairment charges related to outstanding balances on loans to farmers whose contracts were terminated as a result of the decision, and impairment charges on certain property and equipment.

Fiscal Year Ended March 31, 2015

In fiscal year 2015, the Company recorded restructuring costs totaling $4.9 million, primarily related to downsizing certain functions at its operations in Brazil and a decision to suspend its operations in Argentina. The costs in Argentina included employee termination benefits, as well as costs to exit the Company's business arrangements with a supplier. Restructuring costs were also incurred in connection with downsizing efforts at several other locations around the Company.

A summary of the restructuring and impairment costs incurred during the fiscal years ended March 31, 2017, 2016, and 2015, is as follows:

	Fiscal Years Ended March 31,
	2017		2016		2015
Restructuring Costs:
Employee termination benefits	$	2,083	$	1,629	$	4,354
Other restructuring costs	—		96		536
	2,083		1,725		4,890
Impairment Costs:
Property and equipment and farmer loans	2,276		664		—
Total restructuring and impairment costs	$	4,359	$	2,389	$	4,890

A reconciliation of the Company’s liability for employee termination benefits and other restructuring costs for fiscal years 2015 through 2017 is as follows:

	Employee Termination Benefits			Other Costs			Total
Balance at April 1, 2014	$	2,026		$	160		$	2,186
Fiscal Year 2015 Activity:
Costs charged to expense	4,354			536			4,890
Payments	(5,684		)	(498		)	(6,182		)
Balance at March 31, 2015	696			198			894
Fiscal Year 2016 Activity:
Costs charged to expense	1,629			96			1,725
Payments	(2,246		)	(92		)	(2,338		)
Balance at March 31, 2016	79			202			281
Fiscal Year 2017 Activity:
Costs charged to expense	2,083			—			2,083
Payments	(1,861		)	(159		)	(2,020		)
Balance at March 31, 2017	$	301		$	43		$	344

The majority of the restructuring liability at March 31, 2017 will be paid in the early part of fiscal year 2018. Universal continually reviews its business for opportunities to realize efficiencies, reduce costs, and realign its operations in response to business changes. The Company may incur additional restructuring and impairment costs in future periods as business changes occur and additional cost savings initiatives are implemented.

XML

Earnings Per Share

12 Months Ended

Mar. 31, 2017

Earnings Per Share [Abstract]

Earnings Per Share

EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share:

	Fiscal Year Ended March 31,
(in thousands, except share and per share data)	2017			2016			2015
Basic Earnings Per Share
Numerator for basic earnings per share
Net income attributable to Universal Corporation	$	106,304		$	109,016		$	114,608
Less: Dividends on convertible perpetual preferred stock	(11,061		)	(14,748		)	(14,824		)
Less: Cost in excess of carrying value on conversion or repurchase of convertible perpetual preferred stock	(74,353		)	—			(36		)
Earnings available to Universal Corporation common shareholders for calculation of basic earnings per share	20,890			94,268			99,748
Denominator for basic earnings per share
Weighted average shares outstanding	23,433,860			22,683,290			23,035,920
Basic earnings per share	$	0.89		$	4.16		$	4.33
Diluted Earnings Per Share
Numerator for diluted earnings per share
Earnings available to Universal Corporation common shareholders	$	20,890		$	94,268		$	99,748
Add: Dividends on convertible perpetual preferred stock (if conversion assumed)	—			14,748			14,824
Add: Cost in excess of carrying value on conversion or repurchase of convertible perpetual preferred stock (if dilutive)	—			—			36
Earnings available to Universal Corporation common shareholders for calculation of diluted earnings per share	20,890			109,016			114,608
Denominator for diluted earnings per share
Weighted average shares outstanding	23,433,860			22,683,290			23,035,920
Effect of dilutive securities (if conversion or exercise assumed)
Convertible perpetual preferred stock	—			4,853,268			4,843,309
Employee share-based awards	336,228			288,933			342,035
Denominator for diluted earnings per share	23,770,088			27,825,491			28,221,264
Diluted earnings per share	$	0.88		$	3.92		$	4.06

In December 2016, 111,072 shares of the Company’s Series B 6.75% Convertible Perpetual Preferred Stock were converted into approximately 2.5 million shares of the Company's common stock. In January 2017, the Company announced a mandatory conversion of all 107,418 remaining outstanding shares of the preferred stock after meeting the requirements to initiate the mandatory conversion under the original terms of the preferred shares. The Company chose to satisfy the conversion obligation for the mandatory conversion in cash. Although the conversions of the preferred stock into common stock or for cash did not impact the Company’s net income, the shares converted for cash under the mandatory conversion in January 2017 resulted in a one-time reduction of retained earnings of approximately $74.4 million during the fourth quarter ending March 31, 2017, representing the excess of the conversion cost over the carrying value of those shares. The reduction in retained earnings resulted in a corresponding one-time reduction of earnings available to common shareholders for the fiscal year ending March 31, 2017 for purposes of determining the amounts reported for basic and diluted earnings per share. The effects of the conversions on the computation of basic and diluted earnings per share for the fiscal year ended March 31, 2017, are included in the table above. See Note 11 for additional information.

For the fiscal years ended March 31, 2017, 2016, and 2015, the Company had the following potentially dilutive securities (stock appreciation rights) outstanding that were not included in the computation of diluted earnings per share because their effect would have been antidilutive:

	Fiscal Year Ended March 31,
	2017		2016		2015
Potentially dilutive securities	—		133,600		156,200
Weighted-average exercise price	$	—	$	62.66	$	61.83

XML

Income Taxes

12 Months Ended

Mar. 31, 2017

Income Tax Disclosure [Abstract]

Income Taxes

INCOME TAXES

The Company operates in the United States and many foreign countries and is subject to the tax laws of many jurisdictions. Changes in tax laws or the interpretation of tax laws can affect the Company’s earnings, as can the resolution of pending and contested tax issues. The Company's consolidated effective income tax rate is affected by a number of factors, including the mix of domestic and foreign earnings, the effect of exchange rate changes on deferred taxes, and the Company’s ability to utilize foreign tax credits.

Income Tax Expense

Income taxes for the fiscal years ended March 31, 2017, 2016, and 2015 consisted of the following: 

	Fiscal Year Ended March 31,
	2017		2016			2015
Current
United States	$	3,422	$	5,371		$	4,126
State and local	147		1,116			657
Foreign	36,537		32,897			46,885
	40,106		39,384			51,668
Deferred
United States	5,434		5,780			3,352
State and local	561		(445		)	159
Foreign	10,631		9,711			(17,173		)
	16,626		15,046			(13,662		)
Total	$	56,732	$	54,430		$	38,006

Foreign taxes include U.S. tax expense on earnings of foreign subsidiaries. The Company has no undistributed earnings of consolidated foreign subsidiaries that are classified as permanently reinvested.

Consolidated Effective Income Tax Rate

A reconciliation of the statutory U.S. federal rate to the Company’s effective income tax rate is as follows:

	Fiscal Year Ended March 31,
	2017		2016		2015
Statutory tax rate	35.0	%	35.0	%	35.0	%
State income taxes, net of federal benefit	0.3		0.3		0.3
Dividends received from deconsolidated operations	(2.3	)	(1.5	)	(1.3	)
Effect of exchange rate changes on deferred income taxes	0.4		(1.6	)	(4.9	)
Tax benefit arising from payment of a portion of a fine by a subsidiary	—		—		(5.0	)
Other, including changes in liabilities recorded for uncertain tax positions	0.1		(0.7	)	(0.1	)
Effective income tax rate	33.5	%	31.5	%	24.0	%

During the first quarter of fiscal year 2015, the Company recorded a consolidated income tax benefit of $8 million arising from the ability of its subsidiary, Deltafina S.p.A., to pay a significant portion of a fine and related interest charges in Italy that were settled during that quarter following the unsuccessful appeal of a case involving anti-competitive activities in the Italian tobacco market. Deltafina and Universal Corporation were jointly liable for the fine and interest charges. The Company’s initial accrual of the amounts imposed in September 2011 assumed that the entire obligation would be paid by Universal Corporation due to uncertainty with respect to Deltafina’s financial capacity to bear any significant portion of the cost upon the eventual settlement and to uncertainty as to when the payment would be made. Deltafina ultimately was able to assume responsibility for approximately $30 million of the total $53 million obligation for the fine and interest when those amounts were paid. Although the portion of the fine paid by Deltafina was not deductible for income tax purposes in Italy, it reduced the subsidiary’s cumulative undistributed earnings and the associated consolidated tax liability, resulting in the $8 million benefit in the Company's consolidated income tax provision. This discrete item reduced the effective income tax rate for fiscal year 2015 by 5.0%.

Components of Income Before Income Taxes

The U.S. and foreign components of income before income taxes were as follows:

	Fiscal Year Ended March 31,
	2017		2016		2015
United States	$	31,468	$	37,877	$	27,181
Foreign	137,770		134,701		131,286
Total	$	169,238	$	172,578	$	158,467

Deferred Income Tax Liabilities and Assets

Significant components of deferred tax liabilities and assets were as follows:  

	March 31,
	2017			2016
Liabilities
Foreign withholding taxes	$	44,702		$	39,770
Undistributed earnings	24,629			19,553
Goodwill	30,851			30,851
All other	11,015			10,424
Total deferred tax liabilities	$	111,197		$	100,598
Assets
Employee benefit plans	$	38,804		$	43,362
Reserves and accruals	11,756			12,911
Deferred income	4,672			3,938
Currency translation losses of foreign subsidiaries	13,244			9,939
Local currency exchange losses of foreign subsidiaries	3,669			3,597
Foreign tax credit carryforward	2,799			4,664
All other	14,327			16,546
Total deferred tax assets	89,271			94,957
Valuation allowance	(636		)	—
Net deferred tax assets	$	88,635		$	94,957

At March 31, 2017, the Company had no material net operating loss carryforwards in either its domestic or foreign operations.

Combined Income Tax Expense (Benefit)

The combined income tax expense (benefit) allocable to continuing operations, other comprehensive income, and direct adjustments to shareholders' equity was as follows:

	Fiscal Year Ended March 31,
	2017		2016			2015
Continuing operations	$	56,732	$	54,430		$	38,006
Other comprehensive income	1,503		1,423			(21,900		)
Direct adjustments to shareholders' equity	—		(805		)	(932		)
Total	$	58,235	$	55,048		$	15,174

Uncertain Tax Positions

A reconciliation of the beginning and ending balance of the gross liability for uncertain tax positions for the fiscal years ended March 31, 2017, 2016 and 2015, is as follows:

	Fiscal Year Ended March 31,
	2017			2016			2015
Liability for uncertain tax positions, beginning of year	$	2,407		$	2,894		$	3,809
Additions:
Related to tax positions for the current year	94			98			272
Related to tax positions for prior years	—			—			—
Reductions:
Due to lapses of statutes of limitations	(112		)	(215		)	(478		)
Related to tax positions for prior years	(3		)	—			(143		)
Effect of currency rate movement	40			(370		)	(566		)
Liability for uncertain tax positions, end of year	$	2,426		$	2,407		$	2,894

Of the total liability for uncertain tax positions at March 31, 2017, approximately $1.8 million could have an effect on the consolidated effective tax rate if the tax benefits are recognized. The liability for uncertain tax positions includes $0.1 million related to tax positions for which it is reasonably possible that the amounts could change significantly before March 31, 2018. This amount reflects a possible decrease in the liability for uncertain tax positions that could result from the completion and resolution of tax audits and the expiration of open tax years in various tax jurisdictions.

The Company recognizes accrued interest related to uncertain tax positions as interest expense, and it recognizes penalties as a component of income tax expense. Amounts accrued or reversed for interest and penalties were not material for any of the fiscal years 2015 through 2017, and liabilities recorded for interest and penalties at March 31, 2017 and 2016 also were not material.

Universal and its subsidiaries file a U.S. federal consolidated income tax return, as well as returns in several U.S. states and a number of foreign jurisdictions. As of March 31, 2017, the Company's earliest open tax year for U.S. federal income tax purposes was its fiscal year ended 2014. Open tax years in state and foreign jurisdictions generally range from 3 to 6 years.

XML

Credit Facilities

12 Months Ended

Mar. 31, 2017

Line of Credit Facility [Abstract]

Credit Facilities

CREDIT FACILITIES

Bank Credit Agreements

In December 2014, the Company entered into a senior unsecured bank credit agreement that replaced its previous short-term and long-term borrowing facilities, consolidating and extending the maturities of those facilities. The agreement established a $430 millionfive-year revolving credit facility, along with a $150 millionfive-year term loan and a $220 millionseven-year term loan. Borrowings under the revolving credit facility bear interest at a variable rate based on either (1) LIBOR plus a margin that is based on the Company's credit measures or (2) the higher of the federal funds rate plus 0.5%, prime rate, or one-month LIBOR plus 1.0%, each plus a margin. In addition to interest, the Company pays a facility fee on the revolving credit facility. No amounts were outstanding under the revolving credit facility at March 31, 2017. The credit agreement provides for an expansion of the facility under certain conditions to allow additional borrowings of up to $100 million. Additional information related to the term loans is provided in Note 6. The credit agreement includes financial covenants that require the Company to maintain a minimum level of tangible net worth and observe limits on debt levels. The Company was in compliance with those covenants at March 31, 2017.

Short-Term Credit Facilities

The Company maintains short-term uncommitted lines of credit in the United States and in a number of foreign countries. Foreign borrowings are generally in the form of overdraft facilities at rates competitive in the countries in which the Company operates. Generally, each foreign line is available only for borrowings related to operations of a specific country. As of March 31, 2017 and 2016, approximately $59 million and $66 million, respectively, were outstanding under these uncommitted lines of credit. The weighted-average interest rates on short-term borrowings outstanding as of March 31, 2017 and 2016, were approximately 3.1% and 2.2%, respectively. At March 31, 2017, the Company and its consolidated affiliates had unused uncommitted lines of credit totaling approximately $248 million.

XML

Long-Term Debt

12 Months Ended

Mar. 31, 2017

Debt Disclosure [Abstract]

Long-term Debt [Text Block]

LONG-TERM DEBT

The Company's long-term debt at March 31, 2017 and 2016 consisted of the following:

	March 31,
	2017			2016
Senior bank term loans	$	370,000		$	370,000
Total outstanding	370,000			370,000
Less: current portion	—			—
Less: unamortized debt issuance costs	(1,267		)	(1,620		)
Long-term debt	$	368,733		$	368,380

As discussed in Note 5, the Company entered into a bank credit agreement in December 2014 that established a $150 millionfive-year term loan and a $220 millionseven-year term loan. Both term loans were fully funded at closing, and the Company concurrently repaid approximately $250 million aggregate principal amount on term loans outstanding under two previous bank credit facilities and reduced its revolving credit borrowings by approximately $120 million. The term loans require no amortization and are prepayable without penalty prior to maturity. Under the credit agreement, both term loans bear interest at variable rates plus a margin based on the Company's credit measures. However, following closing on the term loans, the Company entered into receive-floating / pay-fixed interest rate swap agreements that convert the variable benchmark rate on both loans to a fixed rate over their full terms to maturity. With the swap agreements in place, the effective interest rate on the $150 millionfive-year loan and the $220 millionseven-year loan were 2.94% and 3.48%, respectively, at March 31, 2017 and 2016. The effective rates will change only if a change in the Company's credit measures results in adjustments to the applicable credit spreads specified in the underlying loan agreement. The $150 millionfive-year term loan matures in fiscal year 2020, and the $220 millionseven-year term loan matures in fiscal year 2022.

In November 2014, the Company filed an undenominated universal shelf registration statement with the U.S. Securities and Exchange Commission to provide for the future issuance of an undefined amount of additional debt or equity securities as determined by the Company and offered in one or more prospectus supplements prior to issuance.

Disclosures about the fair value of long-term debt are provided in Note 9.

XML

Leases

12 Months Ended

Mar. 31, 2017

Leases [Abstract]

Leases

LEASES

The Company’s subsidiaries lease various production, storage, distribution, and other facilities, as well as vehicles and equipment used in their operations. Some of the leases have options to extend the lease term at market rates. These arrangements are classified as operating leases for accounting purposes. Rent expense on operating leases totaled $15.3 million in fiscal year 2017, $14.7 million in fiscal year 2016, and $15.8 million in fiscal year 2015. Future minimum payments under non-cancelable operating leases total $11.5 million in 2018, $8.5 million in 2019, $7.2 million in 2020, $5.8 million in 2021, $4.1 million in 2022, and $13.7 million after 2022.

XML

Derivatives And Hedging Activities

12 Months Ended

Mar. 31, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives And Hedging Activities

DERIVATIVES AND HEDGING ACTIVITIES

Universal is exposed to various risks in its worldwide operations and uses derivative financial instruments to manage two specific types of risks – interest rate risk and foreign currency exchange rate risk. Interest rate risk has been managed by entering into interest rate swap agreements, and foreign currency exchange rate risk has been managed by entering into forward foreign currency exchange contracts. However, the Company’s policy also permits other types of derivative instruments. In addition, foreign currency exchange rate risk is also managed through strategies that do not involve derivative instruments, such as using local borrowings and other approaches to minimize net monetary positions in non-functional currencies. The disclosures below provide additional information about the Company’s hedging strategies, the derivative instruments used, and the effects of these activities on the consolidated statements of income and comprehensive income and the consolidated balance sheets. In the consolidated statements of cash flows, the cash flows associated with all of these activities are reported in net cash provided by operating activities.

Cash Flow Hedging Strategy for Interest Rate Risk

In January 2015, the Company entered into receive-floating/pay-fixed interest rate swap agreements that were designated and qualified as hedges of the exposure to changes in interest payment cash flows created by fluctuations in variable interest rates on its two outstanding non-amortizing bank term loans (see Notes 5 and 6). Although no significant ineffectiveness is expected with this hedging strategy, the effectiveness of the interest rate swaps is evaluated on a quarterly basis. At March 31, 2017, the total notional amount of the interest rate swaps was $370 million, which corresponded with the aggregate outstanding balance of the term loans.

Cash Flow Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Forecast Purchases of Tobacco and Related Processing Costs

The majority of the tobacco production in most countries outside the United States where Universal operates is sold in export markets at prices denominated in U.S. dollars. However, purchases of tobacco from farmers and most processing costs (such as labor and energy) in those countries are usually denominated in the local currency. Changes in exchange rates between the U.S. dollar and the local currencies where tobacco is grown and processed affect the ultimate U.S. dollar cost of the processed tobacco. From time to time, the Company enters into forward contracts to sell U.S. dollars and buy the local currency at future dates that coincide with the expected timing of a portion of the tobacco purchases and processing costs. This strategy offsets the variability of future U.S. dollar cash flows for tobacco purchases and processing costs for the foreign currency notional amount hedged. This hedging strategy has been used mainly for tobacco purchases and processing costs in Brazil. The aggregate U.S. dollar notional amount of forward contracts entered for these purposes during fiscal years 2017, 2016, and 2015 was as follows:

	Fiscal Year Ended March 31,
(in millions)	2017		2016		2015
Tobacco purchases	$	70.7	$	43.1	$	105.6
Processing costs	24.0		13.2		22.9
Total	$	94.7	$	56.3	$	128.5

The reduced U.S. dollar notional amounts for tobacco purchases and processing costs hedged during fiscal year 2016 reflected the reduced size of the 2016 Brazilian crop and a variation in the timing of fixed-price orders from customers for their purchases from that crop year. All contracts related to tobacco purchases were designated and qualified as hedges of the future cash flows associated with the forecast purchases of tobacco. As a result, except for amounts related to any ineffective portion of the hedging strategy or any early de-designation of the hedge arrangement, changes in fair values of the forward contracts have been recognized in comprehensive income as they occurred, but only recognized in earnings upon sale of the related tobacco to third-party customers. Forward contracts related to processing costs have not been designated as hedges, and gains and losses on those contracts have been recognized in earnings on a mark-to-market basis.

For substantially all hedge gains and losses recorded in accumulated other comprehensive loss at March 31, 2017, the Company expects to complete the sale of the tobacco and recognize the amounts in earnings during fiscal year 2018. At March 31, 2017, all hedged forecast purchases of tobacco not yet completed remained probable of occurring within the originally designated time period and, as a result, no hedges had been discontinued. Purchases of the 2017 Brazilian crop are expected to be completed by July 2017, and all forward contracts to hedge those purchases will mature and be settled by that time.

Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Net Local Currency Monetary Assets and Liabilities of Foreign Subsidiaries

Most of the Company’s foreign subsidiaries transact the majority of their sales in U.S. dollars and finance the majority of their operating requirements with U.S. dollar borrowings, and therefore use the U.S. dollar as their functional currency. These subsidiaries normally have certain monetary assets and liabilities on their balance sheets that are denominated in the local currency. Those assets and liabilities can include cash and cash equivalents, accounts receivable and accounts payable, advances to farmers and suppliers, deferred income tax assets and liabilities, recoverable value-added taxes, and other items. Net monetary assets and liabilities denominated in the local currency are remeasured into U.S. dollars each reporting period, generating gains and losses that the Company records in earnings as a component of selling, general, and administrative expenses. The level of net monetary assets or liabilities denominated in the local currency normally fluctuates throughout the year based on the operating cycle, but it is most common for monetary assets to exceed monetary liabilities, sometimes by a significant amount. When this situation exists and the local currency weakens against the U.S. dollar, remeasurement losses are generated. Conversely, remeasurement gains are generated on a net monetary asset position when the local currency strengthens against the U.S. dollar. To manage a portion of its exposure to currency remeasurement gains and losses, the Company enters into forward contracts to buy or sell the local currency at future dates coinciding with expected changes in the overall net local currency monetary asset or liability position of the subsidiary. Gains and losses on the forward contracts are recorded in earnings as a component of selling, general, and administrative expenses for each reporting period as they occur, and thus directly offset the related remeasurement losses or gains in the consolidated statements of income for the notional amount hedged. The Company does not designate these contracts as hedges for accounting purposes. The contracts are generally arranged to hedge the subsidiary's projected exposure to currency remeasurement risk for specified periods of time, and new contracts are entered as necessary throughout the year to replace previous contracts as they mature.  During the fiscal years ended March 31, 2017, 2016, and 2015, the Company used forward currency contracts to manage its exposure to currency remeasurement risk in Brazil. The total notional amounts of contracts outstanding at March 31, 2017 and 2015 were approximately $33.0 million and $80.4 million, respectively. At March 31, 2016 , the net local monetary asset position in Brazil was not significant, and there were no foreign currency contracts outstanding. To further mitigate currency remeasurement exposure, the Company’s foreign subsidiaries may utilize short-term local currency financing during certain periods. This strategy, while not involving the use of derivative instruments, is intended to minimize the subsidiary’s net monetary position by financing a portion of the local currency monetary assets with local currency monetary liabilities and thus hedging a portion of the overall position.

Several of the Company’s foreign subsidiaries transact the majority of their sales and finance the majority of their operating requirements in their local currency, and therefore use their respective local currencies as the functional currency for reporting purposes. From time to time, these subsidiaries sell tobacco to customers in transactions that are not denominated in the functional currency. In those situations, the subsidiaries routinely enter into forward exchange contracts to offset currency risk for the period of time that a fixed-price order and the related trade account receivable are outstanding with the customer. The contracts are not designated as hedges for accounting purposes.

Effect of Derivative Financial Instruments on the Consolidated Statements of Income

The table below outlines the effects of the Company’s use of derivative financial instruments on the consolidated statements of income for the fiscal years ended March 31, 2017, 2016, and 2015.

	Fiscal Year Ended March 31,
	2017			2016			2015
Cash Flow Hedges - Interest Rate Swap Agreements
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	8,999		$	(12,824	)	$	(4,044	)
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	(3,916	)	$	(5,108	)	$	(1,929	)
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Interest expense
Ineffective Portion of Hedge
Gain (loss) recognized in earnings	$	—		$	—		$	—
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Floating rate interest payments on term loans
Cash Flow Hedges - Forward Foreign Currency Exchange Contracts
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	454		$	1,774		$	1,410
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	945		$	993		$	3,099
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Cost of goods sold
Ineffective Portion and Early De-designation of Hedges
Gain (loss) recognized in earnings	$	246		$	685		$	257
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Forecast purchases of tobacco in Brazil
Derivatives Not Designated as Hedges - Forward Foreign Currency Exchange Contracts
Gain (loss) recognized in earnings	$	(2,591	)	$	5,973		$	13,178
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses

For the interest rate swap agreements, the effective portion of the gain or loss on the derivative is recorded in accumulated other comprehensive loss and any ineffective portion is recorded in selling, general and administrative expenses. For the forward foreign currency exchange contracts designated as cash flow hedges of tobacco purchases in Brazil, an immaterial net hedge gain, representing unrealized gains on contracts related to the 2017 crop, remained in accumulated other comprehensive loss at March 31, 2017. No hedge gain or loss had been reclassified to earnings at March 31, 2017 since shipments of those tobaccos had not yet started. The majority of the balance in accumulated other comprehensive loss will be recognized in earnings as a component of cost of goods sold in fiscal year 2018 as the 2017 Brazilian crop tobacco is sold to customers. Based on the hedging strategy, as the gain or loss is recognized in earnings, it is expected to be offset by a change in the direct cost for the tobacco or by a change in sales prices if the strategy has been mandated by the customer. Generally, margins on the sale of the tobacco will not be significantly affected.

Effect of Derivative Financial Instruments on the Consolidated Balance Sheets

The table below outlines the effects of the Company’s derivative financial instruments on the consolidated balance sheets at March 31, 2017 and 2016:

	Derivatives in a Fair Value Asset Position					Derivatives in a Fair Value Liability Position
	Balance Sheet Location	Fair Value as of March 31,				Balance Sheet Location	Fair Value as of March 31,
		2017		2016			2017		2016
Derivatives Designated as Hedging Instruments
Interest rate swap agreements	Other non-current assets	$	2,149	$	—	Other long-term liabilities	$	—	$	10,766
Forward foreign currency exchange contracts	Other current assets	56		475		Accounts payable and accrued expenses	55		—
Total		$	2,205	$	475		$	55	$	10,766
Derivatives Not Designated as Hedging Instruments
Forward foreign currency exchange contracts	Other current assets	$	917	$	297	Accounts payable and accrued expenses	$	120	$	5
Total		$	917	$	297		$	120	$	5

Substantially all of the Company's forward foreign currency exchange contracts are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. The Company has elected to present these contracts on a gross basis in the consolidated balance sheets.

XML

Fair Value Measurements

12 Months Ended

Mar. 31, 2017

Fair Value Disclosures [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

Universal measures certain financial and nonfinancial assets and liabilities at fair value based on applicable accounting guidance. The financial assets and liabilities measured at fair value include money market funds, trading securities associated with deferred compensation plans, interest rate swap agreements, forward foreign currency exchange contracts, and guarantees of bank loans to tobacco growers. The application of the fair value guidance to nonfinancial assets and liabilities primarily includes the determination of fair values for goodwill and long-lived assets when indicators of potential impairment are present.

Under the accounting guidance, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The framework for measuring fair value is based on a fair value hierarchy that distinguishes between observable inputs and unobservable inputs. Observable inputs are based on market data obtained from independent sources. Unobservable inputs require the Company to make its own assumptions about the value placed on an asset or liability by market participants because little or no market data exists. There are three levels within the fair value hierarchy.

Level	Description
1	quoted prices in active markets for identical assets or liabilities that the Company has the ability to access as of the reporting date;
2	quoted prices in active markets for similar assets or liabilities, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability; and
3	unobservable inputs for the asset or liability.

As permitted under the accounting guidance, the Company uses net asset value per share ("NAV") as a practical expedient to measure the fair value of its money market funds. As discussed in Note 1, under updated accounting guidance adopted effective April 1, 2016, the fair values for those funds are no longer categorized within the fair value hierarchy and are presented under the heading "NAV" in the tables that follow in this disclosure.

In measuring the fair value of liabilities, the Company considers the risk of non-performance in determining fair value. Universal has not elected to report at fair value any financial instruments or any other assets or liabilities that are not required to be reported at fair value under current accounting guidance.

At March 31, 2017 and 2016, the Company had certain financial assets and financial liabilities that were required to be measured and reported at fair value on a recurring basis. These assets and liabilities are listed in the tables below and are classified based on how their values were determined under the fair value hierarchy or the NAV practical expedient:

	March 31, 2017
			Fair Value Hierarchy
	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	137,145	$	—	$	—	$	—	$	137,145
Trading securities associated with deferred compensation plans	—		17,726		—		—		17,726
Interest rate swap agreements	—		—		2,149		—		2,149
Forward foreign currency exchange contracts	—		—		973		—		973
Total financial assets measured and reported at fair value	$	137,145	$	17,726	$	3,122	$	—	$	157,993
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,177	$	1,177
Forward foreign currency exchange contracts	—		—		175		—		175
Total financial liabilities measured and reported at fair value	$	—	$	—	$	175	$	1,177	$	1,352
	March 31, 2016
			Fair Value Hierarchy
	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	116,618	$	—	$	—	$	—	$	116,618
Trading securities associated with deferred compensation plans	—		17,817		—		—		17,817
Forward foreign currency exchange contracts	—		—		772		—		772
Total financial assets measured and reported at fair value	$	116,618	$	17,817	$	772	$	—	$	135,207
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,628	$	1,628
Interest rate swap agreements	—		—		10,766		—		10,766
Forward foreign currency exchange contracts	—		—		5		—		5
Total financial liabilities measured and reported at fair value	$	—	$	—	$	10,771	$	1,628	$	12,399

Money market funds

The fair value of money market funds, which are reported in cash and cash equivalents in the consolidated balance sheets, is based on NAV, which is the amount at which the funds are redeemable and is used as a practical expedient for fair value. These funds are not classified in the fair value hierarchy, but are disclosed as part of the fair value table above.

Trading securities associated with deferred compensation plans

Trading securities represent mutual fund investments that are matched to employee deferred compensation obligations. These investments are bought and sold as employees defer compensation, receive distributions, or make changes in the funds underlying their accounts. Quoted market prices (Level 1) are used to determine the fair values of the mutual funds.

Interest rate swap agreements

The fair values of interest rate swap agreements are determined based on dealer quotes using a discounted cash flow model matched to the contractual terms of each instrument. Since inputs to the model are observable and significant judgment is not required in determining the fair values, interest rate swaps are classified within Level 2 of the fair value hierarchy.

Forward foreign currency exchange contracts

The fair values of forward foreign currency exchange contracts are also determined based on dealer quotes using a discounted cash flow model matched to the contractual terms of each instrument. Since inputs to the model are observable and significant judgment is not required in determining the fair values, forward foreign currency exchange contracts are classified within Level 2 of the fair value hierarchy.

Guarantees of bank loans to tobacco growers

The Company guarantees bank loans to tobacco growers in Brazil for crop financing. In the event that the farmers default on their payments to the banks, the Company would be required to perform under the guarantees. The Company regularly evaluates the likelihood of farmer defaults based on an expected loss analysis and records the fair value of its guarantees as an obligation in its consolidated financial statements. The fair value of the guarantees is determined using the expected loss data for all loans outstanding at each measurement date. The present value of the cash flows associated with the estimated losses is then calculated at a risk-adjusted interest rate that is aligned with the expected duration of the liability and includes an adjustment for nonperformance risk. This approach is sometimes referred to as the “contingent claims valuation method.” Although historical loss data is an observable input, significant judgment is required in applying this information to the portfolio of guaranteed loans outstanding at each measurement date and in selecting a risk-adjusted interest rate. Significant increases or decreases in the risk-adjusted interest rate may result in a significantly higher or lower fair value measurement. The guarantees of bank loans to tobacco growers are therefore classified within Level 3 of the fair value hierarchy.

A reconciliation of the change in the balance of the financial liability for guarantees of bank loans to tobacco growers (Level 3) for the fiscal years ended March 31, 2017 and 2016 is provided below.

	Fiscal Year Ended March 31,
	2017			2016
Balance at beginning of year	$	1,628		$	1,674
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of prior crop year loans from the portfolio)	(2,550		)	(1,826		)
Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop year loans)	1,854			1,834
Change in discount rate and estimated collection period	59			106
Currency remeasurement	186			(160		)
Balance at end of year	$	1,177		$	1,628

Long-term Debt

The fair value of the Company’s long-term debt was approximately $370 million at each of the balance sheet dates March 31, 2017 and 2016. The Company estimates the fair value of its long-term debt using Level 2 inputs which are based upon quoted market prices for the same or similar obligations or on calculations that are based on the current interest rates available to the Company for debt of similar terms and maturities.

XML

Pension And Other Postretirement Benefit Plans

12 Months Ended

Mar. 31, 2017

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Pension And Other Postretirement Benefit Plans

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS

Defined Benefit Plans

Description of Plans

 The Company sponsors several defined benefit pension plans covering U.S. salaried employees and certain foreign and other employee groups. These plans provide retirement benefits based primarily on employee compensation and years of service. Plan assets consist primarily of equity and fixed income investments. The Company also sponsors defined benefit plans that provide postretirement health and life insurance benefits for eligible U.S. employees who have attained specific age and service levels, although postretirement life insurance benefits were discontinued for active employees during fiscal year 2015. The health benefits are funded by the Company as the costs of those benefits are incurred. The plan design includes cost-sharing features such as deductibles and coinsurance. The life insurance benefits are funded with deposits to a reserve account held by an insurance company. The Company has the right to amend or discontinue its pension and other postretirement benefit plans at any time.

In the following disclosures, the term “accumulated benefit obligation” (“ABO”) represents the actuarial present value of estimated future benefit payments earned by participants in the Company's defined benefit pension plans as of the balance sheet date without regard to the estimated effect of future compensation increases on those benefits. The term does not apply to other postretirement benefits. “Projected benefit obligation” refers to the projected benefit obligation (“PBO”) for pension benefits and the accumulated postretirement benefit obligation (“APBO”) for other postretirement benefits. These amounts represent the actuarial present value of estimated future benefit payments earned by participants in the benefit plans as of the balance sheet date. For pension benefits, the projected benefit obligation includes the estimated effect of future compensation increases on those benefits.

Actuarial Assumptions

Assumptions used for financial reporting purposes to compute net periodic benefit cost and benefit obligations for the Company's primary defined benefit plans were as follows:

	Pension Benefits						Other Postretirement Benefits
	2017		2016		2015		2017		2016		2015
Discount rates:
Benefit cost for plan year	4.10	%	3.80	%	4.50	%	3.80	%	3.70	%	4.30	%
Benefit obligation at end of plan year	4.10	%	4.10	%	3.80	%	3.90	%	3.80	%	3.70	%
Expected long-term return on plan assets:
Benefit cost for plan year	7.00	%	7.25	%	7.75	%	3.00	%	3.00	%	4.30	%
Salary scale:
Benefit cost for plan year	4.00	%	4.50	%	4.50	%	4.00	%	4.50	%	4.50	%
Benefit obligation at end of plan year	4.00	%	4.00	%	4.50	%	4.00	%	4.00	%	4.50	%
Healthcare cost trend rate	N/A		N/A		N/A		6.70	%	7.00	%	7.20	%

Changes in the discount rates in the above table reflect prevailing market interest rates at the end of each fiscal year when the benefit obligations are actuarially measured. The reduction in the expected long-term return on plan assets assumption from fiscal year 2015 to fiscal year 2016 is primarily due to changes in the underlying plan assets. These changes reflect a move toward a liability-driven investment strategy in the Company's ERISA-regulated U.S. defined benefit pension plan due to the high percentage of retired and inactive participants in the plan and the high funded status of the plan. The healthcare cost trend rate used by the Company is based on a study of medical cost inflation rates that is reviewed annually for continued applicability. The revised trend assumption of 6.70% in 2017 declines gradually to 4.50% in 2037.

Benefit Obligations, Plan Assets, and Funded Status

The following table reflects the changes in benefit obligations and plan assets in 2017 and 2016, as well as the funded status of the plans at March 31, 2017 and 2016:

	Pension Benefits						Other Postretirement Benefits
	March 31,						March 31,
	2017			2016			2017			2016
Actuarial present value of benefit obligation:
Accumulated benefit obligation	$	266,764		$	273,479
Projected benefit obligation	269,250			275,505			$	36,786		$	37,225
Change in projected benefit obligation:
Projected benefit obligation, beginning of year	$	275,505		$	288,908		$	37,225		$	40,863
Service cost	5,382			5,953			247			286
Interest cost	10,441			10,037			1,535			1,539
Effect of discount rate change	489			(10,036		)	(191		)	(402		)
Foreign currency exchange rate changes	(1,111		)	330			286			(215		)
Settlements	(10,955		)	—			—			—
Other	4,108			(486		)	766			(1,104		)
Benefit payments	(14,609		)	(19,201		)	(3,082		)	(3,742		)
Projected benefit obligation, end of year	$	269,250		$	275,505		$	36,786		$	37,225
Change in plan assets:
Plan assets at fair value, beginning of year	$	217,859		$	224,553		$	1,565		$	2,115
Actual return on plan assets	16,450			61			71			69
Employer contributions	10,676			12,504			4,500			3,123
Settlements	(10,322		)	—			—			—
Foreign currency exchange rate changes	97			(58		)	—			—
Benefit payments	(14,609		)	(19,201		)	(3,082		)	(3,742		)
Plan assets at fair value, end of year	$	220,151		$	217,859		$	3,054		$	1,565
Funded status:
Funded status of the plans, end of year	$	(49,099	)	$	(57,646	)	$	(33,732	)	$	(35,660	)

The settlements for pension benefits in fiscal year 2017 were attributable to the termination of a foreign pension plan during the year and the transfer of assets in settlement of the participants' benefit obligations to defined contribution plans. The Company funds its non-regulated U.S. pension plan, one of its foreign pension plans, and its postretirement medical plans on a pay-as-you-go basis as the benefit payments are incurred. Those plans account for approximately 71% of the $49.1 million unfunded pension obligation and approximately 85% of the $33.7 million unfunded postretirement benefit obligation shown on the funded status line in the above table at March 31, 2017.

The funded status of the Company’s plans at the end of fiscal years 2017 and 2016 was reported in the consolidated balance sheets as follows:

	Pension Benefits						Other Postretirement Benefits
	March 31,						March 31,
	2017			2016			2017			2016
Non-current asset (included in other noncurrent assets)	$	1,710		$	2,044		$	—		$	—
Current liability (included in accounts payable and accrued expenses)	(1,106		)	(630		)	(2,746		)	(2,543		)
Non-current liability (reported as pensions and other postretirement benefits)	(49,703		)	(59,060		)	(30,986		)	(33,117		)
Amounts recognized in the consolidated balance sheets	$	(49,099	)	$	(57,646	)	$	(33,732	)	$	(35,660	)

Additional information on the funded status of the Company’s plans as of the respective measurement dates for the fiscal years ended March 31, 2017 and 2016, is as follows:

	Pension Benefits				Other Postretirement Benefits
	March 31,				March 31,
	2017		2016		2017		2016
For plans with a projected benefit obligation in excess of plan assets:
Aggregate projected benefit obligation (PBO)	$	260,826	$	270,058	$	36,786	$	37,225
Aggregate fair value of plan assets	210,017		210,368		3,054		1,565
For plans with an accumulated benefit obligation in excess of plan assets:
Aggregate accumulated benefit obligation (ABO)	258,424		268,087		N/A		N/A
Aggregate fair value of plan assets	210,017		210,368		N/A		N/A

Net Periodic Benefit Cost

The components of the Company’s net periodic benefit cost were as follows:

	Pension Benefits									Other Postretirement Benefits
	Fiscal Year Ended March 31,									Fiscal Year Ended March 31,
	2017			2016			2015			2017			2016			2015
Components of net periodic benefit cost:
Service cost	$	5,382		$	5,953		$	5,099		$	247		$	286		$	347
Interest cost	10,441			10,037			11,215			1,535			1,539			1,699
Expected return on plan assets	(15,154		)	(15,110		)	(15,493		)	(42		)	(58		)	(102		)
Curtailment gain	—			—			—			—			—			(1,465		)
Settlement gain	(912		)	—			—			—			—			—
Net amortization and deferral	4,576			4,394			6,169			(394		)	(431		)	(671		)
Net periodic benefit cost	$	4,333		$	5,274		$	6,990		$	1,346		$	1,336		$	(192	)

The curtailment gain for other postretirement benefits in fiscal year 2015 was attributable to the discontinuation of postretirement life insurance benefits for active U.S. employees. A one-percentage-point increase in the assumed healthcare cost trend rate would increase the March 31, 2017 accumulated postretirement benefit obligation by approximately $800 thousand, while a one-percentage-point decrease would reduce the benefit obligation by approximately $700 thousand. The aggregate service and interest cost components of the net periodic postretirement benefit expense for fiscal year 2018 would not change by a significant amount as a result of a one-percentage-point increase or decrease in the assumed healthcare cost trend rate.

Amounts Included in Accumulated Other Comprehensive Loss

Amounts included in accumulated other comprehensive loss at the beginning of the year are amortized as a component of net periodic benefit cost during the year. The amounts recognized in other comprehensive income or loss for fiscal years 2017 and 2016 and the amounts included in accumulated other comprehensive loss at the end of those fiscal years are shown below. All amounts shown are before allocated income taxes.

	Pension Benefits						Other Postretirement Benefits
	March 31,						March 31,
	2017			2016			2017			2016
Change in net actuarial loss (gain):
Net actuarial loss (gain), beginning of year	$	79,299		$	81,544		$	(7,234	)	$	(6,402	)
Losses (gains) arising during the year	2,313			4,787			554			(1,263		)
Amortization included in net periodic benefit cost during the year	(7,567		)	(7,032		)	394			431
Net actuarial loss (gain), end of year	74,045			79,299			(6,286		)	(7,234		)
Change in prior service cost (benefit):
Prior service cost (benefit), beginning of year	(15,061		)	(17,630		)	(108		)	—
Prior service cost (benefit) arising during the year	—			111			(4		)	(108		)
Amortization included in net periodic benefit cost during the year	2,991			2,458			—			—
Prior service cost (benefit), end of year	(12,070		)	(15,061		)	(112		)	(108		)
Total amounts in accumulated other comprehensive loss at end of year, before income taxes	$	61,975		$	64,238		$	(6,398	)	$	(7,342	)

Amounts in the above table reflect the Company and its consolidated subsidiaries. The accumulated other comprehensive loss reported in the consolidated balance sheets also includes pension and other postretirement benefit amounts related to ownership interests in unconsolidated affiliates.

The Company expects to recognize approximately $5.2 million of the March 31, 2017 net actuarial loss and $2.4 million of the March 31, 2017 prior service benefit in net periodic benefit cost during fiscal year 2018.

Allocation of Pension Plan Assets

The Company has established, and periodically adjusts, target asset allocations for its investments in its U.S. ERISA-regulated defined benefit pension plan, which represents 94% of consolidated plan assets and 83% of consolidated PBO at March 31, 2017, to balance the needs of liquidity, total return, and risk control. The assets are required to be diversified across asset classes and investment styles to achieve that balance. During the year, the asset allocation is reviewed for adherence to the target policy and rebalanced to the targeted weights. The Company reviews the expected long-term returns of the asset allocation each year to help determine whether changes are needed. The return is evaluated on a weighted-average basis in relation to inflation. The assumed long-term rate of return used to calculate annual benefit expense is based on the asset allocation and expected market returns for the respective asset classes.

The weighted–average target pension asset allocation and target ranges at the March 31, 2017 measurement date and the actual asset allocations at the March 31, 2017 and 2016 measurement dates by major asset category were as follows:

							Actual Allocation
	Target Allocation						March 31,
Major Asset Category			Range				2017		2016
Equity securities	26.0	%	16	%	-	36%	31.9	%	22.4	%
Fixed income securities (1)	69.0	%	59	%	-	79%	61.7	%	71.5	%
Alternative investments	5.0	%	0	%	-	10%	6.4	%	6.1	%
Total	100.0	%					100.0	%	100.0	%

⁽¹⁾  Actual amounts include high yield securities and cash balances held for the payment of benefits.

Universal makes regular contributions to its pension and other postretirement benefit plans. As previously noted, for postretirement health benefits, contributions reflect funding of those benefits as they are incurred. The Company expects to make contributions of approximately $7.8 million to its defined benefit pension plans in fiscal year 2018, including $6.0 million to its ERISA-regulated U.S. plan and $1.8 million to its non-ERISA regulated and other plans.

Estimated future benefit payments to be made from the Company’s plans are as follows:

Fiscal Year	Pension Benefits		Other Postretirement Benefits
2018	$	15,031	$	3,142
2019	22,040		3,129
2020	20,162		3,015
2021	16,727		2,930
2022	17,019		2,797
2023 - 2027	88,929		12,554

Fair Values of Pension Plan Assets

Assets held by the Company's defined benefit pension plans primarily consist of equity securities, fixed income securities, and alternative investments. Equity securities are primarily invested in actively-traded mutual funds with underlying common stock investments in U.S. and foreign companies ranging in size from small to large corporations. Fixed income securities are also held primarily through actively-traded mutual funds with the underlying investments in both U.S. and foreign securities. The methodologies for determining the fair values of the plan assets are outlined below. Where the values are based on quoted prices for the securities in an active market, they are classified as Level 1 of the fair value hierarchy. Where secondary pricing sources are used, they are classified as Level 2 of the hierarchy. Pricing models that use significant unobservable inputs are classified as Level 3.

• Equity securities: Investments in equity securities through actively-traded mutual funds are valued based on the net asset values of the units held in the respective funds, which are determined by obtaining quoted prices on nationally recognized securities exchanges. These securities are classified as Level 1.

• Fixed income securities: Fixed income investments that are held through mutual funds are valued based on the net asset values of the units held in the respective funds, which are determined by obtaining quoted prices on nationally recognized securities exchanges. These securities are classified as Level 1. Other fixed income investments are valued at an estimated price that a dealer would pay for a similar security on the valuation date using observable market inputs and are classified as Level 2. These market inputs may include yield curves for similarly rated securities. Small amounts of cash are held in common collective trusts. Fixed income securities also include insurance assets, which are valued based on an actuarial calculation. Those securities are classified as Level 3.

• Alternative investments: Real estate assets are valued using valuation models that incorporate income and market approaches, including external appraisals, to derive fair values. The hedge fund allocation is a fund of hedge funds and is valued by the manager based on the net asset value of each fund. These models use significant unobservable inputs and are classified as Level 3 within the fair value hierarchy.

Fair values of the assets of the Company’s pension plans as of March 31, 2017 and 2016, classified based on how their values were determined under the fair value hierarchy are as follows:

	March 31, 2017
	Level 1		Level 2		Level 3		Total
Equity securities	$	65,637	$	—	$	—	$	65,637
Fixed income securities(1)	128,215		10,134		3,072		141,421
Alternative investments	—		—		13,094		13,094
Total investments	$	193,852	$	10,134	$	16,166	$	220,152

	March 31, 2016
	Level 1		Level 2		Level 3		Total
Equity securities	$	43,807	$	—	$	—	$	43,807
Fixed income securities(1)	141,218		7,491		13,382		162,091
Alternative investments	—		—		11,961		11,961
Total investments	$	185,025	$	7,491	$	25,343	$	217,859

⁽¹⁾  Includes high yield securities and cash and cash equivalent balances.

Other Benefit Plans

Universal and several subsidiaries offer employer defined contribution savings plans. Amounts charged to expense for these plans were approximately $2.6 million for fiscal year 2017, $2.4 million for fiscal year 2016, and $1.5 million for fiscal year 2015.

XML

Common And Preferred Stock

12 Months Ended

Mar. 31, 2017

Class of Stock Disclosures [Abstract]

Common And Preferred Stock

COMMON AND PREFERRED STOCK

Common Stock

At March 31, 2017, the Company’s shareholders had authorized 100,000,000 shares of its common stock, and 25,274,506 shares were issued and outstanding. Holders of the common stock are entitled to one vote for each share held on all matters requiring a vote. Holders of the common stock are also entitled to receive dividends when, as, and if declared by the Company’s Board of Directors. The Board of Directors customarily declares and pays regular quarterly dividends on the outstanding common shares; however, such dividends are at the Board’s full discretion, and there is no obligation to continue them.

Preferred Stock

Authorized and Outstanding Shares

The Company is also authorized to issue up to 5,000,000 shares of preferred stock, 500,000 shares of which are reserved for Series A Junior Participating Preferred Stock and 220,000 of which were reserved for Series B 6.75% Convertible Perpetual Preferred Stock. No Series A Junior Participating Preferred Stock has been issued. In 2006, 220,000 shares of Series B 6.75% Convertible Perpetual Preferred Stock were issued under this authorization. As discussed below, all of those shares were converted during fiscal year 2017, and none were outstanding at March 31, 2017.

Conversion of Series B 6.75% Convertible Perpetual Preferred Stock

In December 2016, holders of 111,072 shares of the Series B 6.75% Convertible Perpetual Preferred Stock voluntarily exercised their conversion rights under the original issuance terms of the preferred shares. The Company chose to satisfy the full conversion obligation for those preferred shares with shares of its common stock, issuing 2,487,118 common shares at the applicable conversion rate in exchange for the preferred shares tendered. The consolidated balance sheet at March 31, 2017 reflects a non-cash reclassification of $107.6 million from preferred stock to common stock to reflect the conversion of those preferred shares.

On January 9, 2017, the Company announced a mandatory conversion of all 107,418 remaining outstanding shares of the preferred stock after meeting the requirements to initiate the mandatory conversion under the original terms of the preferred shares. The Company chose to satisfy the conversion obligation for the mandatory conversion in cash, paying approximately $178.4 million for those preferred shares on January 31, 2017 to complete the conversion.

With the completion of the mandatory conversion in January 2017, the Company’s outstanding equity securities consist only of its common stock. Dividend payments on the preferred shares, which previously totaled approximately $15 million annually, have been discontinued. Although the conversions of the preferred stock into common stock or for cash did not impact the Company’s net income, the shares converted for cash under the mandatory conversion in January 2017 resulted in a one-time reduction of retained earnings of approximately $74.4 million during the fourth quarter ended March 31, 2017, representing the excess of the conversion cost over the carrying value of those shares. The reduction in retained earnings resulted in a corresponding one-time reduction of earnings available to common shareholders for the fiscal year ended March 31, 2017 for purposes of determining the amounts reported for basic and diluted earnings per share.

Share Repurchase Programs

Universal’s Board of Directors has authorized programs to repurchase outstanding shares of the Company’s capital stock (common and preferred stock). Under these programs, the Company has made and may continue to make share repurchases from time to time in the open market or in privately negotiated transactions at prices not exceeding prevailing market rates. Programs have been in place continuously throughout fiscal years 2015 through 2017. The current program, which replaced an expiring program, was authorized and became effective on November 5, 2015. It authorizes the purchase of up to $100 million of the Company's outstanding common stock and expires on the earlier of November 15, 2017, or when the funds authorized for the program have been exhausted. At March 31, 2017, the full $100 million authorization remained available for share repurchases under the current program.

Share repurchases under the programs for the fiscal years ended March 31, 2017, 2016, and 2015 were as follows:

	Fiscal Year Ended March 31,
	2017		2016		2015
Common Stock
Number of shares repurchased	—		—		719,993
Cost of shares repurchased (in thousands of dollars)	$	—	$	—	$	31,227
Weighted-average cost per share	$	—	$	—	$	43.37
Series B 6.75% Convertible Perpetual Preferred Stock
Number of shares repurchased	—		—		1,509
Cost of shares repurchased (in thousands of dollars)	$	—	$	—	$	1.497
Weighted-average cost per share	$	—	$	—	$	992.27

XML

Executive Stock Plans And Stock-Based Compensation

12 Months Ended

Mar. 31, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Executive Stock Plans And Stock-Based Compensation

EXECUTIVE STOCK PLANS AND STOCK-BASED COMPENSATION

Executive Stock Plans

The Company’s shareholders have approved executive stock plans under which officers, directors, and employees of the Company may receive grants and awards of common stock, restricted stock, restricted stock units (“RSUs”), performance share awards (“PSAs”), stock appreciation rights (“SARs”), incentive stock options, and non-qualified stock options. Currently, grants are outstanding under the 1997 Executive Stock Plan, the 2002 Executive Stock Plan, and the 2007 Stock Incentive Plan. Together, these plans are referred to in this disclosure as the “Plans.” Up to 2 million shares of the Company’s common stock may be issued under each of the Plans; however, direct awards of common stock, restricted stock, or RSUs are limited to 500,000 shares under the 2002 Executive Stock Plan and 1,350,000 shares under the 2007 Stock Incentive Plan.

The Company’s practice is to award grants of stock-based compensation to officers at the first regularly-scheduled meeting of the Executive Compensation, Nominating, and Corporate Governance Committee of the Board of Directors (the “Compensation Committee”) in the fiscal year following the public release of the Company’s financial results for the prior year. In recent years, the Compensation Committee has awarded only grants of RSUs and PSAs, and all stock options and SARs granted in previous years were either exercised or had expired by the end of fiscal year 2017. Outside directors automatically receive restricted stock units following each annual meeting of shareholders.

Non-qualified stock options and SARs previously granted under the Plans had an exercise price equal to the market price of a share of common stock on the date of grant. SARs granted under the Plans vested in equal one-third tranches one, two, and three years after the grant date and expired 10 years after the grant date, except that SARs granted after fiscal year 2007 expired on the earlier of 3 years after the grantee’s retirement date or 10 years after the grant date. RSUs awarded under the Plans vest 5 years from the grant date and are then paid out in shares of common stock. Under the terms of the RSU awards, grantees receive dividend equivalents in the form of additional RSUs that vest and are paid out on the same date as the original RSU grant. The PSAs vest 3 years from the grant date, are paid out in shares of common stock at the vesting date, and do not carry rights to dividends or dividend equivalents prior to vesting. Shares ultimately paid out under PSA grants are dependent on the achievement of predetermined performance measures established by the Compensation Committee and can range from zero to 150% of the stated award. RSUs awarded to outside directors vest 3 years after the grant date, and restricted stock vests upon the individual’s retirement from service as a director.

Stock Options and SARs

The following tables summarize the Company’s stock option and SAR activity and related information for fiscal years 2015 through 2017:

	Shares		Weighted-Average Exercise Price
Fiscal Year Ended March 31, 2015:
Outstanding at beginning of year	257,340		$	54.83
Exercised	(63,539	)	38.50
Cancelled/expired	(24,200	)	62.66
Outstanding at end of year	169,601		59.82
Fiscal Year Ended March 31, 2016:
Exercised	(6,200	)	51.32
Cancelled/expired	(11,200	)	62.66
Outstanding at end of year	152,201		59.96
Fiscal Year Ended March 31, 2017:
Exercised	(135,334	)	61.72
Cancelled/expired	(16,867	)	45.82
Outstanding at end of year	—		$	—

As indicated in the table, with the exercise and/or expiration of all remaining SARs during fiscal year 2017, there were no SARs or stock options outstanding at March 31, 2017.

	Fiscal Year Ended March 31,
	2017		2016		2015
Total intrinsic value of stock options and SARs exercised	$	555	$	26	$	1,091
Total fair value of SARs vested	$	—	$	—	$	375

Intrinsic value in the above table is based on the difference between the market price of the underlying shares at the exercise date and the exercise price of the SARs or stock options.

RSUs, Restricted Stock, and PSAs

The following table summarizes the Company’s RSU, restricted stock, and PSA activity for fiscal years 2015 through 2017:

	RSUs				Restricted Stock				PSAs
	Shares		Weighted-Average Grant Date Fair Value		Shares		Weighted-Average Grant Date Fair Value		Shares		Weighted-Average Grant Date Fair Value
Fiscal Year Ended March 31, 2015:
Unvested at beginning of year	293,180		$	44.33	48,100		$	42.33	149,387		$	41.76
Granted	94,539		51.86		—		—		57,580		46.41
Vested	(123,322	)	42.02		—		—		(50,092	)	31.95
Forfeited	—		—		—		—		(3,400	)	53.56
Unvested at end of year	264,397		48.10		48,100		42.33		153,475		45.58
Fiscal Year Ended March 31, 2016:
Granted	80,932		51.62		—		—		86,212		45.06
Vested	(42,384	)	41.64		—		—		(85,387	)	38.14
Unvested at end of year	302,945		49.95		48,100		42.33		154,300		48.13
Fiscal Year Ended March 31, 2017:
Granted	74,776		55.27		—		—		58,805		49.17
Vested	(51,544	)	44.57		(17,900	)	42.26		(52,230	)	53.56
Forfeited	(539	)	55.63		—		—		(525	)	49.17
Unvested at end of year	325,638		$	52.01	30,200		$	42.37	160,350		$	46.86

Shares granted and vested in the above table include dividend equivalents on RSUs and any shares awarded above the base grant under the performance provisions of PSAs. Shares forfeited or canceled include any reductions from the base PSA grant under those same performance provisions. The fair values of RSUs, restricted stock, and PSAs are based on the market price of the common stock on the grant date.

Stock-Based Compensation Expense

Fair value expense for stock-based compensation is recognized ratably over the period from grant date to the earlier of (1) the vesting date of the award, or (2) the date the grantee is eligible to retire without forfeiting the award. For employees who are already eligible to retire at the date an award is granted, the total fair value of the award is recognized as expense at the date of grant. For the fiscal years ended March 31, 2017, 2016, and 2015, total stock-based compensation expense and the related income tax benefit recognized were as follows:

	Fiscal Year Ended March 31,
	2017		2016		2015
Total stock-based compensation expense	$	6,475	$	5,206	$	6,230
Income tax benefit recorded on stock-based compensation expense	$	2,266	$	1,822	$	2,181

At March 31, 2017, the Company had $6.0 million of unrecognized compensation expense related to stock-based awards, which will be recognized over a weighted-average period of approximately 1.1 years. All stock options were exercised, cancelled, or expired before the end of fiscal year 2015, and cash proceeds from the exercise of stock options were not material for that fiscal year.

XML

Commitments And Other Matters

12 Months Ended

Mar. 31, 2017

Commitments And Other Matters [Abstract]

Commitments And Other Matters

COMMITMENTS, CONTINGENCIES, AND OTHER MATTERS

Commitments

The Company enters into contracts to purchase tobacco from farmers in a number of the countries where it operates. Contracts in most countries cover one annual growing season. Primarily with the farmer contracts in Brazil, Malawi, Mozambique, the Philippines, Guatemala, and Mexico, the Company provides seasonal financing to support the farmers’ production of their crops or guarantees their financing from third-party banks. At March 31, 2017, the Company had contracts to purchase approximately $622 million of tobacco to be delivered during the coming fiscal year and $68 million of tobacco to be delivered in subsequent years. These amounts are estimates since actual quantities purchased will depend on crop yields, and prices will depend on the quality of the tobacco delivered and other market factors. Tobacco purchase obligations have been partially funded by advances to farmers and other suppliers, which totaled approximately $104 million, net of allowances, at March 31, 2017. The Company withholds payments due to farmers on delivery of the tobacco to satisfy repayment of the financing it provided to the farmers. As noted above and discussed in more detail below, the Company also has arrangements to guarantee bank loans to farmers in Brazil, and payments are also withheld on delivery of tobacco to satisfy repayment of those loans. In addition to its contractual obligations to purchase tobacco, the Company had commitments related to agricultural materials, approved capital expenditures, and various other requirements that approximated $48 million at March 31, 2017.

Guarantees and Other Contingent Liabilities

Guarantees of Bank Loans and Other Contingent Liabilities

Guarantees of bank loans to growers for crop financing have long been industry practice in Brazil and support the farmers’ production of tobacco there. The Company's operating subsidiary in Brazil had guarantees outstanding at March 31, 2017, all of which expire within one year. As noted above, the subsidiary withholds payments due to the farmers on delivery of tobacco and forwards those payments to the third-party banks. Failure of farmers to deliver sufficient quantities of tobacco to the subsidiary to cover their obligations to the third-party banks could result in a liability for the subsidiary under the related guarantees; however, in that case, the subsidiary would have recourse against the farmers. The maximum potential amount of future payments that the Company’s subsidiary could be required to make at March 31, 2017, was the face amount, $17 million including unpaid accrued interest ($13 million as of March 31, 2016). The fair value of the guarantees was a liability of approximately $1 million at March 31, 2017 ($2 million at March 31, 2016). In addition to these guarantees, the Company has other contingent liabilities totaling approximately $2 million at March 31, 2017, primarily under outstanding letters of credit.

Value-Added Tax Assessments in Brazil

As discussed in Note 1, the Company's local operating subsidiaries pay significant amounts of value-added tax ("VAT") in connection with their normal operations. In Brazil, VAT is assessed at the state level when green tobacco is transferred between states. The Company's operating subsidiary there pays VAT when tobaccos grown in the states of Santa Catarina and Parana are transferred to its factory in the state of Rio Grande do Sul for processing. The subsidiary has received assessments for additional VAT plus interest and penalties from the tax authorities for the states of Santa Catarina and Parana based on audits of the subsidiary's VAT filings for specified periods. In June 2011, tax authorities for the state of Santa Catarina issued assessments for tax, interest, and penalties for periods from 2006 through 2009 totaling approximately $15 million. In September 2014, tax authorities for the state of Parana issued an assessment for tax, interest, and penalties for periods from 2009 through 2014 totaling approximately $18 million. These amounts are based on the exchange rate for the Brazilian currency at March 31, 2017. Management of the operating subsidiary and outside counsel believe that errors were made by the tax authorities for both states in determining all or significant portions of these assessments and that various defenses support the subsidiary's positions.

With respect to the Santa Catarina assessments, the subsidiary took appropriate steps to contest the full amount of the claims. As of March 31, 2017, a portion of the subsidiary's arguments had been accepted, and the outstanding assessment had been reduced, although interest on the remaining assessment has continued to accumulate. The reduced assessment, together with the related accumulated interest through the end of the current reporting period, totaled approximately $15 million at the March 31, 2017 exchange rate. The subsidiary is continuing to contest the full remaining amount of the assessment. While the range of reasonably possible loss is zero up to the full $15 million remaining assessment, based on the strength of the subsidiary's defenses, no loss within that range is considered probable at this time and no liability has been recorded at March 31, 2017.

With respect to the Parana assessment, management of the subsidiary and outside counsel challenged the full amount of the claim. A significant portion of the Parana assessment was based on positions taken by the tax authorities that management and outside counsel believe deviate significantly from the underlying statutes and relevant case law. In addition, under the law, the subsidiary's tax filings for certain periods covered in the assessment were no longer open to any challenge by the tax authorities. In December 2015, the Parana tax authorities withdrew the initial claim and subsequently issued a new assessment covering the same tax periods. The new assessment totaled approximately $6 million at the March 31, 2017 exchange rate, reflecting a substantial reduction from the original $18 million assessment. Notwithstanding the reduction, management and outside counsel continue to believe that the new assessment is not supported by the underlying statutes and relevant case law and have taken the necessary steps to challenge the full amount of the claim. The range of reasonably possible loss is considered to be zero up to the full $6 million assessment. However, based on the strength of the subsidiary's defenses, no loss within that range is considered probable at this time and no liability has been recorded at March 31, 2017.

In both states, the process for reaching a final resolution to the assessments is expected to be lengthy, and management is not currently able to predict when either case will be concluded. Should the subsidiary ultimately be required to pay any tax, interest, or penalties in either case, the portion paid for tax would generate value-added tax credits that the subsidiary may be able to recover.

Other Contingent Liabilities

Various subsidiaries of the Company are involved in other litigation and tax examinations incidental to their business activities.  While the outcome of these matters cannot be predicted with certainty, management is vigorously defending the matters and does not currently expect that any of them will have a material adverse effect on the Company’s business or financial position.  However, should one or more of these matters be resolved in a manner adverse to management’s current expectation, the effect on the Company’s results of operations for a particular fiscal reporting period could be material.

Major Customers

A material part of the Company’s business is dependent upon a few customers. The Company's six largest customers are Altria Group, Inc, British American Tobacco plc, China Tobacco International, Inc., Imperial Brands plc, Japan Tobacco, Inc., and Philip Morris International, Inc. In the aggregate, these customers have accounted for more than 65% of consolidated revenue for each of the past three fiscal years. For the fiscal years ended March 31, 2017, 2016, and 2015, revenue from Philip Morris International, Inc. was approximately $590 million, $640 million, and $580 million, respectively. For the same periods, British American Tobacco plc accounted for revenue of approximately $220 million, $230 million, and $220 million, respectively, and Imperial Brands plc accounted for revenue of approximately $230 million, $210 million, and $280 million, respectively. These customers primarily do business with various affiliates in the Company’s flue-cured and burley leaf tobacco operations. The loss of, or substantial reduction in business from, any of these customers could have a material adverse effect on the Company.

Accounts Receivable

The Company’s operating subsidiaries perform credit evaluations of customers’ financial condition prior to the extension of credit. Generally, accounts receivable are unsecured and are due within 30 days. When collection terms are extended for longer periods, interest and carrying costs are usually recovered. Credit losses are provided for in the financial statements, and historically such amounts have not been material. The allowance for doubtful accounts was approximately $4 million and $9 million at March 31, 2017 and 2016, respectively. At March 31, 2017 and 2016, net accounts receivable by reportable operating segment were as follows:

	March 31,
	2017		2016
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	111,520	$	85,985
Other Regions	294,799		303,932
Subtotal	406,319		389,917
Other Tobacco Operations	32,969		38,742
Consolidated accounts receivable, net	$	439,288	$	428,659

Acquisition of Partner's Interest in Tobacco Processing Joint Venture

For a number of years, the Company held a 50% joint venture ownership interest in Procesadora Unitab, S.A., a tobacco processing entity in Guatemala. In December 2015, the Company acquired the 50% interest held by its joint venture partner for $6 million in cash. In accordance with Accounting Standards Codification Topic 805, "Business Combinations" (“ASC 805”), the transaction was accounted for using the acquisition method of accounting, which required the Company to record all underlying assets and liabilities of the entity at their fair values as of the transaction date and to consolidate the financial statements of the entity.  Based on those fair values, the Company recorded a pretax gain of $3.4 million on the transaction during the third quarter of fiscal year 2016. The gain is reported in Other Income in the consolidated statements of income. The purchase price of the newly-acquired 50% interest approximated fair value, and the gain resulted from remeasuring the Company’s original 50% ownership interest in the entity to fair value. No goodwill or identifiable intangible assets were recorded as part of the transaction, and acquisition-related costs were not significant.

The allocation of the fair values to the net assets acquired was complete at the time the transaction was recorded. Based on the nature of its operations, the net assets of the acquired entity are comprised primarily of property, plant, and equipment, and the fair values recorded for those assets totaled approximately $12 million based primarily on a third-party appraisal. The acquired entity is included in the Company’s North America operating segment.

Reversal of Valuation Allowance on IPI Tax Credits in Brazil

During fiscal year 2014, a longstanding lawsuit filed by the Company’s operating subsidiary in Brazil related to certain excise tax credits (IPI tax credits) was concluded following a decision in the subsidiary’s favor in the Brazilian federal courts and the expiration of the time period for the government to appeal the decision. IPI tax credits were established under Brazilian tax laws to allow recovery of a portion of the excise taxes paid on manufactured products when those products are sold in export markets; however, the Brazilian tax authorities subsequently issued certain regulations that prevented the subsidiary from claiming those credits. The lawsuit filed by the subsidiary challenged the denial of the tax credits based on the law.

The final court decision entitled the subsidiary to approximately $104 million of IPI tax credits (based on the exchange rate at the date of the decision), which were eligible to be used to offset other Brazilian federal tax payments for a period of up to five years from the date the subsidiary’s right to claim the credits was confirmed. The subsidiary recorded a gain on the favorable outcome of the case in fiscal year 2014, which was net of a valuation allowance based on estimates of the tax credits that were not probable of being realized prior to their expiration. In the fourth quarter of fiscal year 2015, based on actual realization of the tax credits to date, as well as updated tax payment projections for future periods, revised estimates indicated that all remaining IPI tax credits would be fully utilized prior to their expiration. On that basis, the subsidiary reversed the full valuation allowance on the credits of $12.7 million (based on the then current exchange rate) during that quarter. That reversal was reported in Other Income in the consolidated statement of income.

XML

Operating Segments

12 Months Ended

Mar. 31, 2017

Segment Reporting [Abstract]

Operating Segments

OPERATING SEGMENTS

Universal’s operations involve selecting, procuring, processing, packing, storing, shipping, and financing leaf tobacco for sale to, or for the account of, manufacturers of consumer tobacco products throughout the world. Through various operating subsidiaries located in tobacco-growing countries around the world and significant ownership interests in unconsolidated affiliates, the Company processes and/or sells flue-cured and burley tobaccos, dark air-cured tobaccos, and oriental tobaccos. Flue-cured, burley, and oriental tobaccos are used principally in the manufacture of cigarettes, and dark air-cured tobaccos are used mainly in the manufacture of cigars, pipe tobacco, and smokeless tobacco products. A substantial portion of the Company’s revenues are derived from sales to a limited number of large, multinational cigarette manufacturers.

The principal approach used by management to evaluate the Company’s performance is by geographic region, although the dark air-cured and oriental tobacco businesses are each evaluated on the basis of their worldwide operations. Oriental tobacco operations consist principally of a 49% interest in an affiliate, and the performance of those operations is evaluated based on the Company’s equity in the pretax earnings of that affiliate. Under this structure, the Company has the following primary operating segments: North America, South America, Africa, Europe, Asia, Dark Air-Cured, Oriental, and Special Services. North America, South America, Africa, Europe, and Asia are primarily involved in flue-cured and/or burley leaf tobacco operations for supply to cigarette manufacturers. The Dark Air-Cured group supplies dark air-cured tobacco principally to manufacturers of cigars, pipe tobacco, and smokeless tobacco products, and the Oriental business supplies oriental tobacco to cigarette manufacturers. From time to time, the segments may trade in tobaccos that differ from their main varieties, but those activities are not significant to their overall results. Special Services includes the Company's laboratory services business, which provides physical and chemical product testing and smoke testing for customers, its food ingredients business, as well as its liquid nicotine joint venture.

The five regional operating segments serving the Company’s cigarette manufacturer customer base share similar characteristics in the nature of their products and services, production processes, class of customer, product distribution methods, and regulatory environment. Based on the applicable accounting guidance, four of the regions – South America, Africa, Europe, and Asia – are aggregated into a single reporting segment, “Other Regions”, because they also have similar economic characteristics. North America is reported as an individual operating segment because its economic characteristics differ from the other regions, generally because its operations require lower working capital investments for crop financing and inventory. The Dark Air-Cured, Oriental and Special Services segments, which have dissimilar characteristics in some of the categories mentioned above, are reported together as “Other Tobacco Operations” because each is below the measurement threshold for separate reporting.

Universal incurs overhead expenses related to senior management, sales, finance, legal, and other functions that are centralized at its corporate headquarters, as well as functions performed at several sales and administrative offices around the world. These overhead expenses are allocated to the various operating segments, generally on the basis of tobacco volumes planned to be purchased and/or processed. Management believes this method of allocation is representative of the value of the related services provided to the operating segments. The Company evaluates the performance of its segments based on operating income after allocated overhead expenses, plus equity in the pretax earnings of unconsolidated affiliates.

Reportable segment data as of, or for, the fiscal years ended March 31, 2017, 2016, and 2015, is as follows:

	Sales and Other Operating Revenues						Operating Income
	Fiscal Year Ended March 31,						Fiscal Year Ended March 31,
	2017		2016		2015		2017			2016			2015
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	416,438	$	361,827	$	305,028	$	35,151		$	31,147		$	31,060
Other Regions(1)	1,422,991		1,538,971		1,739,781		143,349			143,596			125,839
Subtotal	1,839,429		1,900,798		2,044,809		178,500			174,743			156,899
Other Tobacco Operations(2)	231,789		219,575		226,992		9,984			11,325			10,326
Segment total	2,071,218		2,120,373		2,271,801		188,484			186,068			167,225
Deduct: Equity in pretax earnings of unconsolidated affiliates (3)							(5,774		)	(5,422		)	(7,137		)
Restructuring and impairment costs(4)							(4,359		)	(2,389		)	(4,890		)
Add: Other income(5)							—			3,390			12,676
Consolidated total	$	2,071,218	$	2,120,373	$	2,271,801	$	178,351		$	181,647		$	167,874
	Segment Assets						Goodwill
	March 31,						March 31,
	2017		2016		2015		2017			2016			2015
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	357,406	$	364,003	$	281,449	$	—		$	—		$	—
Other Regions(1)	1,465,109		1,548,517		1,607,846		97,159			97,318			97,372
Subtotal	1,822,515		1,912,520		1,889,295		97,159			97,318			97,372
Other Tobacco Operations(2)	300,890		318,657		297,180		1,644			1,713			1,713
Segment and consolidated totals	$	2,123,405	$	2,231,177	$	2,186,475	$	98,803		$	99,031		$	99,085
	Depreciation and Amortization						Capital Expenditures
	Fiscal Year Ended March 31,						Fiscal Year Ended March 31,
	2017		2016		2015		2017			2016			2015
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	4,626	$	4,314	$	4,284	$	4,202		$	2,282		$	5,814
Other Regions(1)	26,106		29,187		28,827		21,619			25,122			39,303
Subtotal	30,732		33,501		33,111		25,821			27,404			45,117
Other Tobacco Operations (2)	5,238		4,143		4,213		9,809			19,749			13,268
Segment and consolidated totals	$	35,970	$	37,644	$	37,324	$	35,630		$	47,153		$	58,385

⁽¹⁾  Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

⁽²⁾  Includes Dark Air-Cured, Oriental, and Special Services, as well as intercompany eliminations. Sales and other operating revenues, goodwill, depreciation and amortization, and capital expenditures include limited amounts or no amounts for Oriental because the business is accounted for on the equity method and its financial results consist principally of equity in the pretax earnings of the unconsolidated affiliate. The investment in the unconsolidated affiliate is included in segment assets and was approximately $78.1 million, $81.8 million, and $74.9 million, at March 31, 2017, 2016, and 2015, respectively.

⁽³⁾  Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income.

⁽⁴⁾  Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income (see Note 2).

⁽⁵⁾  Other income in fiscal year 2016 represents a gain from remeasuring to fair value the Company's original 50% ownership in Procesadora Unitab, S.A., a tobacco processing joint venture in Guatemala, upon acquiring the 50% interest held by the Company's joint venture partner (See Note 13). Other income in fiscal year 2015 represents the reversal of a valuation allowance on IPI excise tax credits in Brazil (See Note 13).

Geographic data as of, or for, the fiscal years ended March 31, 2017, 2016, and 2015, is presented below. Sales and other operating revenues are attributed to individual countries based on the final destination of the shipment. Long-lived assets generally consist of net property, plant, and equipment, goodwill, and other intangibles.

Geographic Data	Sales and Other Operating Revenues
	Fiscal Year Ended March 31,
	2017		2016		2015
Belgium	$	320,735	$	371,580	$	336,396
United States	320,731		275,147		290,950
Germany	123,649		155,180		170,338
China	137,855		135,032		174,872
Netherlands	91,266		121,767		113,297
Russia	84,784		109,559		126,652
All other countries	992,198		952,108		1,059,296
Consolidated total	$	2,071,218	$	2,120,373	$	2,271,801
	Long-Lived Assets
	March 31,
	2017		2016		2015
United States	$	85,145	$	84,072	$	70,929
Brazil	134,074		133,727		135,980
Mozambique	50,311		53,069		55,733
All other countries	146,698		154,090		141,893
Consolidated total	$	416,228	$	424,958	$	404,535

XML

Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income (Loss)

12 Months Ended

Mar. 31, 2017

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Accumulated Other Comprehensive Income (Loss), Net of Tax

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The following table summarizes the changes in the balances for each component of accumulated other comprehensive income (loss) attributable to the Company for the fiscal years ended March 31, 2017, 2016, and 2015:

	Fiscal Year Ended March 31,
(in thousands of dollars)	2017			2016			2015
Foreign currency translation:
Balance at beginning of year	$	(26,992	)	$	(31,138	)	$	(8,476	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on foreign currency translation (net of tax (expense) benefit of $3,715, $(2,119), and $12,181)	(6,899		)	3,934			(22,625		)
Less: Net loss (gain) on foreign currency translation attributable to noncontrolling interests	753			212			(37		)
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(6,146		)	4,146			(22,662		)
Balance at end of year	$	(33,138	)	$	(26,992	)	$	(31,138	)
Foreign currency hedge:
Balance at beginning of year	$	675		$	(1,834	)	$	769
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $991, $(1,060), and $2,304)	(1,841		)	1,969			(4,280		)
Reclassification of net loss to earnings (net of tax benefit of $(489), $(291), and $(903))(1)	908			540			1,677
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(933		)	2,509			(2,603		)
Balance at end of year	$	(258	)	$	675		$	(1,834	)
Interest rate hedge:
Balance at beginning of year	$	(6,997	)	$	(1,982	)	$	(608	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $(3,150), $4,489, and $1,416)	5,849			(8,335		)	(2,628		)
Reclassification of net loss to earnings (net of tax benefit of $(1,370), $(1,788), and $(675))(2)	2,546			3,320			1,254
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	8,395			(5,015		)	(1,374		)
Balance at end of year	$	1,398		$	(6,997	)	$	(1,982	)
Pension and other postretirement benefit plans:
Balance at beginning of year	$	(39,036	)	$	(40,040	)	$	(26,017	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net losses arising during the year (net of tax benefit of $751, $1,035, and $9,719)(3)	(1,395		)	(1,921		)	(18,049		)
Amortization included in earnings (net of tax benefit of $(1,546), $(1,576), and $(2,163)) (4)	2,870			2,925			4,026
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	1,475			1,004			(14,023		)
Balance at end of year	$	(37,561	)	$	(39,036	)	$	(40,040	)
Total accumulated other comprehensive income (loss) at end of year	$	(69,559	)	$	(72,350	)	$	(74,994	)

⁽¹⁾Gain (loss) on foreign currency cash flow hedges related to forecast purchases of tobacco is reclassified from accumulated other comprehensive income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 8 for additional information.

⁽²⁾Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when the related interest payments are made on the debt or upon termination of the interest rate swap agreements prior to their scheduled maturity dates. See Note 8 for additional information.

⁽³⁾These items arise from the remeasurement of the assets and liabilities of the Company's defined benefit pension plans. Those remeasurements are made on an annual basis at the end of the fiscal year. See Note 10 for additional information.

⁽⁴⁾This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 10 for additional information.

XML

Unaudited Quarterly Financial Data

12 Months Ended

Mar. 31, 2017

Quarterly Financial Information Disclosure [Abstract]

Unaudited Quarterly Financial Data

UNAUDITED QUARTERLY FINANCIAL DATA

Unaudited quarterly financial data for the fiscal years ended March 31, 2017 and 2016 is provided in the table below. Due to the seasonal nature of the Company's business, management believes it is generally more meaningful to focus on cumulative rather than quarterly results.

	First Quarter			Second Quarter		Third Quarter		Fourth Quarter
Fiscal Year Ended March 31, 2017
Operating Results:
Sales and other operating revenues	$	295,475		$	456,942	$	668,771	$	650,030
Gross profit	52,197			87,844		135,453		119,185
Net income (loss)	(7,504		)	26,498		57,062		36,450
Net income (loss) attributable to Universal Corporation	(5,476		)	25,264		53,647		32,869
Earnings (loss) available to Universal Corporation common shareholders after dividends on convertible perpetual preferred stock	(9,163		)	21,577		49,960		(41,484		)
Earnings (loss) per share attributable to Universal Corporation common shareholders:
Basic	(0.40		)	0.95		2.17		(1.64		)
Diluted	(0.40		)	0.90		1.92		(1.64		)
Cash Dividends Declared:
Per share of convertible perpetual preferred stock	16.88			16.87		16.88		—
Per share of common stock	0.53			0.53		0.54		0.54
Market Price Range of Common Stock:
High	57.75			61.69		64.20		83.35
Low	52.26			55.29		52.40		63.30
Fiscal Year Ended March 31, 2016
Operating Results:
Sales and other operating revenues	$	275,419		$	456,382	$	584,592	$	803,980
Gross profit	48,389			98,094		119,906		140,942
Net income (loss)	(6,125		)	25,064		46,615		52,594
Net income (loss) attributable to Universal Corporation	(5,947		)	22,465		44,534		47,964
Earnings (loss) available to Universal Corporation common shareholders after dividends on convertible perpetual preferred stock	(9,634		)	18,778		40,847		44,277
Earnings (loss) per share attributable to Universal Corporation common shareholders:
Basic	(0.43		)	0.83		1.80		1.95
Diluted	(0.43		)	0.81		1.60		1.72
Cash Dividends Declared:
Per share of convertible perpetual preferred stock	16.88			16.87		16.88		16.87
Per share of common stock	0.52			0.52		0.53		0.53
Market Price Range of Common Stock:
High	57.76			58.41		57.72		57.27
Low	46.80			46.98		49.70		51.49

Note: Earnings per share amounts for each fiscal year may not equal the total of the four quarterly amounts due to differences in weighted-average outstanding shares for the respective periods and to the fact that the Company’s convertible perpetual preferred stock may be antidilutive for some periods.

Significant items included in the quarterly results were as follows:

Fiscal Year Ended March 31, 2017

• Second Quarter – Restructuring and impairment costs totaling $3.7 million, primarily related to the Company's decision to close its tobacco processing facility in Hungary. The Company is now processing tobaccos sourced from Hungary in its factories in Italy. The costs incurred for the change in operations in Hungary included statutory employee termination benefits and impairment charges related to certain property and equipment. Those costs reduced net income attributable to Universal Corporation by $2.4 million and diluted earnings per share by $0.09.

• Fourth Quarter – The conversion of 107,418 shares of the Company's Series B 6.75% Convertible Perpetual Preferred Stock for cash resulted in a one-time reduction of retained earnings of approximately $74.4 million during the quarter ending March 31, 2017, representing the excess of the conversion cost over the carrying value of those preferred shares. The reduction in retained earnings resulted in a corresponding one-time reduction of earnings available to common shareholders for purposes of determining the amounts reported for basic and diluted earnings per share for those periods. The reduction in earnings available to common shareholders decreased diluted earnings per share for the quarter by $2.90.

Fiscal Year Ended March 31, 2016

• First Quarter – Restructuring and impairment costs totaling $2.4 million, related to a decision to significantly scale back the Company's operations in Zambia. The costs included statutory employee termination benefits, impairment charges related to outstanding balances on loans to farmers whose contracts were terminated as a result of the decision, and impairment charges on certain property and equipment. The restructuring and impairment costs reduced net income attributable to Universal Corporation by $1.6 million and diluted earnings per share by $0.06.

• Third Quarter – A $3.4 million pretax gain arising from the acquisition of a joint venture partner's 50% ownership interest in a tobacco processing entity in Guatemala. The transaction increased the Company's ownership interest in the entity to 100%, requiring consolidation of the financial statements of the entity and remeasurement of the Company's original 50% ownership interest to fair value, resulting in the gain. The gain increased net income attributable to Universal Corporation by $2.2 million and diluted earnings per share by $0.08.

XML

Schedule II - Valuation And Qualifying Accounts

12 Months Ended

Mar. 31, 2017

Valuation and Qualifying Accounts [Abstract]

Schedule II - Valuation And Qualifying Accounts

Schedule II - Valuation and Qualifying Accounts

Universal Corporation

Fiscal Years Ended March 31, 2017, 2016, and 2015

Description	Balance at Beginning of Year		Net Additions (Reversals) Charged to Expense			Additions Charged to Other Accounts		Deductions(1)			Balance at End of Year
(in thousands of dollars)
Fiscal Year Ended March 31, 2015:
Allowance for doubtful accounts (deducted from accounts receivable)	$	6,536	$	1,341		$	—	$	(2,395	)	$	5,482
Allowance for supplier accounts (deducted from advances to suppliers and other noncurrent assets)	46,078		3,734			—		(15,139		)	34,673
Allowance for recoverable taxes (deducted from other current assets and other noncurrent assets)	29,504		1,855			—		(8,141		)	23,218
Fiscal Year Ended March 31, 2016:
Allowance for doubtful accounts (deducted from accounts receivable)	$	5,482	$	6,970		$	—	$	(3,353	)	$	9,099
Allowance for supplier accounts (deducted from advances to suppliers and other noncurrent assets)	34,673		815			—		(6,623		)	28,865
Allowance for recoverable taxes (deducted from other current assets and other noncurrent assets)	23,218		1,755			—		(6,221		)	18,752
Fiscal Year Ended March 31, 2017:
Allowance for doubtful accounts (deducted from accounts receivable)	$	9,099	$	(5,071	)	$	—	$	(81	)	$	3,947
Allowance for supplier accounts (deducted from advances to suppliers and other noncurrent assets)	28,865		(857		)	—		(934		)	27,074
Allowance for recoverable taxes (deducted from other current assets and other noncurrent assets)	18,752		(3,392		)	—		(2,808		)	12,552

⁽¹⁾ Includes direct write-offs of assets and currency remeasurement.

XML

Nature Of Operations And Significant Accounting Policies Nature of Operations and Significant Accounting Policies (Policies)

12 Months Ended

Mar. 31, 2017

Accounting Policies [Abstract]

Nature Of Operations [Policy Text Block]

Nature of Operations

Universal Corporation, which together with its subsidiaries is referred to herein as “Universal” or the “Company,” is the leading global leaf tobacco supplier. The Company conducts business in over 30 countries, primarily in major tobacco-producing regions of the world.

Consolidation, Policy [Policy Text Block]

Consolidation

The consolidated financial statements include the accounts of Universal Corporation and all domestic and foreign subsidiaries in which the Company maintains a controlling financial interest. Control is generally determined based on a voting interest of greater than 50%, such that Universal controls all significant corporate activities of the subsidiary. All significant intercompany accounts and transactions are eliminated in consolidation.

The equity method of accounting is used for investments in companies where Universal Corporation has a voting interest of 20% to 50%. These investments are accounted for under the equity method because Universal exercises significant influence over those companies, but not control. The Company received dividends totaling $5.1 million in fiscal year 2017, $3.4 million in fiscal year 2016, and $5.2 million in fiscal year 2015, from companies accounted for under the equity method. Investments where Universal has a voting interest of less than 20% are not significant and are accounted for under the cost method. Under the cost method, the Company recognizes earnings upon its receipt of dividends to the extent they represent a distribution of retained earnings.

The Company's 49% ownership interest in Socotab L.L.C. (“Socotab”), a leading supplier of oriental tobaccos with operations located principally in Eastern Europe and Turkey, is the primary investment accounted for under the equity method. The investment in Socotab is an important part of the Company's overall product and service arrangements with its major customers. As discussed further below, the Company reviews the carrying value of its investments in unconsolidated affiliates on a regular basis and considers whether any factors exist that might indicate an impairment in value that is other than temporary. At March 31, 2017, the Company determined that no such factors existed with respect to the investment in Socotab. The Company, together with Socotab management, regularly evaluates the outlook for the business, and an impairment charge could be recorded in a future period if it is determined that the fair value of the investment is less than the carrying value and the decline in value is not temporary.

In fiscal year 2006, the Company deconsolidated its operations in Zimbabwe under accounting requirements that apply under certain conditions to foreign subsidiaries that are subject to foreign exchange controls and other government restrictions. Since that time, the investment has been accounted for using the cost method, as required under the accounting guidance. The investment in the Zimbabwe operations was zero at March 31, 2017 and 2016. The Company has a net foreign currency translation loss associated with the Zimbabwe operations of approximately $7.2 million, which remains a component of accumulated other comprehensive loss. As a regular part of its reporting, the Company reviews the conditions that resulted in the deconsolidation of the Zimbabwe operations to confirm that such accounting treatment is still appropriate. Dividends from the Zimbabwe operations are recorded in income in the period received.

The Company holds less than a 100% financial interest in certain consolidated subsidiaries. The net income and shareholders’ equity attributable to the noncontrolling interests in these subsidiaries are reported on the face of the consolidated financial statements. During fiscal years 2017, 2016, and 2015, there were no changes in the Company’s ownership percentage in any of these subsidiaries.

Investment, Policy [Policy Text Block]

Investments in Unconsolidated Affiliates

The Company’s equity method investments and its cost method investments, which include its Zimbabwe operations, are non-marketable securities. Universal reviews such investments for impairment whenever events or changes in circumstances indicate that the carrying amount of an investment may not be recovered. For example, the Company would review such an investment for impairment if the investee were to lose a significant customer, suffer a large reduction in sales margins, experience a major change in its business environment, or undergo any other significant change in its normal business. In assessing the recoverability of equity or cost method investments, the Company follows the applicable accounting guidance in determining the fair value of the investments. In most cases, this involves the use of discounted cash flow models (Level 3 of the fair value hierarchy under the accounting guidance). If the fair value of an equity or cost method investee is determined to be lower than its carrying value, an impairment loss is recognized. The determination of fair value using discounted cash flow models is normally not based on observable market data from independent sources and therefore requires significant management judgment with respect to estimates of future operating earnings and the selection of an appropriate discount rate. The use of different assumptions could increase or decrease estimated future operating cash flows, and the discounted value of those cash flows, and therefore could increase or decrease any impairment charge related to these investments.

In its consolidated statements of income, the Company reports its proportional share of the earnings of unconsolidated affiliates accounted for on the equity method based on the pretax earnings of those affiliates, as permitted under the applicable accounting guidance. All applicable foreign and U.S. income taxes are provided on these earnings and reported as a component of consolidated income tax expense. For unconsolidated affiliates located in foreign jurisdictions, repatriation of the Company’s share of the earnings through dividends is assumed in determining consolidated income tax expense.

The following table provides a reconciliation of (1) equity in the pretax earnings of unconsolidated affiliates, as reported in the consolidated statements of income to (2) equity in the net income of unconsolidated affiliates, net of dividends, as reported in the consolidated statements of cash flows for the fiscal years ended March 31, 2017, 2016, and 2015:

	Fiscal Year Ended March 31,
	2017			2016			2015
Equity in pretax earnings reported in the consolidated statements of income	$	5,774		$	5,422		$	7,137
Less: Equity in income taxes	(1,092		)	(2,156		)	(834		)
Equity in net income	4,682			3,266			6,303
Less: Dividends received on investments(1)	(5,078		)	(3,422		)	(5,228		)
Equity in net income, net of dividends, reported in the consolidated statements of cash flows	$	(396	)	$	(156	)	$	1,075

⁽¹⁾  In accordance with the applicable accounting guidance, dividends received from unconsolidated affiliates accounted for on the equity method that represent a return on capital (i.e., a return of earnings on a cumulative basis) are presented as operating cash flows in the consolidated statements of cash flows.

Earnings Per Share, Policy [Policy Text Block]

Earnings Per Share

 The Company calculates basic earnings per share based on earnings available to common shareholders after payment of dividends on the Company’s Series B 6.75% Convertible Perpetual Preferred Stock prior to its conversion in fiscal year 2017 (see Note 11). The calculation uses the weighted average number of common shares outstanding during each period. Diluted earnings per share is computed in a similar manner using the weighted average number of common shares and dilutive potential common shares outstanding. Dilutive potential common shares include unvested restricted stock units and performance share awards that are assumed to be fully vested and paid out in shares of common stock, dilutive stock options and stock appreciation rights that were assumed to be exercised, and shares of convertible perpetual preferred stock that were assumed to be converted when the effect was dilutive. In periods when the effect of the convertible perpetual preferred stock was dilutive and these shares were assumed to be converted into common stock, dividends paid on the preferred stock were excluded from the calculation of diluted earnings per share.

Calculations of earnings per share for the fiscal years ended March 31, 2017, 2016, and 2015, are provided in Note 3.

Cash and Cash Equivalents [Policy Text Block]

Cash and Cash Equivalents

 All highly liquid investments with a maturity of three months or less at the time of purchase are classified as cash equivalents.

Advances to Suppliers [Policy Text Block]

Advances to Suppliers

In many sourcing origins where the Company operates, it provides agronomy services and seasonal advances of seed, fertilizer, and other supplies to tobacco farmers for crop production, or makes seasonal cash advances to farmers for the procurement of those inputs. These advances are short term, are repaid upon delivery of tobacco to the Company, and are reported in advances to suppliers in the consolidated balance sheets. In several origins, the Company has made long-term advances to tobacco farmers to finance curing barns and other farm infrastructure. In some years, due to low crop yields and other factors, individual farmers may not deliver sufficient volumes of tobacco to fully repay their seasonal advances, and the Company may extend repayment of those advances into future crop years. The long-term portion of advances is included in other noncurrent assets in the consolidated balance sheets. Both the current and the long-term portions of advances to suppliers are reported net of allowances recorded when the Company determines that amounts outstanding are not likely to be collected. Short-term and long-term advances to suppliers totaled approximately $134 million at both March 31, 2017 and 2016. The related valuation allowances totaled $27 million at March 31, 2017, and $29 million at March 31, 2016, and were estimated based on the Company’s historical loss information and crop projections. The allowances were reduced by net recoveries of approximately $0.9 million in fiscal year 2017, but increased by net provisions for estimated uncollectible amounts of approximately $0.8 million in fiscal year 2016 and $3.7 million in fiscal year 2015. These provisions are included in selling, general, and administrative expenses in the consolidated statements of income. Interest on advances is recognized in earnings upon the farmers’ delivery of tobacco in payment of principal and interest. Advances on which interest accrual had been discontinued totaled approximately $11 million at both March 31, 2017 and 2016.

Inventory, Policy [Policy Text Block]

Inventories

Tobacco inventories are valued at the lower of cost or market. Raw materials primarily consist of unprocessed leaf tobacco, which is clearly identified by type and grade at the time of purchase. The Company tracks the costs associated with this tobacco in the final product lots, and maintains this identification through the time of sale. This method of cost accounting is referred to as the specific cost or specific identification method. The predominant cost component of the Company’s inventories is the cost of the unprocessed tobacco. Direct and indirect processing costs related to these raw materials are capitalized and allocated to inventory in a systematic manner. The Company does not capitalize any interest or sales-related costs in inventory. Freight costs are recorded in cost of goods sold. Other inventories consist primarily of seed, fertilizer, packing materials, and other supplies, and are valued principally at the lower of average cost or market.

Recoverable Value-Added Tax Credits [Policy Text Block]

Recoverable Value-Added Tax Credits

In many foreign countries, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”) on purchases of unprocessed and processed tobacco, crop inputs, packing materials, and various other goods and services. In some countries, VAT is a national tax, and in other countries it is assessed at the state level. Items subject to VAT vary from jurisdiction to jurisdiction, as do the rates at which the tax is assessed. When tobacco is sold to customers in the country of origin, the operating subsidiaries generally collect VAT on those sales. The subsidiaries are normally permitted to offset their VAT payments against the collections and remit only the incremental VAT collections to the tax authorities. When tobacco is sold for export, VAT is normally not assessed. In countries where tobacco sales are predominately for export markets, VAT collections generated on downstream sales are often not sufficient to fully offset the subsidiaries’ VAT payments. In those situations, unused VAT credits can accumulate. Some jurisdictions have procedures that allow companies to apply for refunds of unused VAT credits from the tax authorities, but the refund process often takes an extended period of time, and it is not uncommon for refund applications to be challenged or rejected in part on technical grounds. Other jurisdictions may permit companies to sell or transfer unused VAT credits to third parties in private transactions, although approval for such transactions must normally be obtained from the tax authorities, limits on the amounts that can be transferred may be imposed, and the proceeds realized may be heavily discounted from the face value of the credits. Due to these factors, local operating subsidiaries in some countries can accumulate significant balances of VAT credits over time. The Company reviews these balances on a regular basis and records valuation allowances on the credits to reflect amounts that are not expected to be recovered, as well as discounts anticipated on credits that are expected to be sold or transferred. At March 31, 2017 and 2016, the aggregate balances of recoverable tax credits held by the Company’s subsidiaries totaled approximately $45 million and $52 million, respectively, and the related valuation allowances totaled approximately $13 million and $19 million, respectively. The net balances are reported in other current assets and other noncurrent assets in the consolidated balance sheets.

Property, Plant and Equipment, Policy [Policy Text Block]

Property, Plant and Equipment

Depreciation of plant and equipment is based upon historical cost and the estimated useful lives of the assets. Depreciation is calculated primarily using the straight-line method. Buildings include tobacco processing and blending facilities, offices, and warehouses. Machinery and equipment consists of processing and packing machinery and transport, office, and computer equipment. Estimated useful lives range as follows: buildings - 15 to 40 years; processing and packing machinery - 3 to 11 years; transport equipment - 3 to 10 years; and office and computer equipment - 3 to 10 years. Where applicable and material in amount, the Company capitalizes related interest costs during periods that property, plant and equipment are being constructed or made ready for service. No interest was capitalized in fiscal years 2017, 2016, or 2015.

Goodwill and Intangible Assets, Policy [Policy Text Block]

Goodwill and Other Intangibles

Goodwill and other intangibles principally consist of the excess of the purchase price of acquired companies over the fair value of the net assets. Goodwill is carried at the lower of cost or fair value. Accounting Standards Codification Topic 350 (“ASC 350”) permits companies to base their initial assessments of potential goodwill impairment on qualitative factors, and the Company elected to use that approach at March 31, 2017 and 2016. Those factors did not indicate any potential impairment of the Company's recorded goodwill.

Reporting units are distinct operating subsidiaries or groups of subsidiaries that typically compose the Company’s business in a specific country or location. Goodwill is allocated to reporting units based on the country or location to which a specific acquisition relates, or by allocation based on expected future cash flows if the acquisition relates to more than one country or location. The majority of the Company’s goodwill relates to its reporting unit in Brazil. Significant adverse changes in the operations or estimated future cash flows for a reporting unit with recorded goodwill could result in an impairment charge. No charges for goodwill impairment were recorded in fiscal years 2017, 2016, or 2015.

Impairment or Disposal of Long-Lived Intangible Assets, Impairment, Policy [Policy Text Block]

Impairment of Long-Lived Assets

The Company reviews long-lived assets for impairment whenever events, changes in business conditions, or other circumstances provide an indication that such assets may be impaired. Potential impairment is initially assessed by comparing management’s undiscounted estimates of future cash flows from the use or disposition of the assets to their carrying value. If the carrying value exceeds the undiscounted cash flows, an impairment charge is recorded to reduce the carrying value of the asset to its fair value determined in accordance with the accounting guidance. In many cases, this involves the use of discounted cash flow models that are not based on observable market data from independent sources (Level 3 of the fair value hierarchy under the accounting guidance). In fiscal year 2017, the Company incurred impairment charges of $2.3 million on factory and equipment assets as a result of the Company's decision to close its tobacco processing facility in Hungary (see Note 2). No significant charges for the impairment of long-lived assets were recorded during fiscal years 2016 or 2015.

Income Tax, Policy [Policy Text Block]

Income Taxes

The Company provides deferred income taxes on temporary differences between the book and tax basis of its assets and liabilities. Those differences arise principally from employee benefit accruals, depreciation, deferred compensation, undistributed earnings of unconsolidated affiliates, undistributed earnings of foreign subsidiaries, goodwill, and valuation allowances on farmer advances and value-added tax credits.

Fair Value of Financial Instruments, Policy [Policy Text Block]

Fair Values of Financial Instruments

The fair value of the Company’s long-term debt, disclosed in Note 6, approximates the carrying amount since the variable interest rates in the underlying credit agreement reflect the market interest rates that were available to the Company at March 31, 2017. In periods when fixed-rate obligations are outstanding, fair values are estimated using market prices where they are available and discounted cash flow models based on current incremental borrowing rates for similar classes of borrowers and borrowing arrangements. The fair values of interest rate swap agreements designated as cash flow hedges and used to fix the variable benchmark rate on outstanding long-term debt are determined separately and recorded in other long-term liabilities. Except for interest rate swaps and forward foreign currency exchange contracts that are discussed below, the fair values of all other assets and liabilities that qualify as financial instruments approximate their carrying amounts.

Derivatives, Policy [Policy Text Block]

Derivative Financial Instruments

The Company recognizes all derivatives on the balance sheet at fair value. Interest rate swaps and forward foreign currency exchange contracts are used from time to time to manage interest rate risk and foreign currency risk. The Company enters into such contracts only with counterparties of good standing. The credit exposure related to non-performance by the counterparties and the Company is considered in determining the fair values of the derivatives, and the effect has not been material to the financial statements or operations of the Company. Additional disclosures related to the Company’s derivatives and hedging activities are provided in Note 8.

Foreign Currency Transactions and Translations Policy [Policy Text Block]

Translation and Remeasurement of Foreign Currencies

The financial statements of foreign subsidiaries having the local currency as the functional currency are translated into U.S. dollars using exchange rates in effect at period end for assets and liabilities and average exchange rates applicable to each reporting period for results of operations. Adjustments resulting from translation of financial statements are reflected as a separate component of other comprehensive income or loss. The financial statements of foreign subsidiaries having the U.S. dollar as the functional currency, with certain transactions denominated in a local currency, are remeasured into U.S. dollars. The remeasurement of local currency amounts into U.S. dollars creates remeasurement gains and losses that are included in earnings as a component of selling, general, and administrative expense. The Company recognized net remeasurement losses of $9.3 million in fiscal year 2017, $22.5 million in fiscal year 2016, and $28.8 million in fiscal year 2015.

Foreign currency transactions and forward foreign currency exchange contracts that are not designated as hedges generate gains and losses when they are settled or when they are marked to market under the prescribed accounting guidance. These transaction gains and losses are also included in earnings as a component of selling, general, and administrative expenses. The Company recognized net foreign currency transaction losses of $1.3 million in fiscal year 2017, net transaction gains of $8.0 million in fiscal year 2016, and net transaction gains of $17.7 million in fiscal year 2015.

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition

Revenue from the sale of tobacco is recognized when title and risk of loss is transferred to the customer and the earnings process is complete. Substantially all sales revenue is recorded based on the physical transfer of products to customers. A large percentage of the Company’s sales are to major multinational manufacturers of consumer tobacco products. The Company works closely with those customers to understand and plan for their requirements for volumes, styles, and grades of leaf tobacco from its various growing regions, and extensive coordination is maintained on an ongoing basis to determine and satisfy their requirements for physical shipment of processed tobacco. The customers typically specify, in sales contracts and in shipping documents, the precise terms for transfer of title and risk of loss for the tobacco. Customer returns and rejections are not significant, and the Company’s sales history indicates that customer-specific acceptance provisions are consistently met upon transfer of title and risk of loss.

While most of the Company’s revenue consists of tobacco that is purchased from farmers, processed and packed in its factories, and then sold to customers, some revenue is earned from processing tobacco owned by customers. These arrangements usually exist in specific markets where the customers contract directly with farmers for leaf production, and they have accounted for less than 5% of total revenue on an annual basis through the fiscal year ended March 31, 2017. Processing and packing of leaf tobacco is a short-duration process. Under normal operating conditions, raw tobacco that is placed into the production line exits as processed and packed tobacco within one hour, and is then later transported to customer-designated storage facilities. The revenue for these services is recognized when processing is completed, and the Company’s operating history indicates that customer requirements for processed tobacco are consistently met upon completion of processing.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Stock-Based Compensation

Share-based payments, such as grants of restricted stock units, performance share awards, restricted stock, stock appreciation rights, and stock options, are measured at fair value and reported as expense in the financial statements over the requisite service period. Additional disclosures related to stock-based compensation are included in Note 12.

Use of Estimates, Policy [Policy Text Block]

Estimates and Assumptions

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Accounting Pronouncements [Policy Text Block]

Accounting Pronouncements

Pronouncements Recently Adopted

In April 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 was effective for fiscal years beginning after December 31, 2015. The Company adopted ASU 2015-03 effective for the quarter ending June 30, 2016, which was the first quarter of the fiscal year ending March 31, 2017. The implementation of ASU 2015-03, which required retrospective application, resulted in a $1.6 million reclassification of unamortized debt issuance costs from other noncurrent assets to long-term debt for the comparative prior year ended March 31, 2016.

In April 2015, the FASB issued Accounting Standards Update 2015-05, “Intangibles - Goodwill and Other - Internal-Use Software - Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement” (“ASU 2015-05”). ASU 2015-05 requires customers who enter into a cloud computing arrangement that includes a software license to account for the arrangement as an intangible asset. If the cloud computing arrangement does not include a software license, the arrangement is accounted for as a service contract. The guidance was effective for fiscal years beginning after December 31, 2015, and allows for retrospective or prospective adoption. The Company prospectively adopted ASU 2015-05 effective as of April 1, 2016, the beginning of fiscal year 2017. The Company’s adoption of ASU 2015-05 did not have a material impact on its consolidated financial statements.

In May 2015, the FASB issued Accounting Standards Update No. 2015-07, "Fair Value Measurement, Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share or its Equivalent" ("ASU 2015-07"). ASU 2015-07 removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient and eliminates certain disclosures for investments that are eligible to be measured at fair value using the net asset value per share practical expedient. The Company adopted ASU 2015-07 effective as of April 1, 2016, the beginning of fiscal year 2017. Disclosures for all periods presented in Note 9 - Fair Value Measurements were adjusted accordingly.

In March 2016, the FASB issued Accounting Standards Update No. 2016-09, "Compensation - Stock Compensation (Topic 718)" ("ASU 2016-09"). ASU 2016-09 provides simplification for the accounting for employee stock-based payment transactions, including the related income tax consequences, the classification of awards as either equity or liabilities, and the classification of transactions in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, with early adoption permitted. The Company elected to early-adopt ASU 2016-09 effective April 1, 2016, which was the beginning of its fiscal year ending March 31, 2017. As required by the guidance, employee tax withholding payments and excess tax benefits resulting from stock-based compensation have been classified as financing activities and operating activities, respectively, in the consolidated statements of cash flows for all periods presented.

Pronouncements to be Adopted in Future Periods

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which supersedes substantially all of the current revenue recognition guidance under U.S. generally accepted accounting principles (“U.S. GAAP”).  ASU 2014-09 was developed under a joint project with the International Accounting Standards Board (“IASB”) to improve and converge the existing revenue recognition accounting guidance in U.S. GAAP and International Accounting Standards.  Under ASU 2014-09, the central underlying principle is to recognize revenues when promised goods or services are transferred to customers at an amount determined by the consideration a company expects to receive for those goods or services.  The guidance outlines a five-step process for determining the amount and timing of revenue to be recognized from those arrangements.  It is more principles-based than the existing guidance under U.S. GAAP, and therefore is expected to require more management judgment and involve more estimates than the current guidance.  ASU 2014-09 is effective for annual periods beginning after December 15, 2017, including all interim periods within the year of adoption.   Companies are allowed to select between two transition methods:  (1) a full retrospective transition method with the application of the new guidance to each prior reporting period presented, or (2) a modified retrospective transition method that recognizes the cumulative effect on prior periods at the date of adoption together with additional footnote disclosures. Since the issuance of ASU 2014-09, the FASB has issued several amendments to provide additional supplemental guidance on certain aspects of the original pronouncement.  Universal expects to adopt ASU 2014-09 and the related supplemental amendments effective April 1, 2018, which is the beginning of its fiscal year ending March 31, 2019.  The Company formed a cross-functional project team to review its current revenue accounting policies and control processes, to complete a comprehensive analysis of the new guidance, and to determine the effect it will have on revenue recognition and financial statement disclosures for all customer contracts. The team has classified its customer contracts into primary revenue streams and is currently in the process of completing individual contract reviews and making final determinations with respect to provisions in the new guidance that may impact the timing of revenue recognition for certain customer arrangements. As these activities remain underway at this time, the Company is not currently able to conclude on the impact that ASU 2014-09 will have on its consolidated financial statements. Although a final determination has not been made, it is likely that the Company will select the modified retrospective transition method as its method of adoption.

In July 2015, the FASB issued Accounting Standards Update No. 2015-11, “Simplifying the Measurement of Inventory” (“ASU 2015-11”). ASU 2015-11 requires that most inventory be measured at the lower of cost or net realizable value. ASU 2015-11 defines net realizable value as the "estimated selling price in the ordinary course of business, less reasonable predictable costs of completion, disposal, and transportation." ASU 2015-11 is effective for fiscal years beginning after December 31, 2016, and will be adopted effective April 1, 2017, which is the beginning of its fiscal year ending March 31, 2018. ASU 2015-11 will be applied prospectively after the date of adoption, as required by the guidance, and will not have a material impact on the Company's consolidated financial statements.

In January 2016, the FASB issued Accounting Standards Update No. 2016-01 “Financial Instruments-Recognition and Measurement of Financial Assets and Financial Liabilities” ("ASU 2016-01"). ASU 2016-01 requires all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under the equity method of accounting or those that result in consolidation of the investee). This guidance is effective for fiscal years beginning after December 15, 2017. The Company is currently evaluating the impact that the adoption of ASU 2016-01 will have on its consolidated financial statements.

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). ASU 2016-02 requires a lessee to recognize lease payment obligations as a lease liability and the corresponding right-of-use asset as a leased asset in the balance sheet for the term of the lease. This guidance supersedes Topic 840 “Leases” and is effective for fiscal years beginning after December 15, 2018. The Company will be required to adopt ASU 2016-02 effective April 1, 2019, which is the beginning of its fiscal year ending March 31, 2020, and is currently evaluating the impact that the updated guidance will have on its consolidated financial statements.

In January 2017, the FASB issued Accounting Standards Update No. 2017-04, "Intangibles - Goodwill and Other (Topic 350)" ("ASU 2017-04"). ASU 2017-04 eliminated Step 2 from the goodwill impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of the reporting unit's goodwill with the carrying amount of the goodwill. The guidance is effective for fiscal years beginning after December 15, 2019. The Company will be required to adopt ASU 2017-04 effective April 1, 2020, which is the beginning of its fiscal year ending March 31, 2021, and is currently evaluating the impact that the updated guidance will have on its consolidated financial statements.

In March 2017, the FASB issued Accounting Standards Update No. 2017-07, "Compensation - Retirement Benefits (Topic 715)" ("ASU 2017-07"). ASU 2017-07 requires that an employer report the service cost component of pension or other postretirement benefits expense in the same line item or items as other compensation costs arising from services rendered by the pertinent employees during the period. The other components of net benefit cost are required to be presented in the income statement separately from the service cost component and outside a subtotal of income from operations, if one is presented. If a separate line item or items are used to present the other components of net benefit cost, the line item or items must be appropriately described. If a separate line item or items are not used, the line item or items used in the income statement to present the other components of net benefit cost must be disclosed. The guidance is effective for fiscal years beginning after December 15, 2016. The Company will be required to adopt ASU 2017-07 effective April 1, 2017, which is the beginning of its fiscal year ending March 31, 2018. The line item classification changes required by the new guidance will not impact the Company's pretax earnings or net income; however, operating income and interest expense will increase by offsetting amounts that are not expected to be material to the Company's consolidated financial statements.

Reclassifications [Policy Text Block]

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year’s presentation.

XML

Nature Of Operations And Significant Accounting Policies (Tables)

12 Months Ended

Mar. 31, 2017

Accounting Policies [Abstract]

Reconciliation Of Equity In Unconsolidated Affiliates

The following table provides a reconciliation of (1) equity in the pretax earnings of unconsolidated affiliates, as reported in the consolidated statements of income to (2) equity in the net income of unconsolidated affiliates, net of dividends, as reported in the consolidated statements of cash flows for the fiscal years ended March 31, 2017, 2016, and 2015:

	Fiscal Year Ended March 31,
	2017			2016			2015
Equity in pretax earnings reported in the consolidated statements of income	$	5,774		$	5,422		$	7,137
Less: Equity in income taxes	(1,092		)	(2,156		)	(834		)
Equity in net income	4,682			3,266			6,303
Less: Dividends received on investments(1)	(5,078		)	(3,422		)	(5,228		)
Equity in net income, net of dividends, reported in the consolidated statements of cash flows	$	(396	)	$	(156	)	$	1,075

⁽¹⁾  In accordance with the applicable accounting guidance, dividends received from unconsolidated affiliates accounted for on the equity method that represent a return on capital (i.e., a return of earnings on a cumulative basis) are presented as operating cash flows in the consolidated statements of cash flows.

XML

Restructuring Costs (Tables)

12 Months Ended

Mar. 31, 2017

Restructuring Costs [Abstract]

Cumulative Restructuring Costs

A summary of the restructuring and impairment costs incurred during the fiscal years ended March 31, 2017, 2016, and 2015, is as follows:

	Fiscal Years Ended March 31,
	2017		2016		2015
Restructuring Costs:
Employee termination benefits	$	2,083	$	1,629	$	4,354
Other restructuring costs	—		96		536
	2,083		1,725		4,890
Impairment Costs:
Property and equipment and farmer loans	2,276		664		—
Total restructuring and impairment costs	$	4,359	$	2,389	$	4,890

Reconciliation Of Company's Liability For The Restructuring Costs

A reconciliation of the Company’s liability for employee termination benefits and other restructuring costs for fiscal years 2015 through 2017 is as follows:

	Employee Termination Benefits			Other Costs			Total
Balance at April 1, 2014	$	2,026		$	160		$	2,186
Fiscal Year 2015 Activity:
Costs charged to expense	4,354			536			4,890
Payments	(5,684		)	(498		)	(6,182		)
Balance at March 31, 2015	696			198			894
Fiscal Year 2016 Activity:
Costs charged to expense	1,629			96			1,725
Payments	(2,246		)	(92		)	(2,338		)
Balance at March 31, 2016	79			202			281
Fiscal Year 2017 Activity:
Costs charged to expense	2,083			—			2,083
Payments	(1,861		)	(159		)	(2,020		)
Balance at March 31, 2017	$	301		$	43		$	344

XML

Earnings Per Share (Tables)

12 Months Ended

Mar. 31, 2017

Earnings Per Share [Abstract]

Computation Of Basic And Diluted Earnings (Loss) Per Share

The following table sets forth the computation of basic and diluted earnings per share:

	Fiscal Year Ended March 31,
(in thousands, except share and per share data)	2017			2016			2015
Basic Earnings Per Share
Numerator for basic earnings per share
Net income attributable to Universal Corporation	$	106,304		$	109,016		$	114,608
Less: Dividends on convertible perpetual preferred stock	(11,061		)	(14,748		)	(14,824		)
Less: Cost in excess of carrying value on conversion or repurchase of convertible perpetual preferred stock	(74,353		)	—			(36		)
Earnings available to Universal Corporation common shareholders for calculation of basic earnings per share	20,890			94,268			99,748
Denominator for basic earnings per share
Weighted average shares outstanding	23,433,860			22,683,290			23,035,920
Basic earnings per share	$	0.89		$	4.16		$	4.33
Diluted Earnings Per Share
Numerator for diluted earnings per share
Earnings available to Universal Corporation common shareholders	$	20,890		$	94,268		$	99,748
Add: Dividends on convertible perpetual preferred stock (if conversion assumed)	—			14,748			14,824
Add: Cost in excess of carrying value on conversion or repurchase of convertible perpetual preferred stock (if dilutive)	—			—			36
Earnings available to Universal Corporation common shareholders for calculation of diluted earnings per share	20,890			109,016			114,608
Denominator for diluted earnings per share
Weighted average shares outstanding	23,433,860			22,683,290			23,035,920
Effect of dilutive securities (if conversion or exercise assumed)
Convertible perpetual preferred stock	—			4,853,268			4,843,309
Employee share-based awards	336,228			288,933			342,035
Denominator for diluted earnings per share	23,770,088			27,825,491			28,221,264
Diluted earnings per share	$	0.88		$	3.92		$	4.06

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

For the fiscal years ended March 31, 2017, 2016, and 2015, the Company had the following potentially dilutive securities (stock appreciation rights) outstanding that were not included in the computation of diluted earnings per share because their effect would have been antidilutive:

	Fiscal Year Ended March 31,
	2017		2016		2015
Potentially dilutive securities	—		133,600		156,200
Weighted-average exercise price	$	—	$	62.66	$	61.83

XML

Income Taxes (Tables)

12 Months Ended

Mar. 31, 2017

Income Tax Disclosure [Abstract]

Schedule Of Components of Income Tax Expense

Income taxes for the fiscal years ended March 31, 2017, 2016, and 2015 consisted of the following: 

	Fiscal Year Ended March 31,
	2017		2016			2015
Current
United States	$	3,422	$	5,371		$	4,126
State and local	147		1,116			657
Foreign	36,537		32,897			46,885
	40,106		39,384			51,668
Deferred
United States	5,434		5,780			3,352
State and local	561		(445		)	159
Foreign	10,631		9,711			(17,173		)
	16,626		15,046			(13,662		)
Total	$	56,732	$	54,430		$	38,006

Schedule Of Effective Income Tax Rate Reconciliation

A reconciliation of the statutory U.S. federal rate to the Company’s effective income tax rate is as follows:

	Fiscal Year Ended March 31,
	2017		2016		2015
Statutory tax rate	35.0	%	35.0	%	35.0	%
State income taxes, net of federal benefit	0.3		0.3		0.3
Dividends received from deconsolidated operations	(2.3	)	(1.5	)	(1.3	)
Effect of exchange rate changes on deferred income taxes	0.4		(1.6	)	(4.9	)
Tax benefit arising from payment of a portion of a fine by a subsidiary	—		—		(5.0	)
Other, including changes in liabilities recorded for uncertain tax positions	0.1		(0.7	)	(0.1	)
Effective income tax rate	33.5	%	31.5	%	24.0	%

Schedule Of U.S. And Foreign Components Of Income Before Income Taxes And Other Items

The U.S. and foreign components of income before income taxes were as follows:

	Fiscal Year Ended March 31,
	2017		2016		2015
United States	$	31,468	$	37,877	$	27,181
Foreign	137,770		134,701		131,286
Total	$	169,238	$	172,578	$	158,467

Schedule Of Deferred Tax Assets and Liabilities

Significant components of deferred tax liabilities and assets were as follows:  

	March 31,
	2017			2016
Liabilities
Foreign withholding taxes	$	44,702		$	39,770
Undistributed earnings	24,629			19,553
Goodwill	30,851			30,851
All other	11,015			10,424
Total deferred tax liabilities	$	111,197		$	100,598
Assets
Employee benefit plans	$	38,804		$	43,362
Reserves and accruals	11,756			12,911
Deferred income	4,672			3,938
Currency translation losses of foreign subsidiaries	13,244			9,939
Local currency exchange losses of foreign subsidiaries	3,669			3,597
Foreign tax credit carryforward	2,799			4,664
All other	14,327			16,546
Total deferred tax assets	89,271			94,957
Valuation allowance	(636		)	—
Net deferred tax assets	$	88,635		$	94,957

Schedule Of Combined Income Tax Expense (Benefit) Allocable To Continuing Operations, Other Comprehensive Income, And Adjustments To Shareholders' Equity

The combined income tax expense (benefit) allocable to continuing operations, other comprehensive income, and direct adjustments to shareholders' equity was as follows:

	Fiscal Year Ended March 31,
	2017		2016			2015
Continuing operations	$	56,732	$	54,430		$	38,006
Other comprehensive income	1,503		1,423			(21,900		)
Direct adjustments to shareholders' equity	—		(805		)	(932		)
Total	$	58,235	$	55,048		$	15,174

Reconciliation Of The Gross Liability For Uncertain Tax Positions

A reconciliation of the beginning and ending balance of the gross liability for uncertain tax positions for the fiscal years ended March 31, 2017, 2016 and 2015, is as follows:

	Fiscal Year Ended March 31,
	2017			2016			2015
Liability for uncertain tax positions, beginning of year	$	2,407		$	2,894		$	3,809
Additions:
Related to tax positions for the current year	94			98			272
Related to tax positions for prior years	—			—			—
Reductions:
Due to lapses of statutes of limitations	(112		)	(215		)	(478		)
Related to tax positions for prior years	(3		)	—			(143		)
Effect of currency rate movement	40			(370		)	(566		)
Liability for uncertain tax positions, end of year	$	2,426		$	2,407		$	2,894

XML

Long-Term Debt (Tables)

12 Months Ended

Mar. 31, 2017

Debt Disclosure [Abstract]

Schedule Of Long-Term Debt

The Company's long-term debt at March 31, 2017 and 2016 consisted of the following:

	March 31,
	2017			2016
Senior bank term loans	$	370,000		$	370,000
Total outstanding	370,000			370,000
Less: current portion	—			—
Less: unamortized debt issuance costs	(1,267		)	(1,620		)
Long-term debt	$	368,733		$	368,380

XML

Derivatives And Hedging Activities (Tables)

12 Months Ended

Mar. 31, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Notional Amount of Forward Contracts

The aggregate U.S. dollar notional amount of forward contracts entered for these purposes during fiscal years 2017, 2016, and 2015 was as follows:

	Fiscal Year Ended March 31,
(in millions)	2017		2016		2015
Tobacco purchases	$	70.7	$	43.1	$	105.6
Processing costs	24.0		13.2		22.9
Total	$	94.7	$	56.3	$	128.5

Effect Of Derivative Financial Instruments On The Consolidated Statements Of Income

The table below outlines the effects of the Company’s use of derivative financial instruments on the consolidated statements of income for the fiscal years ended March 31, 2017, 2016, and 2015.

	Fiscal Year Ended March 31,
	2017			2016			2015
Cash Flow Hedges - Interest Rate Swap Agreements
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	8,999		$	(12,824	)	$	(4,044	)
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	(3,916	)	$	(5,108	)	$	(1,929	)
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Interest expense
Ineffective Portion of Hedge
Gain (loss) recognized in earnings	$	—		$	—		$	—
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Floating rate interest payments on term loans
Cash Flow Hedges - Forward Foreign Currency Exchange Contracts
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	454		$	1,774		$	1,410
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	945		$	993		$	3,099
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Cost of goods sold
Ineffective Portion and Early De-designation of Hedges
Gain (loss) recognized in earnings	$	246		$	685		$	257
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Forecast purchases of tobacco in Brazil
Derivatives Not Designated as Hedges - Forward Foreign Currency Exchange Contracts
Gain (loss) recognized in earnings	$	(2,591	)	$	5,973		$	13,178
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses

Effect Of Derivative Financial Instruments On The Consolidated Balance Sheets

The table below outlines the effects of the Company’s derivative financial instruments on the consolidated balance sheets at March 31, 2017 and 2016:

	Derivatives in a Fair Value Asset Position					Derivatives in a Fair Value Liability Position
	Balance Sheet Location	Fair Value as of March 31,				Balance Sheet Location	Fair Value as of March 31,
		2017		2016			2017		2016
Derivatives Designated as Hedging Instruments
Interest rate swap agreements	Other non-current assets	$	2,149	$	—	Other long-term liabilities	$	—	$	10,766
Forward foreign currency exchange contracts	Other current assets	56		475		Accounts payable and accrued expenses	55		—
Total		$	2,205	$	475		$	55	$	10,766
Derivatives Not Designated as Hedging Instruments
Forward foreign currency exchange contracts	Other current assets	$	917	$	297	Accounts payable and accrued expenses	$	120	$	5
Total		$	917	$	297		$	120	$	5

Substantially all of the Company's forward foreign currency exchange contracts are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. The Company has elected to present these contracts on a gross basis in the consolidated balance sheets.

XML

Fair Value Measurements (Tables)

12 Months Ended

Mar. 31, 2017

Fair Value Disclosures [Abstract]

Financial Assets And Liabilities Measured At Fair Value On Recurring Basis

At March 31, 2017 and 2016, the Company had certain financial assets and financial liabilities that were required to be measured and reported at fair value on a recurring basis. These assets and liabilities are listed in the tables below and are classified based on how their values were determined under the fair value hierarchy or the NAV practical expedient:

	March 31, 2017
			Fair Value Hierarchy
	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	137,145	$	—	$	—	$	—	$	137,145
Trading securities associated with deferred compensation plans	—		17,726		—		—		17,726
Interest rate swap agreements	—		—		2,149		—		2,149
Forward foreign currency exchange contracts	—		—		973		—		973
Total financial assets measured and reported at fair value	$	137,145	$	17,726	$	3,122	$	—	$	157,993
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,177	$	1,177
Forward foreign currency exchange contracts	—		—		175		—		175
Total financial liabilities measured and reported at fair value	$	—	$	—	$	175	$	1,177	$	1,352
	March 31, 2016
			Fair Value Hierarchy
	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	116,618	$	—	$	—	$	—	$	116,618
Trading securities associated with deferred compensation plans	—		17,817		—		—		17,817
Forward foreign currency exchange contracts	—		—		772		—		772
Total financial assets measured and reported at fair value	$	116,618	$	17,817	$	772	$	—	$	135,207
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,628	$	1,628
Interest rate swap agreements	—		—		10,766		—		10,766
Forward foreign currency exchange contracts	—		—		5		—		5
Total financial liabilities measured and reported at fair value	$	—	$	—	$	10,771	$	1,628	$	12,399

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

A reconciliation of the change in the balance of the financial liability for guarantees of bank loans to tobacco growers (Level 3) for the fiscal years ended March 31, 2017 and 2016 is provided below.

	Fiscal Year Ended March 31,
	2017			2016
Balance at beginning of year	$	1,628		$	1,674
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of prior crop year loans from the portfolio)	(2,550		)	(1,826		)
Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop year loans)	1,854			1,834
Change in discount rate and estimated collection period	59			106
Currency remeasurement	186			(160		)
Balance at end of year	$	1,177		$	1,628

XML

Pension And Other Postretirement Benefit Plans (Tables)

12 Months Ended

Mar. 31, 2017

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Assumptions Used To Compute Net Periodic Benefit Cost And Benefit Obligations

Assumptions used for financial reporting purposes to compute net periodic benefit cost and benefit obligations for the Company's primary defined benefit plans were as follows:

	Pension Benefits						Other Postretirement Benefits
	2017		2016		2015		2017		2016		2015
Discount rates:
Benefit cost for plan year	4.10	%	3.80	%	4.50	%	3.80	%	3.70	%	4.30	%
Benefit obligation at end of plan year	4.10	%	4.10	%	3.80	%	3.90	%	3.80	%	3.70	%
Expected long-term return on plan assets:
Benefit cost for plan year	7.00	%	7.25	%	7.75	%	3.00	%	3.00	%	4.30	%
Salary scale:
Benefit cost for plan year	4.00	%	4.50	%	4.50	%	4.00	%	4.50	%	4.50	%
Benefit obligation at end of plan year	4.00	%	4.00	%	4.50	%	4.00	%	4.00	%	4.50	%
Healthcare cost trend rate	N/A		N/A		N/A		6.70	%	7.00	%	7.20	%

Benefit Obligations, Plan Assets, And Funded Status

The following table reflects the changes in benefit obligations and plan assets in 2017 and 2016, as well as the funded status of the plans at March 31, 2017 and 2016:

	Pension Benefits						Other Postretirement Benefits
	March 31,						March 31,
	2017			2016			2017			2016
Actuarial present value of benefit obligation:
Accumulated benefit obligation	$	266,764		$	273,479
Projected benefit obligation	269,250			275,505			$	36,786		$	37,225
Change in projected benefit obligation:
Projected benefit obligation, beginning of year	$	275,505		$	288,908		$	37,225		$	40,863
Service cost	5,382			5,953			247			286
Interest cost	10,441			10,037			1,535			1,539
Effect of discount rate change	489			(10,036		)	(191		)	(402		)
Foreign currency exchange rate changes	(1,111		)	330			286			(215		)
Settlements	(10,955		)	—			—			—
Other	4,108			(486		)	766			(1,104		)
Benefit payments	(14,609		)	(19,201		)	(3,082		)	(3,742		)
Projected benefit obligation, end of year	$	269,250		$	275,505		$	36,786		$	37,225
Change in plan assets:
Plan assets at fair value, beginning of year	$	217,859		$	224,553		$	1,565		$	2,115
Actual return on plan assets	16,450			61			71			69
Employer contributions	10,676			12,504			4,500			3,123
Settlements	(10,322		)	—			—			—
Foreign currency exchange rate changes	97			(58		)	—			—
Benefit payments	(14,609		)	(19,201		)	(3,082		)	(3,742		)
Plan assets at fair value, end of year	$	220,151		$	217,859		$	3,054		$	1,565
Funded status:
Funded status of the plans, end of year	$	(49,099	)	$	(57,646	)	$	(33,732	)	$	(35,660	)

Funded Status In Consolidated Balance Sheets

The funded status of the Company’s plans at the end of fiscal years 2017 and 2016 was reported in the consolidated balance sheets as follows:

	Pension Benefits						Other Postretirement Benefits
	March 31,						March 31,
	2017			2016			2017			2016
Non-current asset (included in other noncurrent assets)	$	1,710		$	2,044		$	—		$	—
Current liability (included in accounts payable and accrued expenses)	(1,106		)	(630		)	(2,746		)	(2,543		)
Non-current liability (reported as pensions and other postretirement benefits)	(49,703		)	(59,060		)	(30,986		)	(33,117		)
Amounts recognized in the consolidated balance sheets	$	(49,099	)	$	(57,646	)	$	(33,732	)	$	(35,660	)

Additional Information On Funded Status

Additional information on the funded status of the Company’s plans as of the respective measurement dates for the fiscal years ended March 31, 2017 and 2016, is as follows:

	Pension Benefits				Other Postretirement Benefits
	March 31,				March 31,
	2017		2016		2017		2016
For plans with a projected benefit obligation in excess of plan assets:
Aggregate projected benefit obligation (PBO)	$	260,826	$	270,058	$	36,786	$	37,225
Aggregate fair value of plan assets	210,017		210,368		3,054		1,565
For plans with an accumulated benefit obligation in excess of plan assets:
Aggregate accumulated benefit obligation (ABO)	258,424		268,087		N/A		N/A
Aggregate fair value of plan assets	210,017		210,368		N/A		N/A

Components Of Company's Net Periodic Benefit Cost

The components of the Company’s net periodic benefit cost were as follows:

	Pension Benefits									Other Postretirement Benefits
	Fiscal Year Ended March 31,									Fiscal Year Ended March 31,
	2017			2016			2015			2017			2016			2015
Components of net periodic benefit cost:
Service cost	$	5,382		$	5,953		$	5,099		$	247		$	286		$	347
Interest cost	10,441			10,037			11,215			1,535			1,539			1,699
Expected return on plan assets	(15,154		)	(15,110		)	(15,493		)	(42		)	(58		)	(102		)
Curtailment gain	—			—			—			—			—			(1,465		)
Settlement gain	(912		)	—			—			—			—			—
Net amortization and deferral	4,576			4,394			6,169			(394		)	(431		)	(671		)
Net periodic benefit cost	$	4,333		$	5,274		$	6,990		$	1,346		$	1,336		$	(192	)

Recognized In Accumulated Other Comprehensive Income (Loss) On Pretax Basis

The amounts recognized in other comprehensive income or loss for fiscal years 2017 and 2016 and the amounts included in accumulated other comprehensive loss at the end of those fiscal years are shown below. All amounts shown are before allocated income taxes.

	Pension Benefits						Other Postretirement Benefits
	March 31,						March 31,
	2017			2016			2017			2016
Change in net actuarial loss (gain):
Net actuarial loss (gain), beginning of year	$	79,299		$	81,544		$	(7,234	)	$	(6,402	)
Losses (gains) arising during the year	2,313			4,787			554			(1,263		)
Amortization included in net periodic benefit cost during the year	(7,567		)	(7,032		)	394			431
Net actuarial loss (gain), end of year	74,045			79,299			(6,286		)	(7,234		)
Change in prior service cost (benefit):
Prior service cost (benefit), beginning of year	(15,061		)	(17,630		)	(108		)	—
Prior service cost (benefit) arising during the year	—			111			(4		)	(108		)
Amortization included in net periodic benefit cost during the year	2,991			2,458			—			—
Prior service cost (benefit), end of year	(12,070		)	(15,061		)	(112		)	(108		)
Total amounts in accumulated other comprehensive loss at end of year, before income taxes	$	61,975		$	64,238		$	(6,398	)	$	(7,342	)

Weighted-Average Target Pension Asset Allocation And Target Ranges By Major Asset Category

The weighted–average target pension asset allocation and target ranges at the March 31, 2017 measurement date and the actual asset allocations at the March 31, 2017 and 2016 measurement dates by major asset category were as follows:

							Actual Allocation
	Target Allocation						March 31,
Major Asset Category			Range				2017		2016
Equity securities	26.0	%	16	%	-	36%	31.9	%	22.4	%
Fixed income securities (1)	69.0	%	59	%	-	79%	61.7	%	71.5	%
Alternative investments	5.0	%	0	%	-	10%	6.4	%	6.1	%
Total	100.0	%					100.0	%	100.0	%

Estimated Future Benefit Payments

Estimated future benefit payments to be made from the Company’s plans are as follows:

Fiscal Year	Pension Benefits		Other Postretirement Benefits
2018	$	15,031	$	3,142
2019	22,040		3,129
2020	20,162		3,015
2021	16,727		2,930
2022	17,019		2,797
2023 - 2027	88,929		12,554

Fair Values Of The Assets Under Fair Value Hierarchy

Fair values of the assets of the Company’s pension plans as of March 31, 2017 and 2016, classified based on how their values were determined under the fair value hierarchy are as follows:

	March 31, 2017
	Level 1		Level 2		Level 3		Total
Equity securities	$	65,637	$	—	$	—	$	65,637
Fixed income securities(1)	128,215		10,134		3,072		141,421
Alternative investments	—		—		13,094		13,094
Total investments	$	193,852	$	10,134	$	16,166	$	220,152

	March 31, 2016
	Level 1		Level 2		Level 3		Total
Equity securities	$	43,807	$	—	$	—	$	43,807
Fixed income securities(1)	141,218		7,491		13,382		162,091
Alternative investments	—		—		11,961		11,961
Total investments	$	185,025	$	7,491	$	25,343	$	217,859

XML

Common And Preferred Stock Common and Preferred Stock (Tables)

12 Months Ended

Mar. 31, 2017

Schedule of Repurchases of Shares [Abstract]

Schedule Of Repurchases Of Shares [Table Text Block]

Share repurchases under the programs for the fiscal years ended March 31, 2017, 2016, and 2015 were as follows:

	Fiscal Year Ended March 31,
	2017		2016		2015
Common Stock
Number of shares repurchased	—		—		719,993
Cost of shares repurchased (in thousands of dollars)	$	—	$	—	$	31,227
Weighted-average cost per share	$	—	$	—	$	43.37
Series B 6.75% Convertible Perpetual Preferred Stock
Number of shares repurchased	—		—		1,509
Cost of shares repurchased (in thousands of dollars)	$	—	$	—	$	1.497
Weighted-average cost per share	$	—	$	—	$	992.27

XML

Executive Stock Plans And Stock-Based Compensation (Tables)

12 Months Ended

Mar. 31, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary Of Stock Option And SAR Activity

The following tables summarize the Company’s stock option and SAR activity and related information for fiscal years 2015 through 2017:

	Shares		Weighted-Average Exercise Price
Fiscal Year Ended March 31, 2015:
Outstanding at beginning of year	257,340		$	54.83
Exercised	(63,539	)	38.50
Cancelled/expired	(24,200	)	62.66
Outstanding at end of year	169,601		59.82
Fiscal Year Ended March 31, 2016:
Exercised	(6,200	)	51.32
Cancelled/expired	(11,200	)	62.66
Outstanding at end of year	152,201		59.96
Fiscal Year Ended March 31, 2017:
Exercised	(135,334	)	61.72
Cancelled/expired	(16,867	)	45.82
Outstanding at end of year	—		$	—

As indicated in the table, with the exercise and/or expiration of all remaining SARs during fiscal year 2017, there were no SARs or stock options outstanding at March 31, 2017.

Intrinsic Value And Fair Value Of SARs

	Fiscal Year Ended March 31,
	2017		2016		2015
Total intrinsic value of stock options and SARs exercised	$	555	$	26	$	1,091
Total fair value of SARs vested	$	—	$	—	$	375

Intrinsic value in the above table is based on the difference between the market price of the underlying shares at the exercise date and the exercise price of the SARs or stock options.

Summary Of RSU, Restricted Stock, And PSA Activity

The following table summarizes the Company’s RSU, restricted stock, and PSA activity for fiscal years 2015 through 2017:

	RSUs				Restricted Stock				PSAs
	Shares		Weighted-Average Grant Date Fair Value		Shares		Weighted-Average Grant Date Fair Value		Shares		Weighted-Average Grant Date Fair Value
Fiscal Year Ended March 31, 2015:
Unvested at beginning of year	293,180		$	44.33	48,100		$	42.33	149,387		$	41.76
Granted	94,539		51.86		—		—		57,580		46.41
Vested	(123,322	)	42.02		—		—		(50,092	)	31.95
Forfeited	—		—		—		—		(3,400	)	53.56
Unvested at end of year	264,397		48.10		48,100		42.33		153,475		45.58
Fiscal Year Ended March 31, 2016:
Granted	80,932		51.62		—		—		86,212		45.06
Vested	(42,384	)	41.64		—		—		(85,387	)	38.14
Unvested at end of year	302,945		49.95		48,100		42.33		154,300		48.13
Fiscal Year Ended March 31, 2017:
Granted	74,776		55.27		—		—		58,805		49.17
Vested	(51,544	)	44.57		(17,900	)	42.26		(52,230	)	53.56
Forfeited	(539	)	55.63		—		—		(525	)	49.17
Unvested at end of year	325,638		$	52.01	30,200		$	42.37	160,350		$	46.86

Stock-Based Compensation Expense And Related Income Tax Benefit Recognized

For the fiscal years ended March 31, 2017, 2016, and 2015, total stock-based compensation expense and the related income tax benefit recognized were as follows:

	Fiscal Year Ended March 31,
	2017		2016		2015
Total stock-based compensation expense	$	6,475	$	5,206	$	6,230
Income tax benefit recorded on stock-based compensation expense	$	2,266	$	1,822	$	2,181

XML

Commitments And Other Matters (Tables)

12 Months Ended

Mar. 31, 2017

Commitments And Other Matters [Abstract]

Schedule Of Accounts Receivable By Reportable Operating Segment

At March 31, 2017 and 2016, net accounts receivable by reportable operating segment were as follows:

	March 31,
	2017		2016
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	111,520	$	85,985
Other Regions	294,799		303,932
Subtotal	406,319		389,917
Other Tobacco Operations	32,969		38,742
Consolidated accounts receivable, net	$	439,288	$	428,659

XML

Operating Segments (Tables)

12 Months Ended

Mar. 31, 2017

Segment Reporting [Abstract]

Operating Results For The Company's Reportable Segments

Reportable segment data as of, or for, the fiscal years ended March 31, 2017, 2016, and 2015, is as follows:

	Sales and Other Operating Revenues						Operating Income
	Fiscal Year Ended March 31,						Fiscal Year Ended March 31,
	2017		2016		2015		2017			2016			2015
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	416,438	$	361,827	$	305,028	$	35,151		$	31,147		$	31,060
Other Regions(1)	1,422,991		1,538,971		1,739,781		143,349			143,596			125,839
Subtotal	1,839,429		1,900,798		2,044,809		178,500			174,743			156,899
Other Tobacco Operations(2)	231,789		219,575		226,992		9,984			11,325			10,326
Segment total	2,071,218		2,120,373		2,271,801		188,484			186,068			167,225
Deduct: Equity in pretax earnings of unconsolidated affiliates (3)							(5,774		)	(5,422		)	(7,137		)
Restructuring and impairment costs(4)							(4,359		)	(2,389		)	(4,890		)
Add: Other income(5)							—			3,390			12,676
Consolidated total	$	2,071,218	$	2,120,373	$	2,271,801	$	178,351		$	181,647		$	167,874
	Segment Assets						Goodwill
	March 31,						March 31,
	2017		2016		2015		2017			2016			2015
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	357,406	$	364,003	$	281,449	$	—		$	—		$	—
Other Regions(1)	1,465,109		1,548,517		1,607,846		97,159			97,318			97,372
Subtotal	1,822,515		1,912,520		1,889,295		97,159			97,318			97,372
Other Tobacco Operations(2)	300,890		318,657		297,180		1,644			1,713			1,713
Segment and consolidated totals	$	2,123,405	$	2,231,177	$	2,186,475	$	98,803		$	99,031		$	99,085
	Depreciation and Amortization						Capital Expenditures
	Fiscal Year Ended March 31,						Fiscal Year Ended March 31,
	2017		2016		2015		2017			2016			2015
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	4,626	$	4,314	$	4,284	$	4,202		$	2,282		$	5,814
Other Regions(1)	26,106		29,187		28,827		21,619			25,122			39,303
Subtotal	30,732		33,501		33,111		25,821			27,404			45,117
Other Tobacco Operations (2)	5,238		4,143		4,213		9,809			19,749			13,268
Segment and consolidated totals	$	35,970	$	37,644	$	37,324	$	35,630		$	47,153		$	58,385

⁽¹⁾  Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

⁽²⁾  Includes Dark Air-Cured, Oriental, and Special Services, as well as intercompany eliminations. Sales and other operating revenues, goodwill, depreciation and amortization, and capital expenditures include limited amounts or no amounts for Oriental because the business is accounted for on the equity method and its financial results consist principally of equity in the pretax earnings of the unconsolidated affiliate. The investment in the unconsolidated affiliate is included in segment assets and was approximately $78.1 million, $81.8 million, and $74.9 million, at March 31, 2017, 2016, and 2015, respectively.

⁽³⁾  Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income.

⁽⁴⁾  Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income (see Note 2).

⁽⁵⁾  Other income in fiscal year 2016 represents a gain from remeasuring to fair value the Company's original 50% ownership in Procesadora Unitab, S.A., a tobacco processing joint venture in Guatemala, upon acquiring the 50% interest held by the Company's joint venture partner (See Note 13). Other income in fiscal year 2015 represents the reversal of a valuation allowance on IPI excise tax credits in Brazil (See Note 13).

Schedule Of Sales And Long-Lived Assets By Country

Geographic Data	Sales and Other Operating Revenues
	Fiscal Year Ended March 31,
	2017		2016		2015
Belgium	$	320,735	$	371,580	$	336,396
United States	320,731		275,147		290,950
Germany	123,649		155,180		170,338
China	137,855		135,032		174,872
Netherlands	91,266		121,767		113,297
Russia	84,784		109,559		126,652
All other countries	992,198		952,108		1,059,296
Consolidated total	$	2,071,218	$	2,120,373	$	2,271,801
	Long-Lived Assets
	March 31,
	2017		2016		2015
United States	$	85,145	$	84,072	$	70,929
Brazil	134,074		133,727		135,980
Mozambique	50,311		53,069		55,733
All other countries	146,698		154,090		141,893
Consolidated total	$	416,228	$	424,958	$	404,535

XML

Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income (Loss) (Tables)

12 Months Ended

Mar. 31, 2017

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The following table summarizes the changes in the balances for each component of accumulated other comprehensive income (loss) attributable to the Company for the fiscal years ended March 31, 2017, 2016, and 2015:

	Fiscal Year Ended March 31,
(in thousands of dollars)	2017			2016			2015
Foreign currency translation:
Balance at beginning of year	$	(26,992	)	$	(31,138	)	$	(8,476	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on foreign currency translation (net of tax (expense) benefit of $3,715, $(2,119), and $12,181)	(6,899		)	3,934			(22,625		)
Less: Net loss (gain) on foreign currency translation attributable to noncontrolling interests	753			212			(37		)
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(6,146		)	4,146			(22,662		)
Balance at end of year	$	(33,138	)	$	(26,992	)	$	(31,138	)
Foreign currency hedge:
Balance at beginning of year	$	675		$	(1,834	)	$	769
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $991, $(1,060), and $2,304)	(1,841		)	1,969			(4,280		)
Reclassification of net loss to earnings (net of tax benefit of $(489), $(291), and $(903))(1)	908			540			1,677
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(933		)	2,509			(2,603		)
Balance at end of year	$	(258	)	$	675		$	(1,834	)
Interest rate hedge:
Balance at beginning of year	$	(6,997	)	$	(1,982	)	$	(608	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $(3,150), $4,489, and $1,416)	5,849			(8,335		)	(2,628		)
Reclassification of net loss to earnings (net of tax benefit of $(1,370), $(1,788), and $(675))(2)	2,546			3,320			1,254
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	8,395			(5,015		)	(1,374		)
Balance at end of year	$	1,398		$	(6,997	)	$	(1,982	)
Pension and other postretirement benefit plans:
Balance at beginning of year	$	(39,036	)	$	(40,040	)	$	(26,017	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net losses arising during the year (net of tax benefit of $751, $1,035, and $9,719)(3)	(1,395		)	(1,921		)	(18,049		)
Amortization included in earnings (net of tax benefit of $(1,546), $(1,576), and $(2,163)) (4)	2,870			2,925			4,026
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	1,475			1,004			(14,023		)
Balance at end of year	$	(37,561	)	$	(39,036	)	$	(40,040	)
Total accumulated other comprehensive income (loss) at end of year	$	(69,559	)	$	(72,350	)	$	(74,994	)

⁽¹⁾Gain (loss) on foreign currency cash flow hedges related to forecast purchases of tobacco is reclassified from accumulated other comprehensive income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 8 for additional information.

⁽²⁾Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when the related interest payments are made on the debt or upon termination of the interest rate swap agreements prior to their scheduled maturity dates. See Note 8 for additional information.

⁽³⁾These items arise from the remeasurement of the assets and liabilities of the Company's defined benefit pension plans. Those remeasurements are made on an annual basis at the end of the fiscal year. See Note 10 for additional information.

⁽⁴⁾This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 10 for additional information.

XML

Unaudited Quarterly Financial Data (Tables)

12 Months Ended

Mar. 31, 2017

Quarterly Financial Information Disclosure [Abstract]

Unaudited Quarterly Financial Data

	First Quarter			Second Quarter		Third Quarter		Fourth Quarter
Fiscal Year Ended March 31, 2017
Operating Results:
Sales and other operating revenues	$	295,475		$	456,942	$	668,771	$	650,030
Gross profit	52,197			87,844		135,453		119,185
Net income (loss)	(7,504		)	26,498		57,062		36,450
Net income (loss) attributable to Universal Corporation	(5,476		)	25,264		53,647		32,869
Earnings (loss) available to Universal Corporation common shareholders after dividends on convertible perpetual preferred stock	(9,163		)	21,577		49,960		(41,484		)
Earnings (loss) per share attributable to Universal Corporation common shareholders:
Basic	(0.40		)	0.95		2.17		(1.64		)
Diluted	(0.40		)	0.90		1.92		(1.64		)
Cash Dividends Declared:
Per share of convertible perpetual preferred stock	16.88			16.87		16.88		—
Per share of common stock	0.53			0.53		0.54		0.54
Market Price Range of Common Stock:
High	57.75			61.69		64.20		83.35
Low	52.26			55.29		52.40		63.30
Fiscal Year Ended March 31, 2016
Operating Results:
Sales and other operating revenues	$	275,419		$	456,382	$	584,592	$	803,980
Gross profit	48,389			98,094		119,906		140,942
Net income (loss)	(6,125		)	25,064		46,615		52,594
Net income (loss) attributable to Universal Corporation	(5,947		)	22,465		44,534		47,964
Earnings (loss) available to Universal Corporation common shareholders after dividends on convertible perpetual preferred stock	(9,634		)	18,778		40,847		44,277
Earnings (loss) per share attributable to Universal Corporation common shareholders:
Basic	(0.43		)	0.83		1.80		1.95
Diluted	(0.43		)	0.81		1.60		1.72
Cash Dividends Declared:
Per share of convertible perpetual preferred stock	16.88			16.87		16.88		16.87
Per share of common stock	0.52			0.52		0.53		0.53
Market Price Range of Common Stock:
High	57.76			58.41		57.72		57.27
Low	46.80			46.98		49.70		51.49

XML

Nature Of Operations And Significant Accounting Policies (Narrative) (Details)		12 Months Ended
		Mar. 31, 2017 USD ($)	Mar. 31, 2016 USD ($)	Mar. 31, 2015 USD ($)
Nature Of Operations And Significant Accounting Policies [Line Items]
Number of countries in which entity operates		30
Dividends received on equity method investments	[1]	$ (5,078,000)	$ (3,422,000)	$ (5,228,000)
Advances to suppliers, current and non-current		134,000,000	134,000,000
Valuation allowance amount related to advances to suppliers		27,000,000	29,000,000
Provision (recoveries) for loss on uncollectible advances to suppliers		(900,000)	800,000	3,700,000
Advances to suppliers on which interest has been discontinued		11,000,000	11,000,000
Aggregate balance of recoverable value added tax credits		45,000,000	52,000,000
Valuation allowance on recoverable value added tax credits		13,000,000	19,000,000
Interest costs capitalized		0	0	0
Amount charged for goodwill impairment		0	0	0
Impairment of property, plant and equipment		2,300,000	0	0
Foreign currency remeasurement gain (loss)		9,300,000	22,500,000	28,800,000
Foreign currency transaction gain (loss)		$ 1,300,000	(8,000,000)	$ (17,700,000)
Percentage of revenue earned from processing tobacco owned by customers		5.00%
Zimbabwe [Member]
Nature Of Operations And Significant Accounting Policies [Line Items]
Investment in deconsolidated subsidiary		$ 0	0
Net foreign currency translation loss		$ 7,200,000
Minimum [Member] | Buildings [Member]
Nature Of Operations And Significant Accounting Policies [Line Items]
Estimated useful life		15 years
Minimum [Member] | Processing And Packing Machinery [Member]
Nature Of Operations And Significant Accounting Policies [Line Items]
Estimated useful life		3 years
Minimum [Member] | Transport Equipment [Member]
Nature Of Operations And Significant Accounting Policies [Line Items]
Estimated useful life		3 years
Minimum [Member] | Computer Equipment [Member]
Nature Of Operations And Significant Accounting Policies [Line Items]
Estimated useful life		3 years
Maximum [Member] | Buildings [Member]
Nature Of Operations And Significant Accounting Policies [Line Items]
Estimated useful life		40 years
Maximum [Member] | Processing And Packing Machinery [Member]
Nature Of Operations And Significant Accounting Policies [Line Items]
Estimated useful life		11 years
Maximum [Member] | Transport Equipment [Member]
Nature Of Operations And Significant Accounting Policies [Line Items]
Estimated useful life		10 years
Maximum [Member] | Computer Equipment [Member]
Nature Of Operations And Significant Accounting Policies [Line Items]
Estimated useful life		10 years
Accounting Standards Update 2015-03 [Member]
Nature Of Operations And Significant Accounting Policies [Line Items]
Unamortized Debt Issuance Expense			$ 1,600,000

[1] (1) In accordance with the applicable accounting guidance, dividends received from unconsolidated affiliates accounted for on the equity method that represent a return on capital (i.e., a return of earnings on a cumulative basis) are presented as operating cash flows in the consolidated statements of cash flows.

XML

Nature Of Operations And Significant Accounting Policies (Reconciliation Of Equity In Unconsolidated Affiliates) (Details) - USD ($) $ in Thousands		12 Months Ended
		Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Accounting Policies [Abstract]
Equity in pretax earnings reported in the consolidated statements of income	[1]	$ 5,774	$ 5,422	$ 7,137
Less: Equity in income taxes		(1,092)	(2,156)	(834)
Equity in net income		4,682	3,266	6,303
Less: Dividends received on investments	[2]	5,078	3,422	5,228
Equity in net income, net of dividends, reported in the consolidated statements of cash flows		$ (396)	$ (156)	$ 1,075

[1] Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income.

[2] (1) In accordance with the applicable accounting guidance, dividends received from unconsolidated affiliates accounted for on the equity method that represent a return on capital (i.e., a return of earnings on a cumulative basis) are presented as operating cash flows in the consolidated statements of cash flows.

XML

Restructuring Costs (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Sep. 30, 2016	Jun. 30, 2015	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring and impairment costs			$ 4,359	$ 2,389	$ 4,890
HUNGARY
Restructuring Cost and Reserve [Line Items]
Restructuring and impairment costs	$ 3,700		$ 4,400
ZAMBIA
Restructuring Cost and Reserve [Line Items]
Restructuring and impairment costs		$ 2,400
South America [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and impairment costs					$ 4,900

XML

Restructuring Costs (Cumulative Restructuring Costs) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 2,083	$ 1,725	$ 4,890
Restructuring and impairment costs	4,359	2,389	4,890
Employee Termination Benefits [Member]
Restructuring Cost and Reserve [Line Items]
Employee termination benefits	2,083	1,629	4,354
Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Other restructuring costs	0	96	536
Farmer loans and property and equipment	$ 2,276	$ 664	$ 0

XML

Restructuring Costs (Reconciliation Of Company's Liability For The Restructuring Costs) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2014
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 2,083	$ 1,725	$ 4,890
Payments	(2,020)	(2,338)	(6,182)
Balance	344	281	894	$ 2,186
Employee Termination Benefits [Member]
Restructuring Cost and Reserve [Line Items]
Employee termination benefits	2,083	1,629	4,354
Payments	(1,861)	(2,246)	(5,684)
Balance	301	79	696	2,026
Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Other restructuring costs	0	96	536
Payments	(159)	(92)	(498)
Balance	$ 43	$ 202	$ 198	$ 160

XML

Earnings Per Share Earnings Per Share (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Stock Repurchased And Retired During Period Value Retained Earnings			$ (74,353)	$ 0	$ (36)
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
Conversion of Stock, Shares Converted		111,072	(111,072)	0	0
Stock Repurchased and Retired During Period, Shares	107,418
Stock Repurchased And Retired During Period Value Retained Earnings	$ 74,400		$ 74,353		$ (36)
Common Stock [Member]
Conversion of Stock, Shares Issued		2,487,118

XML

Earnings Per Share (Computation Of Basic And Diluted Earnings (Loss) Per Share) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Numerator for basic earnings per share
Net income attributable to Universal Corporation	$ 32,869	$ 53,647	$ 25,264	$ (5,476)	$ 47,964	$ 44,534	$ 22,465	$ (5,947)	$ 106,304	$ 109,016	$ 114,608
Less: Dividends on convertible perpetual preferred stock									(11,061)	(14,748)	(14,824)
Less: Cost in excess of carrying value on conversion or repurchase of convertible perpetual preferred stock									74,353	0	36
Earnings available to Universal Corporation common shareholders	$ (41,484)	$ 49,960	$ 21,577	$ (9,163)	$ 44,277	$ 40,847	$ 18,778	$ (9,634)	$ 20,890	$ 94,268	$ 99,748
Denominator for basic earnings per share
Weighted average shares outstanding									23,433,860	22,683,290	23,035,920
Basic earnings per share	$ (1.64)	$ 2.17	$ 0.95	$ (0.40)	$ 1.95	$ 1.80	$ 0.83	$ (0.43)	$ 0.89	$ 4.16	$ 4.33
Numerator for diluted earnings per share
Earnings available to Universal Corporation common shareholders	$ (41,484)	$ 49,960	$ 21,577	$ (9,163)	$ 44,277	$ 40,847	$ 18,778	$ (9,634)	$ 20,890	$ 94,268	$ 99,748
Add: Dividends on convertible perpetual preferred stock (if conversion assumed)									0	(14,748)	(14,824)
Add: Cost in excess of carrying value on conversion or repurchase of convertible perpetual preferred stock									0	0	36
Earnings available to Universal Corporation common shareholders for calculation of diluted earnings per share									$ 20,890	$ 109,016	$ 114,608
Denominator for diluted earnings per share:
Weighted average shares outstanding									23,433,860	22,683,290	23,035,920
Effect of dilutive securities (if conversion or exercise assumed) Convertible perpetual preferred stock									0	4,853,268	4,843,309
Effect of dilutive securities (if conversion or exercise assumed) Employee share-based awards									336,228	288,933	342,035
Denominator for diluted earnings per share									23,770,088	27,825,491	28,221,264
Diluted earnings per share	$ (1.64)	$ 1.92	$ 0.90	$ (0.40)	$ 1.72	$ 1.60	$ 0.81	$ (0.43)	$ 0.88	$ 3.92	$ 4.06

XML

Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) (Details) shares in Thousands	12 Months Ended
	Mar. 31, 2017 $ / shares shares	Mar. 31, 2016 $ / shares shares	Mar. 31, 2015 $ / shares shares
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Abstract]
Potentially dilutive securities | shares	0	133,600	156,200
Weighted-average exercise price | $ / shares	0.00	62.66	61.83

XML

Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jun. 30, 2014	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Income Tax [Line Items]
Continuing operations		$ 56,732	$ 54,430	$ 38,006
Fines Imposed By European Commission	$ 53,000
Tax benefit arising from payment of a portion of the European Commission Fine by a subsidiary	5.00%	(0.00%)	(0.00%)	(5.00%)
Unrecognized tax benefits that would impact effective tax rate		$ 1,800
Liability where a significant change in unrecognized tax benefits is reasonably possible		$ 100
U.S. Federal [Member]
Income Tax [Line Items]
Open Tax Year		2014
Minimum [Member] | State And Foreign Jurisdictions [Member]
Income Tax [Line Items]
Open tax years		3 years
Maximum [Member] | State And Foreign Jurisdictions [Member]
Income Tax [Line Items]
Open tax years		6 years
Deltafina [Member]
Income Tax [Line Items]
Continuing operations	$ 8,000
Fines Imposed By European Commission	$ 30,000

XML

Income Taxes (Schedule Of Components of Income Tax Expense) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Income Tax Disclosure [Abstract]
United States, current	$ 3,422	$ 5,371	$ 4,126
State and local, current	147	1,116	657
Foreign, current	36,537	32,897	46,885
Total, current	40,106	39,384	51,668
United States, deferred	5,434	5,780	3,352
State and local, deferred	561	(445)	159
Foreign, deferred	10,631	9,711	(17,173)
Deferred income tax expense (benefit)	16,626	15,046	(13,662)
Total	$ 56,732	$ 54,430	$ 38,006

XML

Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)	3 Months Ended	12 Months Ended
	Jun. 30, 2014	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Statutory tax rate		35.00%	35.00%	35.00%
State income taxes, net of federal benefit		0.30%	0.30%	0.30%
Dividends received from deconsolidated operations		(2.30%)	(1.50%)	(1.30%)
Remeasurement effect		0.40%	(1.60%)	(4.90%)
Tax benefit arising from payment of a portion of the European Commission Fine by a subsidiary	5.00%	(0.00%)	(0.00%)	(5.00%)
Other, including changes in liabilities recorded for uncertain tax positions		0.10%	(0.70%)	(0.10%)
Effective income tax rate		33.50%	31.50%	24.00%

XML

Income Taxes (Schedule Of U.S. And Foreign Components Of Income Before Income Taxes And Other Items) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Income Tax Disclosure [Abstract]
United States	$ 31,468	$ 37,877	$ 27,181
Foreign	137,770	134,701	131,286
Total	$ 169,238	$ 172,578	$ 158,467

XML

Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Foreign withholding taxes	$ 44,702	$ 39,770
Undistributed earnings	24,629	19,553
Goodwill	30,851	30,851
All other	11,015	10,424
Total deferred tax liabilities	111,197	100,598
Employee benefit plans	38,804	43,362
Reserves and accruals	11,756	12,911
Deferred income	4,672	3,938
Currency translation losses of foreign subsidiaries	13,244	9,939
Local currency exchange losses of foreign subsidiaries	3,669	3,597
Foreign tax credit carryforward	2,799	4,664
All other	14,327	16,546
Total deferred tax assets	89,271	94,957
Valuation allowance	(636)	0
Net deferred tax assets	$ 88,635	$ 94,957

XML

Income Taxes (Schedule Of Combined Income Tax Expense (Benefit) Allocable To Continuing Operations, Other Comprehensive Income, And Adjustments To Shareholders' Equity) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Continuing operations	$ 56,732	$ 54,430	$ 38,006
Other comprehensive income	1,503	1,423	(21,900)
Direct adjustments to shareholders' equity	0	(805)	(932)
Total	$ 58,235	$ 55,048	$ 15,174

XML

Income Taxes (Reconciliation Of the Gross Liability For Uncertain Tax Positions) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Liability for uncertain tax positions, beginning of year	$ 2,407	$ 2,894	$ 3,809
Additions: Related to tax positions for the current year	94	98	272
Additions: Related to tax positions for prior years	0	0	0
Reductions: Due to lapses of statutes of limitations	(112)	(215)	(478)
Reductions: Related to tax positions for prior year	(3)	0	(143)
Reductions: Effect of currency rate movement	40	370	566
Liability for uncertain tax positions, end of year	$ 2,426	$ 2,407	$ 2,894

XML

Credit Facilities (Narrative) (Details) - USD ($) $ in Thousands	Dec. 30, 2014	Mar. 31, 2017	Mar. 31, 2016
Debt Instrument [Line Items]
Five-year revolving credit facility	$ 430,000
Additional borrowings under present credit agreement	$ 100,000
Number Of Years Of Bank Credit Agreement	5 years
Outstanding uncommitted lines of credit		$ 59,133	$ 66,179
Weighted average interest rates on short-term borrowings outstanding		3.10%	2.20%
Prime Rate Or One Month Libor [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1.00%
Federal funds rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.50%
Uncommitted lines of credit [Member]
Debt Instrument [Line Items]
Outstanding uncommitted lines of credit		$ 59,000	$ 66,000
Unused lines of Credit [Member]
Debt Instrument [Line Items]
Outstanding uncommitted lines of credit		$ 248,000
Five-year term [Member]
Debt Instrument [Line Items]
Term loan	$ 150,000
Number Of Years Of Bank Credit Agreement	5 years
Seven-year term [Member]
Debt Instrument [Line Items]
Term loan	$ 220,000
Number Of Years Of Bank Credit Agreement	7 years

XML

Long-Term Debt (Narrative) (Details) - USD ($) $ in Millions	Dec. 30, 2014	Mar. 31, 2017
Debt Instrument [Line Items]
Debt Instrument, Term	5 years
Repayments of Debt	$ 250
Reduction in revolving credit borrowings	$ 120
Five-year term [Member]
Debt Instrument [Line Items]
Debt Instrument, Term	5 years
Term loan	$ 150
Debt Instrument, Interest Rate, Effective Percentage		2.94%
Seven-year term [Member]
Debt Instrument [Line Items]
Debt Instrument, Term	7 years
Term loan	$ 220
Debt Instrument, Interest Rate, Effective Percentage		3.48%

XML

Long-Term Debt (Schedule Of Long-Term Debt) (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Mar. 31, 2016
Debt Instrument [Line Items]
Total outstanding	$ 370,000	$ 370,000
Less current portion	0	0
Unamortized debt issuance costs	(1,267)	(1,620)
Long-term debt	368,733	368,380
Senior bank term loans
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 370,000	$ 370,000

XML

Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Leases [Abstract]
Rent expense on operating leases	$ 15.3	$ 14.7	$ 15.8
Operating leases minimum payment in 2018	11.5
Operating leases minimum payment in 2019	8.5
Operating leases minimum payment in 2020	7.2
Operating leases minimum payment in 2021	5.8
Operating leases minimum payment in 2022	4.1
Operating leases minimum payment after 2022	$ 13.7

XML

Derivatives And Hedging Activities (Narrative) (Details) - USD ($) $ in Millions	Mar. 31, 2017	Mar. 31, 2015
Foreign Exchange Forward [Member]
Derivative [Line Items]
Derivative, Notional Amount	$ 33.0	$ 80.4
Cash Flow Hedges [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Derivative, Notional Amount	$ 370.0

XML

Derivatives And Hedging Activities Notional Amount of Forward Contracts (Details) - USD ($) $ in Millions	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Foreign Exchange Contract [Member]
Derivative [Line Items]
Derivative, Notional Amount	$ 94.7	$ 56.3	$ 128.5
Forward contracts related to tobacco purchase [Member] | Derivatives Designated As Hedges [Member]
Derivative [Line Items]
Derivative, Notional Amount	70.7	43.1	105.6
Forward contracts related to tobacco processing costs [Member] | Derivatives Not Designated As Hedges [Member]
Derivative [Line Items]
Derivative, Notional Amount	$ 24.0	$ 13.2	$ 22.9

XML

Derivatives And Hedging Activities (Effect Of Derivative Financial Instruments On The Consolidated Statements Of Income) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Derivatives Designated As Hedges [Member] | Cash Flow Hedges [Member] | Interest Rate Swap [Member] | Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recorded in accumulated other comprehensive loss	$ 8,999	$ (12,824)	$ (4,044)
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	(3,916)	(5,108)	(1,929)
Derivatives Designated As Hedges [Member] | Cash Flow Hedges [Member] | Interest Rate Swap [Member] | Selling, General And Administrative Expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in earnings from ineffective portion and early de-designation of cash flow hedges	0	0	0
Derivatives Designated As Hedges [Member] | Cash Flow Hedges [Member] | Forward Foreign Currency Exchange Contracts [Member] | Cost Of Goods Sold [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recorded in accumulated other comprehensive loss	454	1,774	1,410
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	945	993	3,099
Derivatives Designated As Hedges [Member] | Cash Flow Hedges [Member] | Forward Foreign Currency Exchange Contracts [Member] | Selling, General And Administrative Expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in earnings from ineffective portion and early de-designation of cash flow hedges	246	685	257
Derivatives Not Designated As Hedges [Member] | Forward Foreign Currency Exchange Contracts [Member] | Selling, General And Administrative Expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	$ (2,591)	$ 5,973	$ 13,178

XML

Derivatives And Hedging Activities (Effect Of Derivative Financial Instruments On The Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Mar. 31, 2016
Derivative [Line Items]
Derivatives in a Fair Value Asset Position Designated as Hedging Instruments	$ 2,205	$ 475
Derivatives in a Fair Value Liability Position Designated as Hedging Instruments	55	10,766
Derivatives in a Fair Value Asset Position Not Designated as Hedging Instruments	917	297
Derivatives in a Fair Value Liability Position Not Designated as Hedging Instruments	120	5
Forward Foreign Currency Exchange Contracts [Member] | Other Current Assets [Member]
Derivative [Line Items]
Derivatives in a Fair Value Asset Position Designated as Hedging Instruments	56	475
Derivatives in a Fair Value Asset Position Not Designated as Hedging Instruments	917	297
Forward Foreign Currency Exchange Contracts [Member] | Accounts Payable And Accrued Expenses [Member]
Derivative [Line Items]
Derivatives in a Fair Value Liability Position Designated as Hedging Instruments	55	0
Derivatives in a Fair Value Liability Position Not Designated as Hedging Instruments	120	5
Cash Flow Hedges [Member] | Interest Rate Swap Agreements [Member] | Other Non-Current Assets [Member]
Derivative [Line Items]
Derivatives in a Fair Value Asset Position Designated as Hedging Instruments	2,149	0
Cash Flow Hedges [Member] | Interest Rate Swap Agreements [Member] | Other Noncurrent Liabilities [Member]
Derivative [Line Items]
Derivatives in a Fair Value Liability Position Designated as Hedging Instruments	$ 0	$ 10,766

XML

Fair Value Measurements Fair Value Measurements (Narrative) (Details) - USD ($) $ in Millions	Mar. 31, 2017	Mar. 31, 2016
Fair Value Disclosures [Abstract]
Long-Term Debt, Fair Value	$ 370	$ 370

XML

Fair Value Measurements (Financial Assets And Liabilities Measured At Fair Value On Recurring Basis) (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Mar. 31, 2016
Assets:
Money market funds	$ 137,145	$ 116,618
Trading securities associated with deferred compensation plans	17,726	17,817
Interest rate swap agreements	2,149
Forward foreign currency exchange contracts	973	772
Total financial assets measured and reported at fair value	157,993	135,207
Liabilities:
Guarantees of bank loans to tobacco growers	1,177	1,628
Interest rate swap agreements		10,766
Forward foreign currency exchange contracts	175	5
Total financial liabilities measured and reported at fair value	1,352	12,399
Net Asset Value (NAV) [Member]
Assets:
Money market funds	137,145	116,618
Trading securities associated with deferred compensation plans	0	0
Interest rate swap agreements	0
Forward foreign currency exchange contracts	0	0
Total financial assets measured and reported at fair value	137,145	116,618
Liabilities:
Guarantees of bank loans to tobacco growers	0	0
Interest rate swap agreements		0
Forward foreign currency exchange contracts	0	0
Total financial liabilities measured and reported at fair value	0	0
Level 1 [Member]
Assets:
Money market funds	0	0
Trading securities associated with deferred compensation plans	17,726	17,817
Interest rate swap agreements	0
Forward foreign currency exchange contracts	0	0
Total financial assets measured and reported at fair value	17,726	17,817
Liabilities:
Guarantees of bank loans to tobacco growers	0	0
Interest rate swap agreements		0
Forward foreign currency exchange contracts	0	0
Total financial liabilities measured and reported at fair value	0	0
Level 2 [Member]
Assets:
Money market funds	0	0
Trading securities associated with deferred compensation plans	0	0
Interest rate swap agreements	2,149
Forward foreign currency exchange contracts	973	772
Total financial assets measured and reported at fair value	3,122	772
Liabilities:
Guarantees of bank loans to tobacco growers	0	0
Interest rate swap agreements		10,766
Forward foreign currency exchange contracts	175	5
Total financial liabilities measured and reported at fair value	175	10,771
Level 3 [Member]
Assets:
Money market funds	0	0
Trading securities associated with deferred compensation plans	0	0
Interest rate swap agreements	0
Forward foreign currency exchange contracts	0	0
Total financial assets measured and reported at fair value	0	0
Liabilities:
Guarantees of bank loans to tobacco growers	1,177	1,628
Interest rate swap agreements		0
Forward foreign currency exchange contracts	0	0
Total financial liabilities measured and reported at fair value	$ 1,177	$ 1,628

XML

Fair Value Measurements (Reconciliation Of Change In Balance Of Financial Liability For Guarantees Of Bank Loans To Tobacco Growers) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Fair Value Disclosures [Abstract]
Balance at beginning of year	$ 1,628	$ 1,674
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of prior crop year loans from portfolio)	(2,550)	(1,826)
Provision for loss or transfer from allowance for loss on direct loans to farmers (addition of current crop year loans)	1,854	1,834
Change in discount rate and estimated collection period	59	106
Currency remeasurement	186	(160)
Balance at end of period	$ 1,177	$ 1,628

XML

Pension And Other Postretirement Benefit Plans (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Defined Benefit Plan Disclosure [Line Items]
Revised healthcare cost trend assumption	6.70%
Ultimate healthcare cost trend rate	4.50%
Year that rate reaches healthcare cost trend rate	2037
Effect of one-percentage-point decrease on accumulated postretirement benefit obligation	$ 700
Effect of one-percentage-point increase on accumulated postretirement benefit obligation	800
Net actuarial loss expected in net periodic benefit cost during fiscal year 2014	5,200
Prior service benefit expected in net periodic benefit cost during fiscal year 2014	$ 2,400
Percentage of total plan assets	94.00%
Percentage of total projected benefit obligation	83.00%
Expected company contributions in 2014	$ 7,800
Pension and Other Postretirement Benefit Expense	2,600	$ 2,400	$ 1,500
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Funded status of the plans, end of year	$ 49,099	$ 57,646
Percentage of funded status of plans	71.00%
Other Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Revised healthcare cost trend assumption	6.70%	7.00%	7.20%
Funded status of the plans, end of year	$ 33,732	$ 35,660
Percentage of funded status of plans	85.00%
Non-ERISA regulated and Other Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected company contributions in 2014	$ 1,800
ERISA-regulated U.S. plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected company contributions in 2014	$ 6,000

XML

Pension And Other Postretirement Benefit Plans (Assumptions Used To Compute Net Periodic Benefit Cost And Benefit Obligations) (Details)	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Defined Benefit Plan Disclosure [Line Items]
Healthcare cost trend rate	6.70%
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rates: Benefit cost for plan year	4.10%	3.80%	4.50%
Discount rates: Benefit obligation at end of plan year	4.10%	4.10%	3.80%
Expected long-term return on plan assets: Benefit cost for plan year	7.00%	7.25%	7.75%
Salary scale: Benefit cost for plan year	4.00%	4.50%	4.50%
Salary scale: Benefit obligation at end of plan year	4.00%	4.00%	4.50%
Other Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rates: Benefit cost for plan year	3.80%	3.70%	4.30%
Discount rates: Benefit obligation at end of plan year	3.90%	3.80%	3.70%
Expected long-term return on plan assets: Benefit cost for plan year	3.00%	3.00%	4.30%
Salary scale: Benefit cost for plan year	4.00%	4.50%	4.50%
Salary scale: Benefit obligation at end of plan year	4.00%	4.00%	4.50%
Healthcare cost trend rate	6.70%	7.00%	7.20%

XML

Pension And Other Postretirement Benefit Plans (Benefit Obligations, Plan Assets, And Funded Status) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2017	Mar. 31, 2016
Defined Benefit Plan Disclosure [Line Items]
Plan assets at fair value, beginning of year	$ 217,859
Plan assets at fair value, end of year	220,152	$ 217,859
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligation				$ 266,764	$ 273,479
Projected benefit obligation	275,505	288,908	$ 288,908	269,250	275,505
Projected benefit obligation, beginning of year	275,505	288,908
Service cost	5,382	5,953	5,099
Interest cost	10,441	10,037	11,215
Effect of discount rate change	489	(10,036)
Foreign currency exchange rate changes	(1,111)	330
Settlements	10,955	0
Other	4,108	(486)
Benefit payments	(14,609)	(19,201)
Projected benefit obligation, end of year	269,250	275,505	288,908
Plan assets at fair value, beginning of year	217,859	224,553
Actual return on plan assets	16,450	61
Employer contributions	10,676	12,504
Settlements	10,322	0
Foreign currency exchange rate changes	97	(58)
Plan assets at fair value, end of year	220,151	217,859	224,553
Funded status of the plans, end of year	(49,099)	(57,646)
Other Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	37,225	40,863	40,863	$ 36,786	$ 37,225
Projected benefit obligation, beginning of year	37,225	40,863
Service cost	247	286	347
Interest cost	1,535	1,539	1,699
Effect of discount rate change	(191)	(402)
Foreign currency exchange rate changes	286	(215)
Settlements	0	0
Other	766	(1,104)
Benefit payments	(3,082)	(3,742)
Projected benefit obligation, end of year	36,786	37,225	40,863
Plan assets at fair value, beginning of year	1,565	2,115
Actual return on plan assets	71	69
Employer contributions	4,500	3,123
Settlements	0	0
Foreign currency exchange rate changes	0	0
Plan assets at fair value, end of year	3,054	1,565	$ 2,115
Funded status of the plans, end of year	$ (33,732)	$ (35,660)

XML

Pension And Other Postretirement Benefit Plans (Funded Status In Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Mar. 31, 2016
Defined Benefit Plan Disclosure [Line Items]
Non-current liability (reported as pensions and other postretirement benefits)	$ (80,689)	$ (92,177)
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Non-current asset (reported in other noncurrent assets)	1,710	2,044
Current liability (included in accounts payable and accrued expenses)	(1,106)	(630)
Non-current liability (reported as pensions and other postretirement benefits)	(49,703)	(59,060)
Amounts recognized in the consolidated balance sheets	(49,099)	(57,646)
Other Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Non-current asset (reported in other noncurrent assets)	0	0
Current liability (included in accounts payable and accrued expenses)	(2,746)	(2,543)
Non-current liability (reported as pensions and other postretirement benefits)	(30,986)	(33,117)
Amounts recognized in the consolidated balance sheets	$ (33,732)	$ (35,660)

XML

Pension And Other Postretirement Benefit Plans (Additional Information On Funded Status) (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Mar. 31, 2016
Pension Benefits [Member]
For Plans With A Projected Benefit Obligation In Excess Of Plan Assets:
Aggregate projected benefit obligation	$ 260,826	$ 270,058
Aggregate fair value of plan assets	210,017	210,368
For Plans With An Accumulated Benefit Obligation In Excess Of Plan Assets:
Aggregate accumulated benefit obligation	258,424	268,087
Aggregate fair value of plan assets	210,017	210,368
Other Postretirement Benefits [Member]
For Plans With A Projected Benefit Obligation In Excess Of Plan Assets:
Aggregate projected benefit obligation	36,786	37,225
Aggregate fair value of plan assets	$ 3,054	$ 1,565

XML

Pension And Other Postretirement Benefit Plans (Components Of Company's Net Periodic Benefit Cost) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 5,382	$ 5,953	$ 5,099
Interest cost	10,441	10,037	11,215
Expected return on plan assets	(15,154)	(15,110)	(15,493)
Curtailments	0	0	0
Settlement cost	(912)	0	0
Net amortization and deferral	4,576	4,394	6,169
Net periodic benefit cost	4,333	5,274	6,990
Other Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	247	286	347
Interest cost	1,535	1,539	1,699
Expected return on plan assets	(42)	(58)	(102)
Curtailments	0	0	(1,465)
Settlement cost	0	0	0
Net amortization and deferral	(394)	(431)	(671)
Net periodic benefit cost	$ 1,346	$ 1,336	$ (192)

XML

Pension And Other Postretirement Benefit Plans (Recognized In Accumulated Other Comprehensive Income (Loss) On Pretax Basis) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Net actuarial loss (gain), beginning of year	$ 79,299	$ 81,544
Losses (gains) arising during the year	2,313	4,787
Reclassification adjustments during the year	7,567	7,032
Net actuarial loss (gain), end of year	74,045	79,299
Prior service cost (benefit), beginning of year	(15,061)	(17,630)
Prior service cost (benefit) arising during the year	0	111
Reclassification adjustments during the year	2,991	2,458
Prior service cost (benefit), end of year	(12,070)	(15,061)
Total amounts in accumulated other comprehensive loss at end of year, before income taxes	61,975	64,238
Other Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Net actuarial loss (gain), beginning of year	(7,234)	(6,402)
Losses (gains) arising during the year	554	(1,263)
Reclassification adjustments during the year	(394)	(431)
Net actuarial loss (gain), end of year	(6,286)	(7,234)
Prior service cost (benefit), beginning of year	(108)	0
Prior service cost (benefit) arising during the year	(4)	(108)
Reclassification adjustments during the year	0	0
Prior service cost (benefit), end of year	(112)	(108)
Total amounts in accumulated other comprehensive loss at end of year, before income taxes	$ (6,398)	$ (7,342)

XML

Pension And Other Postretirement Benefit Plans (Weighted-Average Target Pension Asset Allocation And Target Ranges By Major Asset Category) (Details)	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Defined Benefit Plan Disclosure [Line Items]
Target Allocation	100.00%
Actual Allocation	100.00%	100.00%
Domestic Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation	26.00%
Target Allocation Range, Minimum	16.00%
Target Allocation Range, Maximum	36.00%
Actual Allocation	31.90%	22.40%
Fixed Income Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation	69.00%
Target Allocation Range, Minimum	59.00%
Target Allocation Range, Maximum	79.00%
Actual Allocation	61.70%	71.50%
Real Estate Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation	5.00%
Target Allocation Range, Minimum	0.00%
Target Allocation Range, Maximum	10.00%
Actual Allocation	6.40%	6.10%

XML

Pension And Other Postretirement Benefit Plans (Estimated Future Benefit Payments) (Details) $ in Thousands	Mar. 31, 2017 USD ($)
Pension Benefits [Member]
2018	$ 15,031
2019	22,040
2020	20,162
2021	16,727
2022	17,019
2023 - 2027	88,929
Other Postretirement Benefits [Member]
2018	3,142
2019	3,129
2020	3,015
2021	2,930
2022	2,797
2023 - 2027	$ 12,554

XML

Pension And Other Postretirement Benefit Plans (Fair Values Of Assets Under Fair Value Hierarchy) (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Mar. 31, 2016
Defined Benefit Plan Disclosure [Line Items]
Total investments	$ 220,152	$ 217,859
Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	65,637	43,807
Fixed Income Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	141,421	162,091
Alternative Investments [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	13,094	11,961
Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	193,852	185,025
Level 1 [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	65,637	43,807
Level 1 [Member] | Fixed Income Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	128,215	141,218
Level 1 [Member] | Alternative Investments [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	0	0
Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	10,134	7,491
Level 2 [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	0	0
Level 2 [Member] | Fixed Income Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	10,134	7,491
Level 2 [Member] | Alternative Investments [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	0	0
Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	16,166	25,343
Level 3 [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	0	0
Level 3 [Member] | Fixed Income Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	3,072	13,382
Level 3 [Member] | Alternative Investments [Member]
Defined Benefit Plan Disclosure [Line Items]
Total investments	$ 13,094	$ 11,961

XML

Common And Preferred Stock (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended	9 Months Ended	12 Months Ended
	Jan. 31, 2017	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2006
Class of Stock [Line Items]
Common stock, shares authorized		100,000,000		100,000,000
Common Stock, Shares, Outstanding		25,274,506		25,274,506
Preferred stock, shares authorized		5,000,000		5,000,000
Payments for Repurchase of Redeemable Convertible Preferred Stock	$ 178,400			$ 104,012
Dividends, Preferred Stock, Cash		$ 15,000		11,061	$ 14,748	$ 14,824
Stock Repurchase Program, Authorized Amount		100,000		100,000
Stock Repurchased And Retired During Period Value Retained Earnings				(74,353)	$ 0	$ (36)
Stock Repurchase Program, Remaining Authorized Repurchase Amount		$ 100,000		$ 100,000
Common Stock [Member]
Class of Stock [Line Items]
Common stock, shares authorized		100,000,000		100,000,000	100,000,000
Common Stock, Shares, Outstanding		25,274,506		25,274,506	22,717,735
Conversion of Stock, Shares Issued			2,487,118
Series A Junior Participating Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized		500,000		500,000	500,000
Preferred stock, shares issued		0		0	0
Preferred stock, shares outstanding		0		0	0
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized		220,000		220,000	220,000
Preferred stock, shares issued		0		0	218,490			220,000
Conversion of Stock, Shares Converted			111,072	(111,072)	0	0
Conversion of Stock, Amount Converted			$ 107,600
Stock Repurchased and Retired During Period, Shares		107,418
Preferred stock, shares outstanding		0		0	218,490	218,490	219,999
Stock Repurchased And Retired During Period Value Retained Earnings		$ 74,400		$ 74,353		$ (36)

XML

Common And Preferred Stock (Schedule Of Repurchases Of Shares) (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
Class of Stock [Line Items]
Number of shares repurchased	0	0	1,509
Stock Repurchased and Retired During Period, Cost Value	$ 0	$ 0	$ 1,497
Weighted-average cost per share	$ 0.00	$ 0	$ 992.27
Common Stock [Member]
Class of Stock [Line Items]
Number of shares repurchased	0	0	719,993
Cost of shares repurchased (in thousands of dollars)	$ 0	$ 0	$ 31,227
Weighted-average cost per share	$ 0.00	$ 0.00	$ 43.37

XML

Executive Stock Plans And Stock-Based Compensation (Narrative) (Details) $ in Millions	12 Months Ended
	Mar. 31, 2017 USD ($) shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense related to stock-based awards | $	$ 6.0
Unrecognized compensation expense related to stock-based awards, weighted-average period expected to recognized	1 year 1 month 5 days
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares common stock expected to issue under the Plans	2,000,000
Stock Appreciation Rights (SARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period following grant date, in years	10 years
Description of award vesting rights for SARs	vested in equal one-third tranches one, two, and three years after the grant date
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period, in years	5 years
Performance Share Awards Psas [Member
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period, in years	3 years
Performance Share Awards Psas [Member | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of award grant paid	0.00%
Performance Share Awards Psas [Member | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of award grant paid	150.00%
Outside Directors [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period, in years	3 years
Plans After Fiscal 2007 [Member] | Stock Appreciation Rights (SARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period following grant date, in years	10 years
Expiration period following grantee retirement, in years	3 years
2002 Executive Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares common stock expected to issue under the Plans	500,000
2007 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares common stock expected to issue under the Plans	1,350,000

XML

Executive Stock Plans And Stock-Based Compensation (Summary Of Stock Option And SAR Activity) (Details) - $ / shares shares in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Outstanding at beginning of year, Weighted-Average Exercise Price	$ 59.96	$ 59.82	$ 54.83
Outstanding at beginning of year, Shares	152,201	169,601	257,340
Exercised, Shares	(135,334)	(6,200)	(63,539)
Cancelled/expired, Shares	(16,867)	(11,200)	(24,200)
Outstanding at end of year, Shares	0	152,201	169,601
Exercised, Weighted-Average Exercise Price	$ 61.72	$ 51.32	$ 38.50
Cancelled/expired, Weighted-Average Exercise Price	45.82	62.66	62.66
Outstanding at end of year, Weighted-Average Exercise Price	$ 0	$ 59.96	$ 59.82

XML

Executive Stock Plans And Stock-Based Compensation (Intrinsic Value And Fair Value of SARs) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Total intrinsic value of stock options and SARs exercised	$ 555	$ 26	$ 1,091
Total fair value of SARs vested	$ 0	$ 0	$ 375

XML

Executive Stock Plans And Stock-Based Compensation (Summary Of RSU, Restricted Stock, And PSA Activity) (Details) - $ / shares shares in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2014
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Shares	74,776	80,932	94,539
Vested, Shares	(51,544)	(42,384)	(123,322)
Forfeited, Shares	(539)		0
Unvested at end of year, Shares	325,638	302,945	264,397	293,180
Granted, Weighted- Average Grant Date Fair Value	$ 55.27	$ 51.62	$ 51.86
Vested, Weighted- Average Grant Date Fair Value	44.57	41.64	42.02
Forfeited, Weighted- Average Grant Date Fair Value	55.63		0.00
Unvested at end of year, Weighted- Average Grant Date Fair Value	$ 52.01	$ 49.95	$ 48.10	$ 44.33
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Shares	0	0	0
Vested, Shares	(17,900)	0	0
Forfeited, Shares	0		0
Unvested at end of year, Shares	30,200	48,100	48,100	48,100
Granted, Weighted- Average Grant Date Fair Value	$ 0.00	$ 0.00	$ 0.00
Vested, Weighted- Average Grant Date Fair Value	42.26	0.00	0.00
Forfeited, Weighted- Average Grant Date Fair Value	0.00		0.00
Unvested at end of year, Weighted- Average Grant Date Fair Value	$ 42.37	$ 42.33	$ 42.33	$ 42.33
Performance Share Awards Psas [Member
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Shares	58,805	86,212	57,580
Vested, Shares	(52,230)	(85,387)	(50,092)
Forfeited, Shares	(525)		(3,400)
Unvested at end of year, Shares	160,350	154,300	153,475	149,387
Granted, Weighted- Average Grant Date Fair Value	$ 49.17	$ 45.06	$ 46.41
Vested, Weighted- Average Grant Date Fair Value	53.56	38.14	31.95
Forfeited, Weighted- Average Grant Date Fair Value	49.17		53.56
Unvested at end of year, Weighted- Average Grant Date Fair Value	$ 46.86	$ 48.13	$ 45.58	$ 41.76

XML

Executive Stock Plans And Stock-Based Compensation (Stock-Based Compensation Expense And Related Income Tax Benefit Recognized) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]
Total stock-based compensation expense	$ 6,475	$ 5,206	$ 6,230
Income tax benefit recorded on stock-based compensation expense	$ 2,266	$ 1,822	$ 2,181

XML

Commitments And Other Matters (Narrative) (Details)	12 Months Ended
	Mar. 31, 2017 USD ($)	Mar. 31, 2016 USD ($)	Mar. 31, 2015 USD ($)	Jun. 30, 2013 USD ($)
Commitments And Other Matters [Line Items]
Total amount of advances funded towards tobacco purchase	$ 104,000,000
Commitments relating to agricultural materials,capital expenditures	48,000,000
Face amount of guarantee including unpaid accrued interest	17,000,000	$ 13,000,000
Fair value of the guarantees	1,000,000	2,000,000
Other contingent liabilities	$ 2,000,000
Due period of accounts receivables	30
Allowance for doubtful accounts	$ 4,000,000	9,000,000
Total Amount of Brazilian IPI Federal Tax Credits Made Available by Court Decision				$ 104,000,000
Net book value on tax credits from excise tax case after valuation allowance			$ 12,700,000
Payments to Acquire Businesses, Net of Cash Acquired	0	5,964,000	0
Fair value gain upon acquisition of partner's interest in joint venture	0	3,390,000	0
Fair value of assets upon acquisition of partner's interest in joint venture		12,000,000
Philip Morris International, Inc [Member]
Commitments And Other Matters [Line Items]
Revenues from customers	590,000,000	640,000,000	580,000,000
British American Tobacco plc [Member]
Commitments And Other Matters [Line Items]
Revenues from customers	220,000,000	230,000,000	220,000,000
Imperial Tobacco Group, PLC [Member]
Commitments And Other Matters [Line Items]
Revenues from customers	230,000,000	$ 210,000,000	$ 280,000,000
Five largest customers revenue percentage [Member]
Commitments And Other Matters [Line Items]
Revenues from customers	0.65
Santa Catarina [Member]
Commitments And Other Matters [Line Items]
Brazil Audit Assessment For Tax, Penalties, And Interest On Recoverable Value Added Tax Credits	15,000,000
Reduction of Brazil Audit Assessment For Tax, Penalties, And Interest On Recoverable Value Added Tax Credits	15,000,000
Santa Catarina [Member] | Minimum [Member]
Commitments And Other Matters [Line Items]
Estimate of possible loss on remaining VAT audit assessment	0
Santa Catarina [Member] | Maximum [Member]
Commitments And Other Matters [Line Items]
Estimate of possible loss on remaining VAT audit assessment	15,000,000
Parana [Member]
Commitments And Other Matters [Line Items]
Brazil Audit Assessment For Tax, Penalties, And Interest On Recoverable Value Added Tax Credits	18,000,000
Reduction of Brazil Audit Assessment For Tax, Penalties, And Interest On Recoverable Value Added Tax Credits	6,000,000
Parana [Member] | Minimum [Member]
Commitments And Other Matters [Line Items]
Estimate of possible loss on remaining VAT audit assessment	0
Parana [Member] | Maximum [Member]
Commitments And Other Matters [Line Items]
Estimate of possible loss on remaining VAT audit assessment	6,000,000
Fiscal Year 2018 [Member]
Commitments And Other Matters [Line Items]
Tobacco purchase contracts	622,000,000
After Fiscal Year 2018 [Member]
Commitments And Other Matters [Line Items]
Tobacco purchase contracts	$ 68,000,000

XML

Commitments And Other Matters (Schedule Of Accounts Receivable By Reportable Operating Segment) (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Mar. 31, 2016
Segment Reporting Information [Line Items]
Consolidated accounts receivable	$ 439,288	$ 428,659
North America [Member]
Segment Reporting Information [Line Items]
Consolidated accounts receivable	111,520	85,985
Other Regions [Member]
Segment Reporting Information [Line Items]
Consolidated accounts receivable	294,799	303,932
Flue-Cured And Burley Leaf Tobacco Operations [Member]
Segment Reporting Information [Line Items]
Consolidated accounts receivable	406,319	389,917
Other Tobacco Operations [Member]
Segment Reporting Information [Line Items]
Consolidated accounts receivable	$ 32,969	$ 38,742

XML

Operating Segments (Narrative) (Details) - USD ($) $ in Millions	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Segment Reporting [Abstract]
Ownership percentage in affiliate	49.00%
Number of regional operating segments	5
Number of regions into a single reporting segment	4
Investment in unconsolidated affiliate	$ 78.1	$ 81.8	$ 74.9

XML

Operating Segments (Operating Results For The Company's Reportable Segments) (Details) - USD ($) $ in Thousands		12 Months Ended
		Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Segment Reporting Information [Line Items]
Sales and Other Operating Revenues		$ 2,071,218	$ 2,120,373	$ 2,271,801
Operating Income		178,351	181,647	167,874
Equity in pretax earnings of unconsolidated affiliates	[1]	(5,774)	(5,422)	(7,137)
Restructuring and impairment costs	[2]	(4,359)	(2,389)	(4,890)
Other income	[3]	0	3,390	12,676
Segment Assets		2,123,405	2,231,177	2,186,475
Goodwill		98,803	99,031	99,085
Depreciation and Amortization		35,970	37,644	37,324
Capital Expenditures		35,630	47,153	58,385
Operating Segments [Member]
Segment Reporting Information [Line Items]
Sales and Other Operating Revenues		2,071,218	2,120,373	2,271,801
Operating Income		188,484	186,068	167,225
Flue-Cured And Burley Leaf Tobacco Operations [Member]
Segment Reporting Information [Line Items]
Sales and Other Operating Revenues		1,839,429	1,900,798	2,044,809
Operating Income		178,500	174,743	156,899
Segment Assets		1,822,515	1,912,520	1,889,295
Goodwill		97,159	97,318	97,372
Depreciation and Amortization		30,732	33,501	33,111
Capital Expenditures		25,821	27,404	45,117
Flue-Cured And Burley Leaf Tobacco Operations [Member] | North America [Member]
Segment Reporting Information [Line Items]
Sales and Other Operating Revenues		416,438	361,827	305,028
Operating Income		35,151	31,147	31,060
Segment Assets		357,406	364,003	281,449
Goodwill		0	0	0
Depreciation and Amortization		4,626	4,314	4,284
Capital Expenditures		4,202	2,282	5,814
Flue-Cured And Burley Leaf Tobacco Operations [Member] | Other Regions [Member]
Segment Reporting Information [Line Items]
Sales and Other Operating Revenues	[4]	1,422,991	1,538,971	1,739,781
Operating Income	[4]	143,349	143,596	125,839
Segment Assets	[4]	1,465,109	1,548,517	1,607,846
Goodwill	[4]	97,159	97,318	97,372
Depreciation and Amortization	[4]	26,106	29,187	28,827
Capital Expenditures	[4]	21,619	25,122	39,303
Other Tobacco Operations [Member]
Segment Reporting Information [Line Items]
Sales and Other Operating Revenues	[5]	231,789	219,575	226,992
Operating Income	[5]	9,984	11,325	10,326
Segment Assets	[5]	300,890	318,657	297,180
Goodwill	[5]	1,644	1,713	1,713
Depreciation and Amortization	[5]	5,238	4,143	4,213
Capital Expenditures	[5]	$ 9,809	$ 19,749	$ 13,268

[1] Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income.

[2] Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income (see Note 2)

[3] Other income in fiscal year 2016 represents a gain from remeasuring to fair value the Company's original 50% ownership in Procesadora Unitab, S.A., a tobacco processing joint venture in Guatemala, upon acquiring the 50% interest held by the Company's joint venture partner (See Note 13). Other income in fiscal year 2015 represents the reversal of a valuation allowance on IPI excise tax credits in Brazil (See Note 13).

[4] Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

[5] Includes Dark Air-Cured, Oriental, and Special Services, as well as intercompany eliminations. Sales and other operating revenues, goodwill, depreciation and amortization, and capital expenditures include limited amounts or no amounts for Oriental because the business is accounted for on the equity method and its financial results consist principally of equity in the pretax earnings of the unconsolidated affiliate. The investment in the unconsolidated affiliate is included in segment assets and was approximately $78.1 million, $81.8 million, and $74.9 million, at March 31, 2017, 2016, and 2015, respectively.

XML

Operating Segments (Schedule Of Sales And Long-Lived Assets By Country) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Segment Reporting Information [Line Items]
Sales and other operating revenues	$ 2,071,218	$ 2,120,373	$ 2,271,801
Long-Lived Assets	416,228	424,958	404,535
United States [Member]
Segment Reporting Information [Line Items]
Sales and other operating revenues	320,731	275,147	290,950
Long-Lived Assets	85,145	84,072	70,929
Belgium [Member]
Segment Reporting Information [Line Items]
Sales and other operating revenues	320,735	371,580	336,396
Germany [Member]
Segment Reporting Information [Line Items]
Sales and other operating revenues	123,649	155,180	170,338
China [Member]
Segment Reporting Information [Line Items]
Sales and other operating revenues	137,855	135,032	174,872
NETHERLANDS
Segment Reporting Information [Line Items]
Sales and other operating revenues	91,266	121,767	113,297
Russia (Member)
Segment Reporting Information [Line Items]
Sales and other operating revenues	84,784	109,559	126,652
Brazil [Member]
Segment Reporting Information [Line Items]
Long-Lived Assets	134,074	133,727	135,980
Mozambique [Member]
Segment Reporting Information [Line Items]
Long-Lived Assets	50,311	53,069	55,733
All Other Countries [Member]
Segment Reporting Information [Line Items]
Sales and other operating revenues	992,198	952,108	1,059,296
Long-Lived Assets	$ 146,698	$ 154,090	$ 141,893

XML

Accumulated Other Comprehensive Income (Loss) (Narrative) (Details) - USD ($) $ in Thousands		12 Months Ended
		Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Foreign currency translation: [Abstract]
Net gain (loss) on foreign currency translation, net of income taxes		$ (6,899)	$ 3,934	$ (22,625)
Pension and other postretirement benefit plan: [Abstract]
Pension and other postretirement benefit plans, net of income taxes		1,475	1,004	(14,023)
Other Comprehensive Income (Loss), Tax [Abstract]
Total accumulated other comprehensive income (loss) at end of period		(69,559)	(72,350)	(74,994)
Forward Foreign Currency Exchange Contracts [Member]
Cash flow hedges: [Abstract]
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes		(933)	2,509	(2,603)
Interest Rate Swap [Member]
Cash flow hedges: [Abstract]
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes		8,395	(5,015)	(1,374)
Accumulated Translation Adjustment [Member]
Foreign currency translation: [Abstract]
Balance at beginning of year		(26,992)	(31,138)	(8,476)
Net gain (loss) on foreign currency translation, net of income taxes		(6,899)	3,934	(22,625)
Less: Net loss (gain) on foreign currency translation attributable to noncontrolling interests		753	212	(37)
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes		(6,146)	4,146	(22,662)
Balance at end of period		(33,138)	(26,992)	(31,138)
Other Comprehensive Income (Loss), Tax [Abstract]
Taxes on net gain (loss) on foreign currency translation		3,715	(2,119)	12,181
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Forward Foreign Currency Exchange Contracts [Member]
Cash flow hedges: [Abstract]
Balance at beginning of year		675	(1,834)	769
Net gain (loss) on derivative instruments, net of income taxes		(1,841)	1,969	(4,280)
Reclassifications to earnings, net of income taxes	[1]	908	540	1,677
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes		(933)	2,509	(2,603)
Balance at end of period		(258)	675	(1,834)
Other Comprehensive Income (Loss), Tax [Abstract]
Taxes on net gain (loss) on derivative instruments		991	(1,060)	2,304
Taxes on reclassifications to net income		(489)	(291)	(903)
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Interest Rate Swap [Member]
Cash flow hedges: [Abstract]
Balance at beginning of year		(6,997)	(1,982)	(608)
Net gain (loss) on derivative instruments, net of income taxes		5,849	(8,335)	(2,628)
Reclassifications to earnings, net of income taxes	[2]	2,546	3,320	1,254
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes		8,395	(5,015)	(1,374)
Balance at end of period		1,398	(6,997)	(1,982)
Other Comprehensive Income (Loss), Tax [Abstract]
Taxes on net gain (loss) on derivative instruments		(3,150)	4,489	1,416
Taxes on reclassifications to net income		(1,370)	(1,788)	(675)
Accumulated Defined Benefit Plans Adjustment [Member]
Pension and other postretirement benefit plan: [Abstract]
Balance at beginning of year		(39,036)	(40,040)	(26,017)
Gains arising during period, net of income taxes	[3]	(1,395)	(1,921)	(18,049)
Amortization included in earnings, net of income taxes	[4]	2,870	2,925	4,026
Pension and other postretirement benefit plans, net of income taxes		1,475	1,004	(14,023)
Balance at end of period		(37,561)	(39,036)	(40,040)
Other Comprehensive Income (Loss), Tax [Abstract]
Taxes on losses (gains) arising during the period		751	1,035	9,719
Taxes on amortization included in net income		$ (1,546)	$ (1,576)	$ (2,163)

[1] Gain (loss) on foreign currency cash flow hedges related to forecast purchases of tobacco is reclassified from accumulated other comprehensive income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 8 for additional information.

[2] )Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when the related interest payments are made on the debt or upon termination of the interest rate swap agreements prior to their scheduled maturity dates. See Note 8 for additional information.

[3] These items arise from the remeasurement of the assets and liabilities of the Company's defined benefit pension plans. Those remeasurements are made on an annual basis at the end of the fiscal year. See Note 10 for additional information.

[4] This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 10 for additional information.

XML

Unaudited Quarterly Financial Data (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended								12 Months Ended
		Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Unaudited Quarterly Financial Data [Line Items]
Continuing operations										$ 56,732	$ 54,430	$ 38,006
Fair value gain upon acquisition of partner's interest in joint venture										0	3,390	0
Restructuring and impairment costs										4,359	2,389	4,890
Stock Repurchased And Retired During Period Value Retained Earnings										(74,353)	0	(36)
Net income attributable to Universal Corporation		$ 32,869	$ 53,647	$ 25,264	$ (5,476)	$ 47,964	$ 44,534	$ 22,465	$ (5,947)	$ 106,304	$ 109,016	$ 114,608
Diluted earnings per share		$ (1.64)	$ 1.92	$ 0.90	$ (0.40)	$ 1.72	$ 1.60	$ 0.81	$ (0.43)	$ 0.88	$ 3.92	$ 4.06
Gain on settlement of excise tax case										$ 0	$ 0	$ 12,676
Other Operating Income	[1]									0	$ 3,390	12,676
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
Unaudited Quarterly Financial Data [Line Items]
Stock Repurchased And Retired During Period Value Retained Earnings		$ 74,400								74,353		$ (36)
Stock Repurchased and Retired During Period, Shares		107,418
Diluted earnings per share		$ (2.90)
HUNGARY
Unaudited Quarterly Financial Data [Line Items]
Restructuring and impairment costs				$ 3,700						$ 4,400
Net income attributable to Universal Corporation				$ (2,400)
Diluted earnings per share				$ (0.09)
ZAMBIA
Unaudited Quarterly Financial Data [Line Items]
Restructuring and impairment costs									$ 2,400
Net income attributable to Universal Corporation									$ (1,600)
Diluted earnings per share									$ (0.06)
GUATEMALA
Unaudited Quarterly Financial Data [Line Items]
Net income attributable to Universal Corporation							$ 2,200
Diluted earnings per share							$ 0.08
Other Operating Income							$ 3,390

[1] Other income in fiscal year 2016 represents a gain from remeasuring to fair value the Company's original 50% ownership in Procesadora Unitab, S.A., a tobacco processing joint venture in Guatemala, upon acquiring the 50% interest held by the Company's joint venture partner (See Note 13). Other income in fiscal year 2015 represents the reversal of a valuation allowance on IPI excise tax credits in Brazil (See Note 13).

XML

Unaudited Quarterly Financial Data (Unaudited Quarterly Financial Data) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Quarterly Financial Information Disclosure [Abstract]
Sales and other operating revenues	$ 650,030	$ 668,771	$ 456,942	$ 295,475	$ 803,980	$ 584,592	$ 456,382	$ 275,419
Gross profit	119,185	135,453	87,844	52,197	140,942	119,906	98,094	48,389
Net income	36,450	57,062	26,498	(7,504)	52,594	46,615	25,064	(6,125)	$ 112,506	$ 118,148	$ 120,461
Net income attributable to Universal Corporation	32,869	53,647	25,264	(5,476)	47,964	44,534	22,465	(5,947)	106,304	109,016	114,608
Earnings (loss) available to Universal Corporation common shareholders after dividends on convertible perpetual preferred stock	$ (41,484)	$ 49,960	$ 21,577	$ (9,163)	$ 44,277	$ 40,847	$ 18,778	$ (9,634)	$ 20,890	$ 94,268	$ 99,748
Basic	$ (1.64)	$ 2.17	$ 0.95	$ (0.40)	$ 1.95	$ 1.80	$ 0.83	$ (0.43)	$ 0.89	$ 4.16	$ 4.33
Diluted	(1.64)	1.92	0.90	(0.40)	1.72	1.60	0.81	(0.43)	0.88	3.92	4.06
Convertible perpetual preferred stock, cash dividends declared per share	0.00	16.88	16.87	16.88	16.87	16.88	16.87	16.88	50.63	67.50	67.50
Common stock, cash dividends declared per share	0.54	0.54	0.53	0.53	0.53	0.53	0.52	0.52	2.14	2.10	$ 2.06
Market price range of common stock, high	83.35	64.20	61.69	57.75	57.27	57.72	58.41	57.76	83.35	57.27
Market price range of common stock, low	$ 63.30	$ 52.40	$ 55.29	$ 52.26	$ 51.49	$ 49.70	$ 46.98	$ 46.80	$ 63.30	$ 51.49

XML

Schedule II - Valuation And Qualifying Accounts (Details) - USD ($)	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Allowance for doubtful accounts [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Period	$ 9,099	$ 5,482	$ 6,536
Net Additions (Reversals) Charged to Expense	(5,071)	6,970	1,341
Additions Charged to Other Accounts	0	0	0
Deductions	(81)	(3,353)	(2,395)
Balance at End of Period	3,947	9,099	5,482
Allowance for supplier accounts [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Period	28,865	34,673	46,078
Net Additions (Reversals) Charged to Expense	(857)	815	3,734
Additions Charged to Other Accounts	0	0	0
Deductions	(934)	(6,623)	(15,139)
Balance at End of Period	27,074	28,865	34,673
Allowance for recoverable taxes [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Period	18,752	23,218	29,504
Net Additions (Reversals) Charged to Expense	(3,392)	1,755	1,855
Additions Charged to Other Accounts	0	0	0
Deductions	(2,808)	(6,221)	(8,141)
Balance at End of Period	$ 12,552	$ 18,752	$ 23,218